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ABSTRACT 
Medium-ring lactones have become important targets for synthesis as they have been 
isolated in an increasing number of biologically active natural products. The studies 
towards two 8-membered ring lactone natural products, octalactins A 1 and B 2, will 
be described. 
HO 
7 	 15 
octalactin A I 
	
octalactin B 2 
The first section of this thesis examines the application of key methodology (anti 
aldol reaction, Homer Wadsworth Emmons olefination, intermolecular Evans-
Tishchenko coupling and Ring Closing Metathesis) towards the octalactins via the 
synthesis of a model lactone 3 (Chapter 2). 
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The second section (Chapter 3) discusses the extension of the aldol methodology 
from Chapter 2 towards the development of a novel chiral auxiliary 4 to mediate the 
anti aldol reaction. The generality of this new auxiliary in anti aldol reactions will 
also be discussed. 
The final part of this thesis describes the synthesis of the octalactins based on the 
application of the methodology developed from the model studies using the key 
functionalised fragments: aldehyde 5, 3-ketophosphonate ester 6 and aldehyde 7. 
PMBO 0 
	
OP 0 0 
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1.1 	MEDIUM-RING NATURAL PRODUCTS 
Medium-ring lactones (ring sizes 8 - 11) are important in organic synthesis, due to 
the increasing discovery of their presence in natural products that display biological 
activity.' A selection of natural products with the highlighted Medium-ring moiety is 
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Figure 1: A selection of natural products containing a Medium-ring moiety 
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Introduction 
The interesting novel lactone moiety and the overall complexity of these natural 
products, coupled with their biological properties, has resulted in many 
investigations into their synthesis. 
A complex limonoid triterpene, dregeanin 8, was isolated from the timber of the 
small West African tree, Trichilia dreagoreora2 (and from T heudelotti).3  
Schkuhripinnatolide A 9 belongs to a family of sesquiterpene lactones, which were 
found in the aerial part of Schkuhria pinnata,4 a plant that grows principally in the 
tropical areas of Central and South America. Although natural products 8 and 9 have 
no reported biological activity, they have interesting structures that have provided a 
synthetic challenge for a number of groups. 
The 9-membered lactone halicholactone 10, was isolated from a marine organism in 
1989.5,6  This fatty acid metabolite has been discovered in the sponge Halichondri 
okadai, found off the coast of Japan. It is an oxylipin has been shown to inhibit 
lipoxygenase. 
Lactone 11 (Figure 1) belongs to a family of similar oxecan-2-ones called the 
decarestrictines. Decarestrictine D 11 (also known as tuckolide)7 was identified 
during the fermentation of Penicillum simplicissimum and was first isolated in 
1992.89  This 10-membered lactone shows important inhibitory effects on cholesterol 
biosynthesis.10"' 
There are a limited number of known natural products containing an 11 -membered 
ring. The sex pheromone suspensolide 12 was isolated from the male Caribbean fruit 




1.2 	THE OCTALACTINS 
In 1991 Fenical and Clardy investigated the chemistry of micro-organisms of the 
marine-derived actinomycete Streptomyces sp. (Figure 2a).'3 This was collected 
from the gorgonian octacoral Pacflgoria sp. displayed in Figure 2b, found in the 
Sea of Cortez in the Gulf of Mexico. 
(a) 
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Figure 2: (a) Electron microscopy image of Streptomyces sp., (b) Gorgonian 
octacoral 
It was found that the ethyl acetate extraction of isolate PG-19 from the culture broth 
of Streptomyces sp. followed by chromatography, afforded the two metabolites 




Figure 3: Octalactin A 1 and octalactin B 2 
Introduction 
The two octalactins are interesting in that they both contain a highly oxygenated 
Medium-ring lactone moiety and are only differentiated from each other by a C( 10) - 
C(1 1) epoxide moiety. Octalactin A has been shown to have significant in vitro 
cytotoxicity towards HCT-116 human colon cancer tumour cell lines and B-16-F10 
murine melanoma. 13 Intriguingly octalactin B has no reported biological activity. 
This seems to suggest that the epoxide plays a key role in the biological activity of 
the octalactins. 
The octalactins are polyketide derived natural products and it is hypothesised that 
they are made naturally by a series of enzymes in the Polyketide Synthase (PKS) 
pathway, as shown in Figure 4. It can be seen that the PKS pathway involves a series 
of aldol condensations and functional group manipulations (reductions and 
dehydrations) resulting in the linear polyketide. Then a thioesterase (TE) is used and 
the C(7) hydroxyl is activated to react with the terminal thioester to both release the 
polyketide from the PKS, and to allow cyclisation to occur to form octalactin B. A 
modification after release from the enzyme active site (selective epoxidation) would 
afford octalactin A. A synthetic strategy towards the octalactins could be designed on 
this pathway. 
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Figure 4: Proposed PKS pathway for the synthesis of the octalactins 
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1.3 	PREVIOUS SYNTHESES 
The presence of a novel 8-membered lactone makes octalactin A an interesting target 
for synthetic organic chemists. There have been a variety of synthetic approaches 
(Figure 5) towards the octalactins which involve the synthesis of lactone ring 13 via 
either: a ring closing metathesis (RCM); 
14 an intramolecular Reformatsky reaction; 15 
a Baeyer-Villiger oxidation; 
16 a Claisen rearrangement; 17 and the most common 
route, a hydroxyacid macrolactonisation. 
18-22 These routes towards the key fragment 
















Figure 5: Synthetic approaches to lactone 13 
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1.3.1. 	Hydroxyacid Lactonisation 
The first total synthesis of octalactin A (Scheme 1) was achieved by Buszek et al. in 
1994.18 This strategy relied upon the intramolecular lactonisation of an unsaturated 
carboxylic acid 18 to form oxocene 17. Upon hydrogenation of unsaturated lactone 
17 it was envisaged that aldehyde 16 could then undergo an organometallic addition 
with a derivative of vinyl iodide 15 at C(9) to introduce the C(1 O) - C(15) 
component of octalactin. The same reaction would result in the formation of a 
hydroxyl moiety and allow for a directed epoxidation onto the C(1 O) - C(11) alkene. 
Subsequent functional group manipulations would allow the formation of octalactin 
FA 
0 
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7 	 15 
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Scheme 1: Buszek's I st synthesis of octalactin A' 8 
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However, after the successful formation of oxocene 17 via lactonisation it was found 
that the C(5) - C(6) alkene could not be saturated even after attempts with numerous 
hydrogenation procedures.18  Therefore they decided to synthesise lactone 16 from 
the saturated hydroxyacid 19. Successful lactonisation of hydroxyacid 19 allowed for 
the efficient synthesis of lactone 16. Organometallic addition of vinyl iodide 15 to 
the lactone 16 afforded advanced intermediate 14. Subsequent functional group 
manipulations allowed for the first synthesis and full characterisation of the 
octalactins. 
Interestingly, studies towards the lactonisation of simple hydroxyacid 20 have shown 
that it was impossible (Scheme 2) under a variety of lactonisation conditions. 
2' The 
efficient lactonisation of hydroxyacid 21 suggests that the substituents on the 
hydroxyacid influence the conformation required for cyclisation. It has been 
proposed by Andrus et al 
.24  that the cyclisation proceeds via a chair-boat 
conformation 23 which places the methyl and 3-butenyl groups in pseudo-equatorial 
positions upon cyclisation to form lactone 24, as shown in Scheme 2. 
1 R1 OH 
20 R1; R2; R3 = H 










22 R1; R2; R3 = H 
0 
R1. (3i5 
R2" 	7 R3  
23 
	
24 R1  = OTBS; R2 = OH3  
R3 = 
Scheme 2: Lactonisation of hydroxyacids 
Reagents and Conditions: (a) EDCI, DMAP, DMAPHC1, CHCI3, 65 °C (22 = 0 %, 24 = 78 
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Buszek et al.23  have examined lactonisation of hydroxyacids with different 
substituents (Scheme 3) at C(3) - C(7), and have deduced that a single substituent at 
the C(3) is more beneficial to lactonisation than one at C(7). 




25 R1  = CH3; R2 = H 






27 R1  = CH3; R2 = H 
28 R1  = H; R2 = CH20PMB 
Scheme 3: Lactonisation of hydroxyacids 25 and 26 
Reagents and Conditions: (a) (i) 2,2'-dipyridyl sulfide, PPh3, CH2C12, RT; (ii) AgBF4, PhMe, 110 00 
48 h (27 = 18%, 28 = 34%). 
Since the initial synthesis of the octalactins there have been a variety of different 
routes to form hydroxyacid 19.1821 The preceeding lactonisation of hydroxyacid 19 
has been achieved using the Corey-Nicolaou double activation procedure, 
25  as shown 
in Scheme 4. The method involves a proton transfer from the hydroxyl group onto 
the pyridine nitrogen atom to form intermediate 30. With a nucleophilic alkoxide and 
an activated carbonyl group, intermediate 30 could participate in a facile, 
electrostatically driven, cyclisation via intermediate 31 to form lactone 34. 
















Scheme 4: Corey-Nicolaou double activation lactonisation 
Although this technique is generally a very reliable method of lactonisation, Shiina et 
al. have reported problems with the formation of lactone 35 using the Corey- 
8 
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Nicolaou protocol.22  They have stated that high temperatures, silver additives and 
long reaction times (> 96 h) are required to obtain the optimum yield of only 63 %. 
Shiina et al. have reported (Scheme 5) an improved lactonisation procedure for the 
synthesis of octalactin A intermediate 35 using milder conditions. They found that 
treatment of hydroxyacid 33 with anhydride 34 at room temperature produced 
lactone 35 in good yield (90 %)2226 
o OBn 	OH OTBDPS 




Scheme 5: Shiina 's lactonisation of hydroxyacid 33 
Reagents and Conditions: (a) 34, DMAPO (10 rnol%), Et3N, CH2Cl2, RI (90 %). 
Although hydroxyacid lactonisation has been a popular strategy towards intermediate 
13, there have been other interesting approaches to the formation of the 8-membered 
lactone. 
1.3.2. 	Baeyer-Villiger Oxidation 
In 1994 McWilliams and Clardy proposed a synthesis to determine the absolute 
configuration of octalactin A.'6 Their strategy involved the synthesis of lactone 36 
via a Baeyer-Villiger oxidation of heptanone 37. This fragment was synthesised via 
another Baeyer-Villiger oxidation of ketone 39, derived from commercially available 
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Scheme 6: Clardy 's synthesis of octalactins 
Due to the ambiguity of the absolute stereochemistry of the octalactins when Clardy 
et al. proposed their synthesis, it was found upon completion that they had 
synthesised the antipodes of the octalactins, ent-1 and ent-2. Nevertheless, they had 
demonstrated an efficient method towards the key fragment 36. 
1.3.3. 	Reformatsky Cyclisation 
Inoue et al. proposed a method of synthesising octalactin A in 1998 via an 
intramolecular Sm12  promoted Reformatsky reaction of o-(bromoacetoxy)aldehyde 
41, as shown in Scheme 715 
10 
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O Q OBn 
41 
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a HO 'OOBfl 
42 
Scheme 7: Reformatsky approach towards lactone 42 
Reagents and Conditions: (a) Sm12, THF, 0 °C (63 %); (b) (i) Dess-Martin periodinane, CH2C12, (ii) 
NaBH4, MeOH, -23 °C (92 %). 
The Sm12  promoted cyclisation of aldehyde 41, carried out according to Inanga's 
protocol, resulted in the formation of the hydroxylactone as a 2:1 epimeric mixture of 
lactones 42 and 43. The epimer was converted to the required alcohol via oxidation 
and subsequent reduction. Although this is a novel method of cyclisation to form the 
lactone 43, the mixture of epimers at C(3) upon cyclisation makes this a less 
attractive route towards the octalactins. 
1.3.4. 	Ring Closing Metathesis 
Although Buszek et al. synthesised octalactin A via the novel lactonisation of 
saturated hydroxyacid 19, they desired a more practical route to lactone 16.14  They 
decided to revise their original synthetic strategy and incorporate ring closing 
metathesis (RCM) into the construction of the 8-membered lactone ring. It was 
thought that stereochemical constraints favoured reactive diene formation which in 
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Scheme 8: Synthesis of oxocene 19 via RCM44  
Reagents and Conditions: (a) DCC, DMAP, CH2Cl2, RT, 4 h (94 %); (b) Grubbs 1, CH2C12, 40 °C, 24 
h (86 %). 
The RCM precursor was synthesised by a DCC coupling of the respective C(1) - 
C(5) carboxylic acid 44 and the C(6) - C(9) alcohol 45. Treatment of diene 46 with 
Grubbs 1st generation catalyst under reflux for 24 h afforded oxocene 17 in a good 
yield (86 %). Interestingly, when the alkyl chain was extended on lactone 17 to give 
the advanced intermediate 47, the reduction of the C(5) - C(6) alkene was found to 
proceed smoothly using H2  and Pearlman's catalyst, which was unsuccessful with 
oxocene 17.18 
Although the cyclisation of diene 46 gave the oxocene 17 in high yield, the 
fragments (44 and 45) required to synthesise the RCM precursor 46 are produced in a 
poor yield due to the formation of a 1:1 mixture of diastereomers in the initial 
synthetic steps, as shown in Scheme 9. 
12 
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Scheme 9: Synthesis of C(1)-C(5) and C(6)-C(9) segments 
14 
Reagents and Conditions: (a) TBDPSCI, imidazole, CH2Cl2, RT; (b) DIBALH, Et20, -78 °C (87 % 
over 2 steps); (c) Dess-Martin periodinane, CH2Cl2, RT; (d) (CH2=CH)MgBr, THF, -78 °C -> RI (92 
% over 2 steps). 
The formation of the undesired diastereomers 50 and 52 allowed conformational 






Epimer 53 54 55 
Reaction Time /h 168 24 24 
Yield 1% 20 84 90 
Table 1: Synthesis of octalactin epimers via RCM14 
It was thought that the stereocentres in diene 46 restricted the bond angles in such a 
way that they lead to a conformation which favours RCM. The conformational effect 
13 
uction 
of the quaternary centres in controlling torsional angles for example, have been 
reported. 14  Consistent with this view is the observation that the other epimers of 
octalactin undergo RCM with difficulty. It was found that lactone 53 (derived from 
45 and 50) gave only a low yield under similar ring closing conditions, whereas 
lactones 54 (derived from 52 and 44) and 55 (derived from 52 and 50) formed readily 
via RCM (Table 1).' 
1.3.5. 	Claisen Rearrangement 
Since Buszek's synthesis of lactone 18, there have been a variety of routes to the 
octalactins. Holmes et al. have utilized the Claisen rearrangement (Scheme 10) of 
ketene acetal 56 (9 steps from either tetraethoxymethylpropane or 3-
ethoxymethacrolein) to give the key intermediate, oxocene 58 in moderate yield (40 
%, 2 steps). 17 Selective hydrogenation of the C(4) - C(5) alkene allowed the 
formation of lactone, which could then undergo the organometallic addition, as 
reported by Buszek et al. 
18 
SePh 
OO OTBS Claisen 
	
OAc 
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9 
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56 	 57 	 58 
Scheme 10: Holmes "Claisen" strategy to octalactin A' 7 
Most of the synthetic strategies throughout the past 12 years have relied upon the 
synthesis of lactone fragment 13. However, all of these routes suffer from the 
significant problem of a non-selective addition to the aldehyde at C(8) leading to an 




po', 	 OH 	9P epoxidation 
	
OP 	 9 	 15 
0 
PO,,. O 	 60 
59 
"S. 	 H or taIIi1 
addition 	 o 
13 	
LPOS. H P 
9 	 15 
61 
Scheme 11: The problem of epimerisation after organometallic addition 
The original approach taken within the Hulme group was not focussed on the 
synthesis of oxocene 13. This new strategy involved the analysis of the proposed 
enzymatic route with the aim of forming the fully functionalised backbone prior to 
cyclisation. 
1.3.6. 	Intramolecular Evans-Tishchenko Cyclisation 
It is important to note that the simple hydroxyl selection and activation which 
facilitates release from the PKS, as discussed in section 1.2, is straightforward in an 
enzymatic environment, but to synthetically activate and target the same hydroxyl 
would require a careful protection strategy in order to proceed via a similar route. 
The first proposed synthetic route to octalactin A within the Hulme group involved 
the use of an intramolecular Evans-Tishchenko reaction 
27  to cyclise seco-aldehyde 
62, as shown in Scheme 12. This methodology was based on the Evans-Tishchenko 
coupling of aldehydes and 3-hydroxy ketones, which have been shown to form their 
respective anti diol monoesters in good yield with high anti selectivity. 
28 Therefore it 
is proposed that when the C(l) aldehyde moiety of 62 undergoes an Evans- 
15 
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Tishchenko cyclisation with the 3-hydroxy enone, not only would lactonisation occur 
but the C(9) carbonyl would be selectively reduced to give the (R)-hydroxyl. With 
the desired hydroxyl stereochemistry, a stereoselective directed epoxidation of the 
C(10) - C(1 1) alkene could occur. The incorporation of a potentially high yielding 
lactonisation and the selective formation of the (R)-hydroxyl made this a more 
advantageous synthetic strategy to octalactin A than had been previously reported. 
HO 
15 
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62 
Scheme 12: First "intramolecular Evans- Tishchenko " strategy towards octalactin A 
within the Hulme group 29 
The initial model studies within the group (Scheme 13) had shown that treatment of 
simple seco-aldehyde 63 with preformed Sm(III) catalyst gave lactone 65 in a 30 % 
yield with an inseparable 3:1 mixture of diastereomers at C(8). Oxidation of the C(9) 
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Scheme 13: Model intramolecular Evans- Tishchenko cyclisation 
Reagents and Conditions: (a) PhCHO/Sm12  (premixed, 0.1 M in THF, 30 mol%), THF, 0 °C, 3 h (30 
%); (b) IBX, THF/DMSO, RT (82 %). 
These model studies demonstrated that cyclisation to form the 8-membered lactone 
with formation of the (R)-hydroxyl could occur, albeit in low yield and as a mixture 
of epimers at C(8). It was believed that a more functionalised seco-aldehyde would 
experience the Thorpe Ingold effect 30  and improve the lactonisation yield and 
increase the rate of the ring forming step. The intramolecular Evans-Tishchenko 
cyclisation of seco-aldehyde 63 proceeds over a longer reaction time (3 h) than an 
intermolecular Evans-Tishchenko coupling (30 mm) which is believed to be 
responsible for epimerisation at C(8). If the rate of lactonisation was increased then 
the reaction time could be lowered and this could ultimately reduce epimerisation. 
However treatment of the functionalised seco-aldehyde 68 with the Evans-
Tishchenko conditions (Scheme 14) used for the synthesis of the model lactone gave 
17 
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an inseparable mixture of unidentifiable products 
.
29 Further investigations towards 
the synthesis of octalactin A via an intramolecular Evans-Tishchenko cyclisation 
were not pursued due to a limited supply of material. 





Scheme 14: Model intramolecular Evans- Tishchenko cyclisation 
Reagents and Conditions: (a) PhCHO/Sm12  (premixed, 0.1 M in THF, 30 mol%), THF, 0'C, 3 h. 
1.4. 	RETROSYNTHETIC ANALYSIS OF OCTALACTIN A 
The octalactin A synthesis shown in Scheme 12 was not as efficient as predicted, as 
shown by poor cyclisation yields and the new problem of epimerisation at C(8) 
causing a loss of stereochemical integrity. However, the incorporation of the Evans-
Tishchenko reaction in the synthesis of octalactin A was still of interest within our 
group as the selective reduction of the enone moiety to allow a directed epoxidation 
was still considered a useful and key chemical transformation. An alternative 
strategy towards the synthesis of octalactin A was devised. The revised retrosynthetic 
approach taken in this project would involve an intermolecular Evans-Tishchenko 
reaction, also reported to give high yields and high anti selectivity, 
27 and thus 
avoiding epimerisation issues at C(8) found in the first generation synthesis. The 
other key reaction in our synthesis of octalactin A is the closing of the Evans-
Tishchenko ester, which will be carried out using ring closing metathesis. The new 
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Scheme 15: Second generation retrosynthetic analysis of octalactin A 
The intermolecular Evans-Tishchenko step in the strategy shown in Scheme 15 
shows the coupling of f-hydroxy enone 72 (generated from a Homer Wadsworth 
Emmons (HWE) coupling of 0-ketophosphonate ester 6 and aldehyde 7) and 
aldehyde 5 to give anti diol monoester 71. The two terminal alkenes now participate 
in the ring closing metathesis step in order to form the unsaturated 8-membered 
lactone 70. With the hydroxyl in the desired (R)-configuration, a Sharpless 
epoxidation followed by oxidation would install both the C(l0) - C(1 1) epoxide and 
the C(9) ketone. Saturation of oxocene 70 via hydrogenation will afford the fully 
saturated 8-membered lactone that is distinctive in octalactin A. 
19 
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The key intermediates of the revised octalactin A synthetic plan are aldehyde 5 and 
-hydroxy enone 72. The Evans-Tishchenko/ring closing metathesis reactions shown 
in Scheme 15 will be discussed in this chapter and applied in the synthesis of an 
octalactin model (Chapter 2) and towards the total synthesis of octalactin A (Chapter 
3). The key synthetic steps in the synthesis of 3-ketophosphonate ester 6 and 3-
hydroxy enone 72 will be introduced in this chapter and the synthesis of 3-keto 
phosphonate ester 6 will be discussed in detail in Chapter 2. The key synthetic steps 
towards aldehydes 5 and 7 incorporate both Brown's allyl and crotylborations which 




There are a variety of efficient methods for the formation of racemic allylic alcohols 
by nucleophilic addition of an allyl moiety to an aldehyde. However, the allylation of 
an aldehyde to give an allylic alcohol with high enantioselectivity is much less 
refined than the corresponding racemic reaction. The preparation of non-racemic 
homoallylic alcohols through the asymmetric allylboration of aldehydes represents 
an extremely important process that has undergone continuous evolution since its 
discovery by Hoffmann over 25 years ago. 3 ' Brown et al. have investigated the use 
of naturally occurring terpenes in the synthesis of allylboranes (73 - 74) , as shown 








Figure 6: Brown allylation reagents 
The original synthesis of these allylation reagents consisted of the addition of 
allylmagnesium bromide to the methoxy diisopinocampheylborane 77. This method 








Scheme 16: Formation of allyldiisopinocampheylborane 73 
Reagents and Conditions: (a) allylmagnesium bromide, Et20, 0 °C - RT, 1 h (99 
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Brown has reported the addition of a range of aliphatic and aromatic aldehydes to 3-
(-)-allyldiisopinocampheylborane 73 at low temperatures (-78 °C) in the presence of 
magnesium salts. The respective allylic alcohols 78 (Table 2) were produced in good 
yield and enantio selectivity (87 - 96 % e.e.). 
32,33 




73 	 78 
Entry 	R 	Yield (%) e.e. 
(%)a  e.e. (%)° 
1 	CH3 	74 	93 	?99 
2 	'C3H7 	71 	86 	-- 
3 	nC1-19 	72 	87 	96 
4 	tCH9 	88 	83 	?99 
6 	C6H5 	81 	96 	96 
Table 2: Allylboration using reagent 
733233 
Reagents and Conditions: (a) (i) 73 Et20, -78 °C, (ii) RCHO, overnight (73 containing magnesium 
salts); (b) 73, Et20, -100 °C, (ii) RCHO, 1 h (73 containing no magnesium salts). 
Further investigations by Brown et al. into the synthesis of allylic alcohols via 
allylboration, have shown that the presence of the magnesium salts can affect 
reactivity and enantio selectivity of the allylic alcohols. Addition of aldehydes 
(aliphatic and aromatic) to purified (-)-allyldiisopinocampheylborane 73 showed the 
instantaneous formation of the allylic alcohols (Table 	
34 3 5 Brown et al. have 
postulated that the magnesium salt [MgBr(OMe)] generated in the synthesis of 
allylborane 73 (Scheme 17) coordinates to the electrophilic boron atom in borane 79. 
Complex 80 must be stable at low temperatures (-78 °C or -100 °C) and the rate of 
allylboration is thus slowed down due to the low concentration of the uncomplexed 
allylborane 79. They have also concluded that lowering the reaction temperature 
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from -78 °C to -100 °C improves the enantioselectivity of the allylboration and does 
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79 	 80 
Scheme 17: Complexation of allylborane with magnesium salts 
The work carried out by Brown et al. has clearly shown that allylboranes (73, 74, 75 
and 76) can be used under salt free conditions at -100 °C in the allylation of 
aldehydes to give allylic alcohols with high yield and enantioselectivity.34 The 
successful synthesis of allylic alcohols using Brown's reagents has allowed this 
allylboration procedure to become a valuable tool in natural product synthesis. 
Recent studies by Soderquist et al. have shown that treatment of reagent 81 with 
aldehydes (Scheme 18) can give homoallylic alcohols 78 in good yield (70 - 92 %) 
and high enantioselectivity (96 - ~99 % e.e.).36 The formation of homoallylic 
alcohols using reagent 81 can be carried out at -78 °C without the enantioselectivity 
of the homoallylic alcohols being affected, unlike the lower temperatures needed (-
100 °C) for Brown's reagents. The removal of the magnesium salts in the formation 
of reagent 81 is not required to improve reaction times, whereas it is essential to 










Scheme 18: Soderquist reagent for the allylation of aldehydes 36 
Reagents and Conditions: (a) (i) RCHO, Et20, -78 °C, 3 h; (ii) pseudoephedrine, 81 T. 
The use of reagent 81 in the synthesis of homoallylic alcohols is a suitable alternative 
to the allylboration of aldehydes using Brown's protocol. However, the application 
of Brown's allylboration in natural product synthesis is well established compared to 
reagent 	37 The experience within our group in the application of the terpene 
based, chiral boranes made the synthesis of allylic alcohol required for the synthesis 




There are a variety of methods to install the crotyl moiety, but until the 1980's 
achieving stereoselectivity was often a problem. Since then, the development of new 
organometallic reagents displaying high regio- and stereoselectivity has been an area 
of great interest to synthetic chemists. 
In 1986, Brown et al. showed that the reaction of certain allylboranes with aldehydes 
produced homoallylic alcohols with high optical purities (86-96 % e.e.).38 Interest in 
this work led to the extension of the asymmetric synthesis to achieve the 
enantioselective formation of both the syn and anti n-methyl homoallylic alcohols 
via crotylboration reactions using boranes (82 -89) (Figure 7). 
anti 	 syn 
-'a2 	 2 	 ~2 
82 	 83 	 84 	 85 
Bn 
86 	 87 	 88 	 89 
Figure 7: Brown's crotylboration reagents 38 
Unlike the allyl derivatives, little was known about the stability of the crotylboranes. 
It was known was that 3-crotyl derivatives tend to exist as an interconvertible 
mixture of the E- and Z-isomers and that they can add to aldehydes to produce a 
mixture of regioisomers.38 
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A rapid equilibrium exists between the pure E- and Z-crotylboranes (90 and 92) via a 
borotropic rearrangement involving a 1-methylallyl intermediate 91 (Scheme 19). 
The rate of isomerisation is dependent upon the R group attached to the boron: allyl-
BR2 > allyl-BR(OR') > allyl-B(OR')2.38  
R 
I 
R B R - - 
E 	 z 
90 91 	 92 
Scheme 19: Equilibrium between E- and Z-crotylboranes 
Additionally, the rate of reaction of crotylboranes with aldehydes follows the same 
order as the allylboration reaction, and greater optical purity can be seen when 
carrying out the reactions at lower temperatures. It was expected that these 
crotylboranes would react readily with aldehydes, and at a temperature low enough 
to achieve good optical purity, with limited isomerisation. 
The reported synthesis of crotylborane 82 consisted of metallation of trans-but-2-ene 
93 via a "superbase", using conditions discovered by Schlosser. 39 Treatment of the 
crotylpotassium salt 94 with (-)-methoxydiisopinocampheylborane 77 at -78 °C gave 
the boronate complex 95. Treatment of complex 95 with boron trifluoride etherate 
generated the trialkylborane 82 which was used immediately in the crotyl boration 









82 	 95 
Scheme 20: Preparation of E-croiylborane 82 
33 
Reagents and Conditions: (a) (i) 'BuOK, BuLi, THF, -45 °C, 10 mm; (ii) 77, Et20, -78 °C, 30 mm; 
(iii) BF3.Et20, -78 °C. 
Immediate addition of a range of aldehydes to crotylborane 82 results in a 
crotylboration reaction which proceeds via transition state 96, to give homoallylic 
alcohols in good yield (65 - 79 %) with excellent diastereoselectivity [95:5 anti 








96 	 97 
H 	 OH 
4H4 
H 	Hi 
98 	 99 
Yield 
Entry R 97:99 ee. (%) 
(%) 
1 CH3  78 95:5 90 
2 nC21-15 70 95:5 90 
3 'CI-I=CH 65 95:5 90 
4 C6H5 79 94:6 88 
Table 3: Crotylboration using crotyl borane 82 
Reagents and Conditions: (a) Rd-b, THF, -78 °C, A. 
Recent studies by Soderquist et al. have also shown that crotylation of aldehydes 
using reagent 100 under low temperatures (-78 °C) can give 3-methyl homoallylic 
alcohols 101 in good yield (68 - 94 %) with high diastereoselectivity (? 98:2 




a 	 OH 
1t 7 RCHO 
100 	 101 
Scheme 21: Soderquist reagent for crotylation of aldehydes 
36 
Reagents and Conditions: (a) (i) RCHO, Et20, -78 °C, 3 h; (ii) pseudoephedrine, 81 T. 
The use of reagent 100 in the synthesis (Scheme 21) of 3-methylhomoallylic 
alcohols 101 is a suitable alternative to the crotylboration of aldehydes using 
Brown's protocol 36  However, the application of Brown's method in natural product 
1-4 synthesis is more established .43 Georg et al. have investigated the application of 
Brown's crotylboration towards the synthesis of cryptophycin-24 (102)(Figure 8). 
19 16 Ph >!0  




Figure 8: Cryptophycin-24 
Treatment of aldehyde 103, with E-crotylborane 86 afforded n-methyl homoallylic 
alcohol 104 in good yield (76 %) and with good enantioselectivity (91 % e.e.) as 
shown in Scheme 22. 3-Methy1homoallylic alcohol 104 is the antipode of the alcohol 
desired for the synthesis of fragment 5 and it was thought that the opposite 
enantiomer could be synthesised with similarly high yield and enantioselectivity. 
This experience within our group in the application of the terpene based, chiral 
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boranes made the synthesis of 3-methylhomoallylic alcohol required for the synthesis 
of fragment 5 via crotyl borane 82 the preferred route. 
~<2 
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Scheme 22: Synthesis of C(14) - C(1 9) fragment of Cryptophycin-24 
Reagents and Conditions: (a) (i) 86, THF, -78 °C (ii) ethanolamine, RI (76 %, 91 % ex.). 
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1.4.3. 	Boron Mediated Aldol Reaction 
1.4.3.1. 	Relative Stereocontrol 
The relative stereochemistry of a kinetically controlled boron aldol reaction is 
directly proportional to the E:Z geometry of the boron enolates formed. The size of 
the ligands on the boron reagent can selectively form either the E- (where bulky 
cyclohexyl ligands are used) or Z-enolates (where small butyl ligands are used). The 
transfer of enolate geometry to the stereochemistry of the aldol adducts is controlled 
by a Zimmerman-Traxler3° transition state (107, 109, 112 and 114) as shown in 
Scheme 23. The E-boron enolate 106 can potentially form two transitions states (107 
or 109) to form either the syn (108) or anti aldol adducts (110). Due to diaxial 
interactions in transition state 107, the aldol reaction proceeds via transition state 109 
to form the anti aldol adduct 110. Similarly Z-boron enolate 111 forms the syn aldol 
adduct 115 via transition state 114 due to less diaxial interactions. 
4
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Scheme 23: Relative stereocontrol via enolate geometry 
31 
Introduction 
1.4.3.2. 	Absolute Stereocontrol 
It is of great importance in the synthesis of many natural products that the absolute 
stereochemistry of aldol reactions can be controlled and this is when the enolate 
shows a high level of it-facial selectivity (Scheme 24). Therefore one of the it-faces 
of the enolate must be selective for either the si or re face of the aldehyde. 
O OH 	 H L 	 H L 0 OH 
R(R' 	HfJoL 	 R R 
116 	
Ire 	 re 	
117 
	
"Bu 	 'Hex 
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R 	 R 
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Scheme 24: Enantiofacial selectivity 
A high level of it-selectivity for anti aldol reactions can be achieved by using: 
a chiral aldehyde; 44 
a chiral auxiliary (e.g. Evans oxazolidinone 120, Scheme 25); 45 
chiral ligands on the boron enolate; 46-48 
or a metal enolate derived from a chiral carbonyl compound.49 
In our synthesis of C(6)-C(1O) phosphonate fragment 6 we intend to use an achiral 
aldehyde and so cannot use the first method to control the aldol reaction. Potentially 
we could use any of the other three methods but some of them have problems with 
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the generality of reaction or relatively harsh conditions for conducting the reaction. 
Therefore for the synthesis of fragment 6, it was proposed to use the most popular 
method for the formation and control of aldol adducts, the use of a chiral auxiliary. 
a 
120 	 121 
Scheme 25: Propionate derivative of the Evans chiral auxiliary 
Reagents and Conditions: (a) (i) BuLi, THF; (ii) CH3CH2C0CI, 0 °C, lh, (90 %). 
The most common chiral auxiliary used in the control of aldol reactions is the Evans 
oxazolidinone 120, shown in Scheme 25. It is widely used for the synthesis of syn 
aldol adducts generally giving excellent relative and absolute control .45 However the 
use of the propionate derivative of auxiliary 121 in the formation of anti aldol 
adducts was not reported to be as robust as the synthesis is reliant upon careful 
control of the boron reagent. Recently Evans and coworkers 50'51 have investigated the 
use of the propionate derivative 121 in the generation of anti aldol adducts and have 
discovered that by using chelating additives (e.g. M902), the desired anti aldol 
adduct can be obtained in good yields (86 - 94 %) and high diastereoselectivity (26:1 
—32:1 anti:syn). 
Although the Evans oxazolidinone is compatible with the anti aldol reaction, this 
auxiliary is not an attractive candidate to use in our synthesis of octalactin A as it 
requires harsh conditions to remove it from the aldol substrate. Our synthesis of 3-
ketophosphonate ester 6, relies upon the displacement of the chiral auxiliary with a 
mild phosphonate anion. 
Abiko et al. have synthesised a carboxylic ester chiral auxiliary 122 for use in boron 
mediated aldol reactions, as shown in Scheme 26.5255  They have shown that both 
anti and syn aldol adducts can be formed selectively by using the appropriate boron 
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Scheme 26: Propionate derivative of the Abiko-Masamune chiral auxiliary 
53,54 
Reagents and Conditions: (a) CH3CH2COCI, pyridine, 0 °C -* RT, 18 h (69 %). 
Abiko et al. produced the propionate derivative of chiral auxiliary 123 from 
commercially available norephedrine in 3 simple steps-53,54 The syn aldol reaction 
was carried out using a range of aldehydes (vinyl, aliphatic and aromatic) and 
produced the respective syn aldol adducts and the reported yields were high (93 - 
98 %) with a high syn.anti ratio (95:5 - >97:3).' 	The anti aldol reaction was 
shown to be similarly versatile using a range of aldehydes and the anti aldol adducts 
were also produced in high yields (90 - 98 %) and diastereoselectivities(95:5 - 
>99: 
The development, by Masamune, of the norephedrine derived auxiliary for the 
reliable stereoselective construction of anti aldol adducts and its application in the 
synthesis of natural products has been demonstrated. The propionate derivative 123 
is an appropriate candidate for use in our synthesis of octalactin A because of its 
availability, combined with the mildness of the boron-aldol reaction and the ease of 
use. As mentioned earlier, the acylated Evans oxazolidinone 121 requires strong 
conditions to remove it from the aldol substrate, however auxiliary 123 is attached to 
its aldol substrate via a carboxylic ester and so it is believed that it can be removed 
from the aldol substrate using milder conditions. Work within the Hulme group using 
propionate ester 123 has shown that it can be displaced with a phosphonate anion to 
form a 3-ketophosphonate ester. 29 The mild displacement conditions warranted the 




1.4.4. 	Homer Wadsworth Emmons 
The Homer Wadsworth Emmons (HWE) reaction is a versatile method for the 
formation of a,f3-unsaturated carbonyl compounds using 3-ketophosphonate 124 and 
an aldehyde to give either the Z- or E-enones (127 or 130). The mechanism is 
believed to proceed via an oxaphosphetane56 (125 or 128) or the oxyanion 
intermediate 57  (126 or 129) (Scheme 27). The predominant formation of the E-enone 
130 occurs when dialkyiphosphonates 124 (R2 = alkyl) are used due to the 
preferential formation of thermodynamically more stable threo adducts (128 or 
129).58  
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Scheme 27: The HWE reaction and the possible mechanistic pathways 
58 
There have been numerous examples of the HWE coupling of aldehydes to 13-keto 
phosphonates reported in the literature, including modifications to allow the use of 
milder conditions, 59  or conditions to promote higher E:Z selectivity."' The HWE 




1.4.4.1. 	Barium Mediated HWE Reaction 
Paterson et al. have incorporated the use of a 1-IWE into the synthesis of natural 
product scytophycin C 131 (Figure 9)•61.62 
We 
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131 
Figure 9: HWE coupling in the synthesis of scytophycin C 131 
In the synthesis of the C(19)-C(31) segment 134, attempts made to perform the 
coupling via conventional methods (e.g. NaH) gave poor E:Z selectivity. It was 
found that the mild base barium hydroxide induced HWE coupling of aldehyde 132 
and 3-ketophosphonate ester 133, gave the E-enone 134 in a high yield (96 %) and 
high selectivity (Scheme 28).6162 It has been suggested that the microcrystalline 
structure of barium hydroxide is crucial to the catalytic activity in HWE reactions. 61 
BnO19 	
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Scheme 28: HWE coupling in the synthesis offragment 134 
Reagents and Conditions: (a) Ba(OH)2.8H20, 40:1 THFI H20, RT, 6.5 h (96 %). 
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Leahy et al., in their synthesis of natural product rhizoxin D, have also used the mild 
barium hydroxide mediated conditions with the HWE precursor 135 to allow the 
cyclisation of the 16-membered lactone 136.65,66  Although the cyclisation was slow 










. rhizoxin D 
136 
Scheme 29: Incorporation of HWE coupling in the synthesis of rhizoxin D.65' 66 
Reagents and Conditions: (a) Ba(OH)2, THF/H20, RT, 4 days (49 %). 
37 
Introduction 
1.4.5. 	Evans-Tishchenko Coupling 
The Evans-Tishchenko reaction was discovered 16 years ago by Evans and 1-Joveyda. 
It involves the coupling of 3-hydroxy ketones 137 and aldehydes to give the 
respective anti diol monoesters 139 (Scheme 30).28  The Evans-Tishchenko reaction 
typically requires catalysis by 15-30 mol% of a Sm12 solution in THF, and results in 
the directed reduction of a 3-hydroxy ketone to give an anti 1,3-diol with selective 
formation of a monoester (anti .syn >95:5).28 
OH 0 	Sm(lll) 	0-e 
RH o 1  
RfHRO 	 R 	HO H 
Me 	
0 I 0- O 
RH 	
I 	Sm 	 I 
I I I 	 Me  
L L 
137 	 138 	 139 
anti diol monoester 
yields >80%, dr >95:5 
Scheme 30: Intermolecular Evans- Tishchenko reaction 
The proposed mechanism involves intramolecular hydride transfer from an 
intermediate hemiacetal via a tricyclic transition state 138 similar to that shown in 
Scheme 30.28  The active catalyst in the Evans-Tishchenko reaction is believed to be 
a Sm13.SmI(RCHO)2 pinacol adduct 140 which is preformed, or generated in situ. 
The formation of the pinacol adduct may be deduced by a colour change; upon 
addition of the Sm12 solution (very dark blue solution) to an aldehyde (commonly 
acetaldehyde or benzaldehyde) a Sm(III) pinacol adduct is formed and can be 
recognised by the yellow colour as illustrated in Scheme 31. 
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Scheme 31: Proposed active Sm(III) pinacol adduct catalyst28 
The Evans-Tishchenko reaction is an efficient method for the anti reduction of 3-
hydroxy ketone systems and it has been widely used in the synthesis of natural 
products. The first incorporation of the Evans-Ti shchenko reaction into natural 





Rapamycin 141 	X = 0 
142 X=H,a-OH 
Figure 10: Rapamycin 141 and analogue 14267 
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Rapamycin 141 was of interest because of the high affinity binding complex it forms 
with intracellular receptor FKBP 12, which is believed to interfere with signalling 
components of the cell cycle. Crystallography studies of the FKBP-rapamycin 
complex suggested that reduction of the C(32) ketone to the (S)-hydroxyl would 
increase the binding affinity of analogue 142 to FKBP. Schreiber et al. then decided 
to install the highlighted fragment shown in Figure 10 via an Evans-Tishchenko 
coupling with pipecolinal 144.67  Treatment of 3-hydroxy ketone 143 with the pre-
formed samarium pinacol catalyst (shown in Scheme 31), followed by pipecolinal 
144 afforded anti diol monoester 145, in excellent yield (95 %) as a >20:1 mixture of 
anti and syn diol monoesters as shown in Scheme 32.67 
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Scheme 32: Rapamycin synthesis 67 
Reagents and Conditions: (a) 144, (PhCHO)2SmI, THF, -10 °C (95 
Paterson et al. have incorporated the Evans-Tishchenko reaction into the synthesis of 
the polyketide discodermolide 146, shown in Figure 11. The anti-cancer properties 
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Figure 11: Discodermolide44  
Paterson et al. have shown in the synthesis of C(9) - C(13) fragment 148 (Scheme 
33) that the C(11) carbonyl of 3-hydroxy ketone 147 can be reduced using either: 
Me4NBH(OAc)3 (which directly forms the diol 148); or the Evans-Tishchenko 
reaction to give anti diol monoester 149, followed by methanolysis. Although the 
reduction of -hydroxy ketone 147 using Me4NBH(OAc)3 produced diol 148 in high 
yield (97 %) with high diastereo selectivity (>97 % ds), the two-step Evans-
Tishchenko route was preferred due to the consistent high yields obtained upon the 
44 large scale synthesis of diol 148. 
a 
9 	 13 
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Scheme 33: Reduction strategies towards fragment 148 
44 
Reagents and Conditions: (a) Me4NBH(OAc)3, MeCN/AcOH, -40 - -23 °C (94 %, >97% ds); (b) 
SmI,, EtCHO, THF, -10 °C (96 %, >97 % ds); (c) K2CO3, MeOH, 20°C (97 %). 
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As shown in Schemes 32 and 33, the Evans-Tishchenko reaction has commonly been 
used to reduce a f3-hydroxy ketone moiety giving an anti diol monoester in high yield 
and selectivity, but there have been other investigations into the versatility of this 
reaction. Smith III et al. have used the Evans-Tishchenko reaction in their synthesis 
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Figure 12: 13-deoxytedanolide 1506869  
Generally the oxidation of the C(1) hydroxyl to the carboxylic acid in the complex 
polyketide precursor 151 to allow cyclisation, would require harsh conditions that 
could result in the oxidation of other sensitive groups such as the dithiane at C(11), 
as shown in Scheme 33. A Parikh-Doering oxidation of alcohol 151 afforded the 
aldehyde (Scheme 33) which was then treated under Evans-Tishchenko conditions 
with a sacrificial f3-hydroxy ketone 152 to form anti diol monoester 153 in excellent 
yield .70 Hydrolysis of the ester 153 afforded the carboxylic acid 154 in excellent 
yield and a Yamaguchi macrolactonisation of carboxylic acid 154 g ave the 18-
membered lactone 15568,69  Thus Smith et al. have shrewdly shown that the Evans-
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Scheme 33: Mild alcohol oxidation in the synthesis of 13-deoxytedanolide.68'69 
Reagents and Conditions: (a) S03.pyr, DMSO, 'Pr2NEt; (b) Sm12 (35 mol%), 152 (75 % over 2 steps); 
(c) PPTs, MeOH; (d) LiOH, THF/H20, A (63 % over 2 steps); (e) (i) 2,4,6-trichlorobenzoyl chloride, 
'Pr2NEt, THF; (ii) DMAP, toluene (64 %). 
There are a vast number of examples where the Evans-Tishchenko reaction is used in 
the reduction of 3-hydroxy ketones, compared with very limited reports 
27,71  of an 
Evans-Tishchenko reaction using a 3-hydroxy enone, as would be required in this 
project for the synthesis of anti diol monoester 71. 
The first studies within the Hulme group on the synthesis of octalactin A investigated 
the intermolecular Evans-Tishchenko reaction with enones, as well as the 
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intramolecular cyclisation as shown in Scheme 34•27  An Evans-Tishchenko reaction 
with benzaldehyde and protected enone 156 using standard conditions, afforded the 
anti aldol monoester 157 in 70 % yield as a single diastereomer. 
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Scheme 34: Evans- Tishchenko reaction with benzaldehyde27 
Reagents and Conditions: (a) PhCHO (4 eq.), Sm12 (0.1 M in THF, 60 mol%), THF, 0 °C, 10 mm (70 
The efficient and highly selective reductive nature of the Evans-Tishchenko reaction 
has merited its incorporation into the synthesis of many natural products. The 
application of the Evans-Tishchenko reaction of functionalised aldehydes containing 
alkene moieties with -hydroxy enones will be demonstrated and discussed in 
Chapters 2 and 4. 
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1.4.6. 	Ring Closing Metathesis 
Ring closing metathesis (RCM) was discovered in the 1960's but it was not until the 
early 1990's that this transformation became an important tool in synthetic organic 
chemistry. 72-74  It has been used in the construction of an impressive number of 
diverse cyclic structures via the general mechanism shown in Scheme 35. 
[M]CH 
M] 
" n j 
H2C CH2 	 Zm 
Scheme 35: General ring closing metathesis mechanism 
There are a variety of catalysts which can be used for RCM (Figure 13). The main 
two types are: 
Ruthenium alkylidenes (Grubbs) (158, 159, 160) 
Molybdenum alkylidenes (Schrock) (161, 162)72 
The molybdenum catalysts are very reactive and can undergo RCM with terminal 
alkenes and the less reactive trisubstituted alkenes.78 Although the Schrock catalysts 
are highly reactive in RCM and can construct a variety of ring sizes, they are very 
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unstable and have to be handled under strictly anhydrous conditions to prevent 
decomposition of catalyst. The ruthenium based catalysts have a higher stability and 
have comparable efficiency in RCM reactions. We decided to use the ruthenium 
based catalysts in the synthesis of octalactin A on the basis that they have higher 
stability than the Schrock catalysts. 
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Figure 13: Selection of Grubbs and Schrock catalysts 
Grubbs' 1st  generation catalyst 158 has been shown to be effective when catalysing 
the reaction of terminal alkenes.75'76 Although this catalyst is more stable than the 
molybdenum catalysts, anhydrous conditions are still required to give an efficient 
RCM. The addition of the N-heterocyclic carbene (NHC) ligand to catalyst 158 has 
been found to improve catalyst stability and has resulted in improved yields in RCM 
reactions .77,79,80 Therefore, we have decided to use Grubbs 
2nd  generation catalyst 
159 in the synthesis of octalactin A. 
RCM has been responsible for the synthesis of many natural products containing a 
variety of ring sizes. 81,82  The synthesis of a selection of Medium-ring lactone natural 
products using this method will now be discussed. 
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1.4.6.1. 	Formation of 8- and 9-Membered Lactones via 	RCM 
There are a variety of strategies towards the synthesis of 8-membered cyclic 
compounds which incorporate RCM. However the construction of 8-membered 
lactones using RCM is very limited. In fact the only reported synthesis of an 8-
membered lactone (Scheme 36) was the synthesis of oxocene 19, which was carried 
out by Buszek etal. in their synthesis of octalactin A, as discussed in section 1.3.4.14 
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Scheme 36: Buszek's synthesis of oxocene 19' 
Reagents and Conditions: (a) Grubbs 1158, CH2Cl2, 40 °C, 24 h (86 %). 
Similarly the use of RCM towards the synthesis of 9-membered lactones is also very 
limited. A rare example of preparing the 9-membered lactone moiety by RCM was 
reported by Takemoto et al. towards a synthesis of halicholactone 10, as shown in 
Figure 1483.84 
Figure 14: Halicholactone 108384 
Treatment of triene 163 with Grubbs' 1st generation catalyst 158 under high dilution 
in the presence of Ti('OPr)4 gave the Z-isomer 164 as the major product (72 %) along 
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with 11 % of the dimer, as shown in Scheme 37. Mild hydrolysis of the acetate 
groups afforded lactone 10 in a 61 % yield. Interestingly when the hydroxyl groups 
were protected as SEM or MOM ethers, the yield of RCM was lowered (19 %) with 
45 % of recovered starting material and 9 % of the dimer. 
H H OR OAc  
a 	 c5H11 
H 	OAc 	 ' j_O 11 	0 FR 
0 	 0 
163 	 b 	
164R=Ac 
10 R=OH 
Scheme 37: RCM in the synthesis of Halicholactone83' 84 
Reagents and Conditions: (a) Ti('OPr)4, Grubbs 1 158, CH2C12, 40 °C, 24 h (72 %); (b) K2CO3, 
MeOH, RT, 3 h (61 %). 
1.4.6.2. 	Formation of 10-Membered Lactones via RCM 
The synthesis of 10-membered lactones via RCM has been the subject of a number 
of investigations. A variety of natural products containing the 10-membered lactone 
moiety have been constructed and a brief selection is discussed below. 
In 1997 FUrstner et al. carried out the first synthesis of a 10-membered lactone via 
RCM in the synthesis of jasmine ketolactone 165, the oldest natural product known 
to possess an oxecan-2-one framework (Figure 15).85  Lactone 165 is a component of 
the essential oil of Jasmium grandflorium  and was isolated in 1942.86 
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H = 	0 
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Figure 15: Jasmine ketolactone 165 
Treatment of a highly dilute solution of diene 166 with Grubbs catalyst 167 under 
reflux afforded the lactone 165 in 88 % yield as a 1.4:1 (E:Z) mixture of isomers. 
Chromatography allowed the simple separation of the isomers to allow the isolation 
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Scheme 38: Synthesis ofjasmine ketolactone 16585 
Reagents and Conditions: (a) Grubbs catalyst 167 (10 mol%), CH2C12, 40 °C, 24 h (88 %). 
More recently, Curran et al. have used an esterificationlRCM strategy 87towards the 
potent anti-tumor agent dictyostatin 169 (Figure 16), which was first isolated in 
1994 by Petit et al. ,88 when they proposed a partial structure 168. However 
investigations into the structure of dictyostatin (169) by completion of the total 
synthesis have shown that the assignments of the stereocentres at C(7), C(9), C(12), 













Figure 16: Original structure 16888  and actual structure 169 of dictyostatin 
89,90 
Curran et al. applied their esterificationlRCM strategy (Scheme 39) based on the 
original structure 168.87  Treatment of a dilute solution of diene 170 with a high 
loading of Grubbs' 2 nd  generation catalyst 159 (50 mol%) under reflux for 24 h 
afforded lactone 171 in good yield (78 %) with the alkene formation giving only the 
Z-isomer. Reduction of the lactone moiety with LiA1114 afforded an advanced 
intermediate 172 towards dictyostatin A. 
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Scheme 39: Esterication/R CM strategy towards dictyostatin 16887 
Reagents and Conditions: (a) Grubbs 2 159 (50 mol%), CH2Cl2, 40 °C, 24 h (78 %); (b) LiA1H4, THF, 




In summary, it has been shown that there are a variety of routes towards the 
octalactins, however they all suffer from the formation of C(9) epimers upon 
installation of the C(1 O)-C(1 5) alkyl chain to lactone 15. The loss of stereochemical 
integrity affects the selective epoxidation of the C(10) - C(1 1) alkene, a moiety 
which has been reported to be important to the biological activity of octalactin A. 
Therefore, the route that we have proposed towards the octalactins incorporates the 
Evans-Tishchenko reaction followed by RCM. The reduction of f3-hydroxy ketones 
as their anti diol monoester using the Evans-Tishchenko reaction has been shown to 
be very efficient and highly selective in a variety of natural products. Similarly, 
RCM has been shown to be very efficient in the construction of various medium 
lactones in natural product synthesis. The combination of both the Evans-Tishchenko 
reaction and RCM should allow for a highly selective and efficient synthesis of the 
octalactins. 
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RESULTS AND DISCUSSION PART 1 
CHAPTER 2 
MODEL STUDIES 
A model study was conducted so that the retrosynthetic analysis of octalactin A 
shown in Chapter 1 could be explored (Scheme 40). The model study involved the 
intermolecular Evans-Tishchenko coupling of J3-hydroxy enone 176 and hex-6-en-1-
al 175 to give anti diol monoester 174. Ring closing metathesis of the terminal 
alkenes of triene 174 would give oxocene 3, a simple model of octalactin A. Initial 
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Scheme 40: Retrosynthetic analysis of model lactone 3 
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2.1. 	SYNTHESIS OF -HYDROXY ENONE 176 
(CHex)2B 	
Ph 	
1. anti aldol 	
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Scheme 41: Proposed synthesis of/3-hydroxy enone 176 
The strategy proposed for the synthesis of 3-hydroxy enone 176 involved the use of a 
boron mediated anti aldol reaction of the acylated Abiko-Masamune auxiliary 
enolate 177 with acrolein (Scheme 41). This would give an anti aldol adduct which 
could be subsequently protected as the triethylsilyl ether 178. Displacement of the 
Abiko-Masamune auxiliary with the anion of diethyl ethane phosphonate would give 
the J3-ketophosphonate ester 179. This 3-ketophosphonate ester is similar to the key 
fragment presented in the retrosynthesis of octalactin A (Scheme 15). However in 
the synthesis of the model compound 3, 0-ketophosphonate ester 179 would then 
undergo a barium hydroxide induced Homer Wadsworth Emmons (HWE) 
olefination with isovaleraldehyde to give the protected E- enone. Desilylation of the 
E-enone would give the desired 3-hydroxy enone 176. 
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2.1.1. 	Construction of the C(6) - C(9) Fragment: Boron Mediated Anti 
Aldol reaction 
The first step towards the synthesis of 3-hydroxy enone 176 was the construction of 
the C(6) - C(9) moiety. This fragment contains a 3-hydroxy ketone moiety with anti 
stereochemistry at C(7) - C(8). Therefore our strategy towards the synthesis of this 
fragment consisted of a boron mediated anti aldol reaction with a chiral auxiliary and 
acrolein as shown in Scheme 42. As discussed in Chapter 1 the Abiko-Masamune 
chiral auxiliary was chosen due to its formation of anti aldol adducts in high yields 
with high diastereocontrol. 
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Scheme 42: Strategy towards the construction of the C(6) -C(9) fragment 
2.1.1.1. 	Synthesis of the Abiko-Masamune Auxiliary 
The propionate derivative of the Abiko-Masamune auxiliary 123 was synthesised 
(Scheme 43) using the conditions of Masamune in 3 steps (62 % overall yield) .53'54 
Sulfonation of the amino group gave sulfonamide 182, and this was followed by 
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selective N-benzylation to give auxiliary 122. Finally, acylation gave the desired 
propionate derivative 123. 
Ph 
HO Ph 	a HO( 
H2N 	
HNso 








Scheme 43: Synthesis ofpropionate derivative of the Abiko- Masamune auxiliary 53,54 
Reagents and Conditions: (a) MesS020, Et3N, CH2C12, 0 °C, 2 h (95 %); (b) 'BuOK, DMF, 0 °C, 30 
mm; BnBr, RT, 4.5 h (71 %); (c) CH3CH2COC1, pyridine, 0 °C - RT (69 %). 
2.1.1.2. 	Anti Aldol Reaction 
Initial studies were carried out using methacrolein to compare the experimental 
results obtained with the synthesised Masamune auxiliary to those reported in the 
literature. The anti aldol reaction of propionate ester 123 with methacrolein using 
freshly prepared dicyclohexylboron triflate and triethylamine gave aldol adduct 183 
in good yield (84 %) as shown in Scheme 44. Analysis of 'H NMR showed the 
formation of aldol adduct 183 as a mixture of diastereomers (98:2 anti:syn) which 
was is good agreement with the literature. The stereochemistry of the major 
diastereomer of aldol adduct 183 was assigned on the basis of the large coupling (7.0 
Hz) between the C(7)H and C(8)H protons, and the absolute stereochemistry was 
assumed by comparison of the experimental and literature optical rotations; (LUID = - 
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19.1 (c 1.32, CHC13), lit.34 19.7 (c 1.32, CHCI3)). Encouraged by the high yield and 
diastereoselectivity, the reaction was attempted with commercially available 
acrolein.* The enolisation, using the conditions for the formation of aldol adduct 183 
and an excess of enolate (2.5 equiv.), gave a high yield of the desired anti aldol 
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Scheme 44: Anti aldol reaction with acrolein/methacrolein 
Reagents and Conditions: (a) Et3N, (C6H5)2BOTf, -78 °C, 2 h; (b) Rd-b, -78 °C, I h then 0 °C for I 
h. 
There were concerns about the possibility of polymerisation when using acrolein, fortunately this 
was not observed. 
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The stereochemistry of the major diastereomer of aldol adduct 180 was determined 
by the large coupling (7.0 Hz) between the C(2)H and C(3)H protons and the 
absolute stereochemistry was assumed on the basis of literature precedent. 
53,54 
2.1.1.3. 	Syn aldol Reaction 
For comparative purposes, the syn aldol adduct 185 was also generated (Scheme 45) 
by treating propionate ester 123 with commercially available dibutyl boron triflate 
and Hunig's base to give Z-boron enolate 184. Treatment of enolate 184 with 
methacrolein gave the syn aldol adduct 185 in excellent yield (97 %) and high 
diastereoselectivity (>95:5 syn :anti). The stereochemistry of the major diastereomer 
185 was assigned on the basis of the small coupling (3.7 Hz) between the C(2)H and 

















Scheme 45: Syn aldol reaction with methacrolein 
Reagents and Conditions: (a) (i) 'Pr2NEt, Bu2BOTf, -78 °C, 2 h; (ii) methacrolein, -78 °C, h then 0 
°C for 1 h (97 %). 
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The application of auxiliary 122 in the high yielding and highly selective formation 
of anti aldol adducts has been demonstrated with the vinyl aldehyde methacrolein, 
and is comparable to the literature. The application of the propionate derivative of 
auxiliary 123 in the anti aldol reaction with acrolein has allowed the synthesis of 
adduct 181, which contains the C(6) - C(9) fragment of octalactin A, in high yield 
and selectivity. 
2.1.2. 	Carbon Backbone Extension: Anionic Displacement of 
Auxiliary 122 
It was necessary to extend the carbon backbone of the aldol adduct to produce the 
required enone 187, in order to obtain one of the key fragments in the synthesis of 
the octalactin model. This could be achieved by displacement of auxiliary 122 from 
the aldol adduct 186 with the lithiated anion of diethyl ethane phosphonate to form f3-
ketophosphonate ester 6, followed by a Homer Wadsworth Emmons olefination with 
an appropriate aldehyde (Scheme 46). 
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Scheme 46: Proposed displacement ofAbiko-Masamune auxiliary 
Work has been carried out within the Hulme group using the Abiko-Masamune 
chiral auxiliary in the 1st  generation synthesis of octalactin A (Scheme 
47)29  The 
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anti aldol reaction using the propionate derivative of the Abiko-Masamune chiral 
auxiliary 123 and aldehyde 188 gave the anti aldol adduct 189 as an inseparable (6:1) 
epimeric mixture at C(8). The C(1) - C(10) fragment was synthesised by 
displacement of auxiliary 122 using the anion of diethyl ethane phosphonate to 
produce the 3-ketophosphonate ester 190 in 59 % yield as a 3:1 mixture of 
diastereomers at C(10). A further amount (11 %) of product material was also 
isolated and analysis of the 250 MHz 'H NMR implied this was the minor 
diastereomer from the anti aldol reaction. Auxiliary 122 was recovered from the 
reaction in high yield (94 %). 
anti aldol 
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Scheme 47: Phosphonate displacement of auxiliary 122 
Reagents and Conditions: (a) (i) EtP(0)(OEt)2 (4.4 equiv 
nBuLi (4.4 equiv.), THF, -78 °C, 1 h; (ii) 
190, 20 mm, THF, -78 °C followed by 10 min at 0 °C. 
2.1.3. 	Hydroxyl Protection 
The hydroxyl group at C(7) had to be protected prior to anionic displacement of the 
Masamune auxiliary to avoid anion quenching and epimerisation occurring. 
Treatment of aldol adduct 180 (Scheme 48) with both tert-butyldimethylsilyl triflate 
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and the triethylsilyl triflate gave the adduct protected as both the tert-
butyldimethylsilyl ether 191 and the triethylsilyl ether 178 respectively in high yields 
(95 % and 94 
	
OH 0 Ph 	 OR' 0 Ph 
Bn 	SO2 	 Bn N 
180 
	
191 R1 = TBS (95%) 
178: R1 = TES (94%) 
Scheme 48: Silyl protection of anti aldol adducts 
Reagents and Conditions: (a) 2,6-lutidine, 0 °C, 5 mm; TBSOTf or TESOTf, 60 mm, 0°C. 
The a-carbanionic alkyiphosphonate displacement conditions developed from the 
displacement of thioesters9' and Abiko-Masamune auxiliary 122,29  previously carried 
out by members of the Hulme group, were applied to aldol adducts 191 and 178 
(Scheme 49). 
OR' 0 Ph 	 OR' 0 0 	
Ph 
a 11 3 JJO.(OR2 	+ 	HO 
Bn S02Mes 	
I 	 R2 	 Bn LSO2Mes  
191: R1  = TBS 	 179: R1  = TES, R2 = Me, R3 = Et 	122 
178: R1  = TES 192: R1  = TBS, R2 = Me, R3 = Et 
193: R1  = TES, R2 = H, R3 = Me 
Scheme 49: Anionic displacement of Masamune chiral auxiliary 122 
Reagents and Conditions: (a) (i) R2CH2P(0)(0R3)2 (4.4 equiv.), BuLi (4.4 equiv.), THF, -78 °C, I h; 
(ii) 191/178,60 mm, THF, -78 °C. 
The reaction conditions were varied (Table 4) to optimise the yield of 3-
ketophosphonate esters 179 and 192. The displacement was primarily studied with 
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the TES protected compound 178 and it was found that treatment with the ethane 
phosphonate anion gave only recovered starting material (Table 4, entry 1). The 
reaction time was extended, followed by addition of a further 4.4 equivalents of the 
phosphonate anion, but again the reaction only gave recovered starting material 
(Table 4, entry 2). 








1 TES Me Et BuLj, -78 °C, 50 min 98 
'BuLi, -78 °C, 3 h, followed by 
2 TES Me Et -- -- 98 
4.4 equivalents of anion 
DMPU, 'BuLi, -78 °C ---> RT 
3 TES Me Et -- -- -- 
over 4 h 
4 TBS Me Et BuLi, -78 °C, 1 h 51 52 -- 
5 TBS Me Et BuLi, -78 °C, 2 h 46 26 -- 
6 TBS Me Et BuLi, -78 °C -* RT over 4 h 41 19 -- 
7 TBS Me Et '1BuLi, -78 °C -* 0 °C over 4 h 16 50 -- 
BuLi, DMPU, 0 °C -* RT 
8 TBS Me Et 13 35 
over 4 h 
9 TES H Me '7BuLi, -78 °C, 3 h, 0 °C, 8 h 24 23 -- 
10 TBS H Me BuLi, -78 °C, 3 h, 0 °C, 8 h -- -- 92 
Table 4: Phosphonate displacement of aldol adducts 194 and 179 
It was hoped that using stronger reaction conditions (DMPU, 'BuLi warmed from 
-78 °C to RT) would produce 3-ketophosphonate ester 179 (Table 4, entry 3). 
However the reaction conditions were too forcing and the triethylsilyl protecting 
group was removed causing a retro-aldol reaction to occur, producing propionate 
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ester 123 in a high yield (97 %). A proposed mechanism for the retro-aldol reaction 







Bn' N S02Mes 
178 
'Bu 	 Li(D 
Et3Sk) oTI Ph 






	 Bn SO2Mes 
123 
Scheme 50: Retro-aldol reaction 
Reagents and Conditions: DMPU, 'BuLi, -78 °C -* RT over 4 h (97 %). 
The protecting group on the aldol adduct was changed to a bulkier 
tertbutyldimethylsilyl group to prevent desilylation and subsequent retro-aldol 
reactions. Treatment of aldol adduct 191 using standard phosphonate anion 
conditions (Table 4, entry 4) produced a 3:1 mixture of diastereomers (confirmed by 
'H NMR) of 3-ketophosphonate ester 192 in a moderate yield (51 %) with moderate 
recovery of auxiliary 122 (52 %). These diastereomers were not separated since 
previous work within the group which has shown that similar 3-ketophosphonate 
esters 194 afford only a single E-enone 195 upon HWE olefination.*29 Extension of 
TBSO 0 0 	 TBSO 0 	14 
TBSO jfl0Et)2 a10 TBSO 
194 	 195 
Reagents and Conditions: (a) (i) Ba(OH)2 8H20, THF/I-120 (40:1); (ii) isovaleraldehyde, RT, 18 h (85 
%). 
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the reaction time (from 2 h to 4 h, Table 4 entries 5 and 6) did not improve the yield 
of 3-ketophosphonate ester 192. It has also been noted in previous studies of similar 
reactions, 29 that although the reaction may have appeared to have gone to completion 
when monitoring by TLC (indicated by the disappearance of starting material and the 
formation of two low Rf  spots, one of which corresponds to that of the free auxiliary 
122), upon quenching the reaction at -78 °C only starting materials were recovered. 
This suggests that the reaction may have occurred during the sampling process (i.e. 
as the material warmed to > -78 °C). The reaction conditions were adapted to 
accommodate for this phenomenon by warming the reaction to 0 °C, unfortunately 
the yield of -ketophosphonate ester 192 did not increase (Table 4, entry 7). 
Stronger reactions conditions were applied to aldol adduct 191 (BuLi, DMPU, 0 °C 
-> RT over 4 h), and unfortunately 3-ketophosphonate ester 192 was still obtained in 
a low yield (Table 4, entry 8). 
The final approach taken was to alter the reaction conditions by changing the 
phosphonate anion from diethyl ethane phosphonate to dimethyl methane 
phosphonate. Addition of the anion of dimethyl methane phosphonate to TES adduct 
178 produced p-ketophosphonate ester 193 in a low yield, and treatment of the TBS 
adduct 191 with dimethyl methane phosphonate gave no reaction. 
Investigations towards the total synthesis of octalactin A into the displacement of 
auxiliary 122 with a phosphonate anion have shown that the C(6)-C(9) fragment, 13-
ketophosphonate ester 192 can be synthesised in a moderate yield. Therefore these 
studies have shown that the nucleophilic displacement of the ester moiety contained 
in chiral auxiliary 122 poses a problem for the synthesis of 13-ketophosphonate ester 
192. Further investigations towards the optimisation of the 13-ketophosphonate ester 
192 will be discussed in Chapter 3. 
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2.1.4. 	Homer Wadsworth Emmons Coupling 
In the model synthesis of octalactin A, the introduction of the C(1 1) - C(14) 
fragment to 3-ketophosphonate ester 6 was proposed via a 1-lorner Wadsworth 
Emmons (HWE) reaction, as shown in Scheme 51. Based on previous work within 
the group,29  the olefination of 3-ketophosphonate ester 6 with a simple aldehyde, 
isovaleraldehyde (similar to aldehyde 7), under mild conditions would afford enone 
187 in high yield and high selectivity (E:Z). 
P0 0 0 
11 	 HWE 
- 
0 	14 
6 	 H 
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Scheme 51: HWE olefination 
Treatment of both diastereomers of 3-ketophosphonate ester 192 with activated 
barium hydroxide* and isovaleraldehyde gave a,3-unsaturated enone 196 (Scheme 
52) in 80 % yield with E/Z selectivity >95:5. Analysis of the crude products using 
250 MHz 'H NMIR revealed a single geometrical isomer and a single diastereomer, 
thereby confirming that no epimerisation a to the carbonyl had occurred in the 
carbanionic displacement of auxiliary 122 or in the HWE reaction itself. 
* Activation was achieved by heating Ba(OH)2.8H20 in a high temperature (110 °C) oven for >12 h. 
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TBSO 0 0 	a TBSO 0 	
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192 	 196 
Scheme 52: HWE coupling to form the E- enone 196 
Reagents and Conditions: (a) (i) Ba(OH)2.8H20, THF/H20 (40:1); (ii) isovaleraldehyde, RT, 18 h (80 
%). 
Further analysis of 'H NMR (Figure 17) of enone 196 showed a signal at 8 = 6.75, 
br t, J = 6.6 Hz, indicative of an enone proton, this was in good agreement with 
known compound 195 (6 = 6.65, br t, J = 6.6 Hz). 
29,91  Infrared spectroscopy of enone 
196 showed a stretch at 1666 cm indicative of an a,13-unsaturated carbonyl system, 
also in good agreement with that observed for known enone 195 (1660 cm'). 
1HNMR 	 1HNMR 
I 	1666 cm -1 6.75 ppm, br t, J = 6.6 Hz 	I  1660 cm1 	6.65 ppm, br t, J = 6.6 Hz 
14
r 14 







Figure 17: Comparison of spectroscopic data with known compound 195 
The extension of the carbon backbone of enone 196 to introduce the C(1 1) - C(14) 
fragment and install the enone moiety was successfully achieved via a HWE 
olefination. Olefination of -ketophosphonate ester 192 under mild conditions 
(barium hydroxide) afforded the E-enone 196 in high yield (80 %) with high E:Z 
selectivity. Deprotection of 3-hydroxy enone 196 would allow further extension of 
the carbon skeleton of the octalactin A model via Evans-Tishchenko coupling. 
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2.1.5. 	Deprotection of Homer Wadsworth Emmons Adducts 
The desilylation of primary and secondary hydroxyls with HF-based reagents has 
been shown to be milder than the conditions required for TBAF removal of TBS 
groups 92  and was used in the deprotection of HWE adduct 196. 
Care was taken in the monitoring of this reaction as previous studies have shown that 
extended reaction times (? 1 h), or improper quenching, can result in the 
disappearance of the desired products. Studies within the group on the synthesis of 
decarestrictine D (Scheme 53) have shown that extended exposure of 3-hydroxy 
enone 197 to HF results in the formation of undesired product 198. Analysis of 250 
MHz 'H NMR have shown that J3-hydroxy enone 197 undergoes desilylation, 
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198 
Scheme 53: By-products from deprotection of/3-hydroxy enone 197 using HF 
Reagents and Conditions: (a) HF (40 % aqueous), MeCN, 10 mm. 
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In the deprotection of 3-hydroxy enone 196, the reaction time was strictly monitored 
followed by thorough quenching and immediate purification by chromatography to 
reduce the risk of by-product formation. 
HWE adduct 196 was treated with 40 % aqueous HF in MeCN (Scheme 54) for 5 
min and purification produced 3-hydroxy enone 176 in excellent yield (95 %). 
Analysis of the 'H NMR showed f3-hydroxy enone 176 only and no other products. 
The single product indicated that deprotection of HWE adduct 196 had occurred with 
no epimerisation at C(7). Analysis of 'H NMR showed the presence of the vinylic 
enone signal (5 = 6.62, br t, J = 7.4 Hz) and infra red spectroscopy showed a 
hydroxyl stretch (3422 cm') and an a,f3-unsaturated stretch (1662 cm'), confirming 
that by-products were not formed. 




196 	 176 
Scheme 54: Deprotection of HWE adduct 196 
Reagents and Conditions: (a) HF (40 % aqueous), MeCN, 5 mm (95 %). 
Thus, HWE adduct 196 was efficiently deprotected to give f3-hydroxy enone 176 in 
excellent yield (95 %) which has allowed the synthesis of a model C(6) - C(14) 
fragment. 
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2.2 	CARBON BACKBONE EXTENSION: EVANS-TISHCHENKO 
COUPLING 
With the successful formation of -hydroxy enone 176, the installation of the C(1) - 
C(5) backbone via esterification of the C(8) hydroxyl and the selective reduction of 
the C(9) enone was now required for the synthesis of lactone 3. As discussed in 
Chapter 1, we have proposed that the intermolecular Evans-Tishchenko reaction of 
J3-hydroxy enone 176 and hexenal 175 can fulfil all of these criteria in one synthetic 














Scheme 55: The Evans- Tishchenko coupling 
The intermolecular Evans-Tishchenko reaction in this synthesis of octalactin A 
required the coupling of 3-hydroxy enone 176 with an aldehyde 175 containing an 
alkene moiety. Therefore, the Sm(III) pinacol catalyst was generated in situ before 
hexenal 175 was added to the reaction mixture to prevent unwanted cyclisation 
occurring via a ketyl radical anion, which could potentially form cyclopentenol 197 
(Scheme 
	14,11 




Scheme 56: Proposed synthesis of by-product 197 
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Treatment of Sm(III).benzaldehyde pinacol adduct with hexenal 175 for 30 mm, 
followed by the addition of f3-hydroxy enone 176 with stirring for 30 mm, afforded 
the anti diol monoester 174 in 93 % yield and as a 9:1 mixture of diastereomers 
(Scheme 57). 'H NMR studies revealed a significant shift of the C(1 1) vinylic proton 
[6 = 6.64 ppm (176) -* 6 = 5.42 ppm (174)11 indicating reduction of the enone 
functionality. Loss of an aldehyde peak (6 = 9.42 ppm), as well as a shift in the C(7) 
proton [6 = 4.19 ppm (176) -* 6 = 5.22 - 5.14 ppm (174)] also suggesting ester 
formation. Infrared spectroscopy showed a change in the carbonyl region from 1662 
cm-1 (indicative of an a,13-unsaturated carbonyl) to 1726 cm' suggesting the 
formation of anti diol monoester 174. 
IR:1662 cm-1  
(a,13-unsaturated C=O) 
r 6.64 ppm 
7T9 11 
176 
IR:1726 cm-1 (ester) 
no unsaturated ketone signal 
) 	
5.42 ppm 
a 	 0 OH  
174 
Scheme 57: Evans- Tishchenko reaction 
Reagents and Conditions: (a) (i) PhCHO, Sm12  (0.1 M in THF, 30 mol%), followed by hexenal, 30 
mm: (ii) 176, THF, -10 °C, 30 mm (93 %). 
Other possible reactions that could have occurred include a Tishchenko, or a pinacol 
coupling onto the C(9) carbonyl itself. Studies within the group towards the synthesis 
of anti diol monoester 200 via an Evans-Tishchenko coupling of 3-hydroxy ketone 
198 and aldehyde 199, have shown the migration of the ester moiety to give ester 
201, as shown in Scheme 58.96 
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0 	1 
5 II 	 4 
OHO 199 	 OH 
a 79 
198 	 200 
4 - 
No 	 OHO 0 
201 
Scheme 58: Acyl migration 
Reagents and Conditions: (a) (i) PhCHO, Sm12  (0.1 M in THF, 30 mol%), followed by 199, 30 mm: 
(ii) 198, TI-IF, -10 °C, 3 h (94 %). 
These can be excluded on the basis of the 'H NMR data for C(7)H (6 = 5.22 - 5.14, 
m) and C(9)H (6 = 3.88, d, J = 4.8 Hz for 174). The data correlates well with the 
reported values for benzoate 202: C(7)H (6 = 5.02, dt q, J = 6.8 Hz) and C(9)H (6 
= 3.86, d, J— 3.8 Hz), as shown in Figure 18. 
















Figure 18: NMR comparison of anti diol monoesters 174 and 202 
The successful intermolecular Evans-Tishchenko reaction with aldehyde 175 and 3-
hydroxy enone 176 formed the anti diol monoester 174 with high yield (93 %) as a 
9:1 mixture of diastereomers. The inclusion of the two terminal alkenes in triene 174 
could now allow cyclisation to occur, forming the desired 8-membered lactone. 
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2.3 	FORMATION OF THE C(1) - C(7) LACTONE VIA RING 
CLOSING METATHESIS 
The elegant installation of the ester moiety and selective reduction of the C(9) enone 
of 3-hydroxy enone 176 in the formation of anti diol monoester 174 has been 
achieved by the Evans-Tishchenko reaction. The resultant anti diol monoester 174 
was synthesised to contain 2 terminal alkenes which could allow the formation of the 
C(1) - C(7) lactone 3 via Ring Closing Metathesis (RCM) as shown in Scheme 59. 
0 	 0 
5 	 Ii 
-Tho OH 14 	 1 OH 14 RCM .Y  
174 	 3 
Scheme 59: Lactonisation via RCM 
A potential prerequisite for the RCM of triene 174 was the protection of the C(9) 
hydroxyl to allow the metathesis to proceed smoothly. However, previous studies 
within the group have shown that the protection of the C(9) hydroxyl is only required 
to prevent acyl migration in the Evans-Tishchenko coupling. Since no acyl migration 
was observed (Scheme 58) the RCM of triene 174 was attempted without protection 
of the C(9) hydroxyl. Treatment of anti diol monoester 174 (Scheme 60), with the 
Grubbs 2"' generation catalyst 159 (10 mol%) in degassed CH2C12 at room 
temperature for 24 h showed very slight formation (20 %) of lactone 3. Increased 
catalyst loading (20 mol%) and heating under reflux for 24 h produced a 9:1 mixture 
of lactone 3 and substituted cyclopentene 204. 
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10  
1 OH 	 204 
203 
Scheme 60: RCM oftriene 174 
Reagents and Conditions: (a) Grubbs' 2 159 (20 mol%), CH2Cl2, A, 24 h (89 %). 
'H NMR of the major product revealed the loss of the two terminal alkene signals (6 
= 4.98 —4.90, m, C(5)H=CH2; 6 = 5.22 — 5.14, m, C(6)HCH2) and the formation of 
a new alkene signal (6 = 5.44 - 5.29, m, C(5)H & C(6)II) indicating the formation of 
the lactone. The presence of the C(1 1) — C(14) fragment was easily detected by the 
'H NMR (6 = 1.02, d, J = 6.9 Hz, C(13)H(CH3)2) showing that the RCM major 
product was lactone 3. 'H NMR analysis of the minor product has shown the 
presence of two distinctive terminal alkene signals (6 = 5.75, ddd, J = 17.0, 10.3 & 
6.7 Hz, C(5)HCH2; and 5.07 - 4.92, m, C(5)HCH2) and the absence of signals 
corresponding to protons attached to C(1 1) - C(14), which suggested that substituted 
cyclopentene 204 is also formed in the RCM of triene 174. The formation of by-
product 204 is thought to be due to the formation of stable intermediate 203 which 
directs the C(5) alkene away from the C(6) alkene and then allows the metathesis 
with the Q10) tn-substituted alkene. It was thought that a more functionalised anti 
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diol monoester could potentially allow a conformation which would be preferable to 
the formation of an 8-membered lactone.'4 
A convergent approach to the carbon framework of octalactin A 1 has demonstrated 
the highly selective and efficient nature of the intermolecular Evans-Tishchenko 
reaction and the effectiveness of RCM. The synthetic strategy should allow for a 
more efficient synthesis of the octalactins than previously reported, and should also 
allow for the synthesis of novel analogues of octalactin A with potentially improved 
biological activity. 
The key -hydroxy enone 176 in this Evans-Tishchenko/RCM strategy was 
synthesised in high yield (95 %) using a highly efficient HWE reaction between 
isovaleraldehyde and 3-ketophosphonate ester 192. 
-Ketophosphonate ester 192 was synthesised with high stereo-control (due to the 
anti aldol reaction using auxiliary 122) but only in moderate yield due to the poor 
displacement of auxiliary 122 with a phosphonate anion. Since this fragment is also 
required for the total synthesis of octalactin A, further investigation into the 
optimisation of the route leading to 3-ketophosphonate ester 192 was required and 
will be discussed in Chapter 3 
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RESULTS AND DISCUSSION PART 2 
CHAPTER 3 
IMPROVING THE SYNTHESIS OF THE C(6) - C(10) FRAGMENT OF 
OCTALACTIN A: THE GENERATION OF A THIOL DERIVED 
ABIKO-MASAMUNE AUXILIARY 
3.1 	INTRODUCTION 
As explained in Chapter 2, the synthesis of the C(6) - C( 10) fragment of octalactin A 
relies on the use of a chiral auxiliary (Figure 19) to direct a boron mediated anti 
aldol at the C(7) - C(8). The use of chiral auxiliaries in the synthesis of 3-hydroxy 
ketones under these aldol conditions with relative and absolute stereocontrol is a very 
common and efficient tool. One of the most common auxiliaries used to form these 
adducts is an oxazolidinone synthesised by Evans et al.45 Oxazolidinone 120 is 
widely used for the synthesis of syn aldol adducts giving generally excellent relative 
and absolute control. However using similar conditions and increasing the steric 
hindrance of the substituents on the boron ligand does not form the E-boron enolate 
required for anti aldol formation. Evans and co-workers have investigated the use of 
auxiliary 120 in the generation an anti aldol adducts and they have discovered that 
through careful control of the boron reagent, and by using chelating additives (e.g. 
MgCl2), the desired anti aldol adducts can be obtained .50'5 ' However, in general the 
investigation into the selective synthesis of anti aldol adducts using chiral auxiliary 








Figure 19: Evans and Abiko-Masamune chiral auxiliaries 
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The role of carboxylic esters in achiral anti aldol reactions is well known and 
although E-enolate formation is generally preferred, the selectivity in the formation 
of the anti aldol adducts can be poor. However, it has been found that treatment of 
the E-enolate of a hindered phenolic ester (2,6-dimethoxyphenyl propionate) with 
aldehydes can give anti aldol adducts with high diastereoselectivity. In their 
synthesis of discodermolide, Paterson et al. (Scheme 61) used low temperatures (-
100 °C) to form the E-enolate of carboxylic ester 205. Treatment of enolate 206 with 
the functionalised aldehyde 207 gave the anti aldol adduct 208 in high yield (81 %) 
and high dr (>97:3 anti:syn).44  
&0 	OTBS a 
PMBO 	
0, Li 





- 0 OHOPMB 
208 
Scheme 61: Paterson 's synthesis of discodermolide44  
Reagents and Conditions: (a) (i) 205, LiTMP, LiBr, THF; (ii) 207, -100 °C (8 1%). 
Recent studies 5255'97  have shown that chiral carboxylic esters can undergo 
enolisation with alkyl boron triflates and tertiary amines, allowing them to be 
suitable candidates for boron mediated aldol reactions. Abiko et al. have investigated 
the synthesis of anti aldols and have synthesised a carboxylic ester chiral auxiliary 
which can generate aldol adducts in high yield and, in addition, the correct choice of 
reagents can control both anti and syn stereochemistry. The Abiko-Masamune 
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auxiliary 122 (derived in 2 steps from norephedrine) has been used to synthesise a 
variety of aldol adducts using bulky boron triflates and triethylamine with excellent 
selectivity for the anti diastereomer.54 Therefore auxiliary 122 was used to construct 
the anti C(7) - C(8) fragment (Scheme 62) of octalactin A. As discussed in Chapter 
2, the aldol reaction using propionate ester 123 and acrolein gave aldol adduct 180 in 
high yield and selectivity (81 %, 98:2 anti:syn). It was thought that displacement of 
the auxiliary with a phosphonate ester anion would efficiently afford f3-
ketophosphonate ester 192, which could then undergo a HWE olefination with an 
aldehyde to synthesise a key fragment of octalactin A. Unfortunately displacement of 
the Abiko-Masamune auxiliary using this strategy proved problematic. 
OR 	Ph 	 Ph 
OR 	0 
b 
6 1 io(OEt)2 + HO( 
BnSO2Mes 	 BnLS02Mes 
180 R = H 	a 	 192 	 122 
191 R=TBS 
Scheme 62: Synthesis of/3-ketophosphonate ester 192 
Reagents and Conditions: (a) 2,6-lutidine, 0 °C, 5 mm; TBSOTf, 60 mm, 0 °C (51 %); (b) (i) BuLi, 
EtP(0)(OE02, THF, -78 °C; (ii)191, -78 °C (51 %). 
During their synthesis of rhizoxin D (Scheme 63) Leahy et al.66 avoided the direct 
displacement of the Abiko-Masamune auxiliary with a phosphonate anion and 
instead used a 2-step conversion of aldol adduct 209 to intermediate aldehyde 210, 
which reacted with the phosphonate ester anion to give phosphonate ester 211. 
Oxidation of alcohol 211 gave the -ketophosphonate ester 212 in good yield. 
However, avoiding the direct displacement of the Masamune-Abiko auxiliary added 
a further 4 steps to their synthesis. 
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Scheme 63: Synthesis offragment 212 
Reagents and Conditions: (a) DIBALH (100 %); (b) Dess-Martin periodinane (90 %); (c)(i) 'BuLi, 
EtP(0)(OEt)2, THF, -78 °C; (ii) 210, -78 °C (100 %); (d) Dess-Martin periodinane (96 %). 
Due to the poor yield of 3-ketophosphonate ester 192 via direct displacement 
(Scheme 62) we initially decided to adapt our synthesis of the C(6)— C(l0) fragment 
of octalactin A to investigate a longer route towards 3-ketophosphonate ester 192 
which could give a higher overall yield. Our new route (Scheme 64) was based upon 
reaction of the phosphonate anion with an intermediate aldehyde 213, as reported by 
the Leahy group. 
TBSO 0 Ph 	L[H] TBSO 0 	i.phosphonate  TBSO 0 0 -krii.[0] 
6(H 







Scheme 64: Revised synthesis of the C(6) - C(1 0) fragment of octalactin A 
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Our substrate differed from that of Leahy et al. in that a more bulky protecting group 
on the C(3) hydroxyl was required to prevent the decomposition of the aldol adduct 
191 when it was reacted with the phosphonate ester anion. As shown in Chapter 2, 
when a less bulky protecting group (TES) was used in the attempted formation of the 
-ketophosphonate ester 192, no product was found suggesting decomposition of the 
aldol adduct. The difficulty in displacing auxiliary 122 suggests that there is high 
steric hindrance around the carboxylic ester, preventing an efficient nucleophilic 
substitution. To overcome this, Abiko et al. reported the efficient cleavage of aldol 
adducts from auxiliary 122 via a reductive cleavage using LiA1H4.55 Treatment of 
aldol adduct 191 with LiA1H4 (Scheme 65) for a longer reaction time than reported 
(2 h instead of 1 h), showed no starting material by TLC. However upon work up, 
diol 214 was isolated showing that the ester group was reduced but with concomitant 
removal of the TBS group. The requirement for protection of the C(3) hydroxyl prior 
to HWE olefination is crucial to prevent quenching the phosphonate anion and 
epimerisation. Furthermore, reprotection of the C(3) hydroxyl and would require a 
number of unnecessary protecting group manipulations. We therefore decided to 
revise our synthesis towards f3-ketophosphonate ester 192. 
TBSO 0 Ph OH OH 
a 	- 6(4Qy 
Bn SO2Mes 
191 	 214 
Scheme 65: Reductive cleavage of auxiliary 122 
Reagents and Conditions: (a) LiA1H4, THF, 0 °C, 2 h (90 %). 
Due to these complications our new proposed synthesis (Scheme 66) of 13-
ketophosphonate ester 192 consisted of the hydrolysis of auxiliary 
98  122 to give a 
carboxylic acid, followed by conversion to the reactive acid chloride 215. Treatment 
of acid chloride 215 with a phosphonate anion would give the desired fragment 192. 
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TBSO 0 Ph 	 TBSO 0 phosphonate 
6Cl 	 192 
i. hydrolysis displacement 
	
N 	ii. acid chloride 




Scheme 66: Proposed hydrolytic synthesis of/3-ketophosphonate ester 192 
However when aldol adduct 191 was treated with the lithium hydroperoxide no 
reaction took place, even when the reaction time was extended from 3 h to overnight. 
This surprising result suggested that the bulky ester group required stronger 
hydrolysis conditions (Scheme 67). Aldol adduct 191 was then treated with aqueous 
LiOH at room temperature for 3 days and still did not yield the carboxylic acid. The 
hydrolysis of aldol adduct 191 was repeated using aqueous LiOH under reflux with 
careful monitoring by TLC. When TLC showed that there was no starting material 
remaining, the reaction mixture was worked up under standard conditions to give an 
inseparable mixture of desired carboxylic acid 216 and deprotected acid 217. The 
sluggish reaction times and resulting mixtures of protected and deprotected acids 
demonstrated a need for a new approach to solve the problem of the low yielding 
phosphonate displacement. 
TBSO 0 Ph 	
TBSO 0 	 OH 0 
6 ICY 9 0 	
a 	
6((' OH + 6'(oH 
Bn SO2Mes 
191 	 216 	 217 
Scheme 67: Hydrolysis of auxiliary 122 
Reagents and Conditions: LiOH, THF/H20 (1:1), A, 3—+18 h. 
Previous studies within the Hulme group have shown that 3-ketophosphonate esters 
can be easily synthesized via the direct displacement of thioesters using a 
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phosphonate anion.91 An achiral propionate thioester was used in anti aldol reactions 
with simple aldehydes and gave excellent anti:syn selectivities. Treatment of the 
aldol adducts 218 with the anion of an alkyl phosphonate afforded 3-
ketophosphonate esters 219 in good yield (69 - 94 %) as illustrated in Table 591 
Plo 0 Plo 0 0 
pO.1-lLsfBU 	
a or b 
n 	
R1 
218 	 219 
Entry Method n R R' 	P 	P1 	T 	Yield 219 (%) 
1 a 3 Me Me TBS TBS -78 °C 69 
2 b 3 Et Me TBS TBS -78 °C 85 
3 b 3 Et Me PMB TBS -78 °C 86 
4 b 5 Me H TBS TBS -78°C 84 
5 a 5 Me Me TBS TBDPS -42 °C 80 
6 b 5 Et Me TBS TBS -78°C 94 
7 b 8 Et Me TBS TBS -78 °C 94 
Table 5: Phosphonate displacement9' 
Reagents and conditions: (a) (i)'BuLi, DMPU (1 eq.), R'CH2P(0)(OR)2, THF, -78'C; (ii) 218,-78'C 
or -42 °C, 4 h; (b)(i) BuLi, R'CH2P(0)(OR)2, THF, 1 h; (ii) 218,-78'C, 4 h. 
Due to the successful formation of f3-ketophosphonate esters via the displacement of 
tert-butyl thioesters, as shown in Table 5, we decided to apply a similar strategy to 
optimise the formation of fragment 192 in our synthesis of octalactin A. This 
methodology (Table 5) had only been applied to achiral aldol reactions, therefore the 
synthesis of a chiral auxiliary which would generate a thioester was necessary. We 
also wanted to synthesise an auxiliary which had similar functionality to the Abiko-
Masamune auxiliary to maintain excellent relative and absolute stereocontrol in anti 
aldol reactions. Therefore the target for the new auxiliary was the thiol 4 shown in 
Figure 20. 







Figure 20: Thiol auxiliary 4 
3.2. 	GENERAL STRATEGIES TOWARDS AUXLIARY 4 
Our initial strategy was to perform a "direct displacement" (Scheme 68) reaction 
upon the Abiko-Masamune auxiliary 122 by activation of the alcohol and treatment 
with a thiolcarboxylic acid. A simple reduction of the respective thioester would give 
the shortest synthetic route towards auxiliary 220 (5 steps from norephedrine). 
Although this was the most efficient strategy towards auxiliary 220, using this 
strategy would have synthesised the thiol auxiliary with inversion of stereochemistry 
at C(1). Inversion at this position could potentially lower the diastereoselectivity of 










Bn N, S02Mes 
220 
Scheme 68: "Direct displacement" strategy 
We devised a further strategy towards thiol 4 which similarly involved activation of a 
norephedrine-derived compound. Here, activation of the NN-diprotected 
norephedrine (221 or 222) (Scheme 69, pathway 1), should facilitate neighbouring 
group participation of the C(2) nitrogen to give an aziridinium ion, intermediate (223 
or 224), with inversion of stereochemistry at C(1). Treatment with a thiolcarboxylic 
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acid should open the aziridinium ion and install the thiol moiety (masked as a 
thioester) with net retention of stereochemistry at C(l). Similarly if the sulfonamide 
of norephedrine 182 was activated (Scheme 69, pathway 2), the activated species 
could be converted into the stable aziridine 225, with inversion of stereochemistry at 
C(l). Aziridine 225 could be opened with a thiolcarboxylic acid to install a thiol 
moiety with net retention of stereochemistry at C(1). Although the "double 
inversion" strategy was a slightly longer route to auxiliary 4 (6 steps for both 
pathway 1 and pathway 2) than the "direct displacement" (5 steps) the 
stereochemistry at C(1) is the same as the classical Abiko-Masamune auxiliary. 
Retention of stereochemistry at this position should maintain the high 
diastereoselectivity of the adducts formed when used in the anti aldol reaction. 
Pathway 1 Double inversion via an aziridinium ion" 
Ph 
activation 
HO'(' of OH 
R N R1 
221 R = Bn, R1  = Bn 
222 R = Bn, R1  = PMB 
182 R = H, R1  = S02Mes 
N® 
® 
R R '	1  MsO 
223 R = Bn, R1  = Bn 
224 R = Bn, R1  = PMB 
FJ 
R1  















Pathway 2 "Double inversion via an aziridine sulfonamide" 
Scheme 69: The "double inversion" pathways towards auxiliary 4 
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3.2.1. 	Direct Displacement of the Abiko-Masamune Auxiliary 
Our initial strategy to form thioester 220 involved the direct conversion of alcohol 
122 via a Mitsunobu coupling, followed by hydrolysis of thioacetate 226 (Scheme 
70). This strategy was successfully used by Taylor et al. in the synthesis of C-linked 
disaccharides.99 However initial investigations of the Mitsunobu pathway proved 
unsuccessful. Treatment of alcohol 122 with azo-coupling agents (DEAD and DIAD) 
resulted in the recovery of starting material. 
Ph 	 0 P 
HO  




Scheme 70: Attempted Mitsunobu inversion of alcohol 122 
Reagents and Conditions: (a) (i) PPh3, DIAD or DEAD, 0 °C, 1 h; (ii) thiolacetic acid, 122, THF, 0 
°C, 1 h. 
Another potential method to synthesise auxiliary 220 was to convert alcohol 122 into 
the corresponding thiol. Nishio et al. have extended the use of Lawesson's reagent 
227 (Scheme 71), from its normal use in the conversion of carbonyls to 
thiocarbonyls, to the conversion of alcohols into thiols.10
1114  Unfortunately, 
treatment of alcohol 122 with a solution of Lawesson's reagent in DME, and heating 
under reflux afforded recovered starting material. 





122 	 227 	 220 
Scheme 71: Lawesson's Reagent strategy 
Reagents and Conditions: (a) 227, DME, A, 3 h. 
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Another synthetic strategy (Scheme 72) was to convert the Abiko-Masamune 
auxiliary 122 into the propionate derivative of thiol 220 via the mesylate of the 
benzyl protected norephedrine sulfonamide 228. The SN2 nucleophilic displacement 
of mesylate 228 with thiolacetic acid would give the thioester 226. Hydrolysis and 













0 	Ph 	i. hydrolysis 	0 	Ph 
ii. acylation 
BnSO2Mes 	 Bn 1 SO2Mes 
229 	 226 
Scheme 72: Mesylate synthesis of thiopropionate 229 
Studies"',"' into the synthesis of thioesters from amino alcohols 231 (Scheme 73) 
have shown that mesylate 230, generated from the respective hydroxycarbamate, 
does not undergo neighbouring group participation with the C(2) nitrogen. Instead a 
direct SN2 displacement occurs, resulting in inversion of configuration at C(1). Since 
the sulfonamide moiety in mesylate 228 has similar electron-withdrawing properties 








SN2 	 Ill 
FmocN -. 	 FmocN
-
—. 
- 	Ms 	 SAc 
230 	 231 
Scheme 73: "Direct" SN2 nucleophilic displacement 
Alcohol 122 was treated (Scheme 74) with methanesulfonyl chloride and 
triethylamine at 0 °C and the reaction was stirred for 1 h, until mesylate formation 
was complete (no remaining starting material 122 by TLC). Thiolacetic acid was 
then added to mesylate 228 in situ and the reaction was stirred for a further 3 h. 
However, only starting material was recovered after aqueous work up conditions. 
HO)( a MsO( a(H) 0. 
Bn NM 	 Bn 
N 
 S02Mes 	 Bn 
N 
 S02Mes 
122 	 228 	 226 
Scheme 74: Thioester formation of thioacetate 226 via mesylate 
Reagents and Conditions: (a) (i) MsCI, THF, 0 °C, 1 h; (ii) thiolacetic acid, MeCN, K2CO3, 3 h. 
Further investigations (Scheme 75) into the displacement of mesylate moiety were 
attempted using amines as nucleophiles. Treatment of alcohol 122 with 
methanesulfonyl chloride and triethylamine generated the mesylate after 1 h at 0 °C, 
as indicated by TLC. However when cyclohexylamine was added to mesylate 228 
the desired amine 232 was not formed, instead a mixture of alcohol 121 and its 
epimer 233 were obtained. The structure of epimer 233 was tentatively assigned 
using mass spectrometry and 'H NMR. In the latter, the C(1)H displayed a coupling 
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2.0 Hz 	a(ii) 
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Ph 	'\ 	 Ph 
HO<H) + HO "H 
Bn'LSO2Mes 	Bn1'SO2Mes 
122 	 233 
Scheme 75: Direct displacement of mesylate 228 using cyclohexylamine 
Reagents and Conditions: (a) (i) MsC1, Et3N, THF, 0 °C, I h; (ii) cyclohexylamine, Et3N, toluene, A, 
12h(122=24%;233=37%). 
A common method to generate thiols is the hydrolysis of a thiouronium salt 107-109  as 
shown in Scheme 76. However, treatment of the mesylate 228 with thiourea 
followed by reduction with sodium metabisulfite did not produce thiol 220. 
Ph 	 r 6NH2 Ph 	
a(ui) 	
Ph 
HS HO 	 )) H2NAS 
Bn'SO2Mes 	0 	Bn'SO2MesJ 	Bn LSO2Mes  
LOMS 
122 	 234 	 220 
Scheme 76: Thiouronium salt strategy 
Reagents and Conditions: (a) (i) MsCI, Et3N, THF, 0 °C, I h; (ii) Thiourea, i, 3 h; (iii) Na2S205, 
acetone, RT, 8 h. 
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A serendipitous discovery was made when an unknown product 235, formed when 
mesylate 228 was first treated with LiHMDS at -78 °C and then heated under reflux 
with HC1 generated from MeOHIAcC1 (Scheme 77) was isolated. X-Ray 
crystallography (Appendix 1) showed that this was in fact the isoquinoline 235; 
presumably formed by a Friedel-Crafts type reaction of the intermediate mesylate. 
Ph 	 [ 	Ph 	1 	 Ph 




122 	 228 	 235 
Scheme 77: Formation of isoquinoline 235 
Reagents and Conditions: (a) (i) MsC1, Et3N, THF, 0 °C, 1 h; (ii) LiHMDS, THF, -78 °C, 4 h; (iii) 
MeOH, acetyl chloride, A, 3 h (53 %). 
Isoquinolines are the core structures of a variety of biologically active natural 
products (e.g. napthyridinomycin"°" and saframycin A).'12 "4 Further 
investigation into the elucidation of the mechanism of isoquinoline formation is 
currently underway within the Hulme group with application to the synthesis of 







Figure 21: The crystal structure of isoquinoline sulfonamide 235, and the 
highlighted isoquinoline core ofpancratistatin 236 
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In summary, the direct displacement pathway shown in Scheme 68 has been 
attempted using a variety of techniques (mesylation followed by thiolcarboxylic acid 
displacement, thiouronium salt formation, Mitsunobu coupling of a thiolcarboxylic 
acid) as has proved unsuccessful. However, studies into the displacement of the 
mesylate 228 allowed for the serendipitous discovery of isoquinoline 246. The 
unsuccessful formation of thiol 220 using the "direct displacement" strategy led us to 
investigate different routes towards thiol auxiliary 4. 
3.2.2. 	Double Inversion via Intermediate Aziridinium Ion 
The new strategy (Scheme 78) was to convert dibenzylated alcohol 221 into an 
aziridinium ion 223 via the mesylate. Nucleophilic opening of aziridinium ion 223 
with thiolacetic acid would afford thioester 237. Mono-debenzylation of the C(2) 
amine 238 and treatment with mesitylenesulfonyl chloride should generate a 
thioacetate derivative of thiol 4. Hydrolysis of this ester, and subsequent acylation of 
the resultant thiol would produce the desired thiopropionate 239. 
Ph 	 Ph 	mesylate 	Ph,\7 	1 
[ HO( 
benzylation 	 formation 
HO 
NH2 	 NBn2 	 0 Bn' N ® Bn 	I LoMs 	] 
181 	 221 	 223 
10 
SH 




ii. hydrolysis 	NH 	 NBn2 BnSO2Mes ii. acylation Bn 
239 	 238 	 237 
Scheme 78: "Double inversion" strategy via the aziridinium salt 223 
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The mechanism of the mesylate displacement had to be carefully examined to 
confirm the stereochemistry at C(1). O'Brien et al. 119  have reported during their 
synthesis of chiral diamines 242, that the stereochemistry of mesylate 240 can be 
temporarily inverted by nucleophilic attack from the neighbouring amine to form an 
aziridinium intermediate 241, which is then opened with the nucleophile. The overall 













Scheme 79: Proposed "double inversion" mechanism 
Treatment of norephedrine (Scheme 80) with benzyl bromide and potassium 
carbonate efficiently produced dibenzylated alcohol 221. Alcohol 221 was converted 
into the mesylate and treatment with thiol acetic acid and Et3N produced thioacetate 
237 with high yield (86 %)•120  The stereochemistry at C(1) was suggested by a C(1)H 
- C(2)H coupling constant of 10.7 Hz in the 'H NMR and confirmed by X-ray 
crystallography (Appendix 2) which confirms that thioacetate 237 is formed via SN2 



















Scheme 80: Synthesis of thioacetate 237 
Reagents and Conditions: (a) BnBr, K2CO3,  MeCN, RI, 48 h (90 %); (b) (i) MsCI, Et3N, Et20, 0 °C; 
(ii) CH3COSH, Et3N, RT, 48 h (86 %). 
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Reduction of thioacetate 237 could potentially result in a chiral auxiliary for use in 
aldol reactions. The first requirement for the new chiral auxiliary was that it had to 
contain a thioester moiety so that facile displacement with phosphonate ester anions 
could occur. Although thiol 243 did contain a thioester moiety, the second 
requirement for the new chiral auxiliary was that it had to have similar functionality 
to the Abiko-Masamune auxiliary to maintain excellent relative and absolute 
stereocontrol in anti aldol reactions. As can be seen in Figure 22 the difference in 
the two new auxiliaries was the replacement of a smaller benzyl group with a bulkier 
sulfonamide substituent on thiol 243. 
Although thiols 243 and 4 had very similar structures, it was felt that the size and the 
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Figure 22: Crystal structure of thioacetate 237 and comparison of potential chiral 
auxiliary 243 to target auxiliary 4 
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Thioacetate 237 was treated with standard reductive conditions (1-12, Pd/C; H2, 
Pd(OH)2) to mono-debenzylate the C(2) amine (Table 6, entries 1 and 2), but only 
thioacetate 237 was recovered. It was believed that the presence of the thiol moiety 
poisoned the palladium catalyst. Mono-debenzylation of thioacetate 237 using 
stronger reducing conditions (LiDBB), as shown in Table 6, entry 3, only afforded 
recovered starting material. To overcome catalyst poisoning, cleavage of the benzyl 
group via oxidative formation (Table 6, entry 4) of the benzyl benzamide was 
attempted using ceric ammonium nitrate (CAN),'21 however, only starting material 
237 was recovered. 
Ph 	 Ph 
AcS-Y 	
AcS 
NBn2 NH B n' 
237 	 238 
Entry Reaction Recovery of Yield 238 
Conditions 237(%) (%) 
1 PdIC,H2 83 0 
2 Pd(OH)2/C, H2 90 0 
3 LiDBB 46 0 
4 CAN 90 0 
Table 6: Mono-debenzylation of thioacetate 237 
This aziridinium intermediate strategy was adapted to incorporate a protecting group 
that could be removed in the presence of a benzyl group without the requirement for 
reductive conditions as shown in Scheme 81. It was decided to protect the C(2) 
amine with both benzyl and 4-methoxybenzyl groups. Norephedrine was mono-PMB 
protected by treatment with anisaldehyde and NaBH4 to give alcohol 244 in good 
yield. Benzyl protection and installation of the thioacetate moiety were achieved in a 
similar manner to the formation of thioacetate 237. Singh 122  has reported the 
oxidative deprotection of PMB amines using DDQ, however this procedure was 
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found to give only a moderate yield of 30 % of the deprotected amine and can 
sometimes result in over-oxidation. Treatment of thioacetate 245 with DDQ 
unfortunately did not produce thioester 238 but an unidentifiable mixture of 
compounds. 





- -- AcS 
NH2 	 HN..PMB 	Bn 
	
PMB 	Bn 
181 	 244 	 245 	 238 
Scheme 82: Formation of and attempted mono-deprotection thioester 245 
Reagents and Conditions: (a) (i) Anisaldehyde, EtOH, RI, 40 mm; (ii) NaBH4, RT, 30 mm (70 %); 
(b) BnBr, K2CO3,  RI, 16 h (96 %); (c) (i) Et3N, MsCI, 0 °C, 45 mm; (ii) Et3N, CH3COSH, RT, 16 h 
(60 %); (d) DDQ, CH2C12, RI, 24 h. 
The "double displacement" pathway shown in Scheme 69 has been used to 
successfully synthesise thioesters 237 and 245 in good yield (81 % over 2 steps for 
237 and 60 % over 3 steps for 245). X-ray crystallography confirmed that thioacetate 
237 retained stereochemistry at C(l) and C(2), giving further evidence that "double 
inversion" and not direct displacement, occurred using these reaction conditions. The 
unsuccessful mono-deprotection of thioesters 237 or 245 led us to investigate 
alternative routes towards thiol auxiliary 4 which incorporate the "double inversion" 
mechanism. 
3.2.3. 	Double Inversion via Aziridine Sulfonamide 
A new strategy towards thiol 4 was devised which incorporated the "double SN2" 
reaction (Scheme 82). The alcohol of sulfonamide 182 (derived from norephedrine) 
was activated by conversion into the chloride, followed by treatment with base to 
form aziridine 225. Selective opening with a thiocarboxylic acid, followed by 
benzylation and reduction would afford thiol 4. 
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Scheme 82: Strategy towards the synthesis of thiol 4 
Cruz et al. 123  have reported (Scheme 83) the formation of chlorinated norephedrine 
derivatives 247. They have found that the addition of thionyl chloride to an amino 
alcohol gives a mixture of chlorides with inversion and retention of stereochemistry 
at C(1). However, when N-tosyl norephedrine 246 was treated with thionyl chloride 
it was found that the chloride 247 was formed with retention of stereochemistry at 
C(1) only. 
/\ 8.3 Hz 
Ph 	 Ph 
a 	H,,1 
HO"( 	 .Cl 	
H 
H"1'1 'Ts 	 H'Ts 
246 	 247 
Scheme 83: Chlorination with net retention 123 
Reagents and Conditions: (a) SOCl2, RT, 18 h (96 %). 
The similarity between the tosyl and mesityl groups suggested that chlorination of 
182 with SOd 2  would proceed with retention of stereochemistry. Indeed treatment 
of sulfonamide 182 with thionyl chloride (Scheme 84) gave alkyl chloride 248 in 
excellent yield (97 %). 1 H NMR indicated a large coupling constant (9.5 Hz) 
between C(l)H and C(2)H which was similar to that of the tosyl derivative 247 (8.3 
Hz) suggesting that the stereochemistry was retained. 
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Scheme 84: Chlorination of sulfonamide 182 and confirmation of stereochemistry 
Reagents and Conditions: (a) SOCl2, RI, 18 h (97 %). 
Due to the electron withdrawing nature of the sulfonamide group, 182 was treated 
with a strong base (BuOK) to effect deprotonation (Scheme 85), and intramolecular 
displacement of the chloride gave the aziridine 225 in good yield (92 %) with 
inversion of stereochemistry at C(l). 'H NMR showed a reduced coupling constant 
(4.8 Hz) between C(l)H and C(2)H of aziridine 225 which was in good agreement 
with known compound 249 (4.3 Hz), implying inversion of stereochemistry at C(1). 





H'H HN 'H 
HNS02M S02Mes I 	SES 
248 225 L 249 
Scheme 85: Aziridine formation and confirmation of stereochemistry 
Reagents and conditions: (a) tBuOK, DMF, 0 °C, 30 mm -f RI, 4.5 h (92 %). 
Reports by Kellogg et al. 124  have shown (Scheme 86) that the opening of ephedrine 
derived aziridines 250 can be achieved by treatment with thiols. It was also 
reported 124  that when thiol carboxylic acids are used the desired thioester 251 is not 
formed, but spontaneous acyl migration occurs to give an amide 252 followed by 
rapid aerobic oxidation to give disulfide 253. 
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Scheme 86: DisuijIde formation after aziridine opening 
It was felt that the presence of the C(2) sulfonamide has reduced the nucleophilicity 
of the C(2) amine and this would stop acyl migration occurring. Initial attempts to 
open aziridine 225 with thiol acetic acid failed but Hou et al. ' 25"26 have reported the 
use of catalytic PBu3 with amine and thiol nucleophiles to open tosylated amines 
under aqueous conditions. It is believed that the PBu3 initially opens the aziridine 
225 to give the zwitterion 254 which then proceeds to deprotonate the corresponding 
nucleophile. The aziridine opening and nucleophile deprotonation cycle then 
continues until reaction completion, as shown in Scheme 87. 
Ph,,,, 
N 	 Ph 
SO2Mes 
225 





Bu3P 	 AcS 
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S02Mes 	
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Scheme 87: Mechanism of aziridine opening 
Treatment of aziridine 225 with PBu3 and thiolacetic acid gave thioacetate 255 in 
high yield (93 %) with exclusive regioselectivity. It was shown that acyl migration 
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did not occur, thus implying that the presence of the electron withdrawing 
sulfonamide group hinders this phenomenon. The relative stereochemistry of acetate 
255 was determined through increased coupling of the C(1)H and C(2)H signal (4.8 
Hz) of the locked aziridine conformation to the large coupling (9.5 Hz) of the opened 
acetate. This is in good agreement with the C(1)H and C(2)H coupling of alcohol 182 
(8.1 Hz) as shown in Scheme 88. 
/ 	. 9.5 Hz 	 8.1 Hz 
Ph 	 0 P Ph \ 
a R
AS<H) 	 HO <H) 
	
SO2Mes 	 HN.. HN.. 
225 	 255R=Me 	 182 
256 R = Ph 
Scheme 88: Opening of aziridine 225 
Reagents and Conditions: (a) RCOSH, PBu3 (10 mol %), MeCN/H20 (1:4), RT, 24 h (93 %, R = Me), 
(93%, R = Ph). 
For the new auxiliary to mimic the classical Abiko-Masamune auxiliary, the C(2) 
sulfonamide required benzyl protection. However when sulfonamide 255 was treated 
(Scheme 89) with tBuOK  and benzyl bromide, the sulfonamide was not protected, 
instead acetate migration via 257 and subsequent thiol protection occurred to give 
amide 259 in moderate yield (70 %). 












Scheme 89: Attempted benzylation of sulfonamide 255 
Reagents and Conditions: (a) 'BuOK, BnBr, DMF, 0 °C, 30 mm -+ RT, 4.5 h (70 
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It has been reported that acetate protecting groups can be manipulated with specific 
conditions to promote migration, therefore in order to prevent acyl migration 
occurring the thiolcarboxylic acid was changed from the smaller, more versatile 
acetate to the less reactive benzoate group. Treatment of aziridine 225 with 
thiolbenzoic acid using similar conditions for the formation of thioacetate 255 gave 
thiobenzoate 256 as a colourless solid. The stereochemistry was determined by both 
'H NMR, and X-ray crystallography (Appendix 3). The crystal structure shows the 
required (2R,35) stereochemistry in Figure 23. 
0103 0 Ph 	










Figure 23: Crystal structure of thiobenzoate 256 
When thiobenzoate was treated (Table 7) under reaction conditions used to 
synthesise migration product 259, the desired benzoate 260 was produced in 
moderate yield (60 %) with a dibenzyl protected product 261 in low yield (30 %). 
'3C NMR clearly showed a quaternary carbon at 190.24 ppm for 260, which is 
indicative of thioester carbonyl and a signal at 48.53 ppm assigned to the benzylic 
carbon. '3C NMR analysis of by-product 261 showed no signal in the thiocarbonyl 
region and two CH2 signals (8 = 47.88 and 35.50) implying that dibenzyl protection 
has occurred. 'H NMR of thiobenzoate 260 showed a pair of signals in an AB system 
(8 = 4.85, 1H, d, J= 16.2 Hz, CHAHBPh; and 4.53, 1H, d, J= 16.2 Hz, CHAHBPh), 
corresponding to the two benzylic protons. Whereas, by-product 261 showed two 
sets of distinct AB doublets (8 = 5.06, 1H, d, J= 16.4 Hz, CHAHBPh; 6 = 4.79, 1H, d, 
J= 16.4 Hz, CHAHBPh; 6 = 3.73, 1H, d, J = 13.0 Hz, CHxHyPh; and 6 = 3.65, 1H, d, 
J 	13.0 Hz, CHxHyPh), confirming that by-product 261 contains four benzylic 
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protons. Subsequent studies within the group have shown that treatment with a 
milder base (K2CO3)  to protect sulfonamide 256 with a benzyl group does not 
produce desired thioester 260. Gratifyingly, treatment of sulfonamide 256 with 
sodium hydride and benzyl bromide gave thioester 260 exclusively. 
0 Ph 








BnS --Y  
Bn SO2Mes 
261 
Method 	Conditions 	Yield 260 (%) Yield 261 
(%) 
a 	1BuOK, BnBr, DMF, 0°C, 	60 	 30 
30 min —* RT, 4.5h 
b 	K2CO3, MeCN, RT, 24 h 
	
0 	 0 
c 	NaH, BnBr, DMF, 0 °C, 	100 	0127 
30 mm -* RT, 18 h 
Table 7: Protection of sulfonamide 256 
The next step towards the synthesis of thiol 4 required the removal of the benzoate 
group to give the thiol. A major concern regarding the synthesis of thiol auxiliary 4 
was the stability of free thiol to aerial oxidation. As illustrated in the work of Kellogg 
et al. (Scheme 86), opening of aziridine 250 with a thiol carboxylic acid caused rapid 
rearrangement to a thiol 252, which then spontaneously oxidized to give the disulfide 
253. Thiobenzoate 260 was reduced with LiA1H4 to give thiol 4 as a stable colourless 
solid. A sample of thiol 4 was left at room temperature and was monitored by 'H 
NMR as the thiol doublet will disappear if disulfide 124  is generated. The sample was 
monitored for a period of 6 months and thiol doublet was clearly present in the 1H 
NMR (Figure 24), showing that no oxidation of thiol 4 had occurred. This implies 
that the steric hindrance of the substrate is high enough to disfavour the formation of 
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disulfide 262. This is a welcome result as it shows that after the auxiliary has 
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260 	 4 	 262 
Scheme 90: Potential aerial oxidation of auxiliary 4 
Reagents and Conditions: (a) LiAII-14, TI-IF, 0 °C, 2.5 h (95 %). 
250 	 200 	 160  
ppr (Ifl 
Figure 24: 'H NMR oxidation study of thiol 4 showing relative integral sizes over 6 
months 
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Thiol 4 was treated (Scheme 91) with propionyl chloride and pyridine to give the 
thiopropionate 239 in good yield (93 %). X-ray crystallography of thiopropionate 
239 (Appendix 4) was in good agreement with 'H NMR analysis and confirmed the 
regioselectivity and stereoselectivity of the opened aziridine. X-ray crystallography 
of thiopropionate 239 was also in good agreement with the '3C NMR confirming that 
no cleavage of the benzoate group occurred during the efficient benzylation of 
sulfonamide 256, previously shown in Table 7. 
	
Ph 	 0 Ph 
HS 	
a 
Bn'SO2Mes 	 Bn 
N
SO2Mes 
4 	 239 
Scheme 91: Acylation of thiol 4 and crystal structure of thiopropionate 239 
Reagents and Conditions: (a) CH3CH2C0C1, pyridine, CH2Cl2, 0 °C, 18 h (93 %). 
In summary, the "double inversion" pathway shown in Scheme 69 has been used to 
successfully synthesise thioester 239 in good yield (75 % over 6 steps). X-ray 
crystallography and other spectroscopic techniques have confirmed the 
stereochemistry at C(l) and C(2) giving evidence that the formation and opening of 
aziridine 225 proceeds via a "double inversion" mechanism. The formation of thiol 4 
can allow a direct comparison of yields and selectivities of aldol formation and 
auxiliary displacement with mild nucleophiles, with the classical Abiko-Masamune 
auxiliary. 
3.3. 	BORON MEDIATED ANTI ALDOL USING AUXILIARY 4 
As discussed in Chapter 2, Masamune et al. have reported that the enolisation 
conditions used for boron mediated aldols are governed by a selective choice of 
reagents. In the classical auxiliary the formation of the anti aldol is controlled by the 
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addition of a bulky boron compound (cHex)2BOTf  and triethylamine at low 
temperatures to form the kinetic E-enolate. We have used these optimised conditions 
with the propionate derivative 239. Gratifyingly we have found that we can obtain 
anti aldol adducts in high yield and selectivity (Table 8). We have carried out the 
aldol reactions using a variety of aldehydes (vinyl, aliphatic and aromatic) to test the 
versatility of the auxiliary. It was found that using all of these substrates allowed the 
highly selective formation of anti aldol adducts in high yields. The relative 
stereochemistry of the major diastereomers were assigned on the basis of the large 
coupling (-7.0 Hz) between C(2)H and C(3)H protons of the aldol adducts. The 
stereochemistry of the minor diastereomers were assigned by analogy with literature 
precedent. 
O Ph 	 (CHex)B 	Ph 	 OH 0 Ph 
a 	 b R SL( 











265 92 (93:7) 79 (98:2) 
266 90 (92:8) 97 (96:4)14 
267 85 (93:7) 95 (98:2) 14 
268 94 (94:6) -- 
269 85 (91:9) 93 	)54  
O-q 
270 91(97:3) -- 
Table 8: Anti aldol reactions using thiopropionate 239 
Reagents and Conditions: (a) (Hex)2BOTf, Et3N, CH2Cl2, (b) RCHO. 
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In order to confirm the absolute stereochemistry of the major diastereomer at the 
C(1) - C(3) position, the aldol adduct 267 was subjected to a mild reduction (NaBH4) 
to form the known diol'28 271 (Scheme 92) in almost quantitative yield. The 
spectroscopic data for 271 was in good agreement with the literature values,' 28 as 
was the optical rotation value [[al,, = - 18.4 (c 1.0, CHC13), lit. 128 -18.6 (c 2. 0, 
CHC13)]. 
OHO Ph 	 OH OH 	Ph a 	
+ HS 
BnSO2Mes 	 Bn'SO2Mes 
267 	 271 	 4 
Scheme 92: Mild reduction of aldol adduct 267 
Reagents and Conditions: (a) NaBH4, THF, 0 °C, 1 h (99 %). 
Due to the successful formation of anti aldols with thiopropionate 239, investigation 
into the auxiliary's versatility with the formation of syn adducts 273 (Scheme 93) is 
currently being carried out within the group. It has also been reported by Abiko et al. 
that the selective formation of syn adducts may be achieved by using the appropriate 
boron/base combination. In this case propionate 239 was treated with a less sterically 
hindered boron species (Bu2BOTf) and was used along with a bulky base (1Pr2NEt) 
at low temperatures to form the Z-enolate 272. Reactions of propionated auxiliary 
239 with vinyl, aliphatic and aromatic aldehydes are proposed to give syn aldol 
adducts in high yield and high selectivity. 
O Ph 	 1BU2B, 	Ph 	 OH 0 Ph 
r,~,S,y a 0. "'~:~Sy b 
o. RS)( 
Bn S02Mes 	 Bn S02Mes 	 Bn S02Mes 
239 	 272 	 273 
Scheme 93: Syn aldol reactions using thiopropionate 239 
Reagents and Conditions: (a) Bu2BOTf, 'Pr7NEt, CH2Cl2, -78 °C; (b) RCHO, CH2C11, -78 T. 
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The main focus for the synthesis of the thioester auxiliary 4 was its potentially facile 
displacement with mild phosphonate nucleophiles, (Table 9) compared with the 
inefficient Masamune auxiliary. Treatment of protected aldol adducts (Table 9) with 
the anion of diethylethane phosphonate gave the desired 0-ketophosphonate esters 
whilst simultaneously allowing the auxiliary to be recovered. It can be seen that the 
generation of the 0-ketophosphonate esters of vinyl (192 and 281), alkyl (282 and 
283) and aromatic (284) aldol adducts was achieved with high yield (78-91 %) and 
with high recovery of the thiol auxiliary 4 (79-81 %). 0-Ketophosphonate esters 192, 
282 and 284 were produced as a mixture of diastereomers (diastereomeric ratios 
varied from 4:1 to 3:2 which were confirmed by 1H NMR). These diastereomers 
were not separated since it has been reported that similar mixtures of 9-
ketophosphonate esters afford only E-enones upon HWE olefination.29 U-
Ketophosphonate esters 281 and 284 were produced as single diastereomers, but the 
lower yields (81 % and 78 %) suggested that the minor diastereomer might have 
been separated during purification. 




2 + HS'( 
	
BnS02Mes 	 BnS02Mes 
R1 =H 264 	 280 	 4 
R1 =TBS 274 
R 	TBS 	Yield (%) Phosphonate Yield (%) 	Yield 4 (%) 
275 95 192 90(4:1) 91 
276 94 281 81 85 
277 91 282 89(4:1) 85 
278 94 283 91(3:2) 79 
oY 279 93 284 78 80 
Table 9: Displacement of auxiliary 4 with phoshonate anion 
Reagents and Conditions: (a) TBSOTf, CH2Cl2, 0'C; (b) (i) BuLi, EtP(0)(OEt)2, THF, -78 °C; 275 - 
279,-78 °C. 
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The successful displacement of the auxiliary under mild conditions suggests that a 
number of other displacement reactions may be possible. These are summarised in 
Scheme 94. We have previously illustrated in Scheme 92 the mild reductive 
conditions (NaBH4) required to form diol 271 in high yield (99 %). These mild 
conditions prevent the application of harsh hydride sources (LiAIH4, DIBALH) 
required with the classical auxiliary (which are generally incompatible with several 
protecting groups). The difficulty in hydrolysis of aldol substrates 191 from the 
classic auxiliary (as previously shown in Scheme 67) has led to the requirement for 
investigation of hydrolysis of aldol adducts 285 using mild conditions. The reduction 
of an ester moiety to an aldehyde can be achieved by the careful addition of 
DIBALH to an ester at low temperatures (-100 °C) over short reaction times (-30 
mm). However, the over-reduction of the ester moiety to the alcohol is a common 
problem. A more robust method for aldehyde formation is the reduction of Weinreb 
amides or thioesters. Fukuyama et al. 129,  have reported the reduction of decanyl 
thioesters to synthesise aldehydes from thioesters under mild conditions (DIBALH or 
Pd/C and Et3SiH). Therefore we are interested in the application of the reduction of 
aldol adducts 285 using the conditions described by Fukuyama et al. 
Although the formation of alcohols, carboxylic acids 286 and aldehydes 287 from 
adduct 285 are useful chemical transformations, we are also interested in the 
displacement of aldol adduct 285 with more complex nucleophiles. The nucleophilic 
displacement of chiral auxiliaries with N-acetyl cysteamine (NAC), towards the 
formation of the NAC thiol esters are problematic under standard carbodiimide 
coupling conditions. '3 ' Hence the formation NAC thiol esters 288 via displacement 
of auxiliary 4 would be advantageous. An efficient method in the synthesis of 
peptides, is native chemical ligation. We are interested in utilising auxiliary 4 in a 
chemical ligation 112-114  for the synthesis of novel complex peptides 289. Fukuyama et 
al. have also reported Grignard displacements and Sonogashira couplings using 
decanyl thioesters. The incorporation of these methods towards aldol adducts 285, 
along with the others shown in Scheme 94, would display the versatility of chiral 
auxiliary 4 and its potential incorporation into organic synthesis. 
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Scheme 94: Proposed displacements of aldol adduct 285 
3.4 	FURTHER WORK: BORON MEDIATED ACETATE ALDOL 
REACTION 
Abiko et al. have investigated the use of carboxylic esters and their role in boron 
mediated acetate aldols (Scheme 95). They investigated this as an extension of the 
use of auxiliary 122 after having successful initial results using propionate esters. 
However, when the acetate 292 was treated with (cHex)2BOTf  and triethylamine the 
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desired aldol adduct was formed as the minor product of a mixture of 294 and diol 
295 (5:95 294:295). 
O Ph 	
a r(cHex)2B 0 Ph 
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Scheme 95: Double acetate aldol reaction 
Reagents and Conditions: (a) ('Hex)2BOTf, Et3N, CH2C12, -78 °C, 10 mm; (b) RCHO (95 %). 
They have suggested from 'H NMR analysis of an isolated boron enolate 293, that 
the intermediate is doubly borylated'35"36 and this undergoes a double aldol reactions 
to give the diol. Although the formation of this diol via a double aldol process is a 
very interesting reaction, we are interested in the utilisation of thioacetate 296 
towards the formation of mono-aldol adducts as shown in Scheme 95. We are 
encouraged to investigate auxiliary 4 in the acetate aldol reaction since Abiko et al. 
have stated that the double aldol phenomenon should only occur with an acetate ester 
source and not with other carbonyl containing compounds, such as methyl ketones, 
propionate esters and acetate thioesters. We would therefore like to investigate the 
boron mediated acetate aldol with thiol 4 with a variety of aldehydes (aliphatic, vinyl 
and aromatic). If the acetate aldol reaction is successful with these aldehydes, then 
auxiliary 4 can be applied to the synthesis of the C(l l)-C(15) fragment of octalactin 
A. The proposed synthesis (Scheme 95) would consist of an aldol reaction with 
isobutyraldehyde to give the aldol adduct 297. Protection of the adduct with 
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trichloroacetimidate 298 would give the protected aldol adduct 299. Reductive 
cleavage of aldol adduct 299 using either DIBALH or Pd/C and Et3SiH would give 
the aldehyde in 3-steps instead of the longer 4-, 5-step routes which will be discussed 
in Chapter 4. 
Ph 	 OHO Ph 
As.,y ---------------- "T"J"As'y 
Bn''SO2Mes 	
0 
296 	 297 







PMBO 0 Ph 
7 
or Et3SiH, Pd/C 





Scheme 95: Proposed synthesis of C(11)-C (1 5) aldehyde fragment 7 
3.5 	CONCLUSIONS 
The formation of auxiliary 4 has been attempted using three different pathways: 
"Direct displacement" 
"Double inversion" via an aziridinium ion 
"Double inversion" via an aziridine sulfonamide 
Investigations with "direct displacement" and "double inversion" via an aziridinium 
ion strategy were not successful in the synthesis of thiol auxiliary 237. Anti aldol 
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reactions were carried out using the propionate derivative 239 with various aldehydes 
and the resultant aldol adducts were formed in good yield with high selectivity, both 
of which were comparable to reported results with the classical Abiko-Masamune 
auxiliary. Displacement of the aldol adducts with phosphonate anions using mild 
conditions resulted in the formation of 3-ketophosphonate esters with high yields. 
The high yielding synthesis of 0-ketophosphonate esters using propionate derivative 
239 has resulted in the optimisation of the synthesis of C(6) - C(lO) fragment which 
can be used in the total synthesis of octalactin A, and will be discussed in Chapter 4. 
The ease of use in synthesis, its stability, its efficiency in aldol adduct formation and 
facile cleavage of auxiliary 4 with mild nucleophiles has led to further investigations 
into utilisation of this auxiliary in other aldol reactions. 
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RESULTS AND DISCUSSION PART 3 
CHAPTER 4 
TOTAL SYNTHESIS 
After conducting a series of model studies (discussed in Chapter 2), a total synthesis 
of octalactin A was attempted as shown in Scheme 96. The route to this natural 
product will be presented and discussed in the following chapter. The model studies 
had allowed the development of methodology for the major steps in the synthesis 
(including anti aldol coupling, phosphonate displacement, HWE coupling, 
intermolecular Evans-Tishchenko coupling and RCM). The next necessary step was 
to synthesise the two major aldehyde fragments 5 and 7 for the total synthesis. 
octalactin A I 
JJ/ directed epoxidation 
0 



















Scheme 96: Second generation retrosynthetic analysis of octalactin A 
109 
Results and Discussion III 
4.1 	SYNTHESIS OF THE C(11)-C(15) FRAGMENT 
Fragment 7 was previously synthesised within the Hulme group (Scheme 
97)29  using 
a strategy based on an acetate aldol reaction using thiazolidine thione 300 (3 steps 
from valine) with isobutyraldehyde, to give the aldol adduct 301 in good yield (72 
%) with high diastereocontrol (dr 97:3). It was initially thought that protection of the 
free hydroxyl of aldol adduct 301 using trichioroacetimidate 298 would allow for a 
facile and mild deprotection in the latter stages of the synthesis. Reduction of the 
protected aldol adduct would give the key aldehyde 7 in only 3 steps. 
S 0 	 S 0 OH 
)L. 	II i. Acetate aldol 
S N' S N 
\_J 	I 
1 
300 	 301 





Scheme 97: Initial synthetic strategy towards aldehyde 7 
However, the direct installation of the PMB moiety via trichloroacetimidate 298 
under acidic conditions gave no protected adduct, 29  therefore a new route was 
required to install the PMB group. Protection was achieved by cleavage of the aldol 
adduct from the chiral auxiliary to give diol 302. This was followed by the formation 
of PMP acetal 303 and selective reduction to give protected alcohol 304. Oxidation 
of the primary hydroxyl gave aldehyde 7, as shown in Scheme 98. 
29  
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Scheme 98: Initial synthesis of aldehyde 7 
Reagents and Conditions: (a) (i) TiCI4, 'Pr2NEt, C171202, -78 °C, 40 mm; (ii) isobutyraldehyde, 
CH202, -78 °C, 20 mm (72 %, dr 97:3); (b) NaBH4, THF, 0 °C, 1 h (88 %); (c) TsOH•H
20, p-
methoxybenzy dimethyl acetal, DMF, RT, 10 h (89 %); (d) DIBALH (1.0 M in toluene), CH202, RT, 
15 mm (72 %); (e) IBX, DMSO/THF, RT, 1 h (94 %). 
This indirect protection of the C(1 3) hydroxyl resulted in two further steps being 
added to the acetate aldol approach towards the synthesis of aldehyde 7. The 
auxiliary used in this approach (acetylated thiazolidine thione 300) was synthesised 
from the less common amino acid (R)-valine. The increased cost of the less abundant 
valine enantiomer limited the scale of synthesis of acetylated auxiliary 300 and 
aldehyde 7. Therefore a less expensive and more efficient route to aldehyde 7 had to 
be devised. The revised synthesis of aldehyde 7 (Scheme 99) consisted of an 
allylboration with isobutyraldehyde to give allylic alcohol 305. Protection of the 
C(13) alcohol, followed by ozonolysis of the alkene, would afford the key aldehyde 
in 3 steps. 
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305 	 7 
Scheme 99: Revised synthetic strategy towards aldehyde 7 
4.1.1. 	Allylboration 
There are a variety of different methods used for the synthesis of chiral homoallylic 
alcohols. As discussed in Chapter 1, Brown et al. have shown that the treatment of 
allylboranes (derived from naturally occurring terpenes) with aldehydes can allow 
for the efficient synthesis of homoallylic alcohols with high 
enantioselectivity.32'34'35'38  The allylborane 73 (Scheme 100) was chosen as it was 
previously reported to give a high yield and high selectivity in the allylboration of 






Scheme 100: Allylboration of isobutyraldehyde using allylborane 73 
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4.1.1.1. 	Synthesis of Allyldiisopinocampheylborane 
Allylborane 73 was synthesised from the organometallic addition of allylmagnesium 
bromide to methoxydiisopinocampheylborane 77 as shown in Scheme 101. 
Synthesis of (-)-f3-methoxydiisopinocampheylborane 77 from pinene 306 allowed the 
allylboration to be carried out on a large scale. Careful addition of BH3•SMe2 to a-
pinene 306, maintaining the reaction at room temperature, followed by a slow 
crystallisation, afforded borane 307. 137,131 Slow methanolysis of borane 307 at low 
temperature prevents disproportionation occurring, which can lower the subsequent 
enantioselectivity of the allylboration. Dropwise addition of allylmagnesium bromide 
to methoxy borane 77 afforded the allylborane and magnesium salt by-product. 
Removal of the magnesium salts by filtration afforded allylborane 73. 
a 	
b~




306 	 307 	 77 	 73 
Scheme 101: Synthesis of allyldiisopinocampheylborane 73 
Reagents and Conditions: (a) BH3•SMe2, THF, RT; (b) MeOH, Et20, 0 °C -p RI, 2 h; (c) 
allylmagnesium bromide, Et20, 0 °C -+ RT, 1 h. 
Slow addition of isobutyraldehyde (Scheme 102) to a cooled solution (-100 °C) of 
allyl borane 73 for 1 h, followed by an oxidative work up provided the homoallylic 
alcohol 305 in good yield (87 %). Although Brown has reported that allylboration 
takes place instantaneously using salt-free conditions, the reaction time was extended 
to 1 h to allow completion of the reaction. 34 
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Scheme 102: A ilylboration of isobutyraldehyde 
Reagents and Conditions: (a) isobutyraldehyde, Et20, -100 °C, 1 h, (87 %, 93 % e.e.). 
The allylation of aldehydes proceeds through a chair-like transition state 308, where 
the isopropyl group occupies an equatorial position and the facial selectivity of the 
aldehyde derives from the minimisation of steric interactions between the axial 
isopinocampheyl ligand and the allyl group, as shown in Scheme 102. The absolute 
stereochemistry of allylic alcohol 305 was assumed on the basis of precedent. 14  The 
enantiomeric purity (Scheme 103) of alcohol 305 was confirmed by 'H NMR 
analysis (8 = 2.43 ppm, C(12)H2 for the minor, and ö = 2.35 ppm for the major 
Mosher ester 309) and '9F NMR (8 = -72.5 ppm, CF3 for the minor and ö = -72.6 
ppm for the major Mosher ester 309) showing that homoallylic alcohol was 
synthesised with a high selectivity (93 % e.e.). 
19F NMR: -72.6 ppm Major -- 
-72.5ppmMinor F3C . 
OH 	 MeO' 
15 	
a 	
1H NMR: 2.35 ppm Major 	o 	a 
12 	 2.43 ppm Minor 15 
305 	 309 
Scheme 103: 'Hand 19  FNMR analysis of Mosher ester 309 
Reagents and Conditions: (a) MTPA-C1, DMAP, THF, 12 h, RI (80 %). 
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4.1.2 	Oxidative Cleavage of the C(5)-C(6) Alkene 
Protection of the C(13) hydroxyl (Scheme 104) as the PMB ether would allow a mild 
oxidative deprotection in the latter stages of the synthesis of octalactin A. It was also 
decided to protect the C(13) hydroxyl as the benzyl ether to allow selective 
deprotection in the latter stages of the synthesis of octalactin A. This selective 
deprotection strategy could allow the formation of analogues of octalactin A, and so 
facilitate further investigation into the biological activity of the octalactin series. 
Treatment of protected alcohol 305 with PMBCI (or BnBr) and 'BuOK afforded the 
PMB ether 310 (or benzyl ether 311). The conversion of protected alcohol 310 into 
the key aldehyde 7 was attempted using standard ozonolysis conditions, as reported 
by Evans et al. 139 Treatment of alcohol 310 with ozone followed by the addition of 
dimethyl sulfide, gave an inseparable mixture of aldehyde 7 and an unidentifiable by-
product in poor yield (20 %). The conversion of alkenes to aldehydes using 
ozonolysis is generally a very reliable method. However, the addition of ozone to an 
alkene is a non-selective process and the substrate which undergoes ozonolysis must 
only contain alkenes which are required to be oxidatively cleaved. The low yield was 
believed to due to ozonolysis of the aromatic protecting group, 140 as well as the vinyl 
alkene, causing degradation of the aldehyde 7. The low yield for the oxidative 
cleavage of the alkene moiety using ozonolysis demonstrated that a milder oxidative 
cleavage of the vinyl alkene was required. 
OR 
i 305 R=H 	a 





Scheme 104: Protection of alcohol 305 and attempted ozonolysis 
Reagents and Conditions: (a) PMBC1, 'BuOK, THF, RI, 4 h (75 %); (b) BnBr, 'BuOK, THF, RT, 4 h 
(69 %); (c) (i) 03 CH2C12/Me0H, 10 mm; (ii) SMe2, 7 h, (20 %, R = PMB). 
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A new strategy (Scheme 105) towards the formation of PMB protected 3-hydroxy 
aldehyde 7 from alcohol 310 required dihydroxylation of the vinyl alkene, followed 
by oxidative cleavage of the diol to give aldehyde 7. Diol 313 was formed in situ by 
the addition of 0SO4 to protected alcohol 310. Addition of NaT04 over 2 h as 
reported by Cossy et al. 
141  gave aldehyde 7 in good yield (84 %). The same 
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312 R=Bn 
Scheme 105: The dihydroxylation and periodate cleavage of homoallylic alcohols 
310 and 311 
Reagents and Conditions: (a) (i) 0s04, H20/THF, 10 mm; (ii) Na104, 2 h (310 = 84 % and 311 = 79 
%). 
Using the modified method as shown in Scheme 105, aldehyde 7 could now be 
synthesised in 4 steps with an overall yield of 55 %. The relatively low cost of the 
pinene required to synthesise allylborane 73, in comparison to the cost of (R)-valine 
required for acylated thiazolidine thione 300, has allowed for the more economical 
large scale synthesis of aldehyde 7. Fewer synthetic steps using this route have 
resulted in a more efficient route to aldehyde 7. 
4.2 	SYNTHESIS OF C(1)-C(5) FRAGMENT 
The synthesis of fragment 5 (Scheme 106) required mono-protection of propane diol, 
followed by oxidation of the remaining hydroxyl group to the aldehyde 103. This 
aldehyde could then undergo an asymmetric crotylboration using reagent 82 to yield 
the chiral alcohol 315. The manipulation of the PMB group via acetal formation and 
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selective reduction would protect the secondary alcohol, and subsequent oxidation of 
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PMBO 	0 	ii. [H] 0PMB 
H 	iii. [0] 	
--  
5 	 315 
Scheme 106: Synthetic strategy towards aldehyde 5 
4.2.1. 	Mono-Protection of the Diols 
The first step taken was to mono-protect propane- l,3-diol using the p-methoxybenzyl 
(PMB) protecting group. One advantage of using this particular protecting group was 
that both aldehyde 5 and aldehyde 7 would be uniformly protected, thus facilitating a 
one-step global deprotection in the latter stages in the synthesis of octalactin A. An 
added advantage was that manipulation of the PMB group via acetal formation and 
selective reduction would allow an efficient protection of the C(3) hydroxyl. 
Studies by Forsyth et al. have shown that the mono-protection of propane diol can be 
achieved in one-step (Scheme 107) to give mono-protected alcohol 316 in good yield 
(73 %)142 However studies within our group using these conditions have only 
produced a mixture of compounds unidentifiable by 1H NMR. To combat this 
problem, different conditions were used to synthesise alcohol 316. 
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a orb 
HO-"-'OH 	HOOPMB + PMBOOPMB 
316 	 317 
Scheme 107: Mono-protection of], 3-propane diol 
Reagents and Conditions: (a) NaH, PMBCI, BUN,  THF, RT-25 °C, 21 h (73 
%);142  (b) NaH, 
PMBCI, DMF, 100 °C, 1 h, (316 = 50 % and 317 = 40 %). 
Propane-1,3-diol was treated with sodium hydride to generate the sodium salt, 
PMBCI was added and the reaction mixture was heated to 100 °C for 1 h. After this 
time all of the diol starting material had disappeared by TLC. 'H NMR analysis of 
the crude reaction mixture showed both mono- and di-protected propane-(l ,3)-diols, 
which were then separated by chromatography to give the mono-protected product 
316 in moderate yield (50 %). 
4.2.2 	Oxidation of the Protected Diols 
The mild oxidising agent (Scheme 108) o-iodoxybenzoic acid (IBX) 318 has been 
regularly used within our group for the oxidation of alcohols to aldehydes. 27,29  This 
compound is a precursor to the Dess-Martin periodinane, a well known oxidising 
agent for the transformation of alcohols to carbonyl compounds. 143,  Both reagents 
are mild, have wide functional group tolerance and give good yields without 
evidence of over oxidation. 144  Due to it's limited solubility in common organic 
solvents, IBX has generally only been used as a precursor to the popular Dess-Martin 
periodinane. However, Frigerio et al. discovered in 1994 that IBX was soluble in 
DMSO, and for substrates insoluble in DMSO, THF could be used as a co-
solvent. 141,141  Studies by Finney et al. have shown that IBX is partially soluble in 
EtOAc when heated under reflux and oxidations are successful under these 
conditions. 147 
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316 103 
Scheme 108: Oxidation ofprotected diol 316 
Reagents and Conditions: (a) 318, EtOAc, i, 3 h (70 %); (b) DMSO, (COCI)2, Et3N, I h -78 °C to RT, 
(97%). 
Studies within the group 148  have shown that oxidation of alcohol 316 can be achieved 
in moderate yield (70 %) on small scale, using conditions discovered by Finney et al. 
However, these oxidation conditions require 3 equivalents of IBX and it was thought 
that a more efficient oxidation procedure may be applicable to a large scale synthesis 
of aldehyde 103. Oxidation of alcohol 316 using Swern conditions afforded the 
aldehyde in an almost quantitative yield. 
4.2.3. 	Crotylboration 
The C(1) - C(5) aldehyde fragment 5 contained a 3-methyl homoallylic alcohol 
moiety with two chiral centres at C(3) and C(4). There are a variety of methods to 
install the crotyl moiety, however loss of regio- and stereoselectivity is often a 
common problem. As discussed in Chapter 1, Brown et al. have extended their 
investigations from allylboration reactions to the crotylboration of aldehydes in order 
to synthesise 3-methyl homoallylic alcohols in high yield and with high 
enantioselectivity.38'4° Georg et al. synthesised the antipode 104 via a crotylboration 
of aldehyde 103.' Therefore we envisage that aldehyde 103 can be efficiently 
synthesised using similar conditions and crotylborane 82, as shown in Scheme 109. 
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Scheme 109: Proposed crolylboration of aldehyde 103 
4.2.3.1. 	Synthesis of the Homoallylic Alcohol 315 
For the synthesis of E-crotylborane 82, trans-but-2-ene 
93* 
 (Scheme 110) was 
metallated with a "superbase" using the Schlosser procedure 39  to generate an orange 
solution of E-crotylpotassium salt 94. Treatment of salt 94 with (-)-13-methoxy 
diisopinocampheylborane 77 (synthesised from (+)-a-pinene) led to the formation of 
the boronate complex 95. Addition of boron trifluoride etherate to complex 94 led to 
the generation of trialkylborane reagent 82. The aldehyde 103 was then added 
quickly at low temperature and stirred at -78 °C. After 3 h the reaction was quenched 
with a basic hydrogen peroxide solution. Standard work-up procedures followed by 
careful chromatography provided homoallylic alcohol 315. IpcOH and J3-
methyihomoallylic alcohol 315 have similar polarities and careful chromatography (8 
% EtOAc in hexane) was required to separate the compounds. 
Initial investigations into the crotylboration of aldehyde 103 were carried out using 
commercially available (-)-3-methoxydiisopinocampheylborane. Crotylboration of 
aldehyde 103 using the conditions described produced the allylic alcohol 315 in poor 
yield (35 %). The low yield of alcohol 315 was very surprising since Georg et al. 
have reported the synthesis of epimer 104 using similar crotylation conditions in a 
significantly higher yield (70 %) as previously shown in Scheme 22. 
* 
Trans-but-2-ene is a gas, and was condensed at -78 °C to give a known value of liquid, before use. 
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Scheme 110: Crotylboration of aldehyde 103 
Reagents and Conditions: (a) (i) 'BuOK, BuLi, THF, -45 °C, 10 mm; (ii) 77, Et20, -78 °C, 30 min; 
(iii) BF3•Et20, -78 °C; (iv) 103, -78 °C, 3.5 h; (v) H202, NaOH, RT, 18 h (71 %, 91 % e.e.). 
In order to optimise the yield of the crotylboration reaction it was decided that a large 
supply of methoxy borane 77 would be required. Due to the high cost of 
commercially available methoxy borane 77, it was decided to prepare 77 (previously 
shown in Scheme 101). Interestingly, when freshly prepared methoxy borane 77 was 
used in the crotylboration of aldehyde 103 using the same conditions, homoallylic 
alcohol 315 was produced in a significantly higher yield (71 %). The lower yield of 
the alcohol when using the commercially available methoxy borane 77 could be due 
to the very hygroscopic nature of the borane 77 which led to its degradation. 
Examination of the crude 'H NMR showed alcohol 315 as a single diastereomer. The 
spectroscopic data and optical rotation values of alcohol 315 {[a]D = -0.19 (c 2.0, 
CHC13)} were in good agreement with the literature value {[a] = -0.19 (c 2.0, 
121 
Results and Discussion III 
CHCl3)}.443 The enantiomeric purity was determined as 91 % by chiral HPLC 
analysis, (alcohol 315 was compared with alcohol 104 derived from (+)-borane, 
Daicel Chiracel OD-H, 254 nm, 99:1 hexane/propan-2-ol, 0.5 ml min 1, retention 
time: 315 38.1 mm, 104 = 41.1 mm). 
4.2.4. 	PMB Manipulation 
Crotylboration of aldehyde 103 has successfully installed the crotyl moiety with high 
yield, diastereoselectivity and enantioselectivity. However, before fragment 315 can 
be used in the synthesis, the PMB group must be manipulated so that the C(3) 
hydroxyl was protected and the primary hydroxyl was free to be oxidised to aldehyde 
5. Manipulation of the PMB protecting group could be achieved via the DIBALH 
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Scheme 111: Mechanism of the DIBALH reduction 149 
The careful addition of DDQ (1 equivalent) to alcohol 315 at a low temperature (0 
°C), in the presence of activated 4 A molecular sieves for 2 h gave the crude PMB-
acetal 319, as shown in Scheme 112. Immediate purification by chromatography 
afforded acetal 319 in good yield (83 %). The immediate chromatography ensured 
that any residual DDQ was separated from the acetal in order to avoid deprotection. 
'H NMR analysis of acetal 319 clearly showed the loss of the signal at 8 = 4.72 for 
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the benzylic protons of alcohol 315 and the formation of a peak at 6 = 5.47 
corresponding to the acetal. '3C NMR analysis shows the loss of a benzylic CH2 at 
115.34 and the formation of an acetal CH at 100.85. Acetal 319 was used 
immediately in the reductive opening step in order to prevent decomposition. 
MPM 
OH OPMB 	 0  
a i) 
315 	 319 
Scheme 112: Acetal formation 
Reagents and Conditions: (a) DDQ, 4A molecular sieves, CH2Cl2, -15 °C, 2 h (83 %). 
The acetal 319 was treated with DIBALH (Scheme 113) at 0 °C for 2 h and after 
purification provided alcohol 320 in good yield as a single product. Analysis of the 
'H NMR of alcohol 320 showed the loss of acetal signal at 6 = 5.47 indicating that no 
starting material remained, and the new AB signals at 6 = 4.60 and 4.42 indicated the 
formation of a benzylic system. Comparison of 1 H NMR of primary alcohol 320 with 
secondary alcohol 315 showed a change in the signals for the benzylic system (6 = 
4.72, singlet for primary alcohol 320 and 6 = 4.60 & 4.42, AB for secondary alcohol 
315) and the movement of the C(S) vinyl proton signals from 6 = 6.07 for primary 
alcohol 320 to 6 = 5.79 for secondary alcohol 315. '3C NMR analysis shows the loss 
of an acetal CH at 100.85 and the formation of a benzylic CH2 at 74.04. The 
differences in both 'H and 13C NMR of acetal 319, alcohol 315 and alcohol 320 
imply that acetal 319 was selectively reduced to give primary alcohol 320. 
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Scheme 113: Reductive opening of acetal 319 
Reagents and Conditions: (a) DIBALH, CH2Cl2, RT, 20 h (93 %). 
4.2.5. 	Oxidation of Alcohol 
A number of mild methods exist for the formation of aldehydes from primary 
alcohols. Since the oxidation of primary alcohol 316 using Swern conditions 
proceeded smoothly, it was decided to use similar conditions for the oxidation of 
alcohol 320. Oxidation of alcohol 320 gave the desired aldehyde 5 in good yield 
(Scheme 114). 
PMBO OH 	 PMBO 0 
320 	 5 
Scheme 114: Oxidation of alcohol 320 
Reagents and Conditions: (a) DMSO, (Cod)2, Et3N, 1 h, -78 °C to RT, (99 %). 
4.3 	COMPLETION OF FRAGMENT SYNTHESIS 
The highly selective introduction of the crotyl moiety was achieved using Brown's 
crotylboration conditions. Utilisation of high yielding protecting group manipulations 
and oxidations allowed the synthesis of aldehyde 5 in 5 steps (from propane-1,3 diol) 
with a 25 % overall yield. The two key aldehydes (5 and 7) were efficiently 
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synthesised and the third key fragment, J3-ketophosphonate ester 192 has been 
synthesised (Chapter 1) and optimised in Chapter 2. The completion of the key 
fragments allowed the methodology developed in Chapter 1 to be applied towards 
the total synthesis of octalactin A. 
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4.4 	HWE COUPLING: CONSTRUCTION OF THE C(10) - C(11) 
BOND 
The barium hydroxide promoted HWE reaction was shown to be successful using 
isovaleraldehyde as a model for aldehyde 7, as discussed in Chapter 2 giving good 





TBSO 0 0 	 ab 	 TBSO 0 	OR - 
OEt) 	
15 
2 Ur 7 R=PMB 
312 R = Bn 
192 	 321R=PMB 
322 R = Bn 
Scheme 115: HWE offragment 192 with aldehydes 7 and 312 
Reagents and Conditions: (a) (i) Ba(OH)2.8H20, THF/H20 (40:1); (ii) 7 or 312, RT, 18 h (321 = 87% 
and 322 = 85 %). 
Treatment of the 4:1 mixture of diastereomers of -ketophosphonate ester 192 with 
activated barium hydroxide and aldehyde 7 gave c,f3-unsaturated enone 321 
(Scheme 115) in 87 % yield with E/Z selectivity >95:5. HWE olefination using 
similar conditions and aldehyde 312 produced a,-unsaturated enone 322 in good 
yield with high selectivity for the E-enone. Analysis of the crude 'H NMR for both 
321 and 322 showed no minor diastereomers, implying no Z-enone formation. 
Analysis of the 'H NMR of enones 321 and 322 showed signals for the vinyl protons 
(6 = 6.88, br t, J = 6.8 Hz, C(1 1)H for 321; 6 = 6.83, br t, J= 6.8 Hz, C(ll)H for 
322) which are similar to vinyl proton signal (ö = 6.75, br t, J = 6.6 Hz, C(1l)H) for 
model compound 195, and gave further confirmation of the formation of the E-
enone. 
The enone system was believed to be quite rigid and it was thought that nuclear 
Overhauser measurements would confirm the expected stereochemistry. 
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Figure 25: NOESY measurements for the vinylic proton at ö = 6.78 ppm of 321 
Analysis of the NOESY results for enone 321 showed a strong interaction between 
the vinylic proton at ö = 6.78 and the C(8)H ö = 3.35 - 3.29, shown in Figure 25. 
There is also a weaker interaction of the vinylic proton at ö = 6.78 with C(12)H2 at 
= 2.46 and there was no interaction between the vinylic proton at 8 = 6.78 with the 
C(1O)CH3  at 6 = 1.79, again confirming (E) selectivity of enone 321. 
4.5 	DEPROTECTION OF HWE ADDUCTS 
The removal of the TBS group to give a 3-hydroxy enone was required to allow the 
Evans-Tishchenko coupling to proceed. 
The successful conditions used for the deprotection of model enone 195 as discussed 
in Chapter 2, were applied to protected 3-hydroxy enones 321 and 322, as shown in 
Scheme 116. HWE adduct 321 was treated with 40 % aqueous HF in MeCN to give 
deprotected adduct 72 in excellent yield (94 %) with no epimerisation at the C(8). 
Similarly HWE adduct 322 was treated with 40 % aqueous HF in MeCN and gave 
the deprotected 3-hydroxy enone 323 was achieved in excellent yield (95 %). The 
successful synthesis of the functionalised 3-hydroxy enones (72 and 323) could 
permit the intermolecular Evans-Tishchenko coupling with aldehyde 5. 
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Scheme 116: Deprotection of/3-hydroxy enones 321 and 322 
Reagents and Conditions: (a) HF (40 % aqueous), MeCN, 15 mm (72 = PMB, 94 %; 323= Bn, 95 
4.6 	EVANS-TISHCHENKO COUPLING 
Based on the successful synthesis of anti diol monoester 174 (discussed in Chapter 
2), it was envisaged that the reaction of 3-hydroxy enones 72 and 323 with a 
Sm(III)Ibenzaldehyde pinacol adduct and functionalised aldehyde 5 would result in 
the formation of the respective anti diol monoesters. 
Treatment of f3-hydroxy enone 72 with Sm(III)/benzaldehyde pinacol adduct for 30 
mm, followed by the addition of aldehyde 5 afforded the anti diol monoester 71 in 
96 % yield as a single diastereomer (Scheme 117). Treatment of 3-hydroxy enone 
323 using these Evans-Tishchenko conditions successfully generated anti diol 









323 R = Bn 324 R=Bn 
Scheme 117: Evans-Tishchenlw coupling of aldehyde 5 and /3-hydroxy enones 72 
and 323 
Reagents and Conditions: (a) (i) PhCHO, Sm12  (0.1 M in THF, 30 mol%), followed by 5, 30 mm: (ii) 
71 or 337, THF, -10 °C, 30 min (71 = PMB, 96%; 324 = Bn, 91 %). 
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Analysis of the 'H NMR for anti diol monoester 71 showed a significant shift of the 
C(1 1) vinylic proton (6 = 6.75 ppm (72) to 6 = 5.52 ppm (71)) and indicated 
reduction of the enone. Loss of an aldehyde peak (6 = 9.88 ppm) also suggested ester 
formation. Infrared spectroscopy showed a change in the stretch from 1660 cm 1, 
indicative of an a,13-unsaturated  carbonyl, to 1720 cm-1 (ester C=O) suggested the 
formation of anti diol monoester 71. Further analysis of 'H NMR of 71 and 324 
(Table 10) showed that esters were in good agreement with model 174 and the 
Evans-Tishchenko product 202 as shown in Figure 26. 
Ester 6 /ppm multiplicity J /Hz Assignment 
71 5.23 t 6.9 C(7)H 
324 5.29 - 5.20 m -- C(7)H 
174 5.22-2.14 m -- C(7)H 
202 5.02 dtEq 6.8 C(7)H 
71 1.91 -1.78 m -- C(8)H 
324 1.91 -1.78 In C(8)H 
174 1.91-1.84 In -- C(8)H 
202 1.69-1.18 m -- C(8)H* 
71 3.95 d 3.9 C(9)H 
324 3.96 -3.91 m -- C(9)H 
174 3.88 d 4.8 C(9)H 
202 3.86 d 3.8 C(9)H 
Table 10: 'H NMR Assignments of the C(7)-C(9) sections of adducts 71, 324, 174 
and 202 
* ö = 1.69- 1.18, m, 1 1H, C(2)-C(6)H2 & C(8)H. 
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Figure 26: Highlighted C(7)-C(9) sections of Evans- Tishchenko adducts 174 and 
202 
The successful intermolecular Evans-Tishchenko coupling of functionalised [-
hydroxy enones 72 and 323 with functionalised aldehyde 5 allowed the efficient 
synthesis of anti diol monoesters 71 and 324 with high yield and diastereoselectivity. 
4.7 	RING CLOSING METATHESIS 
The use of ring closing metathesis (RCM) in the construction of various medium 
lactones have been reported and discussed in Chapter 1. In Chapter 2 RCM was 
applied to the successful formation of the octalactin A model 3. The inclusion of the 
two terminal alkenes in trienes 71 and 324 could allow cyclisation to occur and 
formation of the 8-membered lactone. 
Treatment of anti diol monoester 71 (Scheme 118) with Grubbs 2nd generation 
catalyst 159 (20 mol%) in degassed CH2C12  and heating under reflux for 24 h 
produced the desired lactone 70 and by-product 326 in an inseparable 1:1 mixture in 
moderate yield (70 %). 
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Scheme 118: RCM oftriene 71 
Reagents and Conditions: (a) Grubbs' 2 159 (20 mol%), CH2Cl2, A, 24 h (70 %). 
Lactone 70 was tentatively assigned by mass spectrometry and 'H NMR analysis due 
to the loss of terminal alkene signals (6 = 5.07, d & 5.06, d, C(5)H=CH2; 6 = 5.26, d 
& 5.23, d, C(6)H=CH2 for 71) and the formation of new alkene signals (6 = 5.49-
5.46, m, C(5)H; and 6 = 5.39-5.36, m, C(6)H for 70). These signals were in good 
agreement with model lactone 3. Analysis of 'H NMR also revealed the formation of 
signals indicative of a terminal alkene (6 = 5.72, ddd, C(5)H; 6 = 4.98, d & 4.97, d; 
C(5)HCH2 for 326). As discussed in the synthesis of model 3, a small amount of 
cyclopentene by-product was detected by 'H NMR. However RCM of fully 
functionalised precursor 71 has shown an increase in the formation of by-product 
326. The formation of cyclopentenol 326 was believed to be due to the addition of 
ruthenium to the C(6) alkene which then forms a stable 6-membered intermediate 
325. This reactive intermediate then directs the C(S) terminal alkene away from 
ruthenium, and the trisubstituted C(10) alkene can undergo metathesis to form by- 
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product 326 as shown in Scheme 118. The yield of the by-product 326 in the 
metathesis of fully functionalised precursor 71 has increased from a (9:1) mixture of 
product and by-product in the model studies (discussed in Chapter 2) to a (1:1) 
mixture. It is believed that the increased level of by-product in the metathesis is due 
to the presence of the C(4) methyl which makes the C(5) terminal alkene less 
reactive. The unsatisfactory level of by-product 326 led to investigations into the 
optimisation of the metathesis step, which are shown in Table 11. 
PMBO, 	 OH 	OPMB 
PMBO 0 
U 	 - 
-O OH OPMB 
70 	
OH 
71 	 PMBO 0 
4~y~ 
a, * [~__ 
326 
Yield Yield Recovery 
Entry 	 Conditions 	 70 	326 	of 71 
1 	Grubbs 2 159 (20 mol%), CH2C12, A, 24 h 	37 	37 
2 	Grubbs 1158 (5 mol%), CH2C12, RT, 24 h 	0 	0 	69 
3 	Grubbs 1 158 (10 mol%), CH2C12, RT, 24 h 	0 	0 	62 
4 	Grubbs 1158 (20 mol%), CH2C12, RT, 24 h 	0 	0 	73 
5 	Grubbs 1158 (20 mol%), CH2C12, A, 24 h 	0 	0 	81 
6 	Grubbs 2 159 (20 mol%), toluene, A, 10 mm 	-- 	 -- 	 -- 
Ti('OPr)4 (10 mol %), Grubbs 2 159 (20 
7 
	
	 30 	0 	35 
mol%), CH202, RT, 24 h 
Ti('OPr)4 (10 mol %), Grubbs 2 159 (20 
8 	 70 	0 	0 
mol%), CH2C12, A, 24 h 
Ti('OPr)4 (20 mol %), Grubbs 2 159 (20 
9 	 69 	0 	0 
mol%), CH202, A, 24 h 
Table 11: RCM oftriene 71 
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Previous investigations into the synthesis of lactone 3 focussed on the RCM of triene 
174 using Grubbs 2' generation catalyst 159. In order to minimise the formation of 
by-product 326, the less reactive Grubbs 	generation catalyst 158 was used in 
order to RCM the terminal alkenes and leave the trisubstituted alkene intact. 150-152 
Treatment of triene 71 with increasing amounts of Grubbs 1st  generation catalyst 158 
(from 5 to 20 mol % Table 11, entries 2 - 4) gave only recovered starting material 
even when the reaction temperature was increased to 40 °C (Table 11, entry 5). The 
recovery of purely starting material demonstrated that Grubbs 1st  generation catalyst 
158 was not reactive enough to RCM triene 71 and that Grubbs 2nd  generation 
catalyst 159 would have to be used. 
Danishefsky et al. have reported the use of RCM in the synthesis of epothilone 
490. 153  They have shown that heating Grubbs 2nd  generation catalyst 159 in toluene 
for 10 min afforded the kinetic product in moderate yield. However when the RCM 
was attempted on triene 71 using conditions described by Danishefsky et al., (Table 
11, entry 6) analysis of 'H NMR showed an inseparable mixture of unidentifiable 
compounds. 
FUrstner et al. have reported the use of titanium additives during their synthesis of 
(-)-gloeosporone.'54 They have postulated that the RCM step can be hindered due to 
the formation of a stable ruthenium reaction intermediate. They have shown that the 
addition of a catalytic amount of Ti('OPr)4 can cause competitive chelation in the 
substrate, and therefore increase the yield of the RCM. The conditions described by 
FUrstner et al. were applied, (Table 11, entry 7) at room temperature and analysis of 
the 'H NMR showed the formation of lactone 70 in low yield with a moderate 
recovery of starting material. It is important to note that there was no formation of 
by-product 326. The reaction conditions were repeated with higher temperatures 
(Table 11, entry 8) and higher loading of the titanium additive (Table 11, entry 9) 
and the yields of lactone 70 were dramatically improved. The optimum conditions 
used for the RCM of triene 71 are shown in (Table 11, entry 8) and allowed for 
isolation of lactone 70 in good yield (70 %). 
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'H NMR analysis of the purified lactone showed the loss of the terminal alkene (6 = 
5.07, d and 5.06, d, C(5)H=CH2, 6 = 5.26, d and 5.23, d, C(6)H=CH2 for 71) and the 
formation of new alkene signals (6 = 5.49-5.46, m, C(5)H; and 6 = 5.39-5.36, m, 
C(6)H for 70) are in good agreement with model lactone 3. The presence of a 
C(1 3)H signal (6 = 3.04, q, J 5.8 Hz), and the C(14)H(CH3)2 signals (6 = 0. 88, d, J 
= 6.9 Hz and 6 = 0. 87, d, J = 6.9 Hz) implied the presence of the intact C(1 1) - 
C(l 5) fragment of lactone 70, which would be lost in the formation of by-product 
326. Analysis of the 'H NMR showed that there were no signals indicative of a 
terminal alkene, as seen for the by-product 326 (6 = 5.72, ddd, C(5)H; 6 = 4.98, d 
and 4.97, d, C(5)H=CH2 for 326). Although the methodology introduced by Fürstner 
et al. has shown a vast improvement in the yield of lactone 70 it was decided to 
investigate other strategies to optimise the RCM reaction. 
The formation of by-product 326 was due to the RCM of the C(6) alkene with the 
C(10) trisubstituted alkene. The latter stages of the synthesis of octalactin A via 
lactone 70 require the introduction of an epoxide moiety at C(10)-C(l l).18  The 
introduction of the epoxide, before attempting the RCM, would remove the 
possibility of reaction with the third alkene. The use of an epoxide to prevent 
competitive metathesis is a common tool in organic synthesis.' 55 Treatment of triene 
71 with VO(acac)2 and tBuOOH (Scheme 119) allowed the epoxidation to occur via 
transition state 327, to give epoxide 328 in good yield (87 %). Analysis of the 'H 
NMR showed the epoxide as a 95:5 mixture of diastereomers. The absolute 
stereochemistry of epoxide 328 was based on literature precedent. 18  A shift in the 
signal of the C(1 1) proton (from 6 = 5.52 to 6 = 3.53 - 3.49) was seen suggesting the 
addition of epoxide over the C(l0) - C(1 1) alkene. RCM was attempted using the 
Grubbs 2' generation catalyst 159 (20 mol%) in CH202, with heating under reflux 
for 24 h, but unfortunately only starting material was recovered. RCM of epoxide 
342 was repeated using the optimised conditions shown in Table 11, and again, only 
starting material was recovered. 
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Scheme 119: RCM ofepoxide 328 
Reagents and Conditions: (a) VO(acac)2, tBuOOH, PhH, RI, 1 h (87 %); (b) Grubbs 2 159 (20 
mol%), CH2Cl2, A, 24 h; (c) Ti('OPr)4 (10 mol%), Grubbs 2 159 (20 mol%), CH2Cl2, A, 24 h. 
It was proposed that the free hydroxyl at C(9) might itself be causing deactivation of 
the catalyst. Since the free hydroxyl group was no longer required once the directed 
epoxidation has been achieved, the C(9) hydroxyl of epoxide 328 was oxidised using 
Dess-Martin periodinane, to give ketone 330 in good yield (98 %) as shown in 
Scheme 120. RCM was attempted using the Grubbs 2nd  generation catalyst 159 (20 
mol%) in C112C12 with heating under reflux for 24 h, and also with the optimised 
conditions from Table 11, and only starting material was recovered. It was thought 
that stronger conditions were required to form the 8-membered ring. Recent reports 
have shown that RCM using microwave conditions can improve the yields and 
cyclise demanding substrates. 156-160  RCM of epoxide 330 using Grubbs 2' 
generation catalyst 159 under microwave conditions resulted in the formation of an 
unidentifiable mixture of compounds. 
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Scheme 120: RCM ofepoxide 330 
Reagents and Conditions: (a) Dess-Martin periodinane, CH2Cl2, RI, 3 h (98 %); (b) Ii('OPr)4 (10 
mol%), Grubbs 2 159 (20 mol%), CH2Cl2, i, 24 h; (c) Grubbs 2 159 (20 mol%), PhMe, 110 °C, 10 
mm, iwave. 
Investigation into the RCM of alternative substrates did not reveal a more efficient 
route towards the 8-membered lactone. In summary the best conditions were those 
shown in Table 11, treating triene 71 with Ti('OPr)4 (10 mol%) followed by Grubbs 
2nd generation catalyst 159 (20 mol%) with heating under reflux for 24 h. This route 
(Scheme 121) afforded lactone 70 in good yield with no formation of by-product 
326. The optimised conditions could be applied to the RCM of triene 324 to give the 
lactone 332. 
0 
R=PMBPMB0 O OH OPMB 
PM BO 0 
0 OH OR 	 70 
OB 




324 R = Bn R = Bn 	 - 
332 
Scheme 121: RCM oftriene 71 
Reagents and Conditions: (a) Ii('OPr)4 (10 mol%), Grubbs 2 159 (20 mol%), CH2Cl2, i, 24 h (70 = 
70 %). 
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The final proposed stages of the synthesis of the octalactins are shown in Scheme 
122. The reactions are very similar to those reported in the synthesis of octalactin A 
by Buszek et al., where the only difference in the route to octalactin A is the choice 
of protecting group on the C(9) hydroxyl (lactone 70 has PMB, Buszek has TB S).14 
The current status is an efficient route to the precursor of both octalactin A 1 and 
octalactin B 2. 
0 
PMBO,/(0 OH OPMB 
- 
epoxidation 	 A 	I 	I 	 I. [0] 
[0] 	: 70 : ii. selective [H] 
[H] iii. deprotection 
deprotection 
O 	 0 
HO,,. 	
- 0 
	OH 	 HO,.( 0yo 	09 H 
 
octalactin A I 	 octalactin B 2 
Scheme 122: Routes towards the octalactins from lactone 70 
4.8 	CONFIRMATION OF THE OCTALACTIN SKELETON 
Lactone 70 is the carbon skeleton of the octalactins (Figure 26) and contains all of 
the stereocentres required for octalactin B (5 stereocentres) and an extra stereocentre 
at C(9) to allow the selective installation (via epoxidation) of the other 2 
stereocentres required for octalactin A. 
The C(1) and C(S) fragment of lactone 70 was added to the carbon skeleton via the 
Evans-Tishchenko coupling of fragment 5. The stereochemistry at C(3) and C(4) was 
generated via a crotyl boration using Brown's reagents. The relative and absolute 
stereochemistry of fragment 5 was assessed on the spectroscopic data of the epimer. 
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The C(11) and C(15) fragment was introduced to the carbon skeleton via a Homer 
Wadsworth Emmons olefination with fragment 7. The stereochemistry at C(13) was 
installed via an allylboration using Brown's reagents. The absolute stereochemistry 
of fragment 7 was assumed on the basis of precedent34  and the enantioselectivity of 
the allylboration reaction was determined by spectroscopic analysis of its Mosher's 
	
ester. The optical rotation of fragment 7 [aJ 	- 65.3 (c 0.3, CHCl3)j was in good 
agreement with literature value [[U]D = - 65.7 (c 0.3, CHC13)],29  further confirming 
the absolute stereochemistry. The C(5) - C(10) fragment of the octalactin carbon 
framework was also introduced by a Homer Wadsworth Emmons olefination with 
fragment 192. The relative stereochemistry was based on the vicinal coupling 
between the C(7) and C(8) protons in the 'H NMR (7.0 Hz).54  The absolute 
stereochemistry for 192 was based on the good agreement of the spectroscopic data 
of diol 271 with the literature values,' 
28  as well as the optical rotation value [laiD 
- 18.4 (c 1.0, CHC13), lit.128 -18.6 (c 2.0, CHC13)]. 
0 




70 	 7 
(OEt)2 
192 
Figure 26: Carbon skeleton of the octalactins 
NOE measurements with the vinylic C(11) proton have allowed the geometry of the 
C(10) - C(1 1) alkene to be assigned as (K), as discussed in section 4.3 of this chapter. 
The stereochemistry of the C(9) hydroxyl was introduced to lactone 70 as a selective 
reduction of C(9) ketone after the Evans-Tishchenko coupling of fragment 5. 
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as anti based on the comparison of the coupling of the C(9) proton with known 
Evans-Tishchenko adducts. 
Analysis of the COSY spectrum (Figure 27) of lactone 70 can clearly show the 
presence of the isopropyl group of the C(11) - C(15) fragment (pink) of the 
octalactins. The presence of this group implies that no competitive metathesis occurs 
in the RCM step since this fragment would be cleaved. The COSY spectrum also 
shows coupling of the C(1) - C(5) fragment (red) with the C(6)-C(9) fragment (blue) 
by a cross peak at 5.46 ppm. The long range coupling [C(9) - C(1 1)1 at 1.70 ppm can 
allow for the complete assignment of the octalactin skeleton and shows that the 
lactone fragment [C(2) - C(9)] is linked to the C(1 1)-C(15) fragment. 
I 
0 	 C(5) & C(1 1) 	 C(2) & C(4) 	
C(17) 
	
C(18) 	C(1 5)6 C(1 9) 
II C(6)&C(7) 	 JC(9) 	
c(i 6) ,,.J C(13) 	C(6) j j 
7.0 	 6.0 	 5.0 	 4.0 	 3.0 	 2.0 	
1.0 	 0.0 
ppm (12) 
Figure 27: COSY spectrum of lactone 70 
Analysis of the HSQC of lactone 70 (Figure 29) implies that the signals (8 = 5.49 - 
5.46 ppm, m and ö = 5.39 - 5.36 ppm) are not terminal alkenes or aliphatic CH, since 
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they are detected in the range of 140-125 ppm (commonly assigned to aromatic CH). 
Since the aromatic carbons for the PMB groups are distinctly shown (6 = 7.18, d, J = 
8.7 Hz and 6 = 6.78, d, J = 8.7 Hz) then it can be assumed the peaks at 6 = 5.49 - 
5.46 ppm, m and 6 = 5.39 - 5.36 ppm belong to the C(S) - C(6) alkene of the lactone. 
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Figure 28: HSQC spectrum of lactone 70 
4.9 	STUDIES TOWARDS THE SYNTHESIS OF OCTALACTIN A 
ANALOGUES 
As discussed in Chapter 1, the isolation of metabolites from the gorgonian octacoral 
afforded both octalactin A 1 and octalactin B 2. The only difference in the two 
compounds is an epoxide moiety at C(10) - C(1 1) however biological screening has 
shown that octalactin A has activity against human colon cancer cell lines and 
murine melanoma, whereas octalactin B was shown to be inactive. Although the 
epoxide moiety seems to confer biological activity, there have been few 
investigations towards the synthesis of analogues of octalactin A to improve this 
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relationship of the octalactin series. Octalactin A and B also contain: a C(l) lactone 
carbonyl; C(9) ketone carbonyl; and C(3) and C(13) hydroxyl groups. These may 
have specific hydrogen bonding roles within cells. It would be interesting to 
synthesise analogues of octalactin A to protect some of these moieties. This would 
allow investigation into which other functional groups are required for the compound 
to display activity and highlight which areas could be targets for modification to 
improve the potency of octalactin A. Investigations towards the synthesis of 
octalactin A suggest that lactone 332 would be a suitable candidate for these studies. 
Lactone 332 contains two different protecting groups and can ultimately result in the 
selective modification of either the C(3) or the C(13) hydroxyl groups. Although 
there have been a variety of strategies towards the synthesis of octalactin A 
containing two different protecting groups, these routes have more synthetic steps 
due to the additional deprotection adding to the overall yield lost. As shown in 
Scheme 123, epoxidation and oxidation using procedures reported by Buszek et al. 
would give lactone 333. Removal of the C(5) - C(6) alkene via hydrogenation would 
also deprotect the C(13) benzyl ether to give the mono-protected octalactin A, 
without increasing the overall synthesis of the compound. It could then be envisaged 
the functionality of the hydroxyl groups could be modified independently. 





332 	 333 
0 
47 
Scheme 123: Strategy towards mono-protected lactone 47 
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Studies within the Hulme group on anisomycin'6 ' have shown that analogues can be 
synthesised via cycloaddition of an azide with a propargyl moiety to form a stable 
triazole. The synthesis of biologically active analogues via this efficient 
cycloaddition process, (commonly referred to as "click" chemistry), could be applied 
to the synthesis of octalactin A analogues. As shown in Scheme 124, the propargyl 
moiety could be installed on the C(13) hydroxyl using trichloroacetimidate 334 to 
give 334. "Click" coupling of the lactone 335 with a series of azides (R = various 
substrates) to give triazole 336. The functionality of the triazole 336 could be altered 
to contain fluorous tags and molecular probes to allow further investigation into why 
octalactin A is active. Such analysis using fluorescent microscopy would identify 
where in the cell the octalactin compound is found. 
NH 	 0 	 IL 
0 


















Scheme 124: Synthesis of octalactin triazoles 
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4.10 	CONCLUSIONS 
The two major aldehyde fragments 5 and 7 required for the synthesis of the 
octalactins were successfully synthesised. The synthetic strategy towards aldehyde 7 
consisted of the Brown allylboration of isobutyraldehyde, protection and oxidative 
cleavage to give the C(l 1) - C(15) aldehyde 7 in 4 steps with an overall 40 % yield. 
The synthetic strategy towards aldehyde 5 consisted of the Brown crotylboration of 
aldehyde 103, protecting group manipulation followed by oxidation to give the C(l) 
- C(5) aldehyde 5 in 5 steps with a 25 % overall yield. 
The successful methodology developed for the major steps in the model synthesis of 
octalactin A and B (including HWE coupling and intermolecular Evans-Tishchenko 
coupling) was directly applied in the total synthesise of the octalactins. The 
incorporation of titanium additives into the RCM of the functionalised anti diol 
monoester 71 allowed for the efficient synthesis of the carbon skeleton of octalactin 
A and B, containing 5 of the 7 required stereocentres. The synthesis of octalactin A 
was halted after the ring closing metathesis of anti diol monoester 71. Attempts to 
install the epoxide at C(10)-C(11) as shown in literature by Buszek were 
unsuccessful with starting material only recovered after reaction. The epoxide 328 
was then installed prior to metathesis and unfortunately, previous conditions for 
cyclisation were unsuccessful. 
It has been shown that installation of the desired stereochemistry at the C(9) can be 
achieved via Evans-Tishchenko coupling and the required 8-membered lactone can 
be efficiently formed using RCM. This strategy also introduces the potential for the 
synthesis of diverse analogues of octalactin A, for example via "click" coupling, to 






5.1 	GENERAL EXPERIMENTAL 
'H nuclear magnetic resonance (NMR) spectra were recorded using an internal 
deuterium lock for the indicated reference at ambient probe temperatures on Varian 
Gemini 200 (200 MHz) and Bruker AC250 (250 MHz), Bruker DPX360 (360 MHz) 
or Bruker AVA600 (600 MHz) Fourier transform instruments. The data is presented 
as follows: chemical shift (in ppm on the cä scale relative to ÔTMS = 0), integration, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, qn = quintet, m = 
multiplet, br = broad), coupling constant and the interpretation. '3C NMR spectra 
were recorded using an internal deuterium lock for the indicated reference at ambient 
probe temperatures on Bruker AC250 (62.9 MHz), Bruker DPX360 (90.5 MHz) or 
Bruker AVA600 (150 MHz) instruments and are reported in ppm on the 6 scale. 
Where Distortionless Enhancement Polarisation Transfer (DEPT) spectra have been 
recorded, the carbon signals due to methyl (CH3), methylene (CH2), methine (CH) 
and quaternary carbon (C) are assigned. 
Infra-red spectra were recorded on a Perkin Elmer Paragon 1000 FT-JR instrument 
using 5 mm sodium chloride plates, or 0.1 mm sodium chloride solution cells. The 
wavelengths of maximum absorbance (Vmax) are quoted in em-1. Electron impact (El) 
mass spectra were obtained using a finnigan 4500 mass spectrometer and fast atom 
bombardment (FAB) mass spectra were performed on a Kratos MS50TC by the 
service at the University of Edinburgh Chemistry department. The parent ion or 
relevant fragments are quoted, followed by significant fragments and their relative 
intensities. Optical rotations were measured on an AA-1000 polarimeter with a path 
length of 0.5 dm at the sodium D line (589 nm) and reported as follows: [aID 
concentration (c in g/100 ml)and solvent. Melting points were determined on a 
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Gallenkamp Electrothermal melting Point apparatus and are uncorrected. TLC was 
performed on Merck 60F254 (0.25 mm) glass silica plates and visualised by 
ultraviolet (UV) light and/or molybdate stain.*  Flash column chromatography was 
carried out on Merck Kieselgel 60 (Merck 9385) under positive pressure by means of 
an air line or hand pump. Eluent compositions are quoted as v/v ratios. High 
performance liquid chromatography (HPLC) was carried out on a Gilson instrument 
using a Spherisorb column (internal diameter: 20 mm) and equipped with a Gilson 
refractive index detector. A standard flow of 10 ml/min was used. Chiral HPLC was 
performed using a Waters instrument with a Chiracel OD column (internal diameter: 
4.6 mm) equipped with a UV detector. A standard flow rate of 0.5 ml/min was used. 
All solvents to be used for HPLC analysis were vacuum filtered and degassed prior 
to use. All HPLC samples were filtered through 0.45 tm nylon syringe filters prior to 
analysis. 
Reagents were purified by standard means. Dichloromethane (CH2C12), 
diisopropylethylamine (DIPEA), hexane, pyridine, 2,6-lutidine and triethylamine 
(Et3N) were distilled from calcium hydride and stored over calcium hydride under an 
argon atmosphere. The achiral aldehydes acrolein, isovaleraldehyde, 
isobutyraldehyde and methacrolein were freshly distilled from calcium chloride 
immediately prior to use. Tetrahydrofuran (THF) was distilled from sodium 
metal/benzophenone ketyl and stored an argon atmosphere. All other reagents were 
used as supplied."Butyl lithium (BuLi) and 'Butyl lithium ('BuLi) solutions were 
titrated against N-pivalolyl-o-toluidine in solution in THF at ambient temperature 
immediately prior to use. All other reagents were used as supplied except where 
otherwise stated in the experimental text. Saturated aqueous solutions of inorganic 
salts are represented as (volume; sat.). 
All experiments were performed in an inert atmosphere of argon or nitrogen under 
anhydrous conditions using oven dried apparatus cooled in a desiccator or flame 
Ammonium molybdate: dip prepared as follows: to water (950 cm3) was added concentrated sulfuric 
acid (50 cm3) and ceric sulfate (3 g). The mixture was stirred until all solid material had disappeared 
and a bright yellow solution remained. 
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dried under argon prior to use. Standard techniques for the handling of air-sensitive 
materials were employed. 
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5.2 	EXPERIMENTAL PROCEDURES FOR CHAPTER 2 




An oven dried 250 ml round bottomed flask capped with septum was charged with 
cyclohexene (35.0 ml, 0.330 mol), and anhydrous Et20 (100 ml), and was kept at 
0 °C under nitrogen. Borane dimethyl sulfide complex (16.6 ml, 0.160 mol) was 
added dropwise during 30 min with stirring and the reaction mixture was stirred for 3 
h at 0 °C, when the solid settled without stirring. The supernatant organic solution 
was removed by syringe and the residual solid was dried under vacuum to give 
dicyclohexylborane. 
The solid was suspended in anhydrous hexane (100 ml) and triflic acid (25.0 g, 0.160 
mol) was added dropwise via syringe during 30 min at 0 °C with constant stirring, 
during which time vigorous gas evolution occurred and the solid gradually 
disappeared. Stirring continued at room temperature for 1 h and the reaction was left 
for 2 h without stirring. Two layers appeared and the top layer of dicyclohexylboron 
triflate was transferred into a dry 250 ml storage flask. The solution was cooled to 
-20 °C overnight, the hexane layer was removed from the crystalline triflate and a 
stock solution of 1.0 M in hexane was prepared. 
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To a stirred solution of(1S,2R) (+)-norephedrine (21.0 g, 0.140 mol) and Et3N (20.0 
ml, 0.140 mol) in CH202  (300 ml) was added mesitylenesulfonyl chloride (31.0 g, 
0.140 mol) at 0 °C. The reaction was stirred at 0 °C for 2 h. The reaction mixture was 
diluted with Et20 (400 ml) and was washed with H20 (2 x 200 ml), HC1 (2 x 200 ml, 
1 N aq.), H20 (2 x 200 ml), NaHCO3 (2 x 200 ml, sat.) and NaC1 (2 x 200 ml, sat.). 
The organics were dried (MgSO4) and the volatiles removed under reduced pressure 
to give sulfonamide 182 as a colourless solid which was recrystallised from 
CH2C12/hexane (44.0 g, 95 %); Rf (3:1-hexane/EtOAc) = 0.24; mp = 120-121 °C 
(CH2Cl2Ihexane); lit.54 120.5 - 121.5 °C; FtzlD = 12.7 (c 1. 10, CHC13); lit.54 12.8 (c 
2.12, CHC13); Vmax (neat)/cm' 3500 (OH), 3295 (NH), 1377 (SO2N), 1155 (SO2N); 
'H NMR 6 (250 MHz, CDC13) 7.41-7.25 (5H, m, An]), 7.01 (2H, s, An]), 4.85 (1H, 
d, J = 8.1 Hz, C(l)HPh), 4.80 (1H, d, J = 3.2 Hz, CHOH), 3.57 (1H, dq, J= 6.8 and 
3.2 Hz, C(2)H), 2.70 (6H, s, 2 x o-CH3), 2.34 (3H, s,p-CH3), 0.92 (3H, d, J= 6.8 Hz, 
C(2)HCH3); '3C NMR 6 (62.9 MHz, CDC13) 142.1 (C), 140.2 (C), 138.7 (2 x C), 
134.1 (C), 131.8 (2 x CH), 128.1 (2 x CH), 127.4 (CH), 125.8 (2 x CH), 75.5 (CH), 
54.4 (CH), 22.8 (2 x CH3), 20.7 (CH3), 14.3 (CH3); ,n/z (FAB, THIOG.) 334 
({M+H]+, 56 %), 316 (87), 183 (64), 134 (75), 119 (100), 91(80), 77 (67); HRMS 
(FAB, THIOG.) [M+H] found 334.1472, C18H24NO3S requires 334.1476. 
1H spectroscopic data in good agreement with the literature. 54 
148 
Experimental 




To a solution of sulfonamide 182 (10.2 g, 30.7 mmol) in DMF (140 ml) was added 
potassium tert-butoxide (3.46 g, 30.7 mmol) at 0 T. The reaction was stirred for 30 
mm, benzyl bromide was added (3.66 ml, 30.7 mmol) and the reaction was stirred for 
a further 4.5 h at RT. NaCl (200 ml, sat.) was added and the mixture was extracted 
with CH2C12 (2 x 200 ml) and EtOAc (2 x 200 ml). The organics were combined, 
dried (MgSO4), and the volatiles were removed under reduced pressure. Flash 
chromatography (CH202) gave benzyl protected sulfonamide 122 as a colourless 
solid (9.21 g, 71 %); Rf (17 % EtOAc in hexane) = 0.41; mp = 123 - 124 °C, lit. 54 
122— 124; IalD=  6.2 (c 1. 10, CHC13); lit.54 6.43 (c 2.05, CHC13); 'H NMR '5 (250 
MHz, CDC13) 7.40 - 7.28 (8H, m, ArE), 7.17 - 7.13 (2H, m, Ark!), 7.01 (2H, s, 
ArE), 5.07 (1H, hr s, C(1)H), 4.86 (1H, J = 16.0 Hz, CHAHBPh), 4.62 (1H, J = 16.0 
Hz, CHAHBPh), 3.91 (1H, qd, J= 7.0 Hz & 2.0 Hz, C(2)H), 2.72 (6H, s, 2 x o-CH3), 
2.36 (3H, s, p-CH3), 2.29 (1H, br d, J = 3.1 Hz, 011), 1.11 (3H, d, J = 7.0 Hz, 
C(2)HCH3); '3C NMR 6 (62.9 MHz, CDC13) 142.51 (C), 142.64 (C), 140.31 (2 x C), 
138.54 (C), 133.21 (C), 132.32 (2 x CH), 128.04 (2 x CH), 127.99 (2 x CH), 127.52 
(2 x CH), 127.22 (CH), 127.13 (CH), 125.41 (2 x CH), 76.49 (CH), 59.66 (CH), 
49.40 (CH2), 22.83 (2 x CH3) 20.72 (CH3), 9.74 (CH3); in/z (FAB, THIOG.) 424 
([M+H], 33 %), 406 (48), 316 (73), 242 (59), 183 (38), 119 (82), 91(100), 77(47); 
HRMS (FAB, THIOG.) [M+H] found 424.1943, C25H30NO3S requires 424.1946. 
'H spectroscopic data in good agreement with the literature. 54 
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To a solution of alcohol 122 (9.00 g, 21.3 mmol) in CH2C12 (100 ml) was added 
pyridine (2.45 ml, 30.2 mmol) followed by propionyl chloride (2.45 ml, 28.1 mmol) 
at 0 T. The reaction mixture was warmed to RT and stirred for 18 h. The reaction 
mixture was diluted with CH2Cl2 (300 ml) and was washed with H20 (200 ml), HC1 
(200 ml, IN aq.), H20 (200 ml), NaHCO3 (200 ml, sat.) and NaCl (200 ml, sat.). The 
organics were dried (MgSO4) and volatiles were removed under reduced pressure to 
give propionate 123 as a colourless solid, which was recrystallised from EtOAc / 
hexane (7.02 g, 69 %); R (20 % EtOAc in hexane) = 0.56; mp = 146 - 148 °C, lit. 54 
146 - 148 °C; [a]0 = -11.1 (c 2.00, CHC13); lit 14 -11.2 (c 2.18, CHCI3); 'H NMR 8 
(250 MHz, CDC13) 7.44 - 7.24 (8H, m, An]), 7.02 - 6.96 (414, m, An]), 5.92 (1H, d, 
J= 4.1 Hz, C(1')H), 4.81 (1H, d, J = 16.6 Hz, CHAHBPh), 4.68 (1H, d, J = 16.6 Hz, 
CHAHBPh), 4.11 (1H, qd, J= 4.1 Hz & 7.0 Hz, C(2')I]), 2.59 (611, s, o-CH3Ar), 2.35 
(3H, s, p-CH3Ar), 2.62 - 2.18 (2H, m, C(0)CH2CH3), 1.19 (3H, d, J = 7.0 Hz, 
C(2')HCH3), 1.09 (3H, t, J= 7.4 Hz, C(0)CH2CH3). 
'H spectroscopic data in good agreement with the literature. 54 
150 
Experimental 
General procedure A: Anti aldol reaction 
To a solution of propionate 123 (148 mg, 0.309 mmol), in CH2C12 (4 ml) at —78 °C 
was added dicyclohexylboron triflate (697 iii, 1.0 M in hexane, 0.697 mmol), then 
Et3N (129 p1, 0.927 mmol). The reaction mixture was stirred for 2 h, then aldehyde 
was added (3.71 mmol). The reaction mixture was stirred at —78 °C for 1 h and 
warmed to 0 °C for 1 h. The reaction was quenched by the addition of pH 7 buffer (4 
ml), MeOH (10 ml) and the careful addition of H202 0  ml). The reaction mixture 
was stirred vigorously for 14 h. H20 (15 ml) was added and the mixture was 
extracted with CH2C12 (3 x 20 ml). The combined organics were washed with 
NaHCO3 (30 ml, sat.) and NaCl (30 ml, sat.), dried (MgSO4) and concentrated under 
reduced pressure to give the crude aldol product. Kugelrohr distillation with 
mesitylene (3 ml) was used to remove residual cyclohexanol. Flash chromatography 
(10 % EtOAc in hexane) removed any impurities. 
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2 '-(N-Benzyl-N-mesitylenesulfonylamino)-1 '-phenylpropyl (1 'S,2S,2'R,3R)-2,4-
dimethyl-3-hydroxypent-4-eneoate 183 
OH 0 Ph 
Bn SO2 
General procedure A was followed with propionate 123 (148 mg, 0.309 mmol), in 
CH2C12 (4 ml) at —78 °C, to which was added dicyclohexylboron triflate (697 tl, 
1.0 M in hexane, 0.697 mmol), then Et3N (129 p1, 0.927 mmol). Methacrolein was 
added (320 p1, 3.71 mmol). Flash chromatography (10 % EtOAc in hexane) gave 
aldol adduct 183 as a colourless solid (132 mg, 79 %). Analysis of the crude 250 'H 
NMR showed this to be a >95:5 mixture of diastereomers; Rf (20 % EtOAc in 
hexane) = 0.23; [a]0 = - 19.1 (c 1.32, CHC13), lit.(ent-183)54 19.7 (c 1.32, CHC13); 
mp = 97 - 98 °C, lit. 54  97 - 98 °C; Major diastereomer: 'H NMR 5 (250 MHz, 
CDC13) 7.41-7.11 (8H, m, ArII), 6.82-6.75 (4H, m, An]), 5.75 (1H, d, J= 3.9 Hz, 
C(1')If), 4.86 (2H, br s, CCH3 CH2), 4.74 (1H, d, J= 16.6 Hz, CHAHBPh), 4.52 (1H, 
d, J= 16.6 Hz, CHAHBPh), 4.06 (1H, br d, J = 8.7 Hz, CHOH), 4.01 (1H, qd, J= 3.9 
& 7.2 Hz, C(2')I]), 2.51 (1H, qd, J= 8.7 Hz & 7.2 Hz, CHCH3), 2.48 (6H, s, o-
CH3Ar), 2.22 (3H, s, p-CH3Ar), 1.66 (3H, s, C(4)CH3), 1.08 (3H, d, J = 7.0 Hz, 
C(2')HCH3), 0.96 (3H, d, J= 7.2 Hz, CHCH3); Minor diastereomer diagnostic peaks: 
5.85 (1H, d, J= 3.9 Hz, C(1')H); '3C NMR ó (62.9 MHz, CDC13) 174.99 (C), 144.33 
(C), 142.96 (C), 140.67 (2 x C), 139.14 (C), 138.62 (C), 133.81 (C), 132.52 (2 x 
CH), 128.80 (2 x CH), 128.71 (2 x CH), 128.30 (CH), 127.99 (2 x CH), 127.52 (CH), 
126.20 (2 x CH), 115.10 (CH2), 78.70 (CH), 78.59 (CH), 57.18 (CH), 48.64 (CH2), 
43.51 (CH), 23.33 (2 x CH3), 21.29 (CH3), 16.99 (CH3), 14.59 (CH3), 13.73 (CH3); 
mlz (FAB, NOBA) 572 ([M+Na], 4 %), 550 ([M+H]', 4), 406 (96), 316 (95), 222 
(52); HRMS (FAB, NOBA) [M+H] found 550.2626, C32H40N05S requires 
550.2627. 
'H and '3C NMR spectroscopic data in good agreement with the literature. 54 
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2 '-(N-Benzyl-N-mesitylenesulfonylamino)-1 '-phenyipropyl 	(1 'S,2S,2 'R,3S)-3- 
hydroxy-2-methyl pent-4-eneoate 180 
OH 0 Ph 
Bn SO2 
General procedure A was followed with propionate 123 (148 mg, 0.309 mmol), in 
CH2C12 (4 ml) at —78 °C, to which was added dicyclohexylboron triflate (697 j.tl of a 
1.0 M in hexane, 0.697 mmol), then Et3N (129 jt1, 0.927 mmol). Acrolein was added 
(247 i1, 3.71 mmol). Flash chromatography (10 % EtOAc in hexane) gave aldol 
adduct 180 as a colourless solid (137 mg, 84 %). Analysis of the crude 250 MHz 'H 
NMR showed this to be a 98:2 mixture of diastereomers; Rf (20 % EtOAc in hexane) 
= 0.23; Vmax (neat) I cm 3684 (OH), 1736 (C=O); [aID = - 12.2 (c 2.0, CHC13); mp 
= 128 - 131 °C; Major diastereomer: 'H NMR 6 (250 MHz, CDC13) 7.25— 7.09 (8H, 
m, An]), 6.81 —6.76 (4H, m, An]), 5.76 (2H, d, J = 3.7 Hz, C(1')I]), 5.72 (1H, ddd, 
J = 16.9, 10.4 & 6.7 Hz, CH=CH2), 5.21 (1H, d, J = 16.9 Hz, CHCHCISHTRANS), 
5.13 (1H, d, J = 10.4 Hz, CHCHCJSHTRANS), 4.71 (1H, J = 16.6 Hz, CHAHBPh), 
4.49 (1H, J = 16.6 Hz, CHAHBPh), 4.07 (1H, m, CHOH), 4.03 (1H, dq, J = 7.2 & 3.7 
Hz, C(2')I]), 2.54 - 2.49 (1H, m, CHCH3), 2.42 (6H, s, o-CH3Ar), 2.39 (3H, s, p-
CH3Ar), 1.12 (3H, d, J = 7.0 Hz, CHCH3), 1.03 (3H, d, J = 7.2 Hz, C(2')HCH3); 
Minor diastereomer diagnostic peak: 5.70 - 5.63 (1H, m, CHCH2); '3C NMR 8 
(62.9 MHz, CDC13) 173.98 (C), 142.44 (C), 140.10 (2 x C), 138.01 (C), 138.43 (C), 
137.73 (CH), 133.23 (C), 131.98 (2 x CH), 128.27 (2 x CH), 128.19 (2 x CH), 
127.80 (CH), 127.45 (2 x CH), 126.99 (CH), 125.72 (2 x CH), 117.20 (CH2), 78.18 
(CH), 74.70 (CH), 56.62 (CH), 48.11 (CH2), 45.22 (CH), 22.79 (2 x CH3), 20.75 
(CH3), 13.78 (CH3), 13.22 (CH3); m/z (FAB, NOBA) 536 ({M+H]+, 4 %), 406 (96), 




2 '-(N-Benzyl-N-mesitylenesulfonylamino)-1 '-phenyipropyl (1 'S,2S,2'R,3S)-2,4-
dimethyl-3-hydroxypent-4-eneoate 185 
OHO Ph YVO) * 
Bn SO2 
To a solution of propionate 123 (148 mg, 0.309 mmol), in CH202 (4 ml) at —78 °C 
was added Bu2BOTf (309 jil, 1.0 M in CH202, 0.309 mmol), then DIPEA (161 p1, 
0.927 mmol). The reaction mixture was stirred for 2 h, then methacrolein was added 
(306 tl, 3.71 mmol). The reaction mixture was stirred at —78 °C for 1 h, then warmed 
to 0 °C for 1 h. The reaction was quenched by the addition of pH 7 buffer (4 ml), 
MeOH (10 ml) and careful addition of H202 (1 ml). The reaction mixture was stirred 
vigorously for 14 h. H20 (15 ml) was added and the mixture was extracted with 
CH2Cl2 (3 x 20 ml). The combined organics were washed with NaHCO3 (30 ml, sat.) 
and NaCl (30 ml, sat.), dried (MgSO4) and concentrated under reduced pressure to 
give the crude aldol product. Flash chromatography (20 % EtOAc in hexane) gave 
aldol adduct 185 as a colourless oil (164 mg, 97 %). Analysis of the crude 250 MHz 
'H NMR showed this to be a >95:5 mixture of diastereomers; Rf (20 % EtOAc in 
hexane) = 0.27, MD = 6.9 (c 1.3, CHC13); Vmax (neat)/cm' 3691 (OH), 1714 (C=O), 
1364 (SO), 1154 (SO); Major diastereomer: 'H NMR 8 (250 MHz, CDC13) 7.25 - 
7.14 (8H, m, An]), 6.93 - 6.90 (2H, m, An]), 6.80 (2H, s, An]), 5.85 (1H, d, J= 3.7 
Hz, C(1')H), 4.94 (1H, br s, CCH3=CHCISHTRANS), 4.82 (1H, br s, 
CCFJ3=CHcIsHTp Ns), 4.61 (1H, d, J= 16.6 Hz, CHAHBPh), 4.53 (1H, d, J= 16.6 
Hz, CHAHBPh), 4.22 (1H, br s, CHOH), 4.00 (1H, dq J = 7.0 & 3.7 Hz, C(2')H), 
2.48 (6H, s, o-CH3Ar), 2.35 (1H, qd, J = 7.3 & 4.3 Hz, CHCH3), 2.20 (3H, s, p-
CH3Ar) 1.61 (3H, s, C(4)CH3), 1.24 (3H, d, J = 7.0 Hz, CHCH3), 1.11 (3H, d, J= 7.0 
Hz, CHCH3); Minor diastereomer diagnostic peaks: 5.75 (1H, d, J= 3.9 Hz, (1')I]); 
'3C NMR 8(62.9 MHz, CDC13), 174.19 (C), 142.48 (C), 140.06 (2 x C), 138.36 (C), 
138.11 (C), 133.10(2 XC), 132.03 (2 x CH), 128.34(4 x CH), 127.85 (CH), 126.98 
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(3 x CH), 125.76 (2 x CH), 111.69 (CH2), 78.42 (CH), 73.39 (CH), 56.71 (CH), 
48.06 (Cl-I2), 41.56 (CH), 22.90 (2 x CH3), 20.70 (Cl-I3), 19.36 (CH3), 12.47 (CH3), 
9.32 (CH3); m/z (FAB, NOBA) 572 ([M+Na], 3 %), 550 ([M+H], 6), 406 (99), 316 
(91), 222 (55); HRMS (FAB, NOBA) found 550.2625, C32H40N05S requires 
550.2627. 
General procedure B: Silyl protection of aldol adducts 
To a solution of aldol adduct (5.12 mmol) in CH2C12 (100 ml) at 0 °C was added 
dropwise 2,6-lutidine (893 jil, 7.68 mmol) followed after 5 min by silyl triflate (5.32 
mmol) dropwise and the reaction mixture was stirred at 0 °C for 70 mm. The reaction 
was diluted with CH2C12 (300 ml), washed with NaHCO3 (500 ml, sat.), NaCl (500 
ml, sat.), dried (MgSO4) and concentrated under reduced pressure to give the crude 
silyl-protected product. Flash chromatography (10 % EtOAc in hexane) removed 
trace impurities to give the silyl-protected compound. 
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2'-(N-Benzyl-N-mesitylenesulfonylamino)-1 '-phenylpropyl 	(1 'S,2S,2 'R,3S)-3- 
tert-butyldimethylsilyloxy-2-methylpent-4-eneoate 191 
TBSO 0 Ph 
Bn 
General procedure B was followed with aldol adduct 180 (4.01 g, 7.50 mmol) in 
CH2C12 (100 ml) at 0 °C, 2,6-lutidine (1.60 ml, 13.9 mmol) was added dropwise 
followed by TBSOTf (2.39 ml, 10.4 mmol). Flash chromatography (10 % EtOAc in 
hexane) gave protected aldol adduct 191 as a colourless oil (4.42 g, 95 %). R f (20 % 
EtOAc in hexane) = 0.48; [a10 = -2.3 (c 0.5, CHCI3 ); Vmax (neat) / cm-1 1736 (C=O); 
'H NMR 8(250 MHz, CDCI3) 7.37 - 7.11 (8H, m, ArE), 6.86 (2H, s, ArE), 6.79 - 
6.76 (2H, m, ArE), 5.73 (1H, J= 5.2 Hz, C(1')E), 5.61 (1H, ddd, J= 13.7, 10.4 & 
6.7 Hz, CHCH2), 5.12 (1H, d, J = 13.7 Hz, CH=CHCISHTRANS), 5.11 (1H, d, J = 
10.4 Hz, CH=CHCISCHTlNs), 4.82 (111, d, J= 16.4 Hz, CHAHBPh), 4.47 (1H, d, J 
16.4 Hz, CHAHBPh), 4.30 (1H, br t, J= 6.7 Hz, CHOTBS), 4.05 (1H, dq, J= 6.9 & 
5.2 Hz, C(2')H), 2.49 (1H, dq qn, J= 6.7 Hz, CHCH3), 2.46 (6H, s, o-CH3Ar), 2.29 
(3H, s, p-CH3Ar), 1.16 (3H, d, J = 6.7 Hz, CHCH3), 0.94 (3H, d, .1 = 6.9 Hz, 
C(2')HCH3), 0.86 (9H, s, SiC(CH3)3), - 0.12 (3H, s, SiCH3), -0.05 (3H, s, SiCH3); 
' 3C NMR 8(62.9 MHz, CDC13) 172.52 (C), 142.31 (C), 140.21 (2 x C), 138.40 (C), 
138.12 (C), 137.89 (CH), 133.00 (C), 131.99 (2 x CH), 128.24 (2 x CH), 128.08 (2 x 
CH), 127.85 (2 x CH), 127.69 (CH), 127.13 (CH), 126.19 (2 x CH), 116.51 (CH2), 
77.75 (CH), 74.90 (CH), 56.57 (CH), 48.04 (CH2), 46.38 (CH), 25.73 (3 x CH3), 
22.79 (2 x CH3), 20.75 (CH3), 18.00 (C), 14.06 (CH3), 12.07 (CH3), - 4.58 (CH3), 
- 4.98 (CH3), m/z (FAB, NOBA) 648 ([M-H]+, 4 %), 406 (92), 316 (80), 222 (60), 




2' -(N-Benzyl-N-mesitylenesulfonylamino)-1 '-phenyipropyl 	(1 'S,2S,2 'R,3S)-3- 
triethylsilyloxy-2-methylpent-4-eneoate 178 
TESO 0 Ph 
CY 1- 0 
Bn S02 
General procedure B was followed with aldol adduct 180 (2.74 g, 5.12 mmol) in 
CH202 (100 ml) at 0 °C, 2,6-lutidine (893 p1, 7.68 mmol) was added dropwise 
followed by TESOTf (1.22 ml, 5.32 mmol). Flash chromatography (EtOAc) gave 
protected aldol adduct 178 as a colourless oil (3.12 g, 94 %). Rf (20 % EtOAc in 
hexane) = 0.89; [a]D = -1.42 (c 0.1, CHC13); Vmax (neat) /cm 1735 (C0); 'H NMR 
(5 (250 MHz, CDC13) 7.42 - 7.06 (1 OH, m, ArH), 6.87 (2H, s, An]), 5.97 (1H, d, .1= 
4.9 Hz, C(1')I]), 5.88 (1H, ddd, J = 17.4, 10.1 & 7.0 Hz, CH=CH2), 5.42 (1H, d, 1= 
17.4 Hz, CHCHCISHTRANS), 5.33 (1H, d, J = 10.1 Hz, CHCHCJSHTRANS), 5.11 (1H, 
d, J= 16.3 Hz, CHAHBPh), 4.71 (1H, d, J = 16.3 Hz, CHAHBPh), 4.56 (1H, br t, J= 
7.0 Hz, CHOTES), 4.26 (1H, dq, J = 7.0 & 4.9 Hz, C(2')I]), 2.71 (1H, dq qn, J= 
7.0 Hz, CHCH3), 2.70 (6H, s, o-CH3Ar), 2.56 (3H, s, p-CH3Ar), 1.37 (3H, d, J = 6.9 
Hz, CHCH3), 1.19 (3H, d, J = 7.0 Hz, C(2')HCH3), 1.18 - 1.06 (9H, m, 3 x 
SiCH2CH3), 0.83 - 0.70 (6H, m, 3 x SiCH2CH3); '3C NMR 8 (62.9 MHz, CDCI3) 
172.24 (C), 141.81 (C), 139.70 (2 x C), 138.07 (C), 137.68 (C), 137.54 (CH), 132.58 
(C), 131.50 (2 x CH), 127.69 (2 x CH), 127.58 (2 x CH), 127.37 (2 x CH), 127.14 (2 
x CH), 126.57 (CH), 125.55 (CH), 116.18 (CH2), 77.20 (CH), 74.75 (CH), 56.11 
(CH), 47.61 (CH2), 46.10 (CH), 22.53 (2 x CH3), 20.24 (CH3), 13.42 (CH3), 11.94 
(CH3), 6.17 (3 x CH3), 5.76 (CH2), 4.21 (2 x CH2); ink (FAB, NOBA) 650 ([M+H]1 , 
3 %), 406 (76), 316 (66), 307 (52), 289 (40); HRMS (FAB, NOBA) found 650.3336, 
C37H52NO5SSi requires 650.3335. 
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General procedure C: Auxiliary displacement 
To a solution of phosphonate (1.32 mmol) in THF (15 ml) was added BuLi (1.20 
ml, 1.10 M solution in hexanes, 1.32 mmol) dropwise at —78 °C. After stirring for 60 
min at —78 °C the light yellow solution was transferred via cannula into a solution of 
aldol adduct (0.300 mmol) in THF (15 ml) at —78 °C. The resulting solution was 
stirred for another 60 min before being carefully poured onto NH4C1 (150 ml, sat.) 
The mixture was extracted with CH2C12 (3 x 100 ml), washed with NaCl (100 ml, 
sat.) and dried (MgSO4). The organics were concentrated under reduced pressure to 
give a mixture of the crude 0-ketophosphonate ester and auxiliary. Flash 
chromatography (gradient elution 20 - 30 % EtOAc in hexane) gave the recovered 






General procedure C was followed with diethylethane phosphonate (212 .il, 1.32 
mmol) and nBuLj (1.20 ml, 1.10 M solution in hexanes, 1.32 mmol) in THF (15 ml) 
which was added to a solution of aldol adduct 275 (200 mg, 0.300 mmol) in THF (15 
ml). Flash chromatography (20 % EtOAc in hexane) gave the recovered auxiliary as 
a colourless solid (112 mg, 85 %) and flash chromatography (30 % EtOAc in 
hexane) afforded the 3-ketophosphonate ester 192 as a 3:1 ratio of diastereomers and 
as a colourless oil (95 mg, 81 %). Rf (50 % EtOAc in hexane) = 0.25; Vmax (neat) I 
cm-' 1715 (C0), 1251 (P0), 1027 (PO); 'H NMR 8(250 MHz, CDC13) 5.74 (1H, 
ddd, J= 17.5, 9.8 & 7.8 Hz, CH=CH2), 5.22 (1H, d, J= 17.5 Hz, CH=CHCISHTRANS), 
5.16 (1H, d, J= 9.8 Hz, CH=CHCISHTRANS), 4.15 (4H, m, 2 x OCH2CH3), 4.15 (1H, 
m, CHOTBS), 3.52 (0.8H, dq, J= 26.8 & 7.0 Hz, CIJP(0)CH2CH3), 3.36 (0.2H, m, 
CHPOCH2CH3), 3.22 (0.8H, dq, J= 9.0 Hz & 6.8 Hz, CHCH3), 3.03 (0.2H, dq qn, 
J—= 7.8 Hz, CHCH3), 1.43 (6H, m, 2 x OCH2CH3), 1.43 (3H, m, POCHCH3), 1.10 
(0.6H, d, J = 6.8 Hz, CHCH3), 1.00 (2.4H, J = 6.8 Hz, CHCH3), 0.99 (1.8H, s, 
C(CH3)3), 0.89 (7.2H, s, C(CH3)3), 0.02 (3H, s, SiCH3), 0.00 (3H, s, SiCH3); 13C 
NMR 6 (62.9 MHz, CDC13) 209.28 (C), 139.41 (CH), 116.88 (CH2), 78.88 (CH), 
62.36 (2 x CH2), 51.97 (CH), 49.16 (CH, 'Jpc = 124.1 Hz), 25.68 (3 x CH3), 17.86 
(C), 16.30 (2 x CH3), 14.02 (2 x CH3), -4.13 (CH3), -4.87 (CH3); mlz (FAB, NOBA) 
393 ([M+H], 17 %), 307 (57), 289 (46), 279 (22), 193 (40); HRMS (FAB, NOBA) 





General procedure C was followed with dimethylmethane phosphonate (73.0 p1, 
0.678 mmol) and BuLi (424 t1, 1.6 M solution in hexanes, 0.678 mmol) in THF (15 
ml) to which was added to a solution of aldol adduct 178 in THF (100 mg, 0.154 
mmol). Flash chromatography (30 % EtOAc in hexane) afforded the 13-
ketophosphonate ester 193 as a colourless oil (12.0 mg, 23 %) and recovered 
auxiliary 122 (16.0 mg, 24 %); R f (20 % EtOAc in hexane) = 0.27; [a]0 = 16.7 (c 
1.5, CHC13); Vmax (neat) / cm = 1711 (C0), 1200 (P=O), 1017 (P0); 'H NMR b 
(250 MHz, CDC13) 5.65 (1H, ddd, J= 16.8, 10.3 & 7.1 Hz, CHCH2), 5.13 (1H, d, J 
= 16.8 Hz, CHCHCISHTRANS), 5.10 (1H, d, J = 10.3 Hz, CHCHCISHTRANS), 4.01 
(1H, br t, J= 8.7 Hz, CHOTES), 3.73 (3H, d, 3JPH = 9.1 Hz, POCH3), 3.72 (3H, d, 
Jp11= 9.1 Hz, POCH3), 3.40 (1H, dd, J= 22.1 & 13.9 Hz, CHAHB), 3.06 (1H, dd, J= 
21.7 & 13.9 Hz, CHAHB), 2.92 (1H, dqqn, J = 8.7 Hz, CHCH3), 0.89 (3H, d, J = 7.1 
Hz, CHCH3), 0.92 - 0.88 (9H, m, SiCH2CH3), 0.51 - 0.45 (6H, m, SiCH2CH3); mz 
(FAB, NOBA) 373 ([M+Na]+, 13 %), 351 ([M+H], 62) , 321 (65), 295 (70), 265 




General Procedure D: Homer Wadsworth Emmons 
To a solution of 3-ketophosphonate ester (0.10 mmol) in THF (2 ml) was added 
Ba(OH)2.8H20 (40 mg, 0.12 mmol) and the mixture stirred for 30 min until it 
became cloudy. Aldehyde (0.15 mmol) in THF:H20 (40:1, 5 ml) was added and the 
reaction stirred at room temperature for 24 h. The reaction mixture was diluted with 
CH2Cl2 (30 ml), washed with NaHCO3  (30 ml, sat.), NaC1 (30 ml, sat.) and dried 
(MgSO4). Organics were removed under reduced pressure to give the crude enone 






General procedure D was followed with f3-ketophosphonate ester 192 (40 mg, 
0.10 mmol), Ba(OH)2.8H20 (38 mg, 0.12 mmol) and isovaleraldehyde (16 p1, 0.15 
mmol). Flash chromatography (10 % EtOAc in hexane) gave 13-hydroxy enone 196 
as a colourless oil (31 mg, 95 %); Rf (20 % EtOAc in hexane) = 0.72; Vmax (neat) / 
cm-1 = 1666 (C0); [a]D = 9.3 (c 0.37, CHC13); 'H NMR 8(250 MHz, CDC13) 6.75 
(1H, t, J = 6.6 Hz, C(4)HCH2), 5.79 (1H, ddd, J= 16.4, 10.2 & 7.8 Hz, CH=CH2), 
5.24 (1H, br d, J = 16.4 Hz, CHCHCISHTRANS), 5.18 (1H, br d, J = 10.2 Hz, 
CH=CHCISHTRANS), 4.31 (1H, br t, J= 7.8 Hz, CHOTBS), 3.37 (1H, dq, J= 7.8 & 
6.6 Hz, C(7)HCH3), 2.19 (2H, br t, J = 6.6 Hz, C(3)H2), 1.94 - 1.78 (1H, m, 
CH(CH3)2), 1.82 (3H, s, C(5)CH3), 0.99 (3H, d, J— 6.6 Hz, CHCH3), 0.95 (6H, d, J 
= 7.0 Hz, CH(CH3)2), 0.83 (9H, s, C(CH3)3), 0.02 (3H, s, SiCH3), -0.01 (3H, s, 
SiCH3); '3C NMR 8 (62.9 MHz, CDC13) 204.70 (C), 141.77 (CH), 139.50 (CH), 
138.11 (C), 116.20 (CH2), 77.22 (CH), 45.07 (CH), 38.16 (CH2), 28.31 (CH), 25.55 
(3 x CH3), 22.45 (2 x CH3), 17.83 (C), 14.41 (CH3), 11.67 (CH3), -4.35 (CH3), -5.06 
(CH3); m/z (FAB, NOBA) 325 ([M+H], 51 %), 307 (48), 267 (70), 171 (72), 155 




General Procedure E: Desilylation of f-hydroxy enones 
To a solution of -hydroxy enone (0.15 mmol) in MeCN (1 ml) at RT was added HF 
(100 p1, 40 % aq.) and the reaction mixture was stirred for 5 mm. The reaction 
mixture was cautiously quenched with NaHCO3 (solid) until effervescence had 
stopped. H20 (20 ml) was added and the reaction mixture was extracted with CH2Cl2 
(3 x 10 ml). The organics were dried (Na2SO4) and volatiles were removed under 
reduced pressure to give the crude J3-hydroxy enone as a yellow oil. Purification by 





General Procedure E was followed with 0-hydroxy enone 196 (50 mg, 0.15 mmol) 
in MeCN (1 ml) at RT and HF (100 p1, 40 % aqueous). Purification by flash 
chromatography (20 % EtOAc in hexane) afforded the 13-hydroxy enone 176 as a 
colourless oil (31 mg, 95 %); Rf (20 % EtOAc in hexane) = 0.32; Vmax (neat) / cm 
3422 (OH), 1662 (C=O), 1607 (CC); [aJ0 = 1.08 (c 0.2, CHC13); 'H NMR 8(250 
MHz, CDC13) 6.62 (1H, br t, J= 7.4 Hz, C(4)I]), 5.79 (1H, ddd, J= 17.1, 10.4 & 6.6 
Hz, CH=CH2), 5.22 (1H, dt, J— 17.1 & 1.6 Hz, CHCISCHTRANS), 5.10 (1H, dt, J= 
10.4 & 1.6 Hz, CHCISCHTRANS), 4.19 (1H, br t, J = 6.6 Hz, CHOH), 3.28 (1H, dq 
qn, J = 6.6 Hz, C(7)HCH3), 2.98 (1H, br s, OH), 2.09 (2H, t, J = 7.5 Hz, C(3)H2), 
1.76 - 1.68 (1H, in, CH(CH3)2), 1.69 (3H, s, C(5)CH3), 1.07 (3H, d, J = 7.2 Hz, 
CHCH3), 0.89 (6H, d, J = 6.5 Hz, CH(CH3)2); '3C NMR 6 (62.9 MHz, CDCI3) 
206.41 (C), 143.03 (CH), 138.76 (CH), 137.41 (C), 116.08 (CH2), 75.39 (CH), 43.87 
(CH), 38.16 (CH2), 28.31 (CH), 22.42 (2 x CH3), 15.89 (CH3), 11.37 (CH3); m/z 
(FAB, THIOG.) 211 ([M+H], 33 %), 210 (7), 209 (6), 195 (5), 193 (24); HRMS 
(FAB, THIOG.) [M+H]1 found 211.1702, C13H2302 requires 211.1698. 
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Samarium (II) Iodide 
A suspension of iodine (259 mg, 1.00 mmol) and samarium (207 mg, 1.40 mmol, 
40 mesh) in THF (10 ml) was heated under reflux in the absence of light*  for 1 h 
after which time a deep blue solution of Sm12 (0.1 M in THF) had formed. The 
solution was then cooled to room temperature where it could be stored under Ar 
before oxidation to a yellow Sm (III) species occurred. 
General procedure F: Evans-Tishchenko coupling 
To a solution of benzaldehyde (100 tl) in THF (10 ml) at 0 °C was Sm12 (5.00 ml, 
0.1 M solution in THF) dropwise and the green solution was stirred for 30 min after 
which time the solution had become yellow (indicating formation of the Sm (III) 
pinacol adduct). To this solution was added aldehyde (2.0 mmol) and the solution 
was stirred at 0 °C for 30 mm. A solution of -hydroxy enone (1.0 mmol) in THF (10 
ml) was added to the reaction mixture and was stirred for 30 mm. The reaction 
mixture was added to a mixture potassium sodium tartrate tetrahydrate/K2CO3 (10:1 
mixture (10:1 mixture, 10 % aq.; 50 ml) and CH2C12 (60 ml), the layers separated 
and the aqueous layer extracted with CH2C12 (2 x 60 ml). The combined organics 
were washed with NaCl (120 ml, sat.), dried (MgSO4) and the volatiles removed 
under reduced pressure. Flash chromatography (10 % EtOAc in hexane) separated 
the ester from any trace impurities. 
* This is not critical but Sm12 is known to be light sensitive and should be treated accordingly. 
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(4E,6R,7R,8S)-8-hex-5' enoyl-2,5,7-trimethyldec-4,9-en-6-ol 174 
0 
4O OH 
General procedure F was followed with benzaldehyde (100 p1) in THF (10 ml) and 
Sm12 (3.00 ml, 0.1 M solution in THF), to which hexenal (186 mg, 1.90 mmol) 
followed by -hydroxy enone 176 (200 mg, 0.952 mmol) in THF (10 ml) were 
added. Flash chromatography (10 % EtOAc in hexane) afforded ester 174 as a 
colourless oil (269 mg, 93 %). Analysis of the 360 MHz 1H NMR showed this to be a 
9:1 mixture of diastereomers; Rf (20 % EtOAc in hexane) = 0.51; [aID = 0.67 (c 1.0, 
CHC13); Vmax (neat) / cm 3492 (OH), 1726 (C0), 1643 (C=C); Major 
diastereomer: 1H NMR 8(360 MHz, CDC13) 5.81 - 5.61 (2H, m, 2 x CH=CH2), 5.42 
(1H, br t, J= 6.9 Hz, C(4)I]), 5.22-5.14 (3H, m, C(1 0)H2 & C(8)If), 4.98-4.90 
(2H, m, C(6')H2), 3.88 (1H, d, J = 4.8 Hz, C(6)HOH), 2.29 (2H, t, J = 7.0 Hz, 
C(2')H2), 2.03 (2H, dt q, J = 7.0 Hz, C(4')H2), 1.91 - 1.84 (3H, m, C(7)HCH3 & 
C(3)H2), 1.67 (2H, qn, J = 7.0 Hz, C(3')H2), 1.65— 1.52 (1H, m, CH(CH3)2), 1.52 
(3H, s, C(5)CH3), 0.83 (6H, d, .1 = 6.9 Hz, CH(CH3)2), 0.80 (3H, d, J = 6.9 Hz, 
C(7)HCH3); Minor diastereomer diagnostic peak: 4.10 - 4.05; (1H, m, C(6)HOH) 
'3c NMR 8(90.5 MHz, CDC13) 178.39 (C), 137.97 (CH), 135.73 (C), 134.80 (CH), 
125.75 (CH), 118.49 (CH2), 115.82 (CH2), 76.74 (CH), 76.11 (CH), 39.82 (CH), 
37.16 (CH2), 34.14 (CH2), 33.40 (CH2), 29.14 (CH), 24.44 (CH2), 22.89 (2 x 
14.47 (CH3), 9.72 (CH3); m/z (FAB, THIOG.) 291 ([(M-H20)+H]+, 26 %), 227 (12), 
223 (8), 214 (23), 206 (8); HRMS (FAB, THIOG.) [(M-H20)+H] found 291.2322 
C19H3102 requires 291.2324. 
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(5Z,7S,8R,9R,1 OE, 13S)-9-Hydroxy-(8,1 0,13-trimethyloct-1 0-enyl)-oxocene-1-one 
3 
To a solution of ester 174 (100 mg, 0.325 mmol) in degassed CH2Cl2 (100 ml) was 
added Grubbs' 2 catalyst 159 (55 mg, 20 mol%) and the reaction mixture was heated 
under reflux for 24 h. After the reaction mixture was cooled to room temperature, 
DMSO (2.0 ml) was added and the reaction mixture was stirred for a further 24 h. 
Volatiles were removed under reduced pressure to give the crude lactone. 
Purification by flash chromatography (30 % EtOAc in hexane) afforded lactone (81 
mg, 89 %). Analysis of the 360 MHz 'H NMR showed this to be a 9:1 mixture of 
lactone 3 and cyclopentenol by product 204; Rf (20 % EtOAc in hexane) = 0.23; laiD 
= 0.30 (c 0.5, CHC13); Vmax (neat) / cm-' 3436 (OH), 1730 (C=O), 1655 (C=C); Major 
product: 'H NMR 5(360 MHz, CDCI3) 5.60-5.59 (1H, m, C(11)HCH2), 5.58 (1H, 
s, C(7)II), 5.44 - 5.29 (2H, in, C(5)H & C(6)I]), 4.30 (1H, br d, J = 6.6 Hz, 
C(9)HOH), 2.33 - 2.26 (2H, in, C(2)H2), 2.19 —2.11 (1H, in, C(8)II), 2.07 - 1.98 
(2H, in, C(4)H2), 1.79 (2H, qn, J= 7.2 Hz, CHC(12)H2), 1.75 (3H, s, C(10)CH3), 
1.73 - 1.51 (3H, in, C(3)H2 & CH(CH3)2), 1.04 (3H, d, J= 6.9 Hz, C(8)HCH3), 1.02 
(6H, d, J = 6.9 Hz, CH(CH3)2); Minor product diagnostic peaks: 5.85 (1H, in, 
CH=CH2), 5.12 - 4.96 (2H, in, CHCH2); '3C NMR S (90.5 MHz, CDC13) 173.67 
(C), 150.11 (C), 130.20 (CH), 129.93 (CH), 125.26 (CH), 84.03 (CH), 77.70 (CH), 
46.36 (CH), 41.83 (CH2), 33.63 (CH2), 31.83 (CH2), 28.49 (CH), 24.74 (CH2), 22.24 
(2 x CH3), 13.57 (CH3), 11.91 (CH3); m/z (FAB, THIOG.) 281 ([M+H], 3 %), (279 
[M-H], 10), 263 ([(M-H20)+H], 37), 227 (13), 43 (100); HRMS (FAB, THIOG.) 
[M-H] found 279.1961, C17H2703 requires 279.1960. 
'H NMR assignments were made on the basis of COSY and HSQC experiments. 
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5.3 	EXPERIMENTAL PROCEDURES FOR CHAPTER 3 
(2R,3S)-2-Methylpent-4-ene-1 ,3-diol 214 
OH OH 
To a solution of aldol adduct 191 (200 mg, 0.308 mmol) in THF (100 ml) at 0 °C 
was added LiA1H4 (13.0 mg, 0.332 mmol). The reaction mixture was warmed to RT 
and stirred for 2.5 h. The reaction mixture was cooled to 0 °C, Na2SO4•10H20 was 
added slowly and the reaction mixture was stirred for 1 h. The reaction mixture was 
filtered through celite and the volatiles removed under reduced pressure to give the 
crude diol. Flash chromatography (30 % EtOAc in hexane) afforded the 1 ,3-diol 214 
as a colourless oil (32.0 mg, 90 %) and recovered auxiliary 4 (104 mg, 80 %); Rf (20 
% EtOAc in hexane) = 0.11; [a]0 = - 6.3 (c 0.4, CHC13); Vmax (neat) / cm 3432 
(OH); 'H NMR 5 (250 MHz, CDC13) 5.83 (1H, ddd, J = 17.0, 10.7 & 6.9 Hz, 
CH=CH2), 5.22 (1H, d, J = 17.0 Hz, CHCHTRANSHCIS), 5.14 (1H, d, J = 8.5 Hz, 
CH=CHTRANSHCIS), 3.96 (1H, br t, J= 6.9 Hz, CHOH), 3.71 (1H, dd, J= 8.5 & 3.5 
Hz, CHAHB), 3.59 (1H, dd, J= 7.7 & 7.0 Hz, CHAHB), 3.28 (2H, br s, 2 x OH), 1.82 
- 1.66 (1H, m, CHCH3), 0.83 (3H, d, J= 7.1 Hz, CHCH3); '3C NMR 5 (90.5 MHz, 
CDC13) 139.51 (CH), 116.07 (CH2), 78.68 (CH), 67.14 (CH2), 39.73 (CH), 13.34 
(CH3); in/z (FAB, NOBA) 117 ([M+H]', 43 %), 109 (63),99 (63), 91 (95), 45 (100); 
HRMS (FAB, NOBA) [M+H] found 117.0919, C6H1302 requires 117.0916. 
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(1R,2R)-2-(N-Benzyl-N-mesitylenesulfonylamino)- 1-phenylpropan-1-ol 233 





To a solution of alcohol 122 (200 mg, 0.470 mmol) in TI-IF (10 ml) was added Et3N 
(200 p.1, 2.00 mmol) at 0 °C. Methanesulfonyl chloride (100 p.!, 1.32 mmol) was 
added dropwise with vigorous stirring. A pale yellow precipitate resulted upon 
addition. The reaction mixture was stirred for 1 h and the solvent removed under 
reduced pressure. To a solution of residue in toluene (10 ml) was added Et3N (180 p.1, 
1.32 mmol) in one portion. Cyclohexylamine (200 p.1, 1.98 mmol) was added and the 
resulting suspension was heated under reflux for 12 h. NaOH (5 ml, 15 %) was added 
and the mixture was washed with NaC1 (20 ml, sat.), dried (K2CO3)  and concentrated 
under reduced pressure to give the crude amine product. Flash chromatography 
(CH202) gave alcohol 122 as a colourless solid (48 mg, 24 %) and alcohol 244 as a 
colourless oil (74 mg, 37 %); Rf (50 % EtOAc in hexane) = 0.25; Vmax (neat) / cm' 
3514 (OH), 1235 (SO), 1146 (SO); 'H NMR 45(250 MHz, CDC13) 7.23 —7.13 (8H, 
m, An]), 6.93 - 6.88 (2H, m, ArII), 6.57 (2H, s, An]), 4.95 (1H, d, J = 4.7 Hz, 
C(1')I]), 4.72 (1H, d, J— 16.6 Hz, CHAHBPh), 4.65 (1H, d, J = 16.6 Hz, CHAHBPh), 
4.24 (1H, dq, J= 7.0 & 4.7 Hz, C(2')HCH3), 2.42 (6H, s, o-CH3Ar), 2.21 (3H, s,p-
CH3Ar), 1.80 (3H, d, J = 6.7 Hz, CHCH3); '3C NMR 6 (62.9 MHz, CDC13) 142.54 
(C), 142.74 (C), 140.24 (2 x C), 138.34 (C), 133.18 (C), 132.75 (2 x CH), 127.99 (2 
x CH), 127.96 (2 x CH), 127.43 (2 x CH), 127.18 (CH), 127.07 (CH), 125.26 (2 x 
CH), 76.21 (CH), 59.96 (CH), 49.38 (CH2), 22.74 (2 x CH3) 20.73 (CH3), 9.71 
(CH3); m/z (FAB, NOBA) 424 ([M+H], 33 %), 406 (48), 316 (73), 242 (59), 183 
(38), 119 (82), 91(100), 77 (47); HRMS (FAB, NOBA) [M+H] found 424.1946, 







To a solution of alcohol 122 (200 mg, 0.470 mmol) in THF (10 ml) was added Et3N 
(200 p1, 2.00 mmol) at 0 C. Methanesulfonyl chloride (100 p1, 1.32 mmol) was 
added dropwise with vigorous stirring. A pale yellow precipitate resulted upon 
addition. The reaction mixture was stirred for 1 h and Et3N (180 p1, 1.32 mmol) was 
added in one portion. LHMDS (177 p1, 0.94 mmol) was added and the resulting 
suspension was heated under reflux for 2 h and stirred at room temperature 
overnight. NaOH (15 ml, 15 %) was added and the mixture was washed with NaCl 
(20 ml, sat.), dried (K2CO3) and concentrated under reduced pressure to give the 
crude amine product. Flash chromatography (20 % EtOAc in hexane) gave 
isoquinoline 235 as a colourless solid (101 mg, 53 %); Rf (20 % EtOAc in hexane) = 
0.62; mp = 176-177 °C (hexane/CH2C12); IU]D = 1.75 (c 1.50, CHC13); Vmax 
(neat)/cm' 1376 (S02),1154  (SO2); 'H NMR ö (360 MHz, CDC13) 7.27 - 7.01 (8H, 
m, ArH), 6.68 - 6.66 (3H, m, Ark!), 4.51 (2H, br s, CH2N), 4.17 (1H, dq, J = 6.7 & 
4.9 Hz, CHCH3), 4.00 (1H, br s, CHPh), 2.25 (6H, s, 2 x o-CH3), 2.21 (3H, s, p-
CH3), 1.47 (3H, d, J = 6.7 Hz, CH3CH); '3C NMR c (90.5 MHz, CDCI3) 146.7 (C), 
144.9 (C), 143.0 (2 x C), 136.0 (C), 135.0 (2 x C), 134.5 (2 x CH), 134.1 (CH), 
130.9 (2 x CH), 130.7 (2 x CH), 130.0 (CH), 129.7 (CH), 129.2 (CH), 128.8 (CH), 
57.5 (CH), 53.7 (CH), 44.5 (CH2), 25.7 (2 x CH3), 23.7 (CH3), 20.5 (CH3); mhz 
(FAB, THIOG.) 406 ([M+H]+, 84 %), 222 (83), 119 (94), 91(100); HRMS (FAB, 
THIOG.) [M+H] found 406.1840, C25H28NO2S requires 406.1840. 
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To a stirred solution of norephedrine (5.32 g, 35.2 mmol) in MeCN (70.0 ml) was 
added K2CO3  (13.8 g, 99.0 mmol) and benzyl bromide (8.37 ml, 70.0 mmol). The 
mixture was then stirred for 48 h at RT. EtOAc (50 ml) was added and the solution 
was washed with water (3 x 10 ml) and NaC1 (2 x 20 ml, sat.). The organics were 
dried (MgSO4) and removed under reduced pressure to give the crude alcohol as a 
yellow oil. Flash chromatography (10 % EtOAc in hexane) gave alcohol 221 as a 
colourless oil (10.3 g, 90 %); Rf (20 % EtOAc in hexane) = 0.45; [ajD = 5.03 (c 1.5, 
CHCI3); Vmax (neat) / cm 3422 (OH); 'H NMR 8 (250 MHz, CDC13) 7.48 - 7.33 
(15H, m, ArE), 4.88 (1H, d, J = 6.7 Hz, CHPh), 3.94 (2H, d, J = 13.8 Hz, 
CHAHBPh), 3.71 (2H, d, J = 13.8 Hz, CHAHBPh), 3.24 (1H, dq qn, J = 6.7 Hz, 
CHCH3), 2.88 (1H, brs, OH), 1.32 (3H, d, J= 6.7 Hz CHCH3); '3C NMR 8 (62.9 
MHz, CDC13) 142.53 (C), 139.27 (2 x C), 128.01 (4 x CH), 127.52 (4 x CH), 127.35 
(2 x CH), 126.64 (CH), 126.18 (2 x CH), 126.09 (2 x CH), 75.32 (CH), 57.72 (CH), 
53.87 (2 x CH2), 8.43 (CH3); in/z (FAB, NOBA) 332 ([M+H], 25 %), 224 (96), 154 








To a solution of alcohol 221 (3.13 g, 9.62 mmol) in Et20 (40 ml) at 0 °C was added 
Et3N (4.00 ml, 28.9 mmol), followed by methanesulfonyl chloride (900 jil, 11.5 
mmol) and the reaction mixture was stirred for 1 h. Et3N (2.70 ml, 19.3 mmol) was 
added and the reaction allowed to warm to RT before addition of thiolacetic acid 
(17.2 ml, 240 mmol). The reaction mixture, which had turned a bright yellow colour, 
was stirred for 48 h at RT. The reaction mixture was washed with H20 (3 x 10 ml) 
and NaHCO3 (5 x 10 ml, sat.). The resulting organic layer was dried (MgSO4) and 
volatiles were removed under reduced pressure to give the crude thioacetate. Flash 
chromatography (2 % EtOAc in hexane) afforded the Thioacetate 237 as an 
orange/brown solid (2.40 g, 86 %); Rf (20 % EtOAc in hexane) = 0.57; mp = 100 - 
102 °C; Vmax (nujol) / cm-1 1689 (C0); LaI D = 4.33 (c 1.29, CHCI3); 'H NMR 8 
(250 MHz, CDC13) 7.20-7.11 (8H, m, ArH), 6.92-6.83 (7H, m, ArH), 4.70 (1H, d, 
J = 10.7 Hz, CHPh), 3.44 (2H, d, J- 13.6 Hz, CHAHBPh), 3.25 (2H, d, J = 13.6 Hz, 
CHAHBPh), 3.20-3.10 (1H, m, CHCH3), 2.18 (3H, s, CH3CO), 1.20 (3H, d, J = 6.5 
Hz, CHCH3); '3C NMR 8 (62.9 MHz, CDCI3) 194.21 (C), 141.43 (C), 139.24 (2 x 
C), 128.91 (4 x CH), 128.53 (2 x CH), 128.05 (2 x CH), 127.87 (4 x CH), 126.65 
(CH), 126.58 (2 x CH), 55.72 (CH), 53.21 (2 x CH2), 51.84 (CH), 30.34 (CH2), 9.66 
(CH3); m/z (FAB, NOBA) 390 ([M+H], 69 %), 307 (79), 224 (93), 154 (100), 91 




(1S,2R)-2-(N-4 '-methoxybenzyl)-1-phenylpropan-1 -ol 244 
Ph 
HO( 
HN PM B 
To a solution of norephedrine (453 mg, 3.00 mmol) in EtOH (3 ml) was added 
anisaldehyde (550 p1, 4.74 mmol) the reaction mixture was stirred at RT for 40 mm. 
NaBH4 (170 mg, 4.48 mmol) was added and the reaction mixture was stirred for 30 
mm. The reaction was cooled to 0 °C and HC1 (10 %) was cautiously added dropwise 
until the pH was 1 (litmus paper). Volatiles were removed under reduced pressure 
and a white solid (1.47 g) was retrieved. This was dissolved in H20 (10.0 ml), 
filtered and basified with NaOH (IN aq.). The aqueous layer was extracted with 
CH202 and dried (Na2SO4). Flash chromatography (10 % EtOAc in hexane) 
afforded the alcohol 244 as a colourless oil (571 mg, 70 %); Rf (33 % EtOAc in 
hexane) = 0.13; Vmax (neat) / cm-1 3335 (OH); 'H NMR 6 (250 MHz, CDCI3) 7.26 - 
7.19 (5H, m, An]), 6.99 (2H, d, J= 11.6 Hz, ArH), 6.81 (2H, d, J= 11.6 Hz, An]), 
4.67 (1H, d, J = 3.9 Hz, CHPh), 3.69 (5H, s, OCH3 & CH2Ph), 2.91 -2.82 (1H, m, 
CHCH3), 0.78 (3H, d, J = 6.5 Hz, CHCH3); '3C NMR 6(62.9 MHz, CDC13) 158.63 
(C), 141.22 (C), 131.91 (C), 129.24 (2 x CH), 127.90 (2 x CH), 126.80 (CH), 125.90 
(2 x CH) 113.70 (2 x CH), 72.90 (CH), 57.40 (CH), 55.1(CH3), 50.41(CH2), 14.39 
(CH3); m/z (FAB NOBA) 272 ([M+H], 87 %), 164 (60 %), 121 (100 %), 91 (76 






To a stirred solution of alcohol 244 (3 10 mg, 1.14 mmol) in MeCN (10 ml) was 
added K2CO3 (239 mg, 1.71 mmol), followed by benzyl bromide (200 j.tl, 1.71 
mmol) and the resultant solution was stirred for at RT for 16 h. H20 (10 ml) was 
added and the mixture was extracted with EtOAc (2 x 20 ml) was added and the 
organic layer extracted and dried (NaSO4). Flash chromatography (10 % EtOAc in 
hexane) afforded the di-protected aminoalcohol 222 as a colourless gum. (265 mg, 
96 %). R (20 % EtOAc in hexane) = 0.41; Vm (neat) / cm-' 3432 (OH); 'H NMR 5 
(250 MHz, CDC13) 7.39-7.32(1011, mArl]), 6.97 (2H, d, J= 11.6 Hz, An]), 6.79 
(2H, d, J= 11.6 Hz, An]), 4.79 (1H, d, J= 6.4 Hz, CHPh), 3.87 (3H, s, OCH3), 3.60 
(411, m, CH21?h), 3.18 (1H, qn, J= 6.7 Hz CHCH3), 2.75 (111, br s, 01]), 1.23 (311, d, 
J= 6.8 Hz, CHCH3); '3C NMR 8(62.9 MHz, CDCI3) 158.91 (C), 143.52 (C), 140.34 
(C), 132.08 (C), 130.26 (2 x CH), 129.07 (2 x CH), 128.63 (2 x CH), 128.31 (2 x 
CH), 127.60 (2 x CH), 127.06(2 x CH), 114.12 (2 x CH), 75.21 (CH), 58.63 (CH), 
55.60 (CH3), 54.68 (CH2), 54.19 (CH2), 9.52 (CH3); m/z (FAB NOBA) 362 
({M+H]+, 63 %), 360 (76), 254 (83), 121 (100), 91(83); HRMS (FAB, NOBA) 
[M+H] found 362.2120, C24H28NO2 requires 362.2120. 
174 
Experimental 
(1S,2R)-2-(N-benzyl-N-4'-methoxy benzyl)-1 -phenyipropyl thioacetate 245 
Ph 
AcS 1 ( 
Bn 1" 'FMB 
To a solution of the di-protected aminoalcohol 222 (235 mg, 0.650 mmol) in Et20 
(10 ml) was added Et3N (270 tl, 1.95 mmol) at 0 °C, followed by methanesulfonyl 
chloride (80.0 jl, 0.980 mmol). The resultant solution was stirred for 30 mm, during 
which time a white precipitate was observed. Et3N (180 t1, 1.03 mmol.) was added 
to the reaction mixture followed by thiolacetic acid (1.16 ml, 16.3 mmol) and the 
reaction was stirred at RT for 16 h. To the reaction mixture was added H20 (15 ml) 
and it was extracted with EtOAc (3 x 15 ml). The organics were combined, washed 
with NaHCO3 (5 x 10 ml) and dried (Na2SO4). Flash chromatography (1.5 % EtOAc 
in hexane) afforded the thioacetate 245 as a brown gum (157 mg, 60 %); Rf (20 % 
EtOAc in hexane) = 0.52; Vmax (neat) / cm' 1691 (C=O); 'H NMR ö (250 MHz, 
CDC13) 7.38 - 6.83 (14H, m, ArE), 4.90 (1H, d, J = 10.8, CHPh), 3.90 (3H, s, 
OCH3), 3.89 - 3.38 (4H, m, 2 x CH21?h), 3.38 - 3.25 (1H, m, CHCH3), 2.40 (3H, s, 
SCOCH3), 1.38 (3H, d, J = 6.5 Hz, CHCH3); '3C NMR 8 (62.9 MHz, CDC13) 
194.21 (C), 158.42 (C), 141.43 (C), 139.36 (C), 131.23 (C), 129.95 (2 x CH), 128.82 
(2 x CH), 128.50 (2 x CH), 127.98 (2 x CH), 127 89 (2 x CH), 126.71 (CH), 126.62 
(CH), 113.20 (2 x CH), 75.41 (CH), 55.46 (CH3), 55.13 (CH), 52.98 (CH2), 52.56 
(CH2), 30.30 (CH3), 9.65 (CH3); m/z (FAB, NOBA) 420 ([M+H], 64 %), 419 (65), 
418 (84), 254 (76), 121 (100); HRMS (FAB, NOBA) [M+H] found 420.2009, 
C26H30NO2S requires 420.1997. 
175 
Experimental 




To sulfonamide 182 (42.0 g, 130 mmol) was added thionyl chloride (30.0 ml, 380 
mmol) and the reaction was stirred at RT for 15 h. The excess thionyl chloride was 
removed under reduced pressure to give the crude chloride as a brown oil. Trituration 
using Et20/hexane gave chloride 248 as a colourless solid (43.1 g, 97 %); Rf (20 % 
EtOAc in hexane) = 0.44; mp 137-138 °C; [aID = 27.2 (c 1.10, CHC13); Vmax 
(nujo1)/cm 3295 (NH), 1377 (SO), 1151 (SO), 723 (CC1); 'H NMR 8(360 MHz, 
CDC13) 7.32 - 7.21 (5H, m, An]), 6.98 (2H, s, ArH), 4.98 (1H, d, J= 3.5 Hz, NI]), 
4.94 (1H, d, J= 9.5 Hz, C(1)H), 3.77 - 3.64 (1H, m, C(2)II), 2.68 (6H, s, 2 x o-CH3), 
2.31 (3H, s,p-CH3), 1.17 (3H, d, J = 4.4 Hz, C(2)HCH3); '3C NMR 5(90.5 MHz, 
CDCI3) 142.82 (C), 139.30 (2 x C), 137.89 (C), 134.85 (C), 132.49 (2 x CH), 128.91 
(2 x CH), 128.72 (CH), 127.51 (2 x CH), 68.44 (CH), 55.46 (CH), 23.39 (2 x CH3), 
21.34 (CH3), 15.50 (CH3); ink (FAB, THIOG.) 352 ([M+H], 80 %), 316 (73), 183 
(68), 119 (100), 91 (84), 77 (71); HRMS (FAB, THIOG.) found 352.1136, 




To a solution of chloride 248 (35.0 g, 100 mmol) in DMF (150 ml) was added 
potassium tert-butoxide (13.5 g, 120 mmol) at 0 °C. The reaction mixture was stirred 
at 0 °C for 30 min and the reaction was stirred for a further 18 h at RT. NaCl (300 
ml, sat.) was added and the mixture was extracted with Et20 (3 x 200 ml). The 
organics were combined and dried (MgSO4) and volatiles were removed under 
reduced pressure to give a solid residue which was recrystallised from hexane to give 
aziridine 225 as a colourless solid (29.0 g, 92 %); Rf (20 % EtOAc in hexane) = 0.65; 
mp 77-78 °C (hexane); Vmax (nujol) / cm-' 1234 (SO); 'H NMR (5 (360 MHz, CDC13) 
7.18 (3H, m, An]), 7.05 —7.01 (2H, m, An]), 6.82 (2H, s, An]), 3.89 (1H, d, J= 4.2 
Hz, C(3)I]), 2.77 (1H, dq, J— 6.2 & 4.2 Hz, C(2)I]), 2.63 (611, s, o-CH3), 2.18 (3H, s, 
p-CH3), 1.75 (3H, d, J = 6.2 Hz, C(2)HCH3); '3C NMR 8(90.5 MHz, CDCI3) 142.41 
(C), 139.32 (2 x C), 136.04 (C), 134.93 (C), 131.59 (2 x CH), 128.37 (2 x CH), 
127.81 (CH), 126.08 (2 x CH), 48.82 (CH), 48.64 (CH), 22.86 (2 x CH3), 20.83 
(CH3), 14.10 (CH3); m/z (FAB, THIOG.) 316 ([M+H] 93 %), 314 (13), 183 (22), 




(1S,2R)-2-(N-Mesitylenesulfonylamino)-1-phenylpropyl thioacetate 255 
O Ph 
HN___ 
To a stirred solution of aziridine 225 (200 mg, 0.64 mmol) and thiolacetic acid (47 
il, 0.64 mmcl) in MeCN (1.00 ml) was added tributyiphosphine (17 !Il, 60 imol) 
followed by H20 (1.00 ml), and the resulting mixture was stirred at RT for 18 h. The 
mixture was extracted with CH202 (3 x 25 ml), and dried (Na2SO4). The organics 
were removed under reduced pressure to give the crude thioacetate as a yellow oil. 
Purification by flash chromatography (10 % EtOAc in hexane) gave the thioacetate 
255 as a colourless oil (207 mg, 93 %); Rf (20 % EtOAc in hexane) = 0.38; laiD = 34 
(c 0.5; CHC13); Vmax (neat) / cm-1 1603 (C0), 1266 (SO), 1158 (SO); 'H NMR 8 
(250 MHz, CDC13) 7.21 - 7.04 (5H, in, ArIf), 6.86 (2H, s, An]), 4.46 ( 1H, d, J= 9.5 
Hz, CIJPh), 4.44 (1H, d, J = 5.5 Hz, NI]), 3.67 - 3.56 (1H, m, CHCH3), 2.54 (6H, s, 
2 x o-CH3), 2.28 (3H, s, COCH3), 2.12 (3H, s, p-CH3), 1.04 (3H, d, J = 6.7 Hz, 
CHCH3); '3C NMR 6(62.9 MHz, CDC13) 193.83 (C), 142.05 (C), 139.09 (2 x C), 
136.99 (C), 133.84 (C), 131.80 (2 x CH), 128.52 (2 x CH), 128.35 (2 x CH), 127.78 
(CH), 53.40 (CH), 53.11 (CH), 30.25 (CH3), 22.91 (2 x CH3), 20.78 (CH3), 19.64 
(CH3); m/z (FAB, NOBA) 392 ([M+H], 57 %), 316 (32), 228 (29), 226 (62), 119 








To a stirred solution of aziridine 225 (25.0 g, 80.0 mmol) and thiolbenzoic acid (12.3 
g, 80.00 mmol) in MeCN (60 ml) was added tributyiphosphine (2.10 ml, 8.00 mmol) 
followed by H20 (50 ml) under argon, and the resulting mixture was stirred at RT for 
18 h. The mixture was extracted with CH202 (3 x 50 ml), and dried (Na2SO4). The 
organics were removed under reduced pressure to give the crude thiobenzoate. 
Purification by flash chromatography (10 % EtOAc in hexane) gave the thiobenzoate 
256 as a colourless solid (33.4 g, 93 %); Rf (20 % EtOAc in hexane) = 0.42; mp 101-
102 °C; [aID = 113 (c 1.10, CHC13); Vmax (nujol) / cm 3288 (NH), 1659 (C0), 
1234 (SO), 1159 (SO); 1H NMR 8(360 MHz, CDC13) 7.81 —7.45 (5H, in, An]), 
7.29 - 7.23 (5H, in, An]), 6.83 (2H, s, An]), 4.71 (1H, d, J= 4.3 Hz, NH), 4.56 (1H, 
d. J = 9.6 Hz, C(1')H), 3.88 - 3.79 (1H, in, CHCH3), 2.62 (6H, s, 2 x o-CH3), 2.15 
(3H, s, p-CH3), 1.23 (3H, d, J = 6.7 Hz, C(2')HCH3); '3C NMR 8 (90.5 MHz, 
CDC13) 190.97 (C), 143.26 (2 x C), 138.02 (C), 137.41 (2 x C), 134.84 (C), 134.61 
(CH), 132.97 (2 x CH), 129.74 (2 x CH), 129.56 (4 x CH), 129.06 (CH), 128.30 
(CH), 54.51 (2 x CH), 24.18 (2 x CH3), 21.92 (CH3), 21.31 (CH3); nv'z (FAB, 
THIOG.) 455 ([M+H],47 %),316 (29), 255 (38), 226 (31), 183 (29); HRMS (FAB, 
THIOG.) found 455.1511, C25H28NO3S2 requires 455.1511. 
179 
Experimental 
(1S,2R)-2-(N-Actetamido-N-mesitylenesulfonylamino)-1 -phenyl-(S-benzyl)-1 - 






To a solution of thioacetate 255 (150 mg, 0.384 mmol) in DMF (10 ml) was added 
potassium tert-butoxide (43 mg, 0.384 mmol) at 0 T. The reaction was stirred for 30 
mm, benzyl bromide was added (46.0 0, 0.384 mmol) and the reaction was stirred 
for a further 4.5 h at RT. NaCl (20 ml, sat.) was added and the mixture was extracted 
with CH2C12 (2 x 20 ml) and EtOAc (2 x 20 ml). The organics were combined, dried 
(MgSO4), and the volatiles were removed under reduced pressure. Flash 
chromatography (20 % EtOAc in hexane) gave amide 259 as a colourless oil (129 
mg, 70 %); Rf (20 % EtOAc in hexane) = 0.71; [ajn = 5.3 (c 1.3, CHC13); Vmax (neat) 
/ cm 1732 (C0); 'H NMR (250 MHz, CDCI3) 7.30 - 7.13 (10 H, m, An]), 7.00 
(2H, s, An]), 4.52 (1H, d, J= 10.2 Hz, C(1)I]), 3.78 (1H, dq, J= 10.2 & 6.6 Hz, 
C(2)II), 3.47 (1H, d, f = 13.0 Hz, CHAHBPh), 3.42 (1H, d, J = 13.0 Hz, CHAHBPh), 
2.48 (6H, s,2 x o-CH3), 2.41 (3H, s, CH3), 2.22 (3H, s,p-CH3), 1.33 (3H, d, J = 6.6 
Hz, C(2)HCH3); 13C NMR 8(62.9 MHz, CDC13) 171.54 (C), 143.76 (C), 140.38 (2 x 
C), 138.82 (C), 137.33 (C), 132.61 (2 x CH), 131.83 (C), 129.05 (2 x CH), 128.65 (2 
x CH), 128.15 (2 x CH), 127.79 (2 x CH), 127.10 (CH), 126.80 (CH), 59.25 (CH), 
52.97 (CH), 36.05 (CH2), 25.84 (CH3), 22.51 (2 x CH3), 26.52 (CH3), 16.96 (CH3); 
m/z (FAB, NOBA) 482 ([M+H]+, 42 %), 406 (16), 360 (8), 358 (94), 91 (100) 
HRI\'IS (FAB, NOBA) found 482.1823, C27H32NO3S2 requires 482.1824. 
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To a solution of thiobenzoate 256 (20.0 g, 43.3 mmol) in DMF (250 ml) was added 
potassium NaH (1.97 g, 46.6 mmol) at 0 °C. The reaction was stirred for 30 mm, 
benzyl bromide was added (5.66 ml, 46.6 mmol) and the reaction was stirred for a 
further 18 h at RT. NaCl (200 ml, sat.) was added and the mixture was extracted with 
Et20 (2 x 200 ml). The organics were combined and dried (MgSO4) and volatiles 
were removed under reduced pressure to give the crude thiobenzoate. Flash 
chromatography (10 % EtOAc in hexane) gave benzyl protected sulfonamide 260 as 
a colourless solid (23.7 g, 100 %); Rf (20 % EtOAc in hexane) = 0.47; mp = 60-61 
°C; [a]D 71.3 (c 1.15, CHCI3); Vmax (neat) / cm 1 1665 (C=O), 1234 (SO), 1155 
(SO); 'H NMR 8(360 MHz, CDC13) 7.91 - 7.89 (2H, m, An]), 7.48 - 7.38 (5H, m, 
An]), 7.32-7.16 (4H, m, ArIf), 7.05 (2H, t, J= 6.3 Hz, ArIf), 6.86 (2H, s, An]), 
6.79 (2H, d, J = 7.9 Hz, ArH), 5.05 (1H, d, J = 9.0 Hz, C(1')H), 4.85 (1H, d, J- 16.2 
Hz, CHAHBPh), 4.53 (1H, d, J = 16.2 Hz, CHAHBPh), 4.33 -4.25 (1H, m, C(2')I]), 
2.24 (6H, s,2 x o-CH3), 2.32 (3H, s,p-CH3), 1.36 (3H, d, J= 6.9 Hz, C(2')HCH3); 
'3C NMR 8(90.5 MHz, CDC13) 190.24 (C), 143.41 (C), 141.66 (2 x C), 141.12 (C), 
139.57 (C), 137.46 (C), 134.87 (C), 134.64 (CH), 133.86 (CH), 133.22 (2 x CH), 
129.79 (2 x CH), 129.65 (2 x CH), 129.50 (2 x CH), 129.46 (2 x CH), 128.75 (2 x 
CH), 128.38 (2 x CH), 128.29 (CH), 57.77 (CH), 52.50 (CH), 48.53 (CH2), 23.97 (2 
x CH3), 21.99 (CH3), 18.61 (CH3); in/z (FAB, NOBA) 544 ([M+H]+, 11 %), 406 
(16), 362 (10), 317 (20), 316 (51); HR1VIS (FAB, NOBA) found 544.1980, 
C32H34NO3S2 requires 544.1980. 
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Experimental  
(lS,2R)-1-(S-Benzyl)-2-(N-benzyl-N-mesjtylenesulfonylam mo)...! -phenyl-1 - 




To a solution of thiobenzoate 256 (200 mg, 0.441 mmol) in DMF (10 ml) was added 
potassium tert-butoxide (50 mg, 0.441 mmol) at 0 °C. The reaction was stirred for 30 
mm, benzyl bromide was added (I 10 il, 0.441 mmol) and the reaction was stirred 
for a further 4.5 h at RT. NaCl (20 ml, sat.) was added and the mixture was extracted 
with CH202  (2 x 20 ml) and EtOAc (2 x 20 ml). The organics were combined, dried 
(MgSO4), and the volatiles were removed under reduced pressure to give a mixture 
of thiobenzoate 260 and amide 261. Flash chromatography (20 % EtOAc in hexane) 
gave thiobenzoate 260 as a colourless solid (140 mg, 60 %) and dibenzylated thiol 
261 as a colourless oil (69 mg, 30 %); (20 % EtOAc in hexane) = 0.58; [aID = 8.2 (c 
2.0, CHC13); Vmax (neat) / cm-' 1206 (SO), 116 (SO); 'H NMR 6(250 MHz, CDC13) 
7.56-7.34 (11H, m, An]), 7.08 (2H, s, An]), 6.97 (2H, d, J= 9.1 Hz, ArE), 5.06 
(1H, d, J= 16.4 Hz, CHAHBPh), 4.79 (1H, d, J= 16.4 Hz, CHAHBPh), 3.99 (1H, d, J 
= 4.5 Hz, CHPh), 3.96 - 3.86 (1 H, m, CHCH3), 3.73 (1H, d, J = 13.0 Hz, 
CHxHyPh), 3.65 (1H, d, J= 13.0 Hz, CHxHyPh), 2.86 (6H, s, 2 x o-CH3), 2.46 (3H, 
s,p-CH3), 1.33 (3H, d, J= 6.7 Hz, CHCH3); '3C NMR 6(62.9 MHz, CDC13) 141.88 
(C), 139.92 (C), 138.83 (2 x C), 138.38 (C), 137.15 (C), 134.25 (C), 131.79 (CH), 
128.70 (CH), 128.43 (3 x CH), 128.30 (5 x CH), 127.42 (3 x CH), 126.99 (2 x CH), 
56.09 (CH), 53.63 (CH), 47.88 (CH2), 35.50 (Cl-I2), 22.81 (2 x CH3), 20.77 (CH3), 
17.55 (CH3); m/z (FAB, NOBA) 530 ({M+H], 31 %), 528 (29), 406 (55), 346 (31), 








To a solution of thiobenzoate 260 (15.0 g, 28.0 mmol) in THF (100 ml) at 0 °C was 
added LiA1H4 (1.20 g, 30.3 mmol). The reaction mixture was warmed to RT and 
stirred for 2.5 h. The reaction mixture was cooled to 0 °C, Na2SO4• 1 0H0 was added 
slowly and the reaction mixture was stirred for 1 h. The reaction mixture was filtered 
through celite and the organics removed under reduced pressure to give the thiol 4 as 
a colourless solid (11.5 g, 95 %); Rf (20 % EtOAc in hexane) = 0.60; mp = 57-58 
°C; [a]n = -10.9 (c 1.10, CHC13); Vmax (nujol) / cm-' 2558 (SH), 1376 (SO), 1152 
(SO); 'H NMR 6(360 MHz, CDCI3) 7.32 - 7.07 (811, in, Ark!), 6.86 - 6.81 (4H, in, 
ArE), 4.73 (1H, d, J- 16.4 Hz, CHAHBPh), 4.48 (1H, d, J = 16.4 Hz, CHAHBPh), 
4.18 - 4.13 (2H, in, C(2)HCH3 & C(1)If), 2.34 (6H, s, 2 x o-CH3), 2.29 (3H, s, p-
CH3), 1.76 (1H, d, J = 5.4 Hz, SIf), 1.31 (3H, d, J = 6.6 Hz, C(2)HCH3); '3C NMR 6 
(90.5 MHz, CDC13) 145.28 (C), 145.02 (C), 143.41 (2 x C), 141.39 (C), 135.81 (C), 
135.03 (2 x CH), 131.41 (2 x CH), 131.33 (2 x CH), 131.24 (2 x CH), 130.32 (CH), 
130.09 (CH), 129.94 (2 x CH), 61.02 (CH), 51.27 (CH), 50.73 (CH2), 25.81 (2 x 
CH3), 23.82 (CH3), 20.00 (CH3); nv'z (FAB, NOBA) 440 ([M+H], 15 %), 406 (13), 
317 (30), 316 (81), 91 (100) HRMS (FAB, NOBA) [M+H] found 440.1725, 
C25H30NO2S2 requires 440.1718. 
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cperimenta1 





To a solution of thiol 4 (9.00 g, 20.5 mmol) in CH2C12 (100 ml) was added pyridine 
(2.18 ml, 24.9 mmol) followed by propionyl chloride (2.19 ml, 26.6 mmol) at 0 T. 
The reaction mixture was warmed to RT and stirred for 18 h. The reaction mixture 
was diluted with CH2Cl2 (300 ml) and was washed with H20 (200 ml), HC1 (200 ml, 
IN aq.), H20 (200 ml), NaHCO3 (200 ml, sat.) and NaCl (200 ml, sat.). The organics 
were dried (MgSO4) and volatiles were removed under reduced pressure to give the 
crude thioester as a colourless oil. Purification by flash chromatography (20 % 
EtOAc in hexane) gave the propionate thioester 239 as a colourless solid (9.39 g, 93 
%); Rf (20 % EtOAc in hexane) = 0.56; mp = 60-61 °C; [aID = 71.3 (c 1. 15, CHC13); 
Vmax (neat) / cm-1 1697 (C0), 1375 (SO), 1147 (SO); 1H NMR 8(360 MHz, 
CDC13) 7.45 (2H, d, J = 6.2 Hz, An]), 7.31 —7.26 (3H, m, ArR), 7.15 (1H, d, J= 7.1 
Hz, ArH), 7.03 (214, t, J = 6.5 Hz, An]), 6.84 (2H, s, An]), 6.70 (21-1, d, J= 7.1 Hz, 
An]), 4.81 (1H, d, J = 16.2 Hz, CHAHBPh), 4.80 (1H, d, J= 9.3 Hz, C(1')H), 4.47 
(1H, d, J= 16.2 Hz, CHAHBPh), 4.16 (1H, dq, J = 9.3 & 6.8 Hz, C(2')H), 2.47 (21-1, 
q, J= 7.4 Hz, CH2CH3), 2.45 (314, s,p-CH3), 2.44 (6H, s, 2 x o-CH3), 1.28 (31-1, d, J 
= 6.8 Hz, C(2')HCH3), 1.11 (3H, t, J = 7.4 Hz, CH2CH3); '3C NMR 8(90.5 MHz, 
CDC13) 197.34 (C), 142.20 (C), 140.47 (2 x C), 140.00 (C), 138.39 (C), 132.62 (C), 
128.62 (2 x CH), 128.33 (2 x CH), 128.27 (2 x CH), 127.40 (3 x CH), 127.28 (2 x 
CH), 127.25 (CH), 56.41 (CH), 50.94 (CH), 47.25 (CH2), 37.09 (CH2), 22.77 (2 x 
CH3), 20.81 (CH3)
1  17.34 (CH3), 9.29 (CH3); m/z (FAB, NOBA) 496 ([M+H], 8 %), 
406 (24), 316 (54), 207 (53), 91(100); HRMS (FAB, NOBA) found 496.1985, 
C28H34NO3S2 requires 496.1980. 
184 
Experimental 
2 '-(N-Benzyl-N-mesitylenesulfonylamino)-1 '-phenyipropyl 	(1 'S,2S,2 'R,3S)-2- 
methyl-3-hydroxythiopent-4-eneoate 268 
OH 0 Ph 
Bn SO2 
General procedure A was followed with thiopropionate 239 (200 mg, 0.404 mmol), 
in CH202 (5 ml) at —78 °C, to which was added dicyclohexylboron triflate (909 I, 
1.0 M in hexane, 0.909 mmol), then Et3N (168 p1, 1.21 mmol). Acrolein was added 
(334 .tl, 5.01 mmol). Flash chromatography (10 % EtOAc in hexane) gave aldol 
adduct 268 as a colourless oil (201 mg, 92 %). Analysis of the crude 360 MHz 1 H 
NMR showed this to be a 93:7 mixture of diastereomers; Rf (20 % EtOAc in hexane) 
= 0.36; [aID = - 10.1 (c 0.8, CHCI3); Vmax (neat) I cm 3476 (OH), 1642 (C=O),  1602 
(C=C); Major diastereomer: 1H NMR (5(360 MHz, CDCI3) 7.42, (2H, d, J= 8.3 Hz, 
o-ArH), 7.29-7.26 (3H, m, ArIf), 7.16 (1H, t, J = 7.4 Hz,p-ArH), 7.04 (2H, t, J= 
7.9 Hz, m-ArH), 6.84 (2H, s, m - ArR), 6.67 (2H, d, J= 8.3 Hz, o-ArH), 5.79 (1H, 
ddd, J = 17.0, 10.5 & 6.5 Hz, CH=CH2), 	5.28 (1H, d, J = 17.0 Hz, 
CH=CHTRAJ'.SHCIS), 5.19 (1H, d, J= 10.5 Hz, CH=CHTRANSHCIS), 4.82 (1H, d, J—= 
8.9 Hz, C(1')I]), 4.78 (1H, d, J = 16.3 Hz, CHAHBPh), 4.49 (1H, d, J = 16.3 Hz, 
CHAHBPh), 4.22 - 4.17 (2H, m, CHOH & C(2')If), 1.96 (1H, dq qn, J= 7.1 Hz, 
CHCH3), 2.31 (9H, s, 3 x CH3), 1.29 (3H, d, J= 6.9 Hz, C(2')HCH3), 1.06 (3H, d, J 
= 7.1 Hz, CHCH3); Minor diastereomer diagnostic peaks: 5.69 (1H, ddd, J = 17.0, 
10.5 & 6.6 Hz, CH=CH2), 4.48 (1H, d, J = 16.2 Hz, CHAHBPh), 4.31 (1H, t, J = 6.6 
Hz, CHOH), 1.17 (3H, d, J = 7.1 Hz, CHCH3); '3C NMR 6 (90.5 MHz, CDC13) 
200.18 (C), 142.20 (C), 140.40 (2 x C), 140.39 (C), 138.31 (C), 137.61 (CH), 132.62 
(C), 131.97 (2 x CH), 128.53 (2 x CH), 128.30 (2 x CH), 128.26 (2 x CH), 127.41 (2 
x CH), 127.21 (CH), 117.07 (CH), 116.99 (CH2), 75.04 (CH), 56.48 (CH), 53.42 
(CH), 51.01 (CH), 47.29 (CH2), 21.05 (2 x CH3), 17.12 (CH3), 14.37 (CH3), 14.32 
(CH3); m/z (FAB,NOBA) 552 ([M+H], 4%), 406 (15), 317 (13), 316(60)91(100); 
HRMS (FAB, NOBA) [M+H] found 552.2246, C31H38N04S2 requires 552.2242. 
185 
Expmenta1 
2'-(N-Benzyl-N-mesitylenesulfonylamjno)l '-phenylpropyl (1 'S,2S,2 'R,3R)-2,4-
dimethyl-3-hydroxythiopent-4-eneoate 266 
OH 0 Ph 
Bn N 
General procedure A was followed with thiopropionate 239 (200 mg, 0.404 mmol), 
in CH202 (5 ml) at —78 °C, to which was added dicyclohexylboron triflate (909 p1, 
1.0 M in hexane, 0.909 mmol), then Et3N (168 p1, 1.21 mmol). Methacrolein was 
added (412 p1, 5.01 mmol). Flash chromatography (10 % EtOAc in hexane) gave 
aldol adduct 266 as a colourless oil (209 mg, 90 %). Analysis of the crude 360 MHz 
'H NMR showed this to be a 92:8 mixture of diastereomers; Rf (20 % EtOAc in 
hexane) = 0.32; [a]D = -18.7 (c 1.3, CHCI3); Vmax (neat) / cm-1 3466 (OH), 1679 
(C0); Major diastereomer: 'H NMR 5 (3 60 MHz, CDCI3) 7.43, (211, d, J= 7.7 Hz, 
0-An]), 7.32 - 7.23 (3H, m, An]), 7.16 (111, t, J = 7.4 Hz, p-ArH), 7.04 (2H, t, J 
7.4 Hz, rn-AnT), 6.82 (2H, s, An]), 6.67 (2H, d, J= 8.3 Hz, o-ArIf), 4.94 (1H, br s, 
CCH3=CH2), 4.91 (1H, br s, CCH3 CH2), 4.82 (1H, d, J= 9.0 Hz, CHPh), 4.79 (111, 
d, J= 16.3 Hz, CHAHBPh), 4.49 (111, d, J= 16.3 Hz, CHAHBPh), 4.22 - 4.12 (2H, m, 
CHOH & C(2')HCH3), 2.78 (1H, dq qn, J= 7. 1, CHCH3), 2.31 (9H, s, 3 x CH3), 
1.71 (3H, s, C(4)CH3), 1.30 (311, d, J= 6.8 Hz, C(2')CH3), 1.09 (311, d, J—= 7.1 Hz, 
CHCH3); Minor diastereomer diagnostic peaks: 4.46 (1H, d, J=  16.3 Hz, CHAHBPh), 
1.04 (311, d, J = 7.1 Hz, CHCH3); '3C NMR 6 (90.5 MHz, CDC13) 200.47 (C), 
143.93 (C), 142.17 (C), 140.42 (2 x C), 139.58 (C), 138.36 (C), 132.67 (C), 131.97 
(2 x CH), 128.58 (2 x CH), 128.30 (2 x CH), 128.19 (2 x CH), 127.36 (2 x CH), 
127.21 (CH), 127.07 (CH), 114.23 (CH2), 78.19 (CH), 56.72 (CH), 51.21 (CH), 
5 1. 01 (CH), 47.14 (CH2), 22.74 (2 x CH3), 20.76 (CH3), 17.04 (CH3), 16.66 (CH3), 
14.71 (CH3); in/z (FAB, NOBA) 566 ([M+H], 25 %), 407 (21), 406 (53), 318 (29) 
91(100); HRMS (FAB, NOBA) found 566.2397, C32H40N04S2 requires 566.2399. 
186 
Ex perimenta1 
2 '-(N-Benzyl-N-mesitylenesulfonylam mo)-! '-phenylpropyl (1 'S,2S,2 'R,3S-2,5-
dimethyl-3-hydroxy-thiopentanoate 267 
OH 0 Ph 
Bn 
General procedure A was followed with thiopropionate 239 (148 mg, 0.309 mmol), 
in CH2C12 (4 ml) at —78 °C, to which was added dicyclohexylboron triflate (697 p1, 
1.0 M in hexane, 0.309 mmol), then Et3N (161 p1, 0.927 mmol). Isobutyraldehyde 
was added (320 jil, 3.71 mmol). Flash chromatography (10 % EtOAc in hexane) gave 
aldol adduct 267 as a colourless oil (132 mg, 85 %). Analysis of the crude 360 MHz 
'H NMR showed this to be a 97:3 mixture of diastereomers; Rf (20 % EtOAc in 
hexane) = 0.34; [cc]. = - 16.2 (c 0.4, CHC13); Vmax (neat) / cm-1 3540 (OH), 1695 
(C=O), Major diastereomer: 'H NMR 5 (360 MHz, CDC13) 7.43, (2H, d, J= 7.7 Hz, 
0-ArE), 7.32 - 7.23 (3H, m, An]), 7.16 (1H, t, J= 7.4 Hz,p-ArI]), 7.04 (2H, t, J= 
7.4 Hz, rn-ArE), 6.85 (2H, s, ArII), 6.67 (2H, d, J= 8.3 Hz, o-ArI]), 4.82 (1H, d, J= 
9.1 Hz, C(P)H), 4.79 (1H, d, J = 16.2 Hz, CHAHBPh), 4.48 (1H, d, J = 16.2 Hz, 
CHAHBPh), 4.21 - 4.15 (1H, m, C(2')HCH3), 3.40 (1H, dd, J = 6.8 & 5.4 Hz, 
CHOH), 2.75 (1H, dq qn, J= 6.8 Hz, CHCH3), 2.31 (9H, s, 3 x CH3), 1.67 (1H, 
dspt oct, J— 6.8 Hz, CH(CH3)2), 1.30 (3H, d, J= 6.8 Hz, C(2')CH3), 1.09 (3H, d, J 
= 7.1 Hz, CHCH3), 0.98 (3H, d, J= 6.8 Hz, CH(CH3)A(CH3)B), 0.90 (3H, d, J= 6.8 
Hz, CH(CH3)A(CH3)B); '3C NMR 6 (90.5 MHz, CDC13) 201.94 (C), 142.73 (C), 
140.11 (2 x C), 138.80 (2 x C), 133.20 (C), 132.51 (2 x CH), 129.09 (2 x CH), 
128.84 (CH), 128.75 (2 x CH), 127.90 (2 x CH), 127.78 (2 x CH), 127.62 (CH), 
78.98 (CH), 57.14 (CH), 51.68 (CH), 51.51 (CH), 47.74 (CH2), 31.28 (CH), 23.28 
(CH3), 21.29 (CH3), 20.16 (CH3), 19.14 (CH3), 17.65 (CH3), 16.55 (CH3), 15.63 
(CH3); rn/z (FAB, NOBA) 568 ([M+H], 16 %), 406 (24), 317 (45), 316 (83) 91 




2 '-(N-Benzyl-N-mesitylenesulfonylamino)-1 '-phenyipropyl (1 'S,2S,2'R,3S)-2,5-
dimethyl-3-hydroxy-thiohexanoate 268 
OH 0 Ph 
Bn N 
General procedure A was followed with thiopropionate 239 (200 mg, 0.404 mmol), 
in CH202 (5 ml) at —78 °C, to which was added dicyclohexylboron triflate (909 p1, 
1.0 M in hexane, 0.909 mmol), then Et3N (168 p1, 1.21 mmol). Isovaleraldehyde was 
added (536 jtl, 5.01 mmol). Flash chromatography (10 % EtOAc in hexane) gave the 
aldol adduct 268 as a colourless foam (132 mg, 94 %). Analysis of the crude 360 
MHz 'H NMR showed this to be a 94:6 mixture of diastereomers; Rf (20 % EtOAc 
in hexane) = 0.35; IalD = - 12.3 (c 0.2, CHC13); Vmax (neat) I cm 1 3532 (OH), 1688 
(C0); Major diastereomer: 'H NMR (5(360 MHz, CDC13) 7.42 (2H, d, J= 8.1 Hz, 
An]), 7.32-7.25 (3H, m, ArII), 7.14 (1H, t, J= 7.8 Hz, ArIf), 7.03 (2H, t, J= 7.4 
Hz, m-ArR), 6.83 (2H, s, ArH), 6.68 (2H, d, J= 7.1 Hz, An]), 4.78 (1H, d, J= 9.0 
Hz, C(1')If), 4.76 (1H, d, J = 16.2 Hz, CHAHBPh), 4.46 (1H, d, J = 16.2 Hz, 
CHAHBPh), 4.19 (1H, dq, J = 9.0 & 6.8 Hz, C(2')HCH3), 3.76 - 3.70 (1H, m, 
CHOH), 2.62 (1H, dq qn, J= 6.9 Hz, CHCH3), 2.30 (9H, s, 3 x CH3), 2.11 (1H, br 
d, J= 7.2 Hz, CHOH), 1.80— 1.69 (1H, m, CH(CH3)2), 1.39 — 1.11 (2H, m, CH2CH), 
1.12 (3H, d, J= 6.8 Hz, C(2')HCH3), 1.09 (3H, d, J— 6.8 Hz, CHCH3), 0.89 (3H, d, 
J = 6.7 Hz, CH(CH3)A(CH3)B), 0.86 (3H, d, J = 6.5 Hz, CH(CH3)A(CH3)B); Minor 
diastereomer diagnostic peak: 0.78 (1H, d, J= 6.6 Hz, CH(CH3)A(CH3)B); '3C NMR 
6 (90.5 MHz, CDC13) 201.39 (C), 142.56 (C), 140.76 (2 x C), 139.90 (C), 138.54 
(C), 132.93 (2 x CH), 132.32 (C), 128.88 (2 x CH), 128.66 (CH), 128.56 (2 x CH), 
127.72 (2 x CH), 127.61 (2 x CH), 127.45 (CH), 72.18 (CH), 56.88 (CH), 54.58 
(CH), 51.36 (CH), 47.58 (CH2), 44.14 (CH2), 24.59 (CH), 23.79 (CH3), 23.09 (2 x 
CH3), 21.73 (CH3), 21.11 (CH3), 17.53 (CH3), 14.92 (CH3); ink (FAB, NOBA) 582 
([M+H], 20 %), 406 (32), 318 (29), 316 (84) 57 (100); HRMS (FAB, NOBA) 
[M+H] found 582.2713, C33H44NO4S2 requires 582.2712. 
188 
Experimental 
2 '-(N-Benzyl-N-mesitylenesulfonylam jno)-1 '-phenyipropyl 	(1 'S,2S,2 'R,3R)-3- 
hydroxy-2-methyl-3-phenylthiopropionate 269 
OH 0 Ph 
iY s y 
BnSO2 
General procedure A was followed with thiopropionate 239 (200 mg, 0.404 mmol), 
in CH202 (5 ml) at -78 °C, to which was added dicyclohexylboron triflate (909 jil, 
1.0 M in hexane, 0.909 mmol), then Et3N (168 j.il, 0.927 mmol). Benzaldehyde was 
added (508 j.tl, 5.01 mmol). Flash chromatography (10 % EtOAc in hexane) gave 
aldol adduct 269 as a colourless solid (206 mg, 85 %). Analysis of the crude 360 
MHz 'H NMR showed this to be a 91:9 mixture of diastereomers; Rf (20 % EtOAc 
in hexane) = 0.41; mp = 56 - 59 °C; Ic1D = -15.3 (c 1.1, CHCI3); Vmax (neat) / cm-1 
3466 (OH), 1689 (C0); Major diastereomer: 'H NMR 5 (360 MHz, CDC13) 7.43 
(2H, d, J = 7.7 Hz, 0-Ark!), 7.33 - 7.24 (8H, m, Ark!), 7.16 (1H, t, J = 7.4 Hz, p-
Ark!), 7.05 (2H, t, J= 7.4 Hz, m-ArH), 6.84 (2H, s, Ark!), 6.66 (2H, d, J= 8.3 Hz, o-
Ark!), 4.83 (1H, d, J= 8.8 Hz, C(l')H), 4.78 (1H, d, J= 16.4 Hz, CHAHBPh), 4.77 
(1H, d, J= 8.0 Hz, CHOH), 4.45 (1H, d, J = 16.4 Hz, CHAHBPh), 4.20 - 4.12 (1H, m, 
CHCH3), 2.92 (1H, dq qn, J= 7.1 Hz, CHCH3), 2.31 (9H, s, 3 x CH3), 1.21 (3H, d, 
J = 6.8 Hz, C(2')CH3), 1.09 (3H, d, J = 7.1 Hz, CHCH3); Minor diastereomer 
diagnostic peaks: 4.48 (1H, d, J = 16.4 Hz, CHAHBPh), 0.96 (3H, d, J = 7.1 Hz, 
CHCH3); '3C NMR ö (90.5 MHz, CDC13) 200.71 (C), 142.24 (C), 141.35 (C), 
140.48 (2 x C), 139.60 (C), 138.39 (C), 132.69 (C), 132.01 (2 x CH), 128.60 (2 x 
CH), 128.45 (2 x CH), 128.35 (2 x CH), 128.25 (CH), 128.06 (2 x CH), 127.40 (2 x 
CH), 127.26 (CH), 127.13 (CH), 126.29 (2 x CH), 76.52 (CH), 56.74 (CH), 55.35 
(CH), 51.13 (CH), 47.19 (CH2), 22.80 (2 x CH3), 20.82 (CH3), 17.00 (CH3), 15.03 
(CH3); m/z (FAB, NOBA) 602 ([M+H], 6%), 406 (18), 317 (14), 316 (66) 91(100); 




2 '-(N-Benzyl-N-mesitylenesulfonylamino)-1 '-phenyipropyl 	(1 'S,2S,2 'R,3R)-3- 
hydroxy-2-methyl-3-piperonylthiopropionate 270 
OH 0 Ph 
0 / 	 S02-0— \—O 0 
General procedure A was followed with thiopropionate 239 (200 mg, 0.404 mmol), 
in CH2C12 (5 ml) at —78 °C, to which was added dicyclohexylboron triflate (909 p1, 
1.0 M in hexane, 0.909 mmol), then Et3N (168 p1, 1.21 mmol). Piperonal was added 
(752 mg, 5.01 mmol). Flash chromatography (10 % EtOAc in hexane) gave aldol 
adduct 270 as a colourless foam (132 mg, 90 %). Analysis of the crude 360 MHz 'H 
NMR showed this to be a 97:3 mixture of diastereomers; Rf (20 % EtOAc in hexane) 
0.36; [a]9 = - 21.1 (c 2.0, CHCI3); Vmax (neat) / cm-1 3467 (OH), 1687 (C0); 
Major diastereomer: 'H NMR ô (3 60 MHz, CDCI3) 7.42 (2H, d, J= 8.3 Hz, o-ArH), 
7.30 - 7.27 (3H, m, An]), 7.16 (1H, t, J= 7.4 Hz,p-ArI]), 7.04 (2H, t, J= 7.9 Hz, m-
ArH), 6.85 (2H, s, m - ArIf), 6.82 (1H, s, An]), 6.73 (2H, s, An]), 6.67 (2H, d, J= 
8.3 Hz, 0-An]), 5.96-5.93 (2H, m, OCH20), 4.82 (1H, d, J = 8.7 Hz, C(1')II), 4.79 
(1H, d, J= 16.3 Hz, CHAHBPh), 4.68 (1H, br d, J= 8.3 Hz, CHOH), 4.47 (1H, d, J 
16.3 Hz, CHAHBPh), 4.21 - 4.15 (1H, m, C(2')HCH3), 2.85 (1H, dq qn, J= 7.2 Hz, 
C(2)HCH3), 2.32 (6H, s, o-CH3), 2.31 (3H, s, p-CH3), 1.25 (3H, d, J = 6.8 Hz, 
C(2')HCH3), 0.89 (3H, d, J = 7.1 Hz, CHCH3); Minor diastereomer diagnostic peak: 
0.94 (3H, d, J = 7.1 Hz, CHCH3); '3C NMR 5 (90.5 MHz, CDC13) 200.53 (C), 
147.72 (C), 147.21 (C), 142.22 (C), 140.41 (2 x C), 139.59 (C), 138.39 (C), 132.66 
(2 x C), 131.98 (2 x CH), 128.60 (2 x CH), 128.54 (2 x CH), 128.49 (CH), 128.20 
(CH), 127.36 (2 x CH), 127.21 (CH), 127.08 (CH), 120.00 (CH), 107.91 (CH), 
101.96 (CH), 100.95 (CH2), 76.90 (CH), 56.74 (CH), 55.42 (CH), 51.11 (CH), 47.13 
(CH2), 22.75 (2 x CH3), 20.78 (CH3), 16.93 (CH3), 14.91 (CH3); m/z (FAB, NOBA) 
646 ([M+H], 11 %), 644 ([M-H], 28 %), 406 (99), 316 (100), 307 (57); HRMS 






To a solution of aldol adduct 267 (200 mg, 0.352 mmol) in THF (10 ml) was added a 
solution of NaBH4  (40.0 mg, 1.06 mmol) in THF (10 ml + 10 drops H20) and the 
reaction stirred at RT for 1 h. HC1 (0.5 M aq.) was added carefully until no 
effervescence occurred and the solution extracted with CH2C12  (3 x 30 ml). The 
organics were dried and the volatiles removed under reduced pressure. Flash 
chromatography (30 % EtOAc in hexane) afforded the 1,3 diol 271 as a colourless oil 
(45.0 mg, 99 %) and recovered auxiliary 4 (130 mg, 84 %); Rf (20 % EtOAc in 
hexane) = 0.14; [a]D= - 18.4 (c 0.4, CHC13), l it.  '28 -18.6 (c 2.0, CHC13); Vmax (neat) I 
cm 1 3450 (OH); 'H NMR 6 (250 MHz, CDC13) 3.86 (1H, dd, J = 10.7 & 3.7 Hz, 
CHAHB), 3.74 (1H, dd, J= 10.7 & 7.6 Hz, CHAHB), 3.44 (1H, dd, J = 7.6 & 3.7 Hz, 
CHOH), 3.01 —2.97 (2H, m, 2 x 011), 2.00— 1.86 (1H, m, CH(CH3)2), 1.07 (3H, d, J 
= 6.9 Hz, CHCH3), 1.00 (3H, d, J= 7.2 Hz, CH(CH3)A(CH3)B), 0.97 (3H, d, J= 7.2 
Hz, CH(CH3)A(CH3)B); 13C NMR c (62.9 MHz, CDC13) 82.40 (CH), 68.47 (CH2), 
37.50 (CH), 30.68 (CH), 20.19 (CH3), 15.38 (CH3), 14.23 (CH3); in/z (FAB, NOBA) 
133 ([M+H], 9 %), 109 (58), 105 (17), 91(100), 77 (17); HRMS (FAB, NOBA) 
[M+H] found 133.1229, C7H1702  requires 133.1229. 
'H and '3C NMR spectroscopic data in good agreement with the literature. 128 
191 
Experimental 
2 '-(N-Benzyl-N-mesitylenesulfonylamino)-1 '-phenyipropyl (1 'S,2S,2 'R,35)-3-
tert-butyldimethylsilyloxy-2-methylthiopent-4-eneoate 275 
TBSO 0 Ph 
Bn N 
General procedure B was followed with aldol adduct 265 (200 mg, 0.360 mmol) in 
CH202 (10 ml) at 0 °C, 2,6-lutidine (62.0 pJ, 0.540 mmol) was added dropwise 
followed by TBSOTf (92.0 p1, 0.400 mmol). Flash chromatography (10 % EtOAc in 
hexane) gave the protected aldol adduct 275 as a colourless oil (225 mg, 95 %); Rf  
(20 % EtOAc in hexane) = 0.76; [a]0 = -5.7 (c 0.6, CHC13); Vmax (neat) / cm 1686 
(C=O), 1601 (C=C); 'H NMR 5 (3 60 MHz, CDC13) 7.42, (2H, d, J = 8.2 Hz, 0-ArE), 
7.32 - 7.27 (3H, m, ArII), 7.16 (1H, t, J= 7.4 Hz, p-An]), 6.99 (2H, t, J= 7.9 Hz, m-
An]), 6.84 (2H, s, ArIf), 6.66 (2H, d, J= 8.0 Hz, 0-An]), 5.58 (1H, ddd, J= 17.3, 
10.1 & 7.1 Hz, CH=CH2), 5.14 (1H, d, J = 17.3 Hz, CHCHTRANSHCIS), 5.10 (1H, d, 
J= 10.1 Hz, CH=CHTRJ\NSHCIS), 4.84 (1H, d, J = 16.3 Hz, CHAHBPh), 4.79 (1H, d, J 
= 6.1 Hz, C(1')HPh), 4.43 (1H, d, J = 16.3 Hz, CHAHBPh), 4.26 (1H, t, J= 7.4 Hz, 
CHOTBS), 4.17 (1H, dq, J = 6.8 & 6.1 Hz, C(2')HCH3), 2.63 (1H, dq qn, J= 7.4 
Hz, CHCH3), 2.32 (3H, s, p-CH3), 2.27 (6H, s, o-CH3), 1.30 (3H, d, J = 6.8 Hz, 
C(2')HCH3), 0.90 (3H, d, J = 7.1 Hz, CHCH3), 0.83 (9H, s, C(CH3)3), -0.01 (6H, s, 2 
x SiCH3); '3C NMR 5 (90.5 MHz, CDC13) 198.57 (C), 142.12 (C), 140.51 (2 x C), 
140.10 (C), 138.36 (C), 137.96 (CH), 132.62 (C), 132.01 (2 x CH), 128.78 (2 x CH), 
128.31 (2 x CH), 128.18 (3 x CH), 127.37 (2 x CH), 126.90 (CH), 116.78 (CH2), 
75.51 (CH), 56.09 (CH), 55.04 (CH), 50.91 (CH), 47.21 (CH2), 25.66 (3 x CH3), 
22.74 (2 x CH3), 20.80 (CH3), 18.14 (CH3), 17.93 (C), 13.22 (CH3), -4.37 (2 x CH3); 
m/z (FAB, NOBA) 666 ([M+H]', 3 %), 407 (15), 406 (49), 404 (25), 91(100); 
HRMS (FAB, NOBA) [M+H] found 666.3107, C37H52NO4S2Si requires 666.3105. 
192 
Experimental 
2 '-(N-Benzyl-N-mesitylenesulfonylamino)-1 '-phenylpropyl 	(1 'S,2S,2'R,3R)-3- 
tert-butyldimethylsilyloxy-2,4-dimethylthiopent-4-eneoate 276 
TBSO 0 Ph 
--Y 
Bn 
General procedure B was followed with aldol adduct 266 (200 mg, 0.350 mmol) in 
CH2C12 (10 ml) at 0 °C, 2,6-lutidine (62.0 t1, 0.540 mmol) was added dropwise 
followed by TBSOTf (92.0 tl, 0.400 mmol). Flash chromatography (10 % EtOAc in 
hexane) gave the protected aldol adduct 276 as a colourless oil (226 mg, 94 %); Rf  
(20 % EtOAc in hexane) = 0.76; [a]D = -9.1 (c 0.7, CHCI3); Vmax (neat) / cm 1685 
(C0), 1602 (C=C); 'H NMR (5(360 MHz, CDCI3) 7.54, (2H, d, J= 7.7 Hz, o-ArIf), 
7.39 - 7.34 (3H, m, ArE), 7.19 (1H, t, J = 7.4 Hz, p-An]), 6.91 (2H, s, ArIf), 6.82 
(2H, s, An]), 6.71 (2H, d, J = 8.3 Hz, o-ArH), 4.91 (1H, br s, CCH3=CHxHy), 4.91 
(1H, br s, CCH3 CHxHy), 4.90 (1H, d, J = 15.9 Hz, CHAHBPh), 4.82 (1H, d, J = 
10.1 Hz, C(1')HPh), 4.48 (1H, d, J= 15.9 Hz, CHAHBPh), 4.30 (1H, d, J = 9.3 Hz, 
CHOTBS), 4.22 (1H, dq, J = 10.1 & 6.8 Hz, C(2')HCH3), 2.72 (1H, dq, J= 9.3 & 
6.8 Hz, CHCH3), 2.39 (3H, s,p-CH3), 2.33 (6H, s, o-CH3), 1.67 (3H, s, CCH3=CH2), 
1.38 (3H, d, J = 6.8 Hz, C(2')HCH3), 0.86 (9H, s, C(CH3)3), 0.82 (3H, d, J= 7.1 Hz, 
CHCH3), -0.05 (3H, s, SiCH3), -0.13 (3H, s, SiCH3); '3C NMR 6 (90.5 MHz, CDC13) 
199.25 (C), 144.26 (C), 142.10 (C), 140.53 (2 x C), 140.20 (C), 138.35 (C), 132.58 
(C), 132.01 (2 x CH), 128.85 (2 x CH), 128.33 (2 x CH), 128.12 (2 x CH), 127.37 (3 
x CH), 126.84 (CH), 114.36 (CH2), 78.76 (CH), 55.95 (CH), 53.09 (CH), 50.98 
(CH), 47.20 (CH2), 25.65 (3 x CH3), 22.73 (2 x CH3), 20.80 (Cl-I3), 18.43 (CH3), 
17.93 (C), 15.80 (CH3), 14.74 (CH3), -4.86 (CH3), -4.61 (CH3); m/z (FAB, NOBA) 
680 ([M+H], 6 %), 407 (24), 406 (62), 316 (79), 91(100); HRMS (FAB, NOBA) 
[M+H] found 680.3246, C38H54NO4S2Si requires 680.3246. 
193 
- 	 perimenta1 
2 '-(N-Benzyl-N_mesitylenesulfonylamino)-1 '-phenylpropyl 	(1 'S,2S,2 'R,3S)-3- 
tert-butyldimethylsilyloxy-5-dimethylthiopentanoate 277 
TBSO 0 Ph 
Bn 
General procedure B was followed with aldol adduct 267 (100 mg, 0.168 mmol) in 
CH202 (10 ml) at 0 °C, 2,6-lutidine (30.0 jii, 0.255 mmol) was added dropwise 
followed by TBSOTf (44.0 tl, 0.190 mmol). Flash chromatography (10 % EtOAc in 
hexane) gave the protected aldol adduct 277 as a colourless oil (109 mg, 91 %); Rf  
(20 % EtOAc in hexane) = 0.81; [aID = -14.3 (c 1. 1, CHC13); Vmax (neat) / cm 1660 
(C0); 'H NMR 6 (360 MHz, CDCI3) 7.41, (2H, d, J = 7.6 Hz, o-ArI]), 7.33 - 7.25 
(3H, m, ArH), 7.12 (1H, t, J= 7.4 Hz, p-ArE), 7.03 (2H, t, J= 7.4 Hz, rn-An]), 6.84 
(2H, s, rn-An]), 6.69 (2H, d, J= 8.3 Hz, 0-AnT), 4.81 (1H, d, J= 9.1 Hz, C(1')I]), 
4.78 (1H, d, J = 16.2 Hz, CHAHBPh), 4.42 (1H, d, J = 16.2 Hz, CHAHBPh), 4.23 - 
4.17 (1H, m, C(2')HCH3), 3.53 (1H, dd, J= 6.8 & 5.4 Hz, CHOTBS), 2.71 (1H, dq 
qn, J= 6.8 Hz, CHCH3), 2.34 (9H, s, 3 x CH3), 1.67 (1H, dspt oct, J = 6.8 Hz, 
CH(CH3)2), 1.24 (3H, d, J = 6.8 Hz, C(2')CH3), 1.02 (3H, d, J= 7.1 Hz, CHCH3), 
0.97 (3H, d, J = 6.8 Hz, CH(CH3)A(CH3)B), 0.91 (3H, d, J = 6.8 Hz, 
CH(CH3)A(CH3)B), 0.81 (3H, s, C(CH3)), -0.02 (3H, s, SiCH3), -0.04 (3H, s, SiCH3); 
'3c NMR ö (90.5 MHz, CDC13) 201.71 (C), 142.24 (C), 139.58 (2 x C), 138.62 (2 x 
C), 133.25 (C), 132.59 (2 x CH), 129.13 (2 x CH), 128.99 (CH), 128.82 (2 x CH), 
127.87 (2 x CH), 127.71 (2 x CH), 127.67 (CH), 78.95 (CH), 57.01 (CH), 51.57 
(CH), 51.49 (CH), 47.73 (CH2), 31.20 (CH), 26.41 (2 x CH3), 23.31 (CH3), 21.24 
(CH3), 20.12 (CH3), 19.17 (CH3), 17.43 (CH3), 16.29 (CH3), 15.48 (CH3), -4.62 
(CH3), -4.68 (CH3); m/z (FAB, NOBA) 682 ([M+H]+, 9 %), 406 (47), 316 (58), 290 








TBSO 0 Ph 
S02-0— 
General procedure B was followed with aldol adduct 268 (200 mg, 0.340 mmol) in 
CH202 (10 ml) at 0 °C, 2,6-lutidine (60.0 p1, 0.510 mmol) was added dropwise 
followed by TBSOTf (87.0 p1, 0.380 mmol). Flash chromatography (10 % EtOAc in 
hexane) gave the protected aldol adduct 278 as a colourless oil (224 mg, 94 %); Rf  
(20 % EtOAc in hexane) = 0.81; [a]D = -14.3 (c 1. 1, CHCI3); Vmax (neat) / cm 1660 
(C0); 'H NMR ö (360 MHz, CDC13) 7.45 (2H, d, J = 8.1 Hz, An]), 7.30 - 7.22 
(3H, m, ArIf), 7.14 (1H, t, J= 7.1 Hz, ArII), 7.00 (2H, t, J= 7.1 Hz, ArH), 6.87 (2H, 
s, An]), 6.67 (2H, d, J = 7.1 Hz, An!), 4.82 (1H, d, J = 9.8 Hz, C(1')HPh), 4.78 (1H, 
d, J= 16.2 Hz, CHAHBPh), 4.44 (1H, d, J = 16.2 Hz, CHAHBPh), 4.17 (1H, dq, J 
9.8 & 6.8 Hz, C(2')HCH3), 4.02— 3.98 (111, m, CHOTBS), 2.75 (1H, dq, J = 7.0 & 
4.2 Hz, CHCH3), 2.31 (3H, s, p-CH3), 2.27 (6H, s, o-CH3), 1.68 - 1.51 (1H, m, 
CH(CH3)2), 1.37— 1.33 (1H, m, CHAHB), 1.28 (3H, d, J= 5.1 Hz, C(2')CH3), 1.05 
(311, d, J—= 7.0 Hz, CHCH3), 0.86 (9H, s, C(CH3)3), 0.88 —0.80 (1H, m, CHAHB), 
0.84 (3H, d, J = 6.8 Hz, CH(CH3)A(CH3)B), 0.72 (3H, d, J = 6.8 Hz, 
CH(CH3)A(CH3)B), 0.06 (3H, s, SiCH3), 0.05 (3H, s, SiCH3);13C NMR 5 (90.5 MHz, 
CDC13) 198.22 (C), 142.47 (C), 140.79 (2 x C), 140.23 (C), 138.60 (C), 132.84 (C), 
132.32 (2 x CH), 129.05 (2 x CH), 128.58 (3 x CH), 127.72 (2 x CH), 127.65 (2 x 
CH),127.30 (CH), 71.43 (CH), 56.51 (CH), 54.96 (CH), 50.96 (CH), 47.53 (CH2), 
41.41 (CH2), 25.95 (3 x CH3), 24.03 (CH3), 23.06 (C), 21.69 (CH3), 21.12 (2 x CH3), 
18.18 (2 x CH3), 18.07 (C), 9.90 (CH3), -4.34 (CH3), -4.46 (CH3); m/z (FAB, 
THIOG.) 696 ([M+H], 10 %), 695 ([M], 7 %) 514 (23), 460 (8), 406 (28), 29 





2 '-(N-Benzyl-N-mesitylenesulfonylam mo)-! '-phenylpropyl 	(1 'S,2S,2 'R,3R)-3- 
tert-butldimethylsiIyloxy2methyl3piperony1thjopropjonate 279 
TBSO 0 Ph 




General procedure B was followed with aldol adduct 270 (200 mg, 0.3 10 mmol) in 
CH2C12 (10 ml) at 0 °C, 2,6-lutidine (54.0 p1, 0.470 mmol) was added dropwise 
followed by TBSOTf (78.0 jtl, 0.340 mmol). Flash chromatography (10 % EtOAc in 
hexane) gave the protected aldol adduct 279 as a colourless oil (219 mg, 93 %); Rf  
(20 % EtOAc in hexane) = 0.81; [a]0 = - 3.64 (c 0.4, CHCI3); Vmax (neat) I cm-1 1685 
(C0); 'H NMR c (3 60 MHz, CDC13) 7.49, (2H, d, J= 8.3 Hz, 0-AnT), 7.33 - 7.30 
(3H, m, ArH), 7.13 (1H, t, J 7.4 Hz,p-ArIf), 6.98 (2H, t, J= 7.9 Hz, rn-ArE), 6.96 
(2H, s, rn-An]), 6.84 (1H, s, ArJI), 6.73 - 6.61 (4H, m, An]), 5.94 - 5.93 (2H, m, 
OCH20), 4.85 (1H, d, J= 16.1 Hz, CHAHBPh), 4.79 (1H, d, J= 10.1 Hz, C(1')HPh), 
4.66 (1H, d, J = 8.9 Hz, CHOTBS), 4.42 (1H, d, J = 16.1 Hz, CHAHBPh), 4.16 (1H, 
dq, J = 10.1 & 6.9 Hz, C(2')HCH3), 2.73 (1H, dq, J= 8.9 & 7.1 Hz, CHCH3), 2.32 
(3H, s,p-CH3) 2.27 (6H, s, o-CH3), 1.32 (3H, d, J = 6.9 Hz, C(2')HCH3), 0.76 (9H, 
S, C(CH3)3), 0.64 (3H, d, J = 7.1 Hz, CHCH3), -0.10 (3H, s, SiCH3), -0.29 (3H, s, 
SiCH3); '3C NMR cä (90.5 MHz, CDC13) 199.19 (C), 147.46 (C), 146.92 (C), 142.12 
(C), 140.54 (C), 140.16 (C), 138.36 (C), 136.01 (C), 132.58 (2 x C), 132.02 (2 x 
CH), 128.86 (2 x CH),128.35 (2 x CH), 128.17 (2 x CH), 127.37 (3 x CH), 126.88 
(CH), 120.32 (CH), 107.55 (CH), 106.85 (CH), 100.84 (CH2), 76.57 (CH), 57.44 
(CH), 55.98 (CH), 50.98 (CH), 47.21 (CH2), 25.64 (3 x CH3), 22.74 (2 x CH3), 20.81 
(CH3), 18.40 (CH3), 17.86 (C), 14.64 (CH3), -4.74 (CH3), -6.41 (CH3); m/z (FAB, 
NOBA) 759 ({M]+, 9 %), 758 ([M-H], 5), 406 (81), 316 (86), 73 (100); HRMS 






General procedure C was followed with diethylethane phosphonate (209[fl, 1.29 
mmol) and BuLj (806 tl, 1.60 M solution in hexanes, 1.29 mmol) in THF (15 ml), 
to which was added to aldol adduct 276 (200 mg, 0.294 mmol). Flash 
chromatography (gradient elution 20 - 30 % EtOAc in hexane) gave the recovered 
auxiliary as a colourless solid (110 mg, 85 %) and 3-ketophosphonate ester 281 as a 
colourless oil (109 mg, 81 %); Rf (50 % EtOAc in hexane) = 0.34; Vmax (neat) I cm-1  
1715 (C0), 1252 (P0), 1051 (P0); 'H NMR 6(360 MHz, CDC13) 4.95 (2H, s, 
CCH2), 4.25 —4.04 (5H, m, 2 x OCH2 & CHOTBS), 3.49 (1H, dq, J= 17.0 & 7.0 
Hz, CHCH3), 3.28 (1H, dq, J = 9.6 & 6.8 Hz, CHCH3), 1.76 (3H, s, CH3), 1.42 - 
1.31 (9H, m, 2 x OCH2CH3 & CHCH3), 0.94 (3H, d, J= 6.8 Hz, CHCH3), 0.88 (9H, 
s, C(CH3)3), 0.02 (3H, s, SiCH3), 0.00 (3H, s, SiCH3); '3C NMR 8 (90.5 MHz, 
CDC13) 210.00 (C), 144.91 (C), 114.86 (CH2), 82.16 (CH), 62.62 (2 x CH2), 49.77 
(CH, 'Ji c = 124.6 Hz), 49.69 (CH), 26.00 (3 x CH3), 18.25 (C), 16.58 (CH3), 16.12 
(CH3), 14.13 (2 x CH3), 10.51 (CH3), -4.40 (CH3), -5.02 (CH3); m/z (FAB, NOBA) 
429 ([M+Na], 7 %), 407 ([M+H]', 67), 49 (36), 275 (65), 73 (100); HRMS (FAB, 





11 1JL1 '(OEt)2 
General procedure C was followed with diethylethane phosphonate (105 jtl, 0.645 
mmol) and '1BuLi (403 jtl, 1.60 M solution in hexanes, 0.645 mmol) in THF (15 ml), 
to which was added to aldol adduct 277 (100 mg, 0.147 mmol). Flash 
chromatography (gradient elution 20 - 30 % EtOAc in hexane) gave the recovered 
auxiliary as a colourless solid (56 mg, 85 %) and 3-ketophosphonate ester 282 as a 
colourless oil (53 mg, 89 %); Rf (50 % EtOAc in hexane) = 0.24; Vmax (neat) I cm 
1715 (C0), 1257 (P0), 1050 (P0); 'H NMR 8 (360 MHz, CDC13) 4.15 - 4.06 
(411, m, 2 x OCH2), 3.79 (0.21-1, dd, J = 6.5 & 4.0 Hz, CHOTBS), 3.64 (0.8H, dd, J= 
7.1 & 3.6 Hz, CH0TBS), 3.38 —3.29 (1.8H, m, 2 x CHCH3), 3.03 (0.21-1, dq qn, J 
6.9 Hz, CHCH3), 1.80 - 1.75 (11-1, m, CH(CH3)2), 1.46 - 1.27 (91-1, m , 2 x 
OCH2CH3 & CHCH3), 1.11 (0.6H, d, J = 7.1 Hz, CHCH3), 1.02 (2.4H, d, J = 6.8 Hz, 
CHCH3), 0.92 - 0.84 (61-1, m, CH(CH3)2), 0.84 (914, s, C(CH3)3), 0.05 (0.6H, s, 
SiCH3), 0.02 (2.4H, s, SiCH3), -0.02 (0.6H, s, SiCH3), -0.05 (2.4H, s, SiCH3); 13C 
NMR 8 (90.5 MHz, CDC13) 209.33 (C),*  208.28 (C), 79.78 (CH), 78.35 (CH),* 
62.55 (2 x CH2, 2Jp = 3.5 Hz), 50.15 (CH), 48.58 (CH),*  46.71 (CH, 2Jpc = 124.1 
Hz), 45.21 (CH, 2Jpc 	124.1 Hz),*  32.79 (CH), 31.45 (CH),*  26.34 (3 x CH3),* 
26.14 (3 x CH3), 20.17 (CH3),*  18.96 (CH3), 18.57 (C),*  18.40 (C), 17.96 (2 x CH3), 
17.48 (CH3),*  16.54 (CH3), 13.86 (CH3), 13.71 (CH3),*  11.71  (CH3),*  10.71 (CH3), - 
3.69 (CH3)5*  -3.81 (CH3), -4.28 (CH3), -4.56 (CH3)*;  m/z (FAB, NOBA) 431 
([M+Na]1 , 18%), 409 ([M+H], 55), 393 (29), 365 (29), 73 (100); HRMS (FAB, 
NOBA) [M+H] found 409.2538, C19H4205PSi requires 409.2539. 





General procedure C was followed with diethylethane phosphonate (204 jtl, 1.26 
mmol) and 'BuLi (788 il, 1.60 M solution in hexanes, 1.26 mmol) in THF (15 ml), 
to which was added to aldol adduct 278 (200 mg, 0.287 mmol). Flash 
chromatography (gradient elution 20 - 30 % EtOAc in hexane) gave the recovered 
auxiliary as a colourless solid (91 mg, 74 %) 13-ketophosphonate ester 283 as a 
colourless oil (110mg, 91 %); Rf (50 % EtOAc in hexane) = 0.25; Vmax (neat) / cm 
1713 (C=0), 1251 (P=0), 1051 (P0); 'H NMR 8(360 MHz, CDC13) 4.17— 4.07 
(41-1, m, 2 x OCH2CH3), 4.06 - 3.96 (1H, m, CHOTBS), 3.42 - 3.28 (1.6H, m, 2 x 
CHCH3), 2.99-2.90 (0.4H, m, CHCH3), 1.81-1.68 (1H, m, CH(CH3)2),1.48 — 1.40 
(1H, m, CHAHB), 1.39— 1.21 (9H, m, 2 x OCH2CH3 & CHCH3), 1.20 (1.21-1, d, J= 
6.9 Hz, CHCH3), 1.04 (1.8H, d, J= 6.8 Hz, CHCH3), 1.03 - 0.92 (1H, m, CHAHB), 
0.91 - 0.85 (6H, m, CH(CH3)2), 0.87 (911, s, C(CH3)3), 0.07 (1.81-1, s, SiCH3), 0.06 
(1.21-1, s, SiCH3), 0.05 (1.21-1, s, SiCH3), 0.04 (1.81-1, s, SiCH3); '3C NMR 6 (90.5 
MHz, CDC13) 209.11 (C),* 207.88 (C), 71.84 (CH), 71.28 (CH),* 62.73 (2 x CH2, 
2Jc = 7.1 Hz), 53.20 (CH), 52.04 (CH),*  47.12 (CH, 1 Jpc = 125.8 Hz), 45.76 (CH, 
1Jc = 125.6 Hz),*  42.69 (CH2), 42.60 (CH2),*  26.00 (3 x CH3), 24.35 (CH3),* 24.13 
(CH), 24.05 (CH),*  22.38 (2 x CH3), 22.24 (CH3),* 18.18 (C), 16.60 (2 x CH3), 
16.54 (CH3),* 11.97 (CH3),* 11.89 (CH3),* 11.79 (2 x Cl-I3), -4.33 (CH3), -4.46 
(CH3); m/z (FAB, NOBA) 445 ([M+Na], 38 %), 423 ([M+H], 60), 407 (40), 397 
(21), 45 (100); HRMS (FAB, NOBA) [M+H] found 423.2698, C20H4405PSi 
requires 423.2696. 








General procedure C was followed with diethylethane phosphonate (186 l, 1.16 
mmol) and BuLi (725 p1, 1.6 M solution in hexanes, 1.16 mmol) in THF (15 ml), to 
which was added to aldol adduct 279 (200 mg, 0.264 mmol). Flash chromatography 
(20 % EtOAc in hexane) gave the recovered auxiliary as a colourless solid (92 mg, 
80 %) and flash chromatography (30 % EtOAc in hexane) afforded the 13-
ketophosphonate ester 284 as a colourless oil (100 mg, 78 %); Rf (50 % EtOAc in 
hexane) 0.32; Vmax (neat) / cm-1 1714 (C0), 1162 (P=0), 1139 (P0); 1H NMR cä 
(360 MHz, CDC13) 6.83 (1H, s, An]), 6.73 (2H, s, ArIf), 6.08 - 6.07 (2H, m, 
OCH20), 4.57 (1H, d, J = 8.1 Hz, CH0TBS), 4.28 - 4.19 (4H, m, 2 x OCH2CH3), 
3.50 (1H, dq, J— 30.0 & 7.0 Hz, CHCH3), 3.30 (1H, dq, J = 8.1 & 6.6 Hz, CHCH3), 
1.40 - 1.21 (9H, m, 2 x OCH2CH3 & CHCH3), 0.79 (9H, s, C(CH3)3), 0.78 (3H, d, J 
= 6.6 Hz, CHCH3), -0.10 (3H, s, SiCH3), -0.32 (3H, s, SiCH3), '3C NMR 5 (90.5 
MHz, CDCI3) 210.04 (C), 147.89 (C), 147.34 (C), 137.14 (C), 120.99 (CH), 107.94 
(CH), 107.40 (CH), 101.27 (CH2), 80.04 (CH), 62.76 (2 x CH2), 54.96 (CH), 49.85 
(CH, 'Jpc = 124.9 Hz), 26.03 (3 x CH3), 18.19 (C), 16.64 (CH3), 14.31 (CH3), 10.61 
(2 x CH3, 2Jpc = 5.7 Hz), -4.30 (CH3), -4.89 (CH3); m/z (FAB, NOBA) 509 
([M+Na], 23 %), 487 ([M+H]+, 6), 429 (19), 355 (46), 73 (100); HRMS (FAB, 
NOBA) [M+H] found 487.2280, C23H4007PSi requires 487.2281. 
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To a solution of thiol 4 (1.00 g, 2.27 mmol) in CH2Cl2 (10 ml) was added pyridine 
(242 p1, 2.77 mmol) followed by acetyl chloride (210 p1, 2.96 mmol) at 0 °C. The 
reaction mixture was warmed to RT and stirred for 18 h. The reaction mixture was 
diluted with CH2C12 (30 ml) and was washed with H20 (20 ml), HC1 (20 ml, IN aq.), 
H20 (20 ml), NaHCO3  (20 ml, sat.) and NaCl (20 ml, sat.). The organics were dried 
(MgSO4) and volatiles were removed under reduced pressure to give the crude 
thioester as a colourless oil. Purification by flash chromatography (20 % EtOAc in 
hexane) gave the thioacetate 296 as a colourless solid (9.39 g, 93 %); Rf (20 % 
EtOAc in hexane) = 0.61; mp = 57 - 59 °C; laiD = 60.3 (c 1.10, CHC13); Vmax (neat) 
/ cm 1691 (C=O), 1387 (SO), 1154 (SO); 'H NMR 8(250 MHz, CDC13) 7.45 (2H, 
d, J = 6.2 Hz, ArH), 7.31 —7.26 (3H, in, An]), 7.15 (1H, d, 7.1 Hz, An]), 7.03 (2H, 
t, J= 6.5 Hz, An]), 6.84 (2H, s, AnIT[), 6.70 (2H, d, J = 7.1 Hz, ArII), 4.78 (1H, d, J 
= 16.0 Hz, CHAHBPh), 4.77 (1H, d, J= 9.3 Hz, CHPh), 4.45 (1H, d, J = 16.0 Hz, 
CHAHBPh), 4.17 (1H, dq, J = 9.3 & 6.8 Hz, CHCH3), 2.29 (9H, s, 2 x o-CH3 & 
CH3), 2.22 (3H, s,p-CH3), 1.28 (3H, d, J= 6.8 Hz, CHCH3), '3C NMR 8(60.9 MHz, 
CDCI3) 192.20 (C), 142.21 (C), 140.47 (2 x C), 139.91 (C), 138.36 (C), 132.03 (C), 
128.65 (2 x CH), 128.34 (2 x CH), 128.28 (2 x CH), 127.42 (3 x CH), 127.33 (2 x 
CH), 127.11 (CH), 56.31 (CH), 51.44 (CH), 47.27 (CH2), 30.26 (CH3), 22.76 (2 x 
CH3), 20.81 (CH3), 17.39 (CH3); 'n/z (FAB, NOBA) 482 ([M+H], 21 %), 404 (20), 
336 (78), 143 (71), 89 (100); HRMS (FAB, NOBA) [M+H]1 found 482.1827, 
C27H32NO3S2 requires 482.1824. 
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5.4 	EXPERIMENTAL PROCEDURES FOR CHAPTER 4 
Synthesis of (-)-f -Methoxydiisopinocamphey1borane 77 
..~BOIAe 
To a solution of (+)-a-pinene (32.7 g, 240 mmol, 91% e.e.) in THF (30 ml) was 
added borane dimethyl sulfide (10.2 ml, 100 mmol) dropwise with stirring. During 
the addition the flask was immersed in a water bath and held at 20 
- 25 °C. 
Immediately following the addition, stirring was discontinued and the reaction was 
left for 12 h to obtain a crystalline solid of diisopinocampheylborane 307. The 
organic solvent was removed by cannula and the crystalline solid was washed with 
ice cold Et20 (3 x 30 ml) and dried under vacuum to obtain a pure crystalline solid of 
diisopinocampheylborane 307 (24.3 g, 83 %). To a stirred suspension of borane 307 
(14.3 g, 50.0 mmol) in Et20 (50 ml) at 0 °C was added ice cold MeOH (1.92 g, 60.0 
mmol) dropwise over 30 mm. After evolution of hydrogen ceased (- 2 h) a clear 
homogeneous solution was formed. The organics were removed under vacuum to 





Allylmagnesium bromide (48.0 ml, 1.0 M in Et20, 48.0 mmol) was added dropwise 
to a well stirred solution of (-)(Jpc)2BOMe (15.8 g, 50 mmol) in Et20 (100 ml) at 
0 °C. The reaction was warmed to RT and stirred vigorously for 1 h. Stirring was 
discontinued and the organic layer was transferred via cannula to 500 ml flask and 
cooled to -100 °C. Isobutyraldehyde (4.60 ml, 50.0 mmol) was added slowly and the 
reaction was stirred for 1 h at -100 °C. The reaction mixture was then warmed to RT, 
NaOH (40 ml, 3N aq.) and H202 (15 ml) were added and the mixture was stirred 
overnight. The organic layer was separated and the aqueous layer was washed with 
Et20 (3 x 50 ml). The organics were combined and dried (Na2SO4) and the volatiles 
were removed under reduced pressure. Kugelrohr distillation (100 °C, 6 torr) 
provided the pure allylic alcohol 305 (4.96 g, 87 %, 94 %e.e.); Rf (20 % EtOAc in 
hexane) = 0.83, bp = 98 - 100 °C (6 ton); laiD = - 3.00 (c 1.0, CHC13); Vmax 
(neat)/cm' 3398 (OH), 1641 (C=C); 'H NMR ö (360 MHz, CDC13) 5.76 (1H, ddd, J 
= 16.6, 10.7 & 6.1 Hz, CH=CH2), 5.08 (1H, d, J = 16.6 Hz, CH=CHTRANSHCIS), 5.06 
(1H, d, J = 10.7 Hz, CHCHTPJ\NSHCIS), 3.34 (1H, ddd, J = 8.8, 6.8 & 2.1 Hz, 
CHOH), 2.30 - 2.22 (1H, m, CHAHB), 2.09 - 2.03 (1H, m, CHAHB), 1.71 - 1.58 (1H, 
In, CH(CH3)2), 1.10 (3H, d, J = 6.8 Hz, CH(CH3)A(CH3)B), 0.88 (3H, d, J= 6.8 Hz, 
CH(CH3)A(CH3)B); 13C NMR 5 (90.5 MHz, CDC13) 135.31 (CH), 117.87 (CH2), 
75.21 (CH), 38.70 (CH2), 32.96 (CH), 18.91 (CH3)5  17.44 (CH3); m/z (FAB, 
THIOG.) 137 ([M+Na], 6%), 125 (11), 107 (22), 79 (10), 34 (100); HRMS (FAB, 
THIOG.) [M+Na] found 137.0938, C7H,40Na requires 137.0942. 






MeO" Co  
5Ly1 
To a solution of alcohol 305 (10.0 mg, 0.400 mmol) and DMAP (54.0 mg, 0.440 
mmol) in THF (3 ml) was added (R)-MTPA-C1 (111 mg, 0.440 mmol) and the 
reaction mixture was stirred for 12 h at RT. The reaction mixture was diluted with 
CH202 (5 ml), washed with H20 (3 x 5 ml) and dried (K2CO3). Volatiles were 
removed under reduced pressure to give the crude Mosher's ester. Purification by 
flash chromatography (5 % EtOAc in hexane) afforded Mosher's ester 309 as a 
colourless oil (53.0 mg, 80 %); Rf (20 % EtOAc in hexane) = 0.91; [a]D = - 3.6 (c 
0.5, CHC13); Vmax (neat) / cm-1 1726 (C=O), Major diastereomer: 'H NMR 8 (360 
MHz, CDC13) 7.56 - 7.54 (2H, in, An]), 7.42 - 7.40 (3H, in, ArH), 5.63 (1H, ddd, J= 
17.2, 10.0 & 7.1 Hz, C(5)H=CH2), 5.05 - 4.98 (3H, in, CH=CH2 & C(3)H), 3.56 (3H, 
s, OCH3), 2.35 (2H, t, J = 7.3 Hz, C(4)H2), 1.95 (1H, dspt 	oct, J = 6.8 Hz, 
CH(CH3)A(CH3)B), 0.95 (3H, d, J = 6.8 Hz, CH(CH3)A(CH3)B), 0.93 (3H, d, J = 6.8 
Hz, CH(CH3)A(CH3)B); Minor diastereomer diagnostic peak: 2.43 (1H, t, J = 7.3 Hz, 
C(4)H2), 0.87 (3H, d, J = 6.8 Hz, CH(CH3)A(CH3)B), 0.85 (3H, d, J = 6.8 Hz, 
CH(CH3)A(CH3)B); 13C NMR ö (90.5 MHz, CDC13) 166.51 (C) 133.41 (CH), 132.40 
(C), 129.70 (CH), 128.49 (2 x CH), 127.78 (CH), 125.16 (CH), 123.39 (CF3, q, 'Jcp 
288.1 Hz), 118.28 (CH2), 84.37 (C, q, JCF = 27.8 Hz), 81.01 (CH), 55.61 (CH3), 
35.47 (CH2), 30.89 (CH), 18.63 (CH3), 17.55 (CH3); ' 9F NMR 6 (50.3 MHz, CDC13) 
-72.5 (minor diastereomer), -72.6 (major diastereomer). 





To a solution of alcohol 305 (4.20 g, 35.1 mmol) in THF (100 ml) was added 
potassium tert-butoxide (3.93 g, 35.1 mmol) followed by PMBC1 (7.67 g, 50.0 
mmol) at 0 °C. The reaction was warmed to RT and stirred fro 4 h. H20 (100 ml) 
was added and the mixture was extracted with Et20 (3 x 70 ml). The organics were 
combined, dried (Na2SO4) and the volatiles were removed under reduced pressure. 
Flash chromatography (5 % EtOAc in hexane) afforded the protected alcohol 310 as 
a colourless oil (6.47 g, 75 %); Rf (20 % EtOAc in hexane) = 0.83, ["ID  = -1.12 (c 
5.3, CHC1); Vmax (neat)/cm' 1613 (C=C); 'H NMR £5 (250 MHz, CDCI3) 7.14 (2H, 
d, J= 8.2 Hz, An]), 6.75 (2H, d, J= 8.2 Hz, An]), 5.76 (1H, ddd, J= 17.2, 9.7 & 6.9 
Hz, CH=CH2), 4.98 (1H, d,J = 17.2 Hz, CHCHTRANSHCIS), 4.92 (1H, d,J= 9.7 Hz, 
CH=CHTPNSHCIS), 4.39 (1H, d, J= 16.6, 11.1 Hz, CHAHBPh), 4.30 (1H, d, J = 16.6, 
11.1 Hz, CHAHBPh), 3.68 (3H, s, OCH3), 3.05 (1H, dt q, J = 6.3 Hz, CHOPMB), 
2.17 (2H, br t, J= 6.9 Hz, C(4)H2), 1.74 (1H, dsept oct, J= 6.3 Hz, CH(CH3)2, 
0.82 (3H, d, J = 6.7 Hz, CH(CH3)A(CH3)B), 0.79 (3H, d, J = 6.7 Hz, 
CH(CH3)A(CH3)B); '3C NMR £5 (62.9 MHz, CDC13) 158.90 (C), 135.63 (CH), 131.05 
(C), 129.17 (2 x CH), 116.28 (CH2), 113.54 (2 x CH), 83.40 (CH), 71.33 (CH2), 
55.15 (CH3), 35.12 (CH2), 30.78 (CH), 18.33 (CH3), 18.09 (CH3); in/z (El) 234 
([M], 29 %), 194 (14), 191 (59), 156 (14), 121 (100); HR1\'IS (El) [M] found 
234.1619, C15H2202 requires 234.1620. 





To a solution of alcohol 305 (4.20 g, 35.1 mmol) in THF (40 ml) was added 'BuOK 
(3.93 g, 35.1 mmol) followed by BnBr (5.98 ml, 50.0 mmol) at 0 °C. The reaction 
was warmed to RT and stirred for 4 h. H20 (100 ml) was added and the mixture was 
extracted with Et20 (3 x 50 ml). The organics were combined, dried (Na2SO4) and 
the volatiles were removed under reduced pressure. Flash chromatography (5 % 
EtOAc in hexane) afforded the protected alcohol 311 as a colourless oil (4.94 g, 69 
%); Rf (20 % EtOAc in hexane) = 0.74, [UID = -4.3 (c 0.3 CHC13); Vmax (neat)/cm 
1612 (C=C); 'H NMR ö (250 MHz, CDC13) 7.32 - 7.19 (5H, m, ArE), 6.08 (1H, 
ddd, J = 17.1, 10.1 & 7.1 Hz, CHCH2), 5.34 (1H, d, J = 17.1 Hz, 
CHCHTRANSHC,S), 5.31 (1H, d, J = 9.7 Hz, CH=CHTRANSHC!S), 4.65 (1H, d, J = 
16.2 Hz, CHAHBPh), 4.45 (1H, d, J = 16.2 Hz, CHAHBPh), 3.45 (1H, dt q, J = 7.0 
Hz, CHOBn), 2.57 (2H, br t, J= 7.1 Hz, CH20), 2.14 (1H, dsept oct, J= 6.8 Hz, 
CH(CH3)2, 1.22 (3H, d, J = 6.8 Hz, CH(CH3)A(CH3)B), 1.19 (3H, d, J 6.8 Hz, 
CH(CH3)A(CH3)B); '3C NMR 5 (62.9 MHz, CDC13) 156.42 (C), 133.32 (2 x CH), 
131.24(2 x CH), 130.53 (CH), 114.28 (CH2), 110.49 (CH), 83.02 (CH), 70.42 (CH2), 
34.89 (CH2), 31.23 (CH), 18.11 (CH3), 17.98 (CH3); in/z (El) 204 ([M], 15 %), 192 






To a solution of alkene 310 (5.00 g, 21.4 mmol) in a mixture of H20/THF (91 ml/364 
ml) was added sequentially 0s04 (4 % solution in H20, 6.64 ml, 1.05 mmol, 5 
mol%) at 0 °C. The reaction mixture was stirred at RT for 10 mm. To the reaction 
mixture was then added a solution of sodium periodate (1.07 g, 42.8 mmol) over a 2 
h interval. To the mixture was added Na2S203 (200 ml, sat.) and extracted with Et20 
(3 x 200 ml). The organic layer was washed with H20 (60 ml), NaCl (60 ml, sat.) and 
dried (Na2SO4). The organics were removed under reduced pressure to give the crude 
aldehyde. Purification by flash chromatography (20 % EtOAc in hexane) gave 
aldehyde 7 as a colourless oil (4.23 g, 84 %); Rf (20 % EtOAc in hexane) = 0.44; 
LUI D = -65.3 (c 0.3, CHC13), lit. 29 -65.7 (c 0.3, CHC13); vmax(neat)/cm' 1710 (C0); 
'H NMR 5 (25 0 MHz, CDC13) 9.78 (1H, t, J= 1.8 Hz, CHO), 7.18 (2H, d, J= 8.7 
Hz, An]), 6.85 (2H, d, J= 8.7 Hz, ArH), 4.53 (1H, d, J— 11.0 Hz, CHAHBPh), 4.48 
(1H, d, J= 11.0 Hz, CHAHBPh), 3.79 (3H, s, OCH3), 3.80-3.69 (1H, m, CHOPMB), 
2.62 (1H, ddd, J= 16.0, 8.1 & 2.8 Hz, C(2)HAHB), 2.51 (1H, ddd, J= 16.0, 3.6 & 1.6 
Hz, C(2)HAHB), 2.05 - 1.89 (1H, in, CH(CH3)2), 0.92 (3H, d, J = 6.8 Hz, 
CH(CH3)A(CH3)B), 0.90 (3H, d, J = 6.8 Hz, CH(CH3)A(CH3)11); 13C NMR 8 (62.9 
MHz, CDC13) 202.16 (CH), 159.59 (C), 130.78 (C), 129.76 (2 x CH), 114.63 (2 x 
CH), 79.07 (CH), 71.76 (CH2), 55.63 (Cl-I3), 45.25 (CH2), 31.20 (CH), 18.80 (CH3), 
17.64 (Cl-I3); m/z (El) 236 ([M], 43 %), 193 (8), 138 (50), 137 (87), 121 (100); 
HRMS (El) [M] found 236.1412, C14H2003 requires 236.1412. 





To a solution of alkene 311 (4.36 g, 21.4 mmol) in a mixture of H20/THF (91 ml/364 
ml) was added sequentially 0504 (4 % solution in H20, 6.64 ml, 1.05 mmol, 5 
mol%) at 0 °C. The reaction mixture was stirred at RT for 10 mm. To the reaction 
mixture was then added a solution of sodium periodate (1.07 g, 42.8 mmol) over a 2 
h interval. To the mixture was added Na2S203 (200 ml, sat.) and extracted with Et20 
(3 x 200 ml). The organic layer was washed with H20 (60 ml), NaCl (60 ml, sat.) and 
dried (Na2SO4). The volatiles were removed under reduced pressure to give the crude 
aldehyde. Purification by flash chromatography (20 % EtOAc in hexane) gave 
aldehyde 312 as a colourless oil (3.48 g, 79 %); Rf (20 % EtOAc in hexane) = 0.58; 
FalD = -31.1 (c 0.4, CHC13), lit. 
162 -34.5 (c 1.0, CHCI3); vmax (neat)/cm' 1711 (C0); 
'H NMR .5 (360 MHz, CDCI3) 10.0 (1H, t, J = 1.9 Hz, CHO), 7.41 -7.22 (5H, m, 
ArII), 4.82 (1H, d, J== 11.4 Hz, CHAHBPh), 4.75 (1H, d, J = 11.4 Hz, CHAHBPh), 
4.06 -4.00 (1H, m, J= CHOBn), 2.89 (1H, ddd, J = 16.3, 8.1 & 2.7 Hz, C(2)HAHB), 
2.73 (1H, ddd, J= 16.3, 8.8 & 1.8 Hz, C(2)HAHB), 2.26 (1H, dspt, J = 8.6 & 6.8 Hz, 
CH(CH3)2), 1.18 (3H, d, J= 6.8 Hz, CHCH3), 1.17 (3H, d, J= 6.8 Hz, CHCH3); 13C 
NMR 8(90.5 MHz, CDC13) 202.51 (CH), 138.67 (C), 128.76(3 x CH), 128.11 (2 x 
CH), 79.43 (CH), 72.13 (CH2), 45.25 (CH2), 31.22 (CH), 18.77 (CH3), 17.63 (CH3); 
m/z (FAB, NOBA) 207 ([M+H], 5 %), 205 ([M-H], 27), 133 (19), 115 (37), 43 
(100); HRMS (FAB, NOBA) [M-H] found 205.1227, C13H1702 requires 205.1229. 





Sodium hydride (1.58 g, 39.6 mmol) was washed with anhydrous ether several times 
and covered with DMF (100 ml). The suspension was treated dropwise at 0 °C with 
1,3-propandiol (2.50 g, 33.0 mmol). The mixture was then stirred at RT with the 
exclusion of atmospheric moisture for 15 min until gas evolution had ceased. PMBC1 
(5.2 g, 33.0 mmol) was added and the mixture was stirred and heated at 100 °C for 1 
h. the mixture was cooled to RT, H20 (5.0 ml) was added and the mixture was stirred 
at RT for 15 mm (to destroy unreacted sodium hydride). The mixture was 
concentrated under reduced pressure and was treated with H20 (50 ml). The aqueous 
mixture was extracted with ether (3 x 100 ml). The combined organics were washed 
with NaCl (100 ml, sat), dried (MgSO4) and concentrated under reduced pressure to 
give the crude mono-protected diol product. Flash chromatography (20 % EtOAc in 
hexane) gave alcohol 316 as a colourless oil (3.41 g, 50 %); Rf (50 % EtOAc in 
hexane) = 0.28; Vmax (Nujol mull)/cm' 3392 (OH); 'H NMR 8 (250 MHz, CDC13) 
7.32 (2H, d, J = 8.3 Hz, An]), 6.95 (2H, d, J = 8.3 Hz, An]), 4.51 (2H, s, OCH2Ar), 
3.87 (3H, s, OCH3), 3.83 (2H, t, J = 5.9 Hz, CH20H), 3.69 (2H, t, J = 5.9 Hz, 
CH20PMB), 2.54 (1H, br s, 01]), 1.91 (2H, qn, J= 5.9 Hz, CH2CH20H); '3C NMR 
8(62.9 MHz, CDC13) 159.04 (C), 129.99 (C), 129.11 (2 x CH), 113.64 (2 x CH), 
72.72 (CH2), 68.83 (CH2), 61.60 (CH2), 55.08 (CH3), 31.91 (CH2); m/z (FAB, 
NOBA) 197 ([M+H], 25 %), 196 (Mt, 58), 195 (59), 194 (14), 193 (21); HRI\'IS 
(FAB, NOBA) [M] found 196.1096, C11H1603 requires 196.1099. 
'H and '3C NMR spectroscopic data in good agreement with the literature. 142 
209 
Experimental 
General Procedure G: Swern oxidation: Oxalyl chloride (2.49 ml, 28.1 mmol) in 
CH202 was cooled to 78 °C and DMSO (3.97 ml, 56.1 mmol) added dropwise and 
stirred for 5 mm. The activated DMSO was transferred into a solution of alcohol 
(25.5 mmol) CH2C12 at -78 °C. After 15 min Et3N (15.6 ml, 112 mmol) was added 
and the dry ice/acetone bath removed. The reaction mixture was allowed to proceed 
until it came to RT ( 60 mm) at which time H20 (50 ml) was added. The layers 
were separated, and the organics washed with H20 (25 ml), NaHCO3 (25 ml, sat.), 
H20 (2 x 25 ml). The organic layer was then dried and concentrated to give the crude 
aldehyde as a yellow oil. Purification by flash chromatography gave the aldehyde as 
a colourless oil. 
3-(4'-Methoxybenzyloxy)-propan-1-al 103 
HOPMB 
General procedure G was used for alcohol 316 (5.00 g, 25.5 mmol) Purification with 
flash chromatography (20 % EtOAc in hexane) gave the aldehyde 103 as a colourless 
oil (4.99 g, 97 %); Rf (30 % EtOAc in hexane) = 0.34; Vmax (neat)/cm' 1731 (C0); 
'H NMR 8(250 MHz, CDC13) 9.88 (1H, t, J— 1.8 Hz, CHO), 7.34 (2H, d, J= 8.7 
Hz, An]), 6.97 (2H, d, J = 8.7 Hz, ArE), 4.56 (2H, s, CH2Ar), 3.90 (3H, s, OCH3), 
3.88 (2H, t, J = 6.5 Hz, CH2CH20PMB), 2.78 (2H, td, J = 6.5 & 1.8 Hz, 
CH2CH20PMB); '3C NMR 8(62.9 MHz, CDC13) 201.13 (C), 159.76 (C), 130.12 
(C), 129.24 (2 x CH), 113.72 (2 x CH), 72.81 (CH2), 63.40 (CH2), 55.17 (CH2), 
43.77 (CH3); m/ (FAB, NOBA) 195 ([M+H], 4 %), 193 ([M-H], 49), 137 (45), 
135 (27), 121 (100); HRMS (FAB, NOBA) EM-H]+ found 193.0865, C,,H1303  
requires 193.0865. 
'H and '3C NMR spectroscopic data in good agreement with the literature 42 
210 
Experimental 
(3R,45)-1 -(4-Methoxybenzyloxy)-4-methyl-s-hexen-3-oI 315 
OH OPMB 
To a cloudy solution of potassium tert-butoxide (880 p1, 1.0 M in THF, 8.80 mmol) 
and trans-2-butene (excess) in THF (20 ml) at -78 °C was added dropwise nBuLi 
(5.50 ml, 1.6 M in hexane, 8.80 mmol). The resulting yellow solution was allowed to 
warm to -45 °C and stirred for 20 mm. The reaction mixture was recooled to -78 °C 
and a solution of (-)-/J-methoxydiisopinocampheylborarie (3.61 g, 11.4 mmol) in 
THF (10 ml) was added. The resulting colourless reaction mixture was stirred at -78 
°C for 35 mm. BF3'Et20 (1.40 ml, 11.3 mmol) was added rapidly followed 
immediately by a solution of the crude aldehyde (1.00 g, 5.20 mmol) in THF (5.0 
ml). The resulting cloudy reaction mixture was stirred at -78 °C for 4 h. The reaction 
was quenched by addition of NaOH (30 ml, 3N aq.) followed by H202 (30 ml). The 
reaction mixture was warmed to 25 °C and stirred overnight. The mixture was 
diluted with ethyl acetate (60 ml) and NaCl (50 ml, sat.). The layers were separated 
and the aqueous layer was extracted with EtOAc (3 x 50 ml). The combined organics 
were dried (Na2SO4) and then concentrated under reduced pressure. Purification by 
flash chromatography (8 % EtOAc in hexane) gave the homoallylic alcohol (919 mg, 
71 %); 91 % enantiomeric excess was determined by chiral HPLC comparing 
alcohol 315 with alcohol 104 derived from (+)-borane (Daicel Chiracel OD-H, 
254nm, 99.1 hexanes/propan-2-ol, 0.5 ml/min) Rt 315 38.1 mm, 104 = 41.1 mm; Rf  
(20 % EtOAc in hexane) = 0.29; laiD = -0.19 (c 2.0, CHC13), lit42 -0.19 (c 2. 0, 
CHC13); Vmax (neat)/cm' 3460 (OH), 1613 (C=C); 'H NMR 6 (360 MHz, CDC13) 
7.23 (2H, d, J = 8.3 Hz, ArH), 6.84 (2H, d, J= 8.3 Hz, An]), 5.77 (1H, ddd, J= 17.9, 
11.9 & 7.9 Hz, CH=CH2), 5.04 (1H, d, J = 11.9 Hz, CHCHCISHTRANS), 5.03 (1H, d, 
J = 17.9 Hz, CHCHCISHT1NS), 4.42 (2H, s, CH2Ar), 3.77 (3H, s, OCH3), 3.68 - 
3.54 (3H, in, C(3)HOH & C(2)H2), 2.76 (1H, br s, 01]), 2.26 - 2.12 (1H, in, 
C(4)HCH3), 1.68 (2H, q, J = 5.5 Hz, C(2)H2), 1.00 (3H, d, J— 6.9 Hz, CHCH3); '3C 
NMR 6(90.5 MHz, CDCI3) 159.12 (C), 140.38 (CH), 129.97 (C), 129.22 (2 x CH), 
211 
Experimental 
115.34 (CH2), 113.70 (2 x CH), 74.20 (CH), 72.86 (CH2), 68.83 (CH2), 55.16 (CH3), 
43.88 (CH), 33.40 (CH2), 15.70 (CH3); m/z (FAB, NOBA) 251 ([M+H], 3 %), 249 
([M-H], 43), 241 (4), 227 (40); HRMS (FAB, NOBA) [M-H] found 249.148 1, 
C15H2103 requires 249.1490. 
1H and '3C NMR spectroscopic data in good agreement with the literature.42 
212 
Experimental 
(1' 'S,2R,4R)-2-(4' -Methoxyphenyl)-4-(1 ' '-methyl-prop-2' '-enyl)- [1,31 -dioxane 
319 
MPM 
To a solution of alcohol 315 (2.10 g, 8.36 mmol), in CH202 (50 ml) at 0 °C was 
added 4 A molecular sieves (2.10 g), then DDQ (2.0 g, 8.78 mmol) was added in 
three portions over 5 mm. The reaction mixture was then stirred for 15 mm, filtered 
through a pad of celite and washed with CH2Cl2 (2 x 20 ml). The organics were 
washed with H20 (2 x 30 ml) and NaCl (2 x 30 ml) and dried (Na2SO4). The 
organics were removed under reduced pressure to give the crude acetal as a yellow 
oil. Purification using flash chromatography gave the pure acetal 319 as a colourless 
oil (1.74 g, 83 %); Rf (20 % EtOAc in hexane) = 0.78; laiD  = -15.3 (c 0.9, CHC13), 
lit.'63 -16.5 (c 0.35, CH202); Vmax (neat) / cm-1 1616 (C=C); 'H NMR 6(250 MHz, 
CDC13) 7.44 (2H, d, J= 8.7 Hz, ArH), 6.90 (2H, d, J = 8.7 Hz, ArE), 5.93 (1H, ddd, 
J = 18.0, 10.0 & 8.4 Hz, CHCH2), 5.47 (1H, s, CHAr), 5.09 (1H, d, J= 18.0 Hz, 
CH=CHTRANSCHCIS), 5.07 (1H, d, J= 10.0 Hz, CHCHTRANSCHCIS), 4.28 (1H, dd, J 
= 11.3 & 4.2 Hz, C(6)HAHB), 3.92 (1H, td, J— 12.2 & 2.5 Hz, C(6)HAHB), 3.81 (3H, 
s, OCH3), 3.75 (1H, ddd, J = 11.3, 5.4 Hz & 2.2 Hz, C(4)H), 2.45 —2.38 (1H, m, 
C(5)HxHy), 1.88 (1H, qd, J = 12.4 & 5.0 Hz, C(5)HxHy), 1.46 - 1.42 (1H, m, 
CHCH3), 1.08 (3H, d, J = 6.9 Hz, CHCH3); 13C NMR 6(62.9 MHz, CDC13) 159.65 
(C), 140.09 (CH), 131.40 (C), 127.17 (2 x CH), 114.69 (CH2), 113.38 (2 x CH), 
100.85 (CH), 80.21 (CH), 66.86 (CH2), 55.15 (CH3), 42.30 (CH), 27.83 (CH2), 14.99 
(CT-I3); m/z (FAB, THIOG.) 249 ({M+H]1 , 43 %), 248 (11), 247 (22), 222 (10), 221 
(68); HRMS (FAB, THIOG.) [M+H]1 found 249.1483, CI 5H2103 requires 249.1491. 




(3R,4S)-3-(4'-Methoxybenzyloxy)-4-methyl-5-hexen-1 -ol 320 
PMBO OH 1 J 
To a solution of acetal 319 (1.50 g, 6.02 mmol) in CH2C12 at 0 °C was added DIBAL 
(18.1 ml, 1.0 M in toluene, 18.1 mmol) and the reaction mixture was stirred for 2 h. 
Rochelle's salt (30 ml, sat.) was added and the reaction mixture was stirred for 30 
mm. HC1 (50 ml, IN aq.) was carefully added to the reaction mixture and was 
vigorously stirred for 30 mm. The reaction mixture was extracted with CH2C12 (3 x 
50 ml) and the combined organics were washed with H20 (2 x 50 ml), NaCl (2 x 50 
ml) and dried (Na2SO4). The organics were removed under reduced pressure to give 
the crude alcohol as a yellow oil. Purification using flash chromatography gave 
alcohol 320 as a colourless oil (1.40 g, 93 %); R f (20 % EtOAc in hexane) = 0.14; 
LalD= 44.2 (c 0.7, CHCI3), lit. 
114 93.8 (c 1.0, CH2Cl2); Vmax (neat) / cm-1 3407 (OH), 
1613 (C=C); 'H NMR 8(250 MHz, CDC13) 7.28 (2H, d, J= 8.4 Hz, An]), 6.89 (2H, 
d, J = 8.4 Hz, ArH), 5.79 (1H, ddd, J= 19.5, 10.5 & 6.9 Hz, CH=CH2), 5.08 (1H, d, 
J = 19.5 Hz, CH-CHCISHTR,NS), 5.07 (1H, d, J = 10.5 Hz, CH=CHCISHTRANS), 4.60 
(1H, d, J= 11.0 Hz, CHAHBPh), 4.42 (1H, d, J— 11.0 Hz, CHAHBPh), 3.81 (3H, s, 
OCH3), 3.73 (2H, t, J = 5.9 Hz, C(1)H20H), 3.61 - 3.56 (1H, in, C(3)I]), 2.72 - 2.68 
(1H, in, C(4)HCH3), 2.09 (1H, br s, 011), 1.74— 1.65 (2H, in, C(2)H2), 1.03 (3H, d, J 
= 6.9 Hz, C(4)HCH3); ' 3C NMR 8 (62.9 MHz, CDC13) 162.13 (C), 143.37 (CH), 
133.18 (C), 132.42 (2 x CH), 117.82 (CH2), 116.74 (2 x CH), 84.44 (CH), 74.04 
(CH2), 64.11 (CH2), 58.14 (CH3), 42.36 (CH), 34.99 (CH2), 16.31 (CH3); ,n/z (FAB, 
THIOG.) 251 ([M+H], 57 %), 250 (41), 249 (68), 248 (12), 247 (16); HRMS (FAB, 
THIOG.) [M+H] found 251.1649, C15H2303 requires 251.1647. 





General procedure G was used with alcohol 320 (1.00 g, 4.03 mmol) to give 
aldehyde 5 (980 mg, 99 %); R f (20 % EtOAc in hexane) = 0.59; Vmax (neat) / cm-1 
1726 (C=O), 1613 (C=C); 'H NMR (5 (250 MHz, CDCI3) 9.88 (1H, t, J= 1.5 Hz, 
CHO), 7.37 (2H, d, J= 8.8 Hz, ArH), 7.01 (2H, d, J= 8.8 Hz, ArH), 5.90 (1H, ddd, J 
= 17.9, 11.3 & 7.0 Hz, CHCH2), 5.22 (1H, d, J = 11.3 Hz, CH=CHCISHTRANS), 5.21 
(1H, d, J= 17.9 Hz, CHCHCISHTJNS), 4.67 (1H, d, J = 11.0 Hz, CHAH BPh), 4.58 
(1H, d, J = 11.0 Hz, CHAHBPh), 4.08 (1H, q, J = 4.1 Hz, C(3)I]), 3.98 (3H, s, OCH3), 
2.81 —2.55 (3H, m, C(4)HCH3 & C(2)H2), 1.19 (3H, d, J = 7.0 Hz, C(4)HCH3 ); ' 3C 
NMR 6 (62.9 MHz, CDC13) 201.71 (CH), 159.13 (C), 139.53 (CH), 130.10 (C), 
129.28 (2 x CH), 115.60 (CH2), 113.68 (2 x CH), 76.85 (CH), 71.35 (CH2), 55.15 
(CH3), 45.05 (CH2), 40.14 (CH), 13.84 (CH3); m/z (FAB, THIOG.) 249 ([M+H]1 , 50 
%), 241 (40), 235 (38), 227 (18), 43 (100); HRMS (FAB, THIOG.) [M+H] found 




trimethylundec-5,1 O-dien-7-one 321 
TBSO 0 	OPMB 
General procedure D was followed with J3-ketophosphonate ester 193 (5.00 g, 12.7 
mmol) in THF (50 ml) was added Ba(OH)2•8H20 (4.81 g, 15.00 mmol) to which 
aldehyde 7 (4.50 g, 19.1 mmol) was added. Flash chromatography (20 % EtOAc in 
hexane) gave HWE adduct 321 as a colourless oil (5.26 g, 87 %); Rf (20 % EtOAc in 
hexane) = 0.81; Vmax (neat) / cm-1 = 1664 (C=O), 1613 (C=C); [a]9 = 0.16 (c 0.5, 
CHCI3); 'H NMR 8(360 MHz, CDC13) 7.27 (2H, d, J= 8.7 Hz, ArE), 6.88 (2H, d, J 
= 8.7 Hz, An]), 6.78 (1H, br t, J= 6.8 Hz, C(5)H), 5.73 (1H, ddd, J= 17.2, 9.2 & 7.7 
Hz, CH=CH2), 5.19 (1H, d, J = 17.2 Hz, CHCHTRANSHCJS), 5.16 (1H, d, J= 9.2 Hz, 
CH=CHTRANSHCIS), 4.48 (2H, s, CH2Ar), 4.24 (1H, t, J = 9.2 Hz, CHOTBS), 3.81 
(3H, s, OCH3), 3.35 - 3.29 (2H, m, C(3)HOPMB & C(8)HCH3), 2.46 (2H, br t, J= 
6.8 Hz, C(4)H2), 1.93 - 1.89 (1H, m, CH(CH3)2), 1.79 (3H, s, C(6)CH3), 0.97 (3H, d, 
J= 6.8 Hz, CH(CH3)A(CH3)B), 0.94 (3H, d, .1= 6.8 Hz, CH(CH3)A(CH3)B), 0.89 (3H, 
d, J = 6.9 Hz, CHCH3), 0.77 (9H, s, C(CH3)3), -0.03 (3H, s, SiCH3), -0.05 (3H, s, 
SiCH3); '3C NMR ö (90.5 MHz, CDCI3) 207.33 (C), 161.72 (C), 142.69 (CH), 
142.23 (CH), 141.21 (C), 133.32 (C), 131.99 (2 x CH), 119.04 (CH2), 116.34 (2 x 
CH), 85.43 (CH), 80.14 (CH), 74.08 (CH2), 57.83 (CH3), 47.51 (CH), 33.69 (CH), 
33.05 (CH2), 28.25 (3 x CH3), 20.95 (CH3), 20.63 (CH3), 20.53 (C), 17.28 (CH3), 
14.42 (CH3), -1.60 (CH3), -2.69 (CH3); ,n/z (FAB, NOBA) 475 ([M+H], 6 %), 281 
(24), 241 (11), 211(24), 121 (100); HRMS (FAB, NOBA) [M+H] found 475.3243, 





TBSO 0 	OBn 
General procedure D was followed with 3-ketophosphonate ester 193 (600 mg, 
1.53 mmol) in THF (10 ml) was added Ba(OH)2'8H20 (600 mg, 1.80 mmol) to 
which aldehyde 312 (472 mg, 2.30 mmol) was added. Flash chromatography (20 % 
EtOAc in hexane) gave HWE adduct 322 as a colourless oil (577 mg, 85 %); Rf (20 
% EtOAc in hexane) = 0.89; Vmax (neat) I cm = 1661 (C=O), 1601 (C=C); [a10 2.40 
= (c 0.3, CHC13); 'H NMR 8(360 MHz, CDC13) 7.40 - 7.30 (5H, m, An]), 6.83 (1H, 
br t, J= 6.8 Hz, C(5)H), 5.73 (1H, ddd, J = 17.3, 10.2 & 7.9 Hz, CHCH2), 5.21 (1H, 
d, J= 17.3 Hz, CHCHCISCHTJNS), 5.17 (1H, d, J = 10.2 Hz, CHCHCISCHTRANS), 
4.59 (2H, s, CH2OBn), 4.23 (1H, br t, J= 8.3 Hz, CHOTBS), 3.40-3.31 (2H, m, 
CHOBn & C(8)HCH3), 2.51 (2H, br t, J = 6.8 Hz, C(4)H2), 2.02 - 1.87 (1H, m, 
CH(CH3)2), 1.84 (3H, s, C(6)CH3), 1.01 (3H, d, J = 6.8 Hz, CHCH3), 0.98 (3H, d, J 
= 7.0 Hz, CH(CH3)A(CH3)B), 0.92 (3H, d, J = 7.0 Hz, CH(CH3)A(CH3)B), 0.80 (9H, 
S, C(CH3)3), 0.00 (3H, s, SiCH3), -0.04 (3H, s, SiCH3); '3C NMR 6 (90.5 MHz, 
CDC13) 204.93 (C), 140.14 (CH), 139.81 (CH), 139.65 (C), 138.82 (C), 128.56 (2 x 
CH), 127.99 (2 x CH), 127.80 (CH), 116.63 (CH2), 83.43 (CH), 75.55 (CH), 72.05 
45.28 (CH), 31.32 (CH), 30.66 (CH2), 25.85 (3 x CH3), 18.51 (CH3), 18.24 
18.13 (C), 14.86 (CH3), 12.03 (CH3), -4.00 (CH3), -5.08 (CH3); m/z (FAB, 
NOBA) 445 ([M+H], 6 %), 281 (27), 253 (12), 211 (29), 73 (100); HRMS (FAB, 





OH 0 	OPMB 
General Procedure E was followed with f3-hydroxy enone 321 (4.50 g; 9.49 mmol) 
in MeCN (45 ml) at RT was added HF (2.0 ml, 40 % aq.) and stirred for 15 mm. 
Purification by flash chromatography (20 % EtOAc in hexane) afforded the I-
hydroxy enone 72 as a colourless oil (3.18 g, 94 %); Rf (20 % EtOAc in hexane) = 
0.31; Vmax (neat) / cm = 3465 (OH), 1660 (C=O), 1612 (C=C); [a]D 0.8 = (c 0.6, 
CHC13); 1H NMR 8(360 MHz, CDCI3); 7.26 (2H, d, J = 8.7 Hz, ArH), 6.88 (2H, d, 
J= 8.7 Hz, An]), 6.75 (1H, hr t, J= 6.8 Hz, C(5)I]), 5.83 (1H, ddd, J= 17.1, 10.4 & 
6.4 Hz, CHCH2), 5.29 (1H, d, J = 17.1 Hz, CHCHTRANSHCIS), 5.16 (1H, d, J = 
10.4 Hz, CHCHTRANSHCIS), 4.51 (1H, d, J = 11.3 Hz, CHAH BPh), 4.44 (1H, d, J 
11.3 Hz, CHAHBPh), 4.24 (1H, t, J= 6.4 Hz, CHOH), 3.81 (3H, s, OCH3), 3.35 - 
3.25 (2H, m, C(3)HOPMB & C(8)HCH3), 2.46 (2H, br t, J= 6.8 Hz, C(4)H2), 1.98-
1.87 (1H, m, J= 6.8 Hz, CH(CH3)2), 1.78 (3H, s, C(6)CH3), 1.12 (3H, d, J= 6.8 Hz, 
CHCH3), 0.97 (3H, d, J = 6.8 Hz, CH(CH3)A(CH3)B), 0.94 (3H, d, J = 6.8 Hz, 
CH(CH3)A(CH3)B); '3C NMR 5 (90.5 MHz, CDCI3) 208.90 (C), 161.74 (C), 143.80 
(CH), 141.42 (CH), 140.40 (C), 133.18 (C), 131.97(2 x CH), 118.80 (CH2), 116.35 
(2 x CH), 85.10 (CH), 78.08 (CH), 73.96 (CH2), 57.83 (CH3), 46.41 (CH), 33.59 
(CH), 32.89 (CH2), 21.14 (CH3), 20.36 (CH3), 18.56 (CH3), 14.11 (CH3); ,n/z (FAB, 
NOBA) 361 ([M+H]+, 14%), 249(11), 241 (14), 225 (12), 121 (100); HRMS (FAB, 
NOBA) [M+H]+ found 361.2378, C22H3304 requires 361.2379. 
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(3S,5E,8S,9S)-3-Benzyloxy-9-hydroxy-2,6,8-trjmethylundec-5,1 O-dien-7-one 323 
OHO 	OBn 
General Procedure E was followed with f3-hydroxy enone 322 (550 mg, 1.24 
mmol) in MeCN (10 ml) at RT was added HF (550 jtl, 40 % aq.) and stirred for 15 
mm. Purification by flash chromatography (20 % EtOAc in hexane) afforded the 13-
hydroxy enone 323 as a colourless oil (388 mg, 95 %); Rf (20 % EtOAc in hexane) = 
0.31; Vmax (neat) / cm' = 3465 (OH), 1660 (C=O), 1642 (C=C); [aID 1.15 = (c 0.2, 
CHCI3); 'H NMR .5 (360 MHz, CDCI3); 7.44-7.29 (5H, in, Ark!), 6.77 (1H, br t, J 
= 7.0 Hz, C(5)H), 5.84 (1H, ddd, J= 17.0, 10.4 & 6.3 Hz, CHCH2), 5.28 (1H, d, J 
17.0 Hz, CHCHTR4J.JSHCIS), 5.13 (1H, d, J= 10.4 Hz, CH=CHTPNSHCIS), 4.57 (1H, 
d, J— 11.7 Hz, CHAHBPh), 4.51 (1H, d, J = 11.7 Hz, CHAHBPh), 4.24 (1H, br t, J 
6.3 Hz, CHOH), 3.37-3.24 (2H, m, C(3)HOBn & C(8)HCH3), 2.48 (2H, br t, J-
5.8 Hz, C(4)H2), 2.00 — 1.91 (1H, in, CH(CH3)2), 1.79 (3H, s, C(6)CH3), 1.16 (3H, d, 
J = 7.2 Hz, C(8)HCH3), 0.97 (3H, d, J = 6.6 Hz, CH(CH3)A(CH3)B), 0.95 (3H, d, J= 
6.6 Hz, CH(CH3)A(CH3)B); '3C NMR ö (90.5 MHz, CDC13) 206.57 (C), 141.32 
(CH), 139.04 (CH), 138.76 (C), 138.12 (C), 128.63 (2 x CH), 128.00 (CH), 127.90 (2 
x CH), 116.47 (CH2) 83.20 (CH), 75.74 (CH), 71.99 (CH2), 44.08 (CH), 31.27 (CH), 
30.55 (CH2), 18.74 (CH3), 18.02 (CH3), 16.18 (CH3), 11.76 (CH3); ,n/z (FAB, 
NOBA) 331 ([M+H], 27%), 220 (22), 163 (24), 145 (11), 43 (100); HRMS (FAB, 
NOBA) [M+H] found 331.2276, C21H3103 requires 331.2273. 
219 
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(3S,3 'R,4'S,5E,7R ,8R ,9S)-9- [3 '-(4" -Methoxybenzyloxy)-4 '-methyl-hex-5-enoyll - 
3-(4' "-methoxybenzyloxy)-2,6,8-trimethylundec-5,1 O-dien-7-ol 71 
PMBO 0 
6 
10 OH 	OPMB 
TY 
General procedure F was followed with a solution of benzaldehyde (100 p1) in 
THF (10 ml) and Sm12 (5.00 ml, 0.1 M solution in THF), to which aldehyde 5 (973 
mg, 3.88 mmol)) followed by f3-hydroxy enone 72 (700 mg, 1.94 mmol) were added. 
Flash chromatography (10 % EtOAc in hexane) afforded ester 71 as a colourless oil 
(1.13 g, 96 %); Rf (20 % EtOAc in hexane) = 0.56; FUID = 0.40 (c 0.4, CHC13); Vmax 
(neat) / cm-1 3459 (OH), 1720 (C=O), 1613 (C=C); 'H NMR 8(360 MHz, CDCI3) 
7.23 (4H, d, J= 8.9 Hz, ArH), 6.83 (4H, d, J= 8.9 Hz, An]), 5.84 - 5.72 (211, m, 2 x 
CHCH2), 5.52 (1H, br t, J = 7.0 Hz, C(5)H), 5.26 (1H, d, J = 17.1 Hz, 
C(10)HCHT, NsHcIs), 5.23 (1H, t, J = 6.9 Hz, C(9)H), 5.16 (1H, d, J = 10.0 Hz, 
C(1O)HCHTRANSHCIS), 5.07 (1H, d, J 17.1 Hz, C(5')HCHTpNsHcIs), 5.06 (1H, d, J 
= 10.0 Hz, C(5')HCHTINSHCIS), 4.50 (1H, d, J = 11.2 Hz, CHAHBAr), 4.49 (2H, s, 
CH2Ar), 4.42 (111, d, J= 11.2 Hz, CHAHBAr), 3.95 (1H, br d, J= 3.9 Hz, C(7)HOH), 
3.89 (1H, dt q, J= 4.2 Hz, C(3')I]), 3.79 (3H, s, OCH3), 3.78 (3H, s, OCH3), 3.20 
(1H, dt q, J= 5.5 Hz, C(3)II), 2.58 - 2.42 (314, m, C(4')HCH3 & C(2')H2), 2.31 - 
2.24 (2H, m, C(4)H2), 1.91 - 1.78 (2H, m, C(8)HCH3 & CH(CH3)2), 1.56 (314, s, 
C(6)CH3), 1.05 (3H, d, J = 6.9 Hz, C(8)HCH3), 0.93 (3H, d, J = 5.9 Hz, 
CH(CH3)A(CH3)B), 0.92 (3H, d, J = 5.9 Hz, CH(CH3)A(CH3)B), 0.80 (3H, d, J = 6.9 
Hz, C(4')HCH3); '3C NMR ô (90.5 MHz, CDC13) 171.70 (C), 159.01 (C), 158.89 
(C), 139.68 (CH), 136.00 (C), 134.43 (CH), 131.16 (C), 130.48 (C), 129.16 (4 x CH), 
122.36 (CH), 118.30 (CH2), 115.39 (CH2), 113.59 (4 x CH), 83.71 (CH), 79.00 (CH), 
76.09 (CH), 74.84 (CH), 71.88 (CH2), 71.37 (CH2), 55.15 (2 x CH3), 40.60 (CH), 
39.32 (CH), 36.94 (CH2), 30.92 (CH), 28.91 (CH2), 18.62 (CH3), 17.82 (CH3), 14.30 
(CH3), 13.15 (Cl3), 9.11 (CH3); m/z (FAB, NOBA) 607 ([M-H]+, 4 %), 591 ([(M-
H20)+H], 5), 307 (56), 289 (50), 121 (100); HRMS (FAB, NOBA) [M-H]+  found 
607.3631, C37H5107 requires 607.3635. 
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jçpqjeiggj 
(3S,3 'R,4 'S,5E,7R,8R,9S)-3-Benzyloxy-9- [3 '-(4-methoxybenzyloxy)-4'-methyl-
hex-5-enoyl] -2,6,8-trimethylundec-5, 1O-en-7-ol 324 
PMBO 0 
6 (10 OH OBn 
General procedure F was followed with a solution of benzaldehyde (100 tl) in 
THF (10 ml) and Sm12 (5.00 ml, 0.1 M solution in THF), to which aldehyde 5 (799 
mg, 3.88 mmol) followed by f3-hydroxy enone 323 (700 mg, 1.94 mmol) were added. 
Flash chromatography (10 % EtOAc in hexane) afforded ester 324 as a colourless oil 
(997 mg, 91 %); Rf (20 % EtOAc in hexane) = 0.56; [a]0 = 0.60 (c 0.4, CHC13); Vmax 
(neat) / cm-1 3467 (OH), 1732 (C=O), 1613 (C=C); 'H NMR 6(360 MHz, CDC13) 
7.36 - 7.28 (5H, m, An]), 7.24 (2H, d, J = 8.7 Hz, ArH), 6.84 (2H, d, J = 8.7 Hz, 
ArH), 5.83 - 5.70 (2H, m, 2 x CHCH2), 5.53 (1H, br t, J = 6.9 Hz, C(5)H), 5.29 - 
5.20 (3H, m, Q1 1)H2 & C(9)II'), 5.09 (1H, d, J = 16.7 Hz, C(6')HTpNsHc1s), 5.07 
(1H, d, J—= 10.7 Hz, C(6')HTRANSHCJS), 4.57 (1H, d, J = 11.6 Hz, CHAHBPh), 4.49 
(1H, d, J = 11.6 Hz, CHAHBPh), 4.48 (2H, s, CH2Ph), 3.96 (1H, br d, J = 4.1 Hz, 
C(7)HOH), 3.91 (1H, dq, J = 8.3 & 4.3 Hz, C(3')I]), 3.78 (3H, s, OCH3), 3.21 (1H, 
dt 	q, J = 5.6 Hz, C(3)I]), 2.56-2.46 (3H, m, C(2')H2 & C(4')HCH3), 2.34-2.27 
(2H, m, C(4)H2), 1.91 - 1.79 (2H, m, C(8)H & CH(CH3)2), 1.56 (3H, s, C(6)CH3), 
1.04 (3H, d, J= 6.9 Hz, C(8)HCH3), 0.99 (3H, d, J= 5.9 Hz, CH(CH3)A(CH3)B), 0.98 
(3H, d, J = 5.9 Hz, CH(CH3)A(CH3)B), 0.80 (3H, d, J = 6.9 Hz, C(4')HCH3); 13C 
NMR 6 (90.5 MHz, CDC13) 196.84 (C), 172.04 (C), 159.28 (C), 141.30 (C), 139.95 
(C), 136.35 (CH), 134.70 (CH), 130.73 (CH), 129.33 (2 x CH), 128.53 (2 x CH), 
127.90 (2 x CH), 127.53 (CH), 122.54 (CH), 118.64 (CH2), 115.71 (CH2), 113.86 
(CH), 84.34 (CH), 78.43 (CH), 76.46 (CH), 75.06 (CH), 72.17 (CH2), 71.99 (CH2), 
55.42 (CH3), 40.68 (CH), 39.55 (CH), 37.19 (CH2), 30.52 (CH), 29.12 (CH2), 18.89 
(CH3), 18.09 (CH3), 14.38 (CH3), 13.45 (CH3), 9.40 (CH3); m/z (FAB, NOBA) 579 
([M+H], 4 %), 460 (11), 307 (66), 154 (100), 137 (87); HRMS (FAB, NOBA) 




trimethyloct-1 0-enylj-3-(4' '-methoxybenzyloxy)-4-methyl-oxocene-1 -one 70 
PMBO.0 .HQP 	
15 
To a solution of ester 71 (80 mg, 0.13 mmol) in degassed CH202 (100 ml) was 
added Ti('OPr)4 (5 j.il, 10 mol%) and the solution was stirred for 30 mm. Grubbs' 2 
catalyst 159 (23 mg, 20 mol%) was then added and the reaction mixture was heated 
under reflux for 24 h. After the reaction mixture was cooled to RT, DMSO (2.0 ml) 
was added and the reaction mixture was stirred for a further 24 h. Volatiles were 
removed under reduced pressure to give the crude lactone. Purification by flash 
chromatography (20 % EtOAc in hexane) afforded a lactone 70 as a colourless oil 
(53 mg, 70 %); Rf (20 % EtOAc in hexane) = 0.24; [UID = 1.22 (c 1.5, CHC13); Vmax 
(neat) / cm' 3436 (OH), 1730 (C=O); 1H NMR 8(360 MHz, CDC13) 7.22 (2H, d, J 
= 8.3 Hz, ArE), 7.18 (2H, d, J = 8.3 Hz, ArII), 6.78 (2H, J= 8.3 Hz, ArE), 6.77 (2H, 
J = 8.3 Hz, An]), 5.49-5.46 (2H, in, C(5)H& C(7)H), 5.39-5.36 (2H, in, C(6)H 
& C(1 1)1]), 4.42 (1H, d, J = 11.1 Hz, CHAHBAr), 4.40 (2H, s, CH20PMB), 4.32 (1H, 
d, J = 11.1 Hz, CHAHBAr), 4.19 (1H, br d, J = 6.1 Hz, C(9)HOH), 3.73 (1H, dq qn, 
J= 4.6 Hz, C(3)I]), 3.72 (6H, s, 2 x OCH3), 3.04 (1H, q, J = 5.8 Hz, C(13)If), 2.38 - 
2.21 (3H, m, C(2)H2 & C(4)HCH3), 2.16 (2H, br t, J= 5.3 Hz, Q1 2)H2), 2.15 —2.13 
(1H, in, C(8)CH3), 1.81 - 1.69 (1H, m, CH(CH3)2), 1.70 (3H, s, C(10)CH3), 1.00 
(3H, d, J= 7.2 Hz, C(4)HCH3), 0.95 (3H, d, J=  6.9 Hz, C(8)HCH3), 0.88 (3H, d, J= 
6.9 Hz, CH(CH3)A(CH3)B), 0.87 (3H, d, J = 6.9 Hz, CH(CH3)A(CH3)B); '3C NMR 8 
(90.5 MHz, CDC13) 171.27 (C), 158.03 (C), 150.09 (C), 149.76 (C), 132.22 (CH), 
130.16 (C), 129.78 (C), 128.28 (4 x CH), 126.98 (CH), 124.24 (CH), 112.63 (4 x 
CH), 83.00 (CH), 82.75 (CH), 78.42 (CH), 77.15 (CH), 70.93 (CH2), 70.35 (CH2), 
54.28 (2 x CH3), 45.44 (CH), 38.78 (CH), 36.01 (CH2), 32.93 (CH2), 29.82 (CH), 
17.45 (CH3), 17.23 (CH3), 14.15 (CH3), 12.64 (CH3), 11.05 (CH3), m/z (FAB, 
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THIOG.) 581 ([M+H]+, 1 %), 579(([M-H], 2 %), 358 (7), 241 (39), 121 (100); 
HRMS (FAB, THIOG.) [M-H] found 579.579.3320, C35H4707 requires 579.3322. 
* Treatment of ester 71 with Grubbs' 2 catalyst 159 in the absence of Ti( OPr)4 
produces a 1:1 mixture of lactone 70 and by-product 326. 
(1S,2R,3R,4Z,3 'R,4'S)- [3 '-(4' '-Methoxybenzyloxy)-4-methyl-hex-5 ' -enoic acid] - 




'H NMR 8(360 MHz, CDC13) 7.22 (2H, d, J = 8.6 Hz, ArH), 6.78 (2H, d, J = 8.6 
Hz, ArR), 5.72 (1H, ddd, J = 17.2, 10.8 & 7.2 Hz, CHCH2), 5.52-5.48 (2H, m, 
C(1)H & C(5)H), 4.98 (1H, d, J = 10.8 Hz, CHCHCISCHTRANS), 4.97 (1H, d, J = 
17.2 Hz, CHCHCISCHTRANS), 4.42 (2H, s, CH2Ar), 4.27 - 4.21 (1H, m, C(3)HOH), 
3.82 (1H, dq, J = 8.3 & 4.3 Hz, C(3')I]), 3.73 (3H, s, OCH3), 2.47-2.28 (3H, m, 
C(2')H2 & C(2)I]), 2.08 (1H, dq, J— 6.6 Hz, C(4')H), 1.72 (3H, s, C(4)CH3), 0.99 
(3H, d, J= 7.2 Hz, C(2)HCH3), 0.97 (3H, d, J=r 6.6 Hz, C(4')HCH3). 
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(3S,3 'R,4'S,5R,6R,7R,8R,9S)-3- 13 '-(4-Methoxybenzyloxy)-4 '-methyl-hex-5-




To solution of ester 71 (100 mg, 0.164 mmol) in benzene (10 ml) was added 
'BuOOH (100 p1, 576 p.mol) and VO(acac)2 (12 mg, 44.3 jtmol) and the mixture was 
stirred at RT for 1 h. The volatiles were removed under reduced pressure to give the 
crude epoxide 328. Flash chromatography (10 % EtOAc in hexane) afforded epoxide 
328 as a 95:5 mixture of diastereomers (89 mg, 87 %); R f (20 % EtOAc in hexane) = 
0.47; Vmax (neat) / cm' 3490 (OH), 1727 (C0), 1612 (C=C); Major diastereomer: 
'H NMR 8(360 MHz, CDC13) 7.61 —7.40 (41-1, m, An]), 7.04 (41-1, d, J= 8.7 Hz, 
An]), 6.06 - 5.83 (21-1, m, C(5')H & C(10)I]), 5.56 - 5.37 (31-1, m, C(11)H2 & 
C(9)H), 5.23 (11-1, d, J = 11.2 Hz, C(6')HT p NsHc Is), 5.22 (11-1, d, J = 17.2 Hz, 
C(6')HTNsHc1s), 4.69 —4.61 (41-1, m, 2 x CH2Ar), 4.09 (11-1, dq qn, J = 4.0 Hz, 
C(3')I]), 3.96 (1H, d, J = 3.0 Hz, C(9)I]), 3.93 (61-1, s,2 x OCH3), 3.62-3.41 (21-1, 
m, C(5)H & C(3)H), 2.72 - 2.64 (31-1, m, C(4')H & C(2')H2), 2.38 - 2.02 (21-1, m, 
C(8)H & C(2)II), 1.95 (21-1, br t, J = 5.8 Hz, C(4)H2), 1.40 (3H, s, C(6)CH3), 1.22 
(3H, d, J = 6.9 Hz, C(4')HCH3), 1.14 (31-1, d, J = 6.8 Hz, C(2)H(CH3)A(CH3)B), 1.13 
(31-1, d, J— 6.8 Hz, C(2)H(CH3)A(CH3)B), 0.98 (31-1, d, J= 6.7 Hz, C(8)HCH3); Minor 
diastereomer diagnostic peak: 1.42 (31-1, s, C(6)CH3); '3C NMR 8 (90.5 MHz, 
CDC13) 171.25 (C), 158.90 (C), 158.87 (C), 140.85 (CH), 136.20 (CH), 130.76 (C), 
130.41 (C), 130.33 (4 x CH), 119.92 (CH2), 116.53 (CH2), 114.73 (4 x CH), 83.10 
(CH), 82.57 (CH),*  80.27  (CH),*  78.49 (CH), 77.31 (CH), 77.01 (CH),*  72.43 
(CH2), 71.44 (CH2), 70.94 (CH), 61.02 (C), 57.81 (CH), 56.26 (2 x Cl-I3), 41.79 
(CH), 39.13 (CH), 38.79 (CH2), 38.09 (CH2),*  31.73 (CH), 30.44 (CH2), 30.00 
(CH2),* 19.58 (CH3), 18.63 (CH3), 16.56 (CH3), 16.21 (CH3), 10.53 (CH3); in/z 
(FAB, THIOG.) 623 ([M-H]+, 9%), 361 (7), 263 (30), 241 (40), 121 (100); HRMS 
(FAB, THIOG.) [M-H]+  found 623.3583, C371-15108 requires 623.3584. 
* Indicates minor diastereomer. 
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(3S,3 'R,4 ' S,5R ,6R,8R ,98)-3- [3 '-(4-Methoxybenzyloxy)-4'-methyl-hex-5-enoyll - 
[3-(4-methoxybenzyloxy)-5,6-oxiranyl] -2,6,8-trimethylundec-5 ',l O-dien-7-one 
328 
PMBO 0 
1_-1Jo 0 	OPMB 
To a solution of epoxide 328 (60 mg, 0.097 mmol) in CH202 (5 ml) was added Dess 
Martin periodinane (255 mg, 0.60 mol) and the suspension was stirred at RT for 3 h. 
The solvent was exchanged on a rotary evaporator so that the solvent did not go dry. 
The resultant white suspension was filtered through a short plug of silica to provide 
ketone 330 as a colourless oil (58 mg, 98 %); Rf (20 % EtOAc in hexane) = 0.59; 
[a]D = -0.35 (c 1. 5, CHC13); Vmax (neat) / cm 1 1735 (C=O), 1711 (C=O), 1612 (C=C); 
'H NMR 6 (360 MHz, CDC13) 7.29 - 7.23 (4H, in, ArH), 6.86 (4H, d, J = 8.7 Hz, 
ArH), 5.69 (1H, ddd, J = 17.1, 10.3 & 6.9 Hz, C(10)II), 5.67 (1H, ddd, J = 17.2, 10.5 
& 6.7 Hz, C(5')I]), 5.49-5.28 (3H, in, C(1 1)H2 & C(9)II), 5.01 (111, d, J= 17.2 Hz, 
C(6')HT p NsHcIs), 4.98 (1H, d, J= 10.5 Hz, C(6')HTRANSHCIS), 4.46 - 4.34 (4H, in, 2 
x CH2Ar), 4.06 (111, dq qn, J = 4.0 Hz, C(3')II), 3.81 (311, s, OCH3), 3.77 (3H, s, 
OCL[3), 3.32— 3.28 (111, in, C(3)II), 3.21 (1H, br t, J= 6.8 Hz, C(5)I]), 2.91 (1H, dq, 
J = 7.1 & 6.9 Hz, C(8)H), 2.40-2.32 (1H, in, C(4')II), 2.29 (2H, br t, 1=5.9Hz, 
C(2')H2), 2.08 - 1.96 (1H, in, C(2)I]), 1.86 - 1.64 (2H, in, C(4)H2), 1.42 (3H, s, 
C(6)CH3), 1.00 (3H, d, J = 6.7 Hz, C(8)HCH3), 0.96 (3H, d, J = 6.8 Hz, 
CH(CH3)A(CH3)B), 0.93 (3H, d, J = 6.8 Hz, C(2)H(CH3)A(CH3)B), 0.92 (3H, d, J = 
6.7 Hz, C(4')HCH3); '3C NMR 6(90.5 MHz, CDC13) 211.02 (C), 170.89 (C), 159.34 
(C), 159.22 (C), 139.98 (CH), 133.93 (CH), 130.92 (C), 130.76 (C), 129.64 (CH), 
129.59 (CH), 129.49 (CH), 129.43 (CH), 120.30 (CH2), 115.54 (CH2),113.94 (CH), 
113.92 (CH), 113.81 (CH), 113.78 (CH), 81.73 (CH), 79.01 (CH), 75.75 (CH), 72.13 
71.30 (CH2), 62.73 (C), 57.74 (CH), 55.44 (CH3), 55.42 (CH3), 41.37 (CH), 
41.35 (CH), 37.24 (CH2), 31.11 (CH), 29.35 (CH2), 18.79 (CH3), 18.16 (CH3), 15.23 
13.85 (CH3), 13.33 (CH3); m/z (FAB, NOBA) 621 ([M-H], 7 %), 501 (25), 
225 
Experimental 
460 (26), 309 (14), 154 (100); HRMS (FAB, NOBA) [M-H]+  found 621.3427, 
C37H4908 requires 621.3427. 
226 
Experimental 
'H NMR 5 (360 MHz, CDC13) for lactone 3 
09 OH 
ppm(fl) 	
(.0 	 b.0 	 5.0 	 4.0 	 3.0 	 20 	 1.0 
'3C NMR 6 (90.5 MHz, CDC13) for lactone 3 
OH 
ppm (11) 	
200 	 150 	 100 	 50 
227 
- 	 - 	 piicqj 







70 	 6.0 	 5.0 	 4.0 	 30 	 20 
ppm (rl) 

















7.0 	 6.0 	 5.0 	 4.0 	 2.0 	 2.0 	 1.0 	 0.0 
ppm (f2) 
4 






1 Rousseau, G., Tetrahedron 1995, 51, 2777. 
2 Connolly, J. D.; Okorie, D. A.; Dalenedewit, L.; Taylor, D. A. H., J Chem. Soc., 
Chem. Commun. 1976, 909. 
3 Taylor, D. A. H., I Chem. Res. (5) 1982, 55. 
4 Jakupovic, J.; Schuster, A.; Ganzer, U.; Bohlmann, F.; Boldt, P. E., Phytochemistry 
1990, 29, 2217. 
5 Niwa, H.; Wakamatsu, K.; Yamada, K., Tetrahedron Lett. 1989, 30, 4543. 
6 Kigoshi, H.; Niwa, H.; Yamada, K.; Stout, T. J.; Clardy, J., Tetrahedron Lett. 1991, 
32, 2427. 
7 Ayer, W. A.; Sun, M.; Bowne, L. M.; Brinen, L. S.; Clardy, J., I Nat. Prod. 1992, 
55, 649. 
8 Gohrt, A.; Zeeck, A.; Hutter, K.; Kirsch, K.; Kluge, H.; Thiericke, R., J. Antibiotics 
1992, 45, 66. 
9 Grabley, S.; Hammann, P.; Hutter, K.; Kirsch, K.; Kluge, H.; Thiericke, R.; Mayer, 
M.; Zeeck, A., I Antibiotics 1992, 45, 1176. 
10 Granzer, S.; Hammann, P.; Wink, J.; Grabley, S., EP477552, Eur. Pat. Appi. 
1992, 922. 
11 Granzer, S.; Hammann, P.; Kirsch, K., EP5 16015, Eur. Pat. App!. 1993, 8597. 
12 Wong, J. W.; Verigin, V.; Oeshlschlager, A. C.; Borden, J. H.; Pierce, H. D.; 
Pierce, A. M.; Chong, L., I Chem. Ecol. 1983, 9, 451. 
13 Tapiolas, D. M.; Roman, M.; Fenical, W.; Stout, T. J.; Clardy, J., I Am. Chem. 
Soc. 1991, 113, 4682. 
14 Buszek, K. R.; Sato, N.; Jeong, Y., Tetrahedron Lett. 2002, 43, 181. 
15 Inoue, S.; Iwabuchi, Y.; Irie, H.; Hatakeyama, S., Synlett 1998, 735. 
16 McWilliams, J. C.; Clardy, J., I Am. Chem. Soc. 1994, 116, 8378. 
17 O'Sullivan, P. T.; Buhr, W.; Fuhry, M. A. M.; Harrison, J. R.; Davies, J. E.; 
Feeder, N.; Marshall, D. R.; Burton, J. W.; Holmes, A. B., I Am. Chem. Soc. 
2004, 126, 2194. 
18 Buszek, K. R.; Sato, N.; Jeong, Y., I Am. Chem. Soc. 1994, 116, 5511. 
19 Buszek, K. R.; Jeong, Y., Tetrahedron Lett. 1995, 36, 7189. 
230 
erences 
20 Bach, J.; Berenguer, R.; Garcia, J.; Vilarrasa, J., Tetrahedron Lett. 1995, 36, 
3425. 
21 Bach, J.; Garcia, J., Tetrahedron Lett. 1998, 39, 6761. 
22 Shiina, I.; Hashizume, M.; Yamai, Y.; Oshiumi, H.; Shimazaki, T.; Takasuna, Y.; 
Ibuka, R., Chem., Eur. 1 2005, 11, 6601. 
23 Buszek, K. R.; Jeong, Y.; Sato, N.; Still, P. C.; Miuno, P. L.; Ghosh, I., Synth. 
Commun. 2001, 31, 1781. 
24 Andrus, M. B.; Argade, A. B., Tetrahedron Lett. 1996, 37, 5049. 
25 Nicolaou, K. C.; Sorensen, E. J., Classics in Total Synthesis. 4th ed.; Wiley-VCH: 
1996. 
26 Shiina, I., I Org. Chem. 2005, 63, 2. 
27 Hulme, A. N.; Howells, G. E., Tetrahedron Lett. 1997, 38, 8245. 
28 Evans, D. A.; Hoveyda, A. H., .1 Am. Chem. Soc. 1990, 112, 6447. 
29 Howells, G. E., PhD Thesis, The University of Edinburgh 1999. 
30 Beesley, R. M.; Ingold, C. K.; Thorpe, J. F., I Chem. Soc 1915, 107, 1080. 
31 Herold, T.; Hoffman, R. W., Angew. Chem., mt. Ed. 1978, 17, 768. 
32 Brown, H. C.; Jadhav, P. K., J. Am. Chem. Soc. 1983, 105, 2092. 
33 Jadhav, P. K.; Bhat, K. S.; Perumal, P. T.; Brown, H. C., I Org. Chem. 1986, 51, 
432. 
34 Racherla, U. S.; Brown, H. C., I Org. Chem, 1991, 56, 401. 
35 Brown, H. C.; Kulkarni, S. V.; Racherla, U. S., J. Org. Chem. 1994, 59, 365. 
36 Burgos, C. H.; Canales, E.; Matos, K.; Soderquist, J. A., I Am. Chem. Soc. 2005, 
127, 8044. 
37 Fraunhoffer, K. J.; Bachovchin, D. A.; White, M. C., Org. Lett. 2005, 7,223. 
38 Brown, H. C.; Bhat, K. S., I Am. Chem. Soc. 1986, 108, 293. 
39 Fujita, K.; Schlosser, M., Helv. Chim. Acta 1982, 65, 1258. 
40 Brown, H. C.; Bhat, K. S.; Randad, R. S., I Org. Chem. 1989, 54, 1570. 
41 Eggen, M. J.; Georg, G. I., Bioorg. Med. Chem. Lett. 1998, 8, 3177. 
42 Eggen, M.; Mossman, C. J.; Buck, S. B.; Nair, S. K.; Bhat, L.; Ali, S. M.; Reiff, 
E. A.; Boge, T. C.; Georg, G. I., I Org. Chem. 2000, 65, 7792. 
43 Tripathy, N. K.; Georg, G. I., Tetrahedron Lett. 2004, 45, 5309. 
231 
- 	References 
44 Paterson, I.; Florence, G. J.; Gerlach, K.; Scott, J. P.; Sereinig, N., J. Am. Chem. 
Soc. 2001, 123, 9535. 
45 Evans, D. A.; Bartroli, J.; Shih, T. L., J. Am. Chem. Soc. 1981, 103, 2127. 
46 Gennari, C.; Hewkin, C. T.; Molinari, F.; Bernardi, A.; Comotti, A.; Goodman, J. 
M.; Paterson, I., J. Org. Chem. 1992, 57, 5173. 
47 Gennari, C.; Moresca, D.; Vulpetti, A.; Pain, G., Tetrahedron Lett. 1994, 35, 
4623. 
48 Gennari, C.; Pain, G.; Moresca, D., J. Org. Chem. 1995, 60, 6248. 
49 Paterson, I.; Wallace, D. J.; Velaquez, S. M., Tetrahedron. Lett. 1994, 35, 9083. 
50 Evans, D. A.; Downey, C. W.; Shaw, J. T.; Tedrow, J. S., Org. Lett. 2002, 4, 
1127. 
51 Evans, D. A.; Tedrow, J. S.; Shaw, J. T.; Downey, C. W., I Am. Chem. Soc. 
2002, 124, 392. 
52 Abiko, A.; Liu, J. F.; Masamune, S., I Org. Chem. 1996, 61, 2590. 
53 Abiko, A.; Liu, J. F.; Masamune, S., J. Am. Chem. Soc. 1997, 119, 2586. 
54 Inoue, T.; Liu, J. F.; Buske, D. C.; Abiko, A., I Org. Chem. 2002, 67, 5250. 
55 Abiko, A., Acc. Chem. Res. 2004, 37, 387. 
56 Breuer, E.; Zbaida, S.; Segall, E., I Chem. Soc., Perkin Trans 11979, 2203. 
57 Durrant, G.; Sutherland, J. K., I Chem. Soc., Perkin Trans 11972, 2582. 
58 Ando, K., I Org. Chem. 1999, 64, 6815. 
59 Still, W. C.; Gennari, C., Tetrahedron Lett. 1983, 24, 4405. 
60 Blanchette, M. A.; Choy, W.; Davis, J. T.; Essenfeld, A. P.; Masamune, S.; 
Roush, W. R.; Sakai, T., Tetrahedron Lett. 1984, 25, 2183. 
61 Paterson, I.; Yeung, K. S.; Smaill, J. B., Synlett 1993, 774. 
62 Paterson, I.; Yeung, K. S.; Watson, C.; Ward, R. A.; Wallace, P. A., Tetrahedron 
1998, 54, 11935. 
63 Paterson, I.; Woodrow, M. D.; Cowden, C. J., Tetrahedron Lett. 1998, 39, 6041. 
64 Paterson, I.; Blakey, S. B.; Cowden, C. J., Tetrahedron Lett. 2002, 43, 6005. 
65 Lafontaine, J. A.; Provencal, D. P.; Gardelli, C.; Leahy, J. W., Tetrahedron Lett. 
1999, 40, 4145. 
66 Lafontaine, J. A.; Provencal, D. P.; Gardelli, C.; Leahy, J. W., I Org. Chem. 
2003, 68, 4215. 
232 
References 
67 Romo, D.; Meyer, S. D.; Johnson, D. D.; Schreiber, S. L., J. Am. Chem. Soc. 
1993, 115, 7906. 
68 Smith, A. B.; Adams, C. M.; Barbosa, S. A. L.; Degnan, A. P., 1 Am. Chem. Soc. 
2003, 125, 350. 
69 Smith, A. B.; Adams, C. M.; Barbosa, S. A. L.; Degnan, A. P., Proc. Nail. Acad. 
Sci. 2004, 101, 12042. 
70 Smith, A. B.; Lee, D.; Adams, C. M.; Kozlowski, M. C., Org. Lett. 2002, 4, 4539. 
71 Schoning, K. U.; Hayashi, R. K.; Powell, D. R.; Kirscbning, A., Tetrahedron. 
Asymmetry 1999, 10, 817. 
72 Schrock, R. R.; Murdezek, J. S.; Bazan, G. C.; Robbins, J.; DiMare, M.; O'Regan, 
M., I Am. Chem. Soc. 1990, 112, 3875. 
73 Fu, G. C.; Grubbs, R. H., I Am. Chem. Soc. 1992, 114, 5426. 
74 Fu, G. C.; Nguyen, S. T.; Grubbs, R. H., I Am. Chem. Soc. 1993, 115, 9856. 
75 Schwab, P.; France, M. B.; Ziller, J. W.; Grubbs, R. H., Angew. Chem., mt. Ed. 
1995, 34, 2039. 
76 Schwab, P.; Grubbs, R. H.; Ziller, J. W., I Am. Chem. Soc. 1996, 118, 100. 
77 Scholl, M.; Ding, S.; Lee, W.; Grubbs, R. H., Org. Lett. 1999, 1, 953. 
78 Schrock, R. R.; Hoveyda, A. H., Angew. Chem., mt. Ed. 2003, 42, 4592. 
79 Herrmann, W. A., Angew. Chem., mt. Ed. 41, 1290. 
80 Herrmann, W. A.; Kocher, C., Angew. Chem., mt. Ed. 1997, 36, 2162. 
81 Deiters, A.; Martin, S. F., Chem. Rev. 2004, 104, 2199. 
82 Nicolaou, K. C.; Bulger, P. G.; Sarlah, D., Angew. Chem., mt. Ed. 2005, 44, 4490. 
83 Takemoto, Y.; Baba, Y.; Saha, G.; Nakao, S.; Iwata, C.; Tanaka, T.; Ibuka, T., 
Tetrahedron Lett. 2000, 41, 3653. 
84 Baba, Y.; Saha, G.; Nakao, S.; Iwata, C.; Tanaka, T.; Ibuka, T.; Ohishi, H.; 
Takemoto, Y., I Org. Chem. 2001, 66, 81. 
85 Furstner, A.; Muller, T., Synlett 1997, 1010. 
86 Naves, Y. R.; Grampoloff, A. V., Helv. Chim. Acta 1942, 25, 1500. 
87 Kangani, C. 0.; Bruckner, A. M.; Curran, D. P., Org. Lett. 2005, 7, 379. 
88 Pettit, G. R.; Chichacz, Z. A.; Gao, F.; Boyd, M. R.; Schmidt, J. M., I Chem. 
Soc., Chem. Commun. 1994, 1111. 
233 
References 
89 Paterson, I.; Britton, R.; Delgado, 0.; Meyer, A.; Wright, A. E., I Chem. Soc., 
Chem. Commun. 2004, 632. 
90 Paterson, I.; Britton, R.; Delgado, 0.; Meyer, A.; Poullennec, K. G., Angew. 
Chem. mt. Ed. 2004, 43, 4629. 
91 Hulme, A. N.; Howells, G. E.; Walker, R. H., Synlett 1998, 828. 
92 Paterson, I.; Rawson, D. J., Tetrahedron Lett. 1989, 30, 7463. 
93 Longden, K. E.; Hulme, A. N., unpublished results. 
94 Molander, G. A.; Harris, C. R., Chem. Rev. 1996, 96, 307. 
95 Edmonds, D. J.; Johnston, D.; Procter, D. J., Chem. Rev. 2004, 104, 3371. 
96 Aird, J. I., PhD Thesis, The University of Edinburgh 2003. 
97 Liu, J. F.; Abiko, A.; Pei, Z. H.; Buske, D. C.; Masamune, S., Tetrahedron Lett. 
1998, 39, 1873. 
98 Kiho, T.; Nakayama, M.; Kogen, H., Tetrahedron 2003, 59, 1685. 
99 Paterson, D. E.; Griffin, F. K.; Alcaraz, M. L.; Taylor, R. J. K., Eur. J. Org. 
Chem. 2002, 1323. 
100 Nishio, T., I Chem. Soc., Chem. Commun. 1989, 205. 
101 Nishio, T.; Okuda, N.; Kashima, C., J. Chem. Soc., Perkin Trans. 1 1992, 899. 
102 Nishio, T., I Chem. Soc., Perkin Trans. 11993, 1113. 
103 Nishio, T., .1. Org. Chem. 1997, 62, 1106. 
104 Jesberger, M.; Davis, T. P.; Barner, L., Synthesis 2003, 1929. 
105 Beumer, R.; Reiser, 0., Tetrahedron 2001, 57, 6497. 
106 Brouwer, A. J.; Monnee, M. C. F.; Liskamp, R. M. J., Synthesis 2000, 1579. 
107 Streicher, H.; Latxague, L.; Wiemann, T.; Rollin, P.; Thiem, J., Carbohydr. Res. 
1995, 278, 257. 
108 Lefoix, M.; Tatibouet, A.; Cottaz, S.; Driguez, H.; Rollin, P., Tetrahedron Lett. 
2002, 43, 2889. 
109 Johnston, B. D.; Pinto, B. M., I Org. Chem. 2000, 65, 4607. 
110 Kluepfel, D.; Baker, H. A.; Piattoni, G.; Sehgal, S. N.; Sidorowicz, A.; Singh, 
K.; Vezina, C., I Antibiotics 1975, 28, 497. 
111 Evans, D. A.; Biller, S. A., Tetrahedron Lett. 1985, 26, 1911. 
112 Arai, T.; Takahashi, K.; Kubo, A., I Antibiotics 1977, 30, 1015. 
113 Arai, T.; Takahashi, K.; Nakahara, S.; Kubo, A., Experientia 1980, 36, 1025. 
234 
- 	References 
114 Fukuyama, T.; Yang, L.; Ajeck, K. L.; Sachieben, R. A., I Am. Chem. Soc. 
1990, 112, 3712. 
115 Pettit, G. R.; Backhaus, R. A.; Boettner, F. E., I Nat. Prod. 1995, 58, 37. 
116 Ko, H. J.; Kim, E.; Park, J. E.; Kim, D.; Kim, S., I Org. Chem. 2004, 69, 112. 
117 Trost, B. M.; Pulley, S. R.,I Am. Chem. Soc. 1995,117, 10143. 
118 Danishefsky, S.; Lee, J. Y., .1. Am. Chem. Soc. 1989, 111, 4829. 
119 de Sousa, S. E.; O'Brien, P.; Poumellec, P., .1 Chem. Soc., Perkin Trans. 1 1998, 
1483. 
120 Hsu, J. L.; Fang, J. M., I. Org. Chem. 2001, 66, 8573. 
121 Molander, G. A., Chem. Rev. 1992, 92, 29. 
122 Singh, S. B., Tetrahedron Lett. 1995, 36, 2009. 
123 Flores-Parra, A.; Suarez-Moreno, P.; Sanchez-Ruiz, S. A.; Tlahuextl, M.; Jaen-
Gaspar, J.; Tlahuext, H.; Salas-Coronado, R.; Cruz, A.; Noth, H.; Contreras, R., 
Tetrahedron Asymmetry 1998, 9, 1661. 
124 Poelert, M. A.; Hof, R. P.; Peper, N.; Kellogg, R. M., Heterocycles 1994, 37, 
461. 
125 Hou, X. L.; Fan, R. H.; Dai, L. X., I. Org. Chem. 2002, 67, 5295. 
126 Fan, R. H.; Hou, X. L., I Org. Chem. 2003, 68, 726. 
127 Fanjul, S.; Hulme, A. N.; White, J. W., 2006, manuscript submitted. 
128 Duthaler, R. 0.; Herold, P.; Wylerhelfer, S.; Riediker, M., Helv. Chim. Acta 
1990, 73, 659. 
129 Fukuyama, T.; Tokuyama, H., Aidrichimica Acta 2004, 37, 87. 
130 Miyazaki, T.; Han-ya, Y.; Tokuyama, H.; Fukuyama, T., Synlett 2004, 477. 
131 Le Sann, C.; Munoz, D. M.; Saunders, N.; Simpson, T. J.; Smith, D. I.; Soulas, 
F.; Watts, P.; Willis, C. L., Org. Biomol. Chem. 2005, 3, 1719. 
132 Dawson, P. E.; Kent, S. B. H.,Annu. Rev. Biochem. 2000, 69, 923. 
133 Dawson, P. E.; Muir, T. W.; Clarkiewis, I.; Kent, S. B. H., Science 1994, 266, 
776. 
134 Liu, C. F.; Tam, J. P., Proc. Nat!. Acad. Sci. 1994, 91, 6584. 
135 Abiko, A.; Inoue, T.; Furuno, H.; Schwalbe, H.; Fieres, C.; Masamune, S., I 
Am. Chem. Soc. 2001, 123, 4605. 
136 Abiko, A.; Inoue, T.; Masamune, S., I Am. Chem. Soc. 2002, 124, 10759. 
235 
137 Brown, H. C.; Joshi, N. N., I Org. Chem. 1988, 53, 4059. 
138 Brown, H. C.; Desai, M. C.; Jadhav, P. K., I Org. Chem. 1982, 47, 5065. 
139 Evans, D. A.; Dart, M. J.; Duffy, J. L.; Yang, M. G., I Am. Chem. Soc. 1996, 
118, 4322. 
140 Antos, S.; Rehse, J.; Diehl, H.; Laue, C., EP 1354865, Eur. Pat. Appi. 2003. 
141 Cossy, J.; Willis, C.; Bellosta, V.; BouzBouz, S., I. Org. Chem. 2002, 67, 1982. 
142 Urbanek, R. A.; Sabes, S. F.; Forsyth, C. J., I Am. Chem. Soc. 1998, 120, 2523. 
143 Nicolaou, K. C.; Montagnon, T.; Baran, P. S., Angew. Chem., mt. Ed. 2002, 41, 
1386. 
144 Wirth, T., Angew. Chem., mt. Ed. 2001, 40, 2812. 
145 Frigerio, M.; Santagostino, M., Tetrahedron Lett. 1994, 35, 8019. 
146 Frigerio, M.; Santagostino, M.; Sputore, S.; Palmisano, G., I Org. Chem. 1995, 
60, 7272. 
147 More, J. D.; Finney, N. S., Org. Lett. 2002, 4, 3 00 1. 
148 Nimmo, F.; Hulme, A. N., unpublished results 2003. 
149 Kocienski, P. J., Protecting Groups. 3rd ed.; Thieme: 2004. 
150 Schuster, M.; Blechert, S., Angew. Chem., mt. Ed. 1997, 36, 2037. 
151 Callam, C. S.; Lowary, T. L., Org. Lett. 2000, 2, 167. 
152 Evano, G.; Schaus, J. V.; Panek, J. S., Org. Lett. 2004, 6, 525. 
153 Biswas, K.; Lin, H.; Njardarson, J. T.; Chappell, M. D.; Chou, T. C.; Guan, Y. 
B.; Tong, W. P.; He, L. F.; Horwitz, S. B.; Danishefsky, S. J., I Am. Chem. Soc. 
2002, 124, 9825. 
154 Furstner, A.; Langemann, K., I Am. Chem. Soc. 1997, 119, 9130. 
155 Chiang, G. C. H.; Bond, A. D.; Ayscough, A.; Pain, G.; Ducki, S.; Holmes, A. 
B., J. Chem. Soc., Chem. Commun. 2005, 1860. 
156 Mayo, K. G.; Nearhoof, E. H.; Kiddie, J. J., Org. Lett. 2002, 4, 1567. 
157 Efskind, J.; Undheim, K., Tetrahedron Lett. 2003, 44, 2837. 
158 Grigg, R.; Martin, W.; Morris, J.; Sridharan, V., Tetrahedron Lett. 2003, 44, 
4899. 
159 Prunet, J., Angew. Chem., mt. Ed. 2003, 42, 2826. 
160 Miles, S. M.; Leatherbarrow, R. J.; Marsden, S. P.; Coates, W. J., Org. Biomol. 
Chem. 2004, 2, 281. 
MR- 
Ref erences 
161 Inverarity, I.; Hulme, A. N.; Viguier, R. F. H., unpublished results. 
162 Mutou, T.; Kondo, T.; Ojika, M.; Yamada, K., J. Org. Chem. 1996, 61, 6340. 
163 Crimmins, M. T.; Siliphalvanh, P., Org. Lett. 2003,5,4641. 














DMF N, N-dimethylformamide 
DMAPO 4-dimethylaminopyridine oxide 
DMAP 4-dimethylaminopyridine 
DMPU 1,3 -dimethyl-3 ,4,5 ,6-tetrahydro-2( 1 H) pyrimidone 
DMS dimethyl sulfide 
DMSO dimethylsulfoxide 
d.s. diastereoselectivity 
e.e. enantiomeric excess (i.e. % major diastereomer - % minor 
diastereomer) 
El electron impact ionisation 
Et ethyl 
FAB fast atom bombardment 
Fmoc Fluorenylmethyloxycarbonyl 
HMDS hexamethyldisilazide 
HPLC high performance liquid chromatography 
HRMS high resolution mass spectrum 
HWE Homer-Wadsworth Emmons 
IBX iodobenzoic acid 
JR infrared 





mp melting point 
Ms, mesylate methane sulfonate 
MTPA methoxytrifluoromethyiphenylacetic acid 
NAC N-acetyl-cysteamine 
P unspecified protecting group 
PMB 4-methoxybenzyl 
ppm parts per million 
Pr propyl 
RCM ring closing metathesis 
Rf  retention factor 
RT room temperature 
Rt retention time 
sat. saturated 
Tf, triflate trifluoromethanesulfonate 
TBAF tetrabutylammonium fluoride 
TBS tert-butyldimethylsilyl 
TES triethylsilyl 
TLC thin layer chromatography 
THF tetrahydrofuran 
TMS trimethylsilyl 




CRYSTAL STRUCTURE DATA 
APPENDIX 1: CRYSTAL STRUCTURE DATA OF ISOQUINOLONE 235 
Figure 30: Crystal structure of iso quinolone 235 
PART A Crystal data 
Empirical formula C25H27NO2S 
Formula weight 405.56 
Wavelength 0.71073 A 
Temperature 150 K 
Crystal system Orthorhombic 
Space group P21 21 21 
Unit cell dimensions a = 9.3591(14) A alpha = 90 deg 
b = 10.6265(16) A beta = 90 deg. 
c = 21.344(3) A gamma = 90 deg. 
Volume 2122.7(5)A 3  
Number of reflections for cell 6188 (2 <0 <29 deg.) 
Z 4 
Density (calculated) 1.269 Mg/m3  




PART B Data collection 
Crystal description colourless block 
Crystal size 0.63 x 0.54 x 0.25 mm 
Theta range for data collection 1.908 to 28.824 deg. 
Index ranges -12<=h<=12, 14<=k<=14, -27<=l<=28 
Reflections collected 18994 
Independent reflections 5181 [R(int) = 0.03] 
Scan type \w 
Absorption correction Semi-empirical from equivalents 
(Trnin 	0.826, Tmax l .000) 
PART C Solution and refinement 
Solution Patterson (DIRDIF) 
Refinement type Full-matrix least-squares on F2 
Program used for refinement CRYSTALS 
Hydrogen atom placement Geom 
Hydrogen atom treatment Noref 
Data 5180 
Parameters 263 
Goodness-of-fit on F2 1.0267 
R 0.0435 
Rw 0.1120 
Absolute structure parameter -0.02(7) 
Final maximum delta/sigma 0.000281 
Weighting scheme Sheidrick Weights 
Largest diff. peak and hole 0.77 and -0.44 e.A 3  
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Table 12: Atomic coordinates (x 1O) and equivalent isotropic displacement 
parameters (A2  x 10) for 235. U(eq) is defined as one third of the trace of the 
orthogonalized UiJ tensor 
x y z U(eq) 
S(1) 718(1) 417(1) 1816(1) 22 
0(1) 1141(2) 1227(1) 2322(1) 29 
0(2) -703(2) -91(1) 1848(1) 31 
N(2) 1825(2) -788(1) 1753(1) 20 
C(3) 1472(2) -1929(2) 2125(1) 19 
C(4) 2236(2) -3043(2) 1809(1) 19 
C(5) 3820(2) -2768(2) 1747(1) 21 
C(6) 4804(2) -3753(2) 1717(1) 26 
C(7) 6257(2) -3522(2) 1670(1) 29 
C(8) 6759(2) -2293(2) 1664(1) 27 
C(9) 5801(2) -1306(2) 1695(1) 24 
C(10) 4321(2) -1533(2) 1730(1) 21 
C(11) 3346(2) -409(2) 1772(1) 23 
C(12) 1520(2) -3391(2) 1189(1) 20 
C(13) 2101(2) -3081(2) 609(1) 28 
C(14) 1371(3) -3362(2) 58(1) 34 
C(15) 78(3) -3979(2) 82(1) 36 
C(16) -510(2) -4305(2) 654(1) 35 
C(17) 212(2) -4008(2) 1204(1) 27 
C(18) 983(2) 1217(2) 1095(1) 22 
C(19) 1699(2) 2384(2) 1069(1) 26 
C(20) 1835(3) 2950(2) 482(1) 33 
C(21) 1336(3) 2405(2) -67(1) 37 
C(22) 653(3) 1251(2) -21(1) 34 
C(23) 448(2) 636(2) 547(1) 27 
C(31) 1865(2) -1816(2) 2819(1) 26 
C(191) 2330(3) 3086(2) 1618(1) 36 
C(211) 1528(4) 3051(3) -688(1) 59 
C(231) -369(3) -581(2) 539(1) 36 
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Table 13: Bond lengths (A)for 235 
Bond Length (A) Bond Length (A) 
S(1)-0(1) 1.4365(15) C(14)-H(141) 1.000 
S(1)-0(2) 1.4371(15) C(15)-C(16) 1.383(3) 
S(1)-N(2) 1.6524(15) C(1 5)-H(1 51) 1.000 
S(1)-C(1 8) 1.7760(19) C(1 6)-C(1 7) 1.392(3) 
N(2)-C(3) 1.487(2) C(1 6)-H(1 61) 1.000 
N(2)-C(1 1) 1.480(2) C(1 7)-H(1 71) 1.000 
C(3)-C(4) 1.538(2) C(1 8)-C(1 9) 1.412(3) 
C(3)-C(3 1) 1.531(3) C(18)-C(23) 1.413(3) 
C(3)-H(31) 1.000 C(19)-C(20) 1.396(3) 
C(4)-C(5) 1.517(2) C(19)-C(191) 1.508(3) 
C(4)-C(12) 1.528(2) C(20)-C(21) 1.387(3) 
C(4)-H(41) 1.000 C(20)-H(201) 1.000 
C(5)-C(6) 1.396(3) C(2 I)-C(22) 1.386(3) 
C(5)-C(10) 1.395(2) C(21)-C(21 1) 1.505(3) 
C(6)-C(7) 1.386(3) C(22)-C(23) 1.391(3) 
C(6)-H(61) 1.000 C(22)-H(221) 1.000 
C(7)-C(8) 1.388(3) C(23)-C(23 1) 1.503(3) 
C(7)-H(71) 1.000 C(3 I)-H(31 1) 1.000 
C(8)-C(9) 1.382(3) C(3 I)-H(312) 1.000 
C(8)-H(8 1) 1.000 C(3 I)-H(313) 1.000 
C(9)-C(10) 1.408(3) C(191)-H(191 1) 1.000 
C(9)-H(91) 1.000 C(191)-H(1912) 1.000 
C(10)-C(11) 1.505(3) C(191)-H(1913) 1.000 
C(11)-H(111) 1.000 C(211)H(2111) 1.000 
C(11)-H(112) 1.000 C(211)-H(2112) 1.000 
C(12)-C(13) 1.392(3) C(21 I)-H(2113) 1.000 
C(12)-C(17) 1.389(3) C(23I)-H(231 1) 1.000 
C(13)-C(14) 1.393(3) C(231)-H(2312) 1.000 
C(13)-H(13 1) 1.000 C(23 I)-H(2313) 1.000 
C(14)-C(15) 1.378(4)  
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0(1)-S(1)-0(2) 116.41(9) C(10)-C(9)-H(91) 119.659 
0(1)-S(1)-N(2) 110.70(8) C(5)-C(1 0)-C(9) 119.59(16) 
0(2)-S(1)-N(2) 107.04(8) C(5)-C(10)-C(1 1) 122.75(16) 
O(1)-S(1)-C(18) 109.07(9) C(9)-C(10)-C(1 1) 117.62(16) 
0(2)-S(1)-C(1 8) 110.44(9) N(2)-C(1 1)-C(1 0) 111.47(15) 
N(2)-S(1)-C(1 8) 102.23(8) N(2)-C(1 1)-H(1 11) 108.967 
S(1)-N(2)-C(3) 116.68(12) C(10)-C(1 1)-H(1 11) 108.963 
S(1)-N(2)-C(1 1) 112.96(12) N(2)-C(1 1)-H(1 12) 108.975 
C(3)-N(2)-C(1 1) 114.86(14) C(10)-C(1 1)-H(1 12) 108.966 
N(2)-C(3)-C(4) 106.89(14) H(1 1 1)-C(1 1)-H(1 12) 109.476 
N(2)-C(3)-C(3 1) 113.57(15) C(4)-C(12)-C(13) 122.73(17) 
C(4)-C(3)-C(3 1) 111.89(16) C(4)-C(12)-C(1 7) 118.77(17) 
N(2)-C(3)-H(3 1) 109.348 C(13)-C(12)-C(17) 118.47(18) 
C(4)-C(3)-H(31) 111.136 C(12)-C(13)-C(14) 120.6(2) 
C(3 1)-C(3)-H(3 1) 104.057 C(12)-C(13)-H(13 1) 119.714 
C(3)-C(4)-C(5) 110.13(14) C(14)-C(13)-H(131) 119.719 
C(3)-C(4)-C(12) 111.21(14) C(13)-C(14)-C(15) 120.1(2) 
C(5)-C(4)-C(12) 113.55(16) C(13)-C(14)-H(141) 119.929 
C(3)-C(4)-H(41) 109.334 C(15)-C(14)-H(141) 119.933 
C(5)-C(4)-H(41) 106.769 C(14)-C(15)-C(16) 120.1(2) 
C(12)-C(4)-H(41) 105.591 C(14)-C(15)-H(151) 119.971 
C(4)-C(5)-C(6) 120.31(17) C(16)-C(15)-H(1 51) 119.941 
C(4)-C(5)-C(10) 120.83(16) C(15)-C(16)-C(1 7) 119.6(2) 
C(6)-C(5)-C(10) 118.85(17) C(15)-C(16)-H(161) 120.189 
C(5)-C(6)-C(7) 121.24(19) C(17)-C(16)-H(161) 120.172 
C(5)-C(6)-H(61) 119.392 C(12)-C(17)-C(16) 121.1(2) 
C(7)-C(6)-H(61) 119.369 C(12)-C(17)-H(171) 119.473 
C(6)-C(7)-C(8) 119.95(18) C(16)-C(17)-H(171) 119.447 
C(6)-C(7)-H(71) 120.006 S(1)-C(1 8)-C(19) 121.37(15) 
C(8)-C(7)-H(71) 120.049 S(1)-C(1 8)-C(23) 117.31(15) 
C(7)-C(8)-C(9) 119.66(18) C(19)-C(18)-C(23) 121.32(18) 
C(7)-C(8)-H(8 1) 120.16 C(18)-C(19)-C(20) 117.17(19) 
C(9)-C(8)-H(81) 120.185 C(1 8)-C(19)-C(191) 126.18(19) 
C(8)-C(9)-C(1 0) 120.70(18) C(20)-C(19)-C(191) 116.65(19) 








C(19)-C(20)-H(201) 118.408 H(1912)-C(191)-H(1913) 109.489 
C(21)-C(20)-H(201) 118.406 C(21)-C(21 1)-H(21 11) 109.464 
C(20)-C(21)-C(22) 117.8(2) C(19)-C(191)-H(1 912) 109.474 
C(20)-C(21)-C(21 1) 120.9(2) C(21)-C(21 I)-H(2112) 109.461 
C(3)-C(3 I)-H(312) 109.464 H(21 1 1)-C(21 I)-H(2112) 109.478 
H(31 1)-C(3 I)-H(312) 109.481 C(21)-C(21 I)-H(2113) 109.46 
C(3)-C(31)-H(313) 109.468 H(2111)-C(211)-H(2113) 109.491 
H(31 1)-C(3 I)-H(313) 109.474 H(2112)-C(21 I)-H(2113 109.472 
H(312)-C(3 I)-H(313) 109.477 C(23)-C(23 I)-H(231 1) 109.467 
C(1 9)-C(1 91 )-H(1 911) 109.457 C(23)-C(23 I)-H(2312) 109.466 
C(19)-C(191)-H(1912) 109.474 H(231 1)-C(23 I)-H(2312) 109.472 
H(1911)-C(191)-H(1912) 109.481 C(23)-C(231)-H(2313) 109.47 
C(19)-C(191)-H(1913) 109.465 H(2311)-C(231)-H(2313) 109.477 
H(1911)-C(191)-H(1913) 109.46 H(2312)-C(231)-H(2313) 109.475 
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Symmetry transformations used to generate equivalent atoms: 
Ull U22 U33 U23 U13 U12 
S(1) 19(1) 20(1) 26(1) -1(1) 4(1) 2(1) 
0(1) 33(1) 25(1) 28(1) -4(1) 4(1) 5(1) 
0(2) 19(1) 28(1) 45(1) 1(1) 6(1) 1(1) 
N(2) 16(1) 18(1) 25(1) 2(1) 2(1) 0(1) 
 19(1) 18(1) 21(1) 2(1) 4(1) -3(1) 
 17(1) 18(1) 21(1) 0(1) -2(1) -1(1) 
C(S) 17(1) 23(1) 22(1) 1(1) 1(1) 0(1) 
 23(1) 21(1) 35(1) 1(1) -3(1) 1(1) 
 22(1) 30(1) 34(1) 0(1) -3(1) 7(1) 
 16(1) 37(1) 29(1) 5(1) -1(1) 1(1) 
 19(1) 26(1) 26(1) 4(1) 0(1) -3(1) 
 18(1) 23(1) 21(1) 2(1) 1(1) 0(1) 
 18(1) 21(1) 31(1) 3(1) 4(1) -2(1) 
 18(1) 21(1) 22(1) -3(1) 0(1) 3(1) 
 23(1) 33(1) 28(1) 1(1) 3(1) 4(1) 
 36(1) 44(1) 22(1) 0(1) 4(1) 14(1) 
 35(1) 45(1) 28(1) -12(1) -8(1) 13(1) 
 24(1) 43(1) 37(1) -11(1) -6(1) -4(1) 
 24(1) 32(1) 27(1) -4(1) -1(1) -5(1) 
 21(1) 20(1) 24(1) 3(1) 0(1) 2(1) 
 26(1) 23(1) 31(1) -2(1) 1(1) 0(1) 
 36(1) 27(1) 37(1) 4(1) 3(1) -6(1) 
 46(1) 36(1) 30(1) 3(1) 4(1) 4(1) 
 41(1) 34(1) 27(1) -5(1) -6(1) 4(1) 
 25(1) 23(1) 32(1) -3(1) -6(1) 2(1) 
C(31) 30(1) 26(1) 22(1) 2(1) 2(1) -5(1) 
C(191) 44(1) 26(1) 37(1) -3(1) -5(1) -13(1) 
C(211) 93(3) 53(2) 31(1) 8(1) 10(1) -3(2) 
C(231) 37(1) 26(1) 44(1) -5(1) -14(1) -4(1) 
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Table 15: Anisotropic displacement parameters (A2 X10 ) for 235. The anisotropic 
displacement factor exponent takes the form. -2z2 [h2 a*2  Ull + ... + 2 h k a* b* 
U12] 
x  Z U(eg) 
H(31) 413 -2054 2127 23 
H(41) 2147 -3806 2080 23 
H(61) 4454 -4641 1729 32 
H(71) 6944 -4241 1640 35 
H(81) 7808 -2124 1637 33 
H(91) 6163 -420 1693 28 
H(111) 3536 44 2174 28 
H(112) 3547 165 1411 28 
H(131) 3052 -2653 588 34 
H(141) 1787 -3114 -356 41 
H(151) -436 -4192 -315 43 
H(161) -1450 -4752 671 42 
H(171) -216 -4244 1617 33 
H(201) 2316 3788 455 40 
H(221) 294 844 -413 41 
 1601 -2612 3041 32 
 2916 -1670 2860 32 
 1334 -1094 3009 32 
H(1911) 2774 3887 1467 43 
H(1912) 1558 3284 1926 43 
H(1913) 3075 2553 1823 43 
H(2111) 1103 2521 -1027 71 
H(2112) 1039 3888 -679 71 
H(2113) 2570 3175 -771 71 
H(2311) -631 -796 97 43 
H(2312) -1257 -491 795 43 
H(2313) 239 -1267 718 43 
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APPENDIX 2: CRYSTAL STRUCTURE DATA OF THIOACETATE 237 
Figure 31: Crystal structure of thioacetate 237 
PART A Crystal data 
Empirical formula C25H27N0S 
Formula weight 389.56 
Wavelength 0.71073 A 
Temperature 150 K 
Crystal system Orthorhombic 
Space group P21 21 21 
Unit cell dimensions a = 7.8897(5) A alpha = 90 deg. 
b= 14.1144(9)A beta 	9odeg. 
c = 19.2079(13) A gamma = 90 deg. 
Volume  
Number of reflections for cell 5507 (3 <0 <29 deg) 
z 4 
Density (calculated) 1.210 Mg/m3  




PART B Data collection 
Crystal description colourless tablet 
Crystal size 0.67 x 0.65 x 0.24 mm 
Theta range for data collection 1.790 to 28.844 deg. 
Index ranges -10<h<10, -18<=k<=18, 24<l<25 
Reflections collected 19372 
Independent reflections 5244 [R(int) = 0.03] 
Scan type \f& co scans 
Absorption correction Semi-empirical from equivalents 
(Tmin 	0.890, Tmax l .000) 
PART C Solution and refinement 
Solution direct (SIR-92) 
Refinement type Full-matrix least-squares on F2 
Program used for refinement CRYSTALS 
Hydrogen atom placement Geom. 
Hydrogen atom treatment Noref 
Data 5227 
Parameters 254 
Goodness-of-fit on F2 0.9825 
R 0.0433 
Rw 0.1054 
Absolute structure parameter 0.04(6) 
Final maximum delta/sigma 0.000313 
Weighting scheme Cale 
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Table 16: Atomic coordinates (x 1O) and equivalent isotropic displacement 
parameters (A2 x 1 O) for 237. U(eq) is defined as one third of the trace of the 
orthogonalized U/ tensor 
x 	 y 	 z 	 U(eq) 
 9161(3) 7469(2) 590(1) 41 
 8008(2) 6630(1) 668(1) 30 
S(3) 7813(1) 6265(1) 1552(1) 33 
C(4) 6486(2) 5206(1) 1476(1) 24 
C(5) 4675(2) 5392(1) 1745(1) 24 
N(6) 3725(2) 4491(1) 1728(1) 21 
 2260(2) 4487(1) 2201(1) 28 
 3176(2) 4217(1) 1029(1) 26 
0(21) 7291(2) 6233(1) 179(1) 41 
C(41) 7370(2) 4397(1) 1846(1) 25 
C(42) 7669(2) 4429(1) 2558(1) 32 
C(43) 8399(3) 3666(2) 2895(1) 43 
C(44) 8855(3) 2862(2) 2528(1) 44 
C(45) 8617(3) 2836(1) 1819(1) 43 
C(46) 7878(2) 3600(1) 1476(1) 34 
C(51) 3808(3) 6207(1) 1357(1) 35 
C(71) 2757(2) 4515(1) 2961(1) 25 
C(72) 1944(2) 5128(1) 3419(1) 31 
C(73) 2390(3) 5151(1) 4117(1) 39 
C(74) 3662(3) 4567(2) 4365(1) 37 
C(75) 4464(3) 3947(1) 3917(1) 33 
C(76) 4004(2) 3913(1) 3218(1) 28 
 2870(2) 3161(1) 954(1) 25 
 3842(2) 2504(1) 1315(1) 30 
 3621(3) 1537(1) 1200(1) 36 
 2411(3) 1225(1) 733(1) 41 
 1434(3) 1870(2) 380(1) 41 
 1656(2) 2838(1) 484(1) 32 
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Table 17: Bond lengths (A)for 237 
Bond Length (A) Bond Length (A) 
C(1)-H(1 3) 1.000 C(45)-H(45 1) 1.000 
C(1 )-H(12) 1.000 C(45)-C(46) 1.392(3) 
C(1)-H(1 1) 1.000 C(46)-H(461) 1.000 
C(1)-C(2) 1.501(3) C(5 1)-H(513) 1.000 
C(2)-0(2 1) 1.232(2) C(5 I)-H(512) 1.000 
C(2)-S(3) 1.7805(18) C(5 I)-H(51 1) 1.000 
S(3)-C(4) 1.8306(16) C(71)-C(76) 1.390(2) 
C(4)-H(4 1) 1.000 C(7 I)-C(72) 1.391(2) 
C(4)-C(4 1) 1.515(2) C(72)-H(72 1) 1.000 
C(4)-C(5) 1.543(2) C(72)-C(73) 1.387(3) 
C(5)-H(51) 1.000 C(73)-H(731) 1.000 
C(5)-C(5 1) 1.532(2) C(73)-C(74) 1.383(3) 
C(5)-N(6) 1.477(2) C(74)-H(741) 1.000 
N(6)-C(8) 1.462(2) C(74)-C(75) 1.381(3) 
N(6)-C(7) 1.470(2) C(75)-H(751) 1.000 
C(7)-H(72) 1.000 C(75)-C(76) 1.392(2) 
C(7)-H(7 1) 1.000 C(76)-H(76 1) 1.000 
C(7)-C(71) 1.512(2) C(8 I)-C(86) 1.394(2) 
C(8)-H(82) 1.000 C(8 I)-C(82) 1.388(2) 
C(8)-H(8 1) 1.000 C(82)-H(82 1) 1.000 
C(8)-C(8 1) 1.517(2) C(82)-C(83) 1.394(3) 
C(41)-C(46) 1.390(2) C(83)-H(831) 1.000 
C(41 )-C(42) 1.390(2) C(83)-C(84) 1.383(3) 
C(42)-H(42 1) 1.000 C(84)-H(84 1) 1.000 
C(42)-C(43) 1.381(3) C(84)-C(85) 1.372(3) 
C(43)-H(43 1) 1.000 C(85)-H(851) 1.000 
C(43)-C(44) 1.384(3) C(85)-C(86) 1.393(3) 
C(44)-H(44 1) 1.000 C(86)-H(861) 1.000 
C(44)-C(45) 1.376(3)  
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H( 1 3)-C(1)-H(1 2) 109.475 H(8 I)-C(8)-N(6) 108.528 
H(13)-C(1)-H(1 1) 109.475 C(81)-C(8)-N(6) 113.21(13) 
H(12)-C(1)-H(1 1) 109.478 C(46)-C(41)-C(42) 118.74(16) 
H(1 3)-C(I)-C(2) 109.465 C(46)-C(4 I)-C(4) 120.17(16) 
H(1 2)-C(1)-C(2) 109.467 C(42)-C(4 1 )-C(4) 121.08(15) 
H( 11 )-C( 1 )-C(2) 109.466 H(421)-C(42)-C(43) 119.783 
0(2 1)-C(2)-S(3) 123.80(14) H(421)-C(42)-C(41) 119.781 
0(21)-C(2)-C(1) 124.07(17) C(43)-C(42)-C(41) 120.44(18) 
S(3)-C(2)-C(1) 112.13(14) H(43 1)-C(43)-C(44) 119.699 
C(4)-S(3)-C(2) 102.11(8) H(431)-C(43)-C(42) 119.695 
H(41)-C(4)-C(41) 108.232 C(44)-C(43)-C(42) 120.61(19) 
H(41)-C(4)-C(5) 105.011 H(441)-C(44)-C(45) 120.283 
C(41)-C(4)-C(5) 113.43(13) H(441)-C(44)-C(43) 120.285 
H(41)-C(4)-S(3) 110.456 C(45)-C(44)-C(43) 119.43(19) 
C(41)-C(4)-S(3) 108.31(11) H(45 I)-C(45)-C(46) 119.837 
C(5)-C(4)-S(3) 111.33(11) H(45 1)-C(45)-C(44) 119.839 
H(5 I)-C(5)-C(5 1) 103.828 C(46)-C(45)-C(44) 120.3(2) 
H(5 1)-C(5)-N(6) 107.977 H(461)-C(46)-C(41) 119.803 
C(5 1)-C(5)-N(6) 114.16(14) H(461)-C(46)-C(45) 119.804 
H(5 1)-C(5)-C(4) 110.117 C(41)-C(46)-C(45) 120.39(19) 
C(5 1)-C(5)-C(4) 112.19(14) H(513)-C(5 I)-H(512) 109.474 
N(6)-C(5)-C(4) 108.40(12) H(513)-C(5 I)-H(51 1)  109.477 
C(8)-N(6)-C(7) 109.43(13) H(512)-C(5 I)-H(51 1) 109.476 
C(8)-N(6)-C(5) 113.49(12) H(513)-C(5 1)-C(5) 109.467 
C(7)-N(6)-C(5) 112.88(13) H(512)-C(5 1)-C(5) 109.466 
H(72)-C(7)-H(71) 109.465 H(51 l )-C(5 1)-C(5) 109.467 
H(72)-C(7)-C(71) 108.561 C(76)-C(71)-C(72) 118.80(15) 
H(71)-C(7)-C(71) 108.562 C(76)-C(71 )-C(7) 120.68(14) 
H(72)-C(7)-N(6) 108.562 C(72)-C(7 I)-C(7) 120.50(16) 
H(7 1 )-C(7)-N(6) 108.564 H(721)-C(72)-C(73) 119.702 
C(71)-C(7)-N(6) 113.08(14) H(721)-C(72)-C(71) 119.701 
H(82)-C(8)-H(8 1) 109.464 C(73)-C(72)-C(71) 120.60(17) 
H(82)-C(8)-C(8 1) 108.53 H(73 1)-C(73)-C(74) 119.887 
H(8 1)-C(8)-C(8 1) 108.531 H(731)-C(73)-C(72) 119.886 








H(741)-C(74)-C(75) 120.149 C(83)-C(82)-C(8 1) 120.43(17) 
H(741)-C(74)-C(73) 120.152 11(831 )-C(83)-C(84) 119.965 
C(75)-C(74)-C(73) 119.70(17) H(831)-C(83)-C(82) 119.964 
H(75 I)-C(75)-C(76) 119.89 C(84)-C(83)-C(82) 120.07(19) 
H(751)-C(75)-C(74) 119.889 H(841)-C(84)-C(85) 120.101 
C(76)-C(75)-C(74) 120.22(18) H(841)-C(84)-C(83) 120.101 
H(761)-C(76)-C(71) 119.788 C(85)-C(84)-C(83) 119.80(18) 
H(761)-C(76)-C(75) 119.789 H(85 1)-C(85)-C(86) 119.652 
C(7 1 )-C(76)-C(75) 120.42(16) H(851)-C(85)-C(84) 119.654 
C(86)-C(8 I)-C(82) 119.00(16) C(86)-C(85)-C(84) 120.69(18) 
C(86)-C(8 1)-C(8) 119.50(16) H(861)-C(86)-C(85) 119.999 
C(82)-C(8 1)-C(8) 121.40(15) H(86 1)-C(86)-C(8 1) 
C(85)-C(86)-C(81) 
119.999 
120.00(18) H(821)-C(82)-C(83) 119.788 
H(821)-C(82)-C(81) 119.782 H(841)-C(84)-C(83) 120.101 
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Symmetry transformations used to generate equivalent atoms: 
U!! U22 U33 U23 U13 U12 
 43(1) 34(1) 44(1) 12(1) 10(1) -6(1) 
 29(1) 31(1) 32(1) 8(1) 6(1) 2(1) 
S(3) 41(1) 32(1) 28(1) 5(1) -3(1) -16(1) 
 25(1) 23(1) 23(1) 1(1) 0(1) -7(1) 
 27(1) 21(1) 23(1) -1(1) 1(1) -1(1) 
N(6) 21(1) 25(1) 18(1) -1(1) 1(1) -2(1) 
 22(1) 36(1) 25(1) -1(1) 2(1) -1(1) 
 27(1) 30(1) 20(1) 2(1) -3(1) 0(1) 
0(21) 47(1) 46(1) 30(1) 6(1) 5(1) -7(1) 
 17(1) 26(1) 31(1) 5(1) 3(1) -5(1) 
 27(1) 38(1) 32(1) 4(1) 1(1) 3(1) 
 29(1) 59(1) 42(1) 21(1) 5(1) 7(1) 
 28(1) 40(1) 65(1) 22(1) 6(1) 3(1) 
 33(1) 27(1) 69(1) -1(1) 7(1) -1(1) 
 28(1) 31(1) 44(1) -4(1) 2(1) -5(1) 
C(51) 37(1) 26(1) 41(1) 5(1) 0(1) 6(1) 
 23(1) 28(1) 23(1) -2(1) 5(1) -6(1) 
 31(1) 31(1) 32(1) -5(1) 3(1) 3(1) 
 45(1) 41(1) 31(1) -12(1) 8(1) 3(1) 
 47(1) 40(1) 23(1) -2(1) 2(1) -5(1) 
 40(1) 34(1) 25(1) 3(1) 2(1) 3(1) 
 34(1) 26(1) 24(1) -1(1) 5(1) 0(1) 
 23(1) 30(1) 20(1) -3(1) 4(1) -4(1) 
 30(1) 30(1) 29(1) -1(1) -2(1) -7(1) 
 42(1) 31(1) 36(1) 2(1) 4(1) -4(1) 
 52(1) 34(1) 38(1) -7(1) 7(1) -15(1) 
 42(1) 50(1) 30(1) -9(1) -2(1) -19(1) 
 29(1) 44(1) 25(1) -2(1) -1(1) -6(1) 
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Table 19: Anisotropic displacement parameters (A2 x 1O) for 237. The anisotropic 
displacement factor exponent takes the form. -2r2 [ h 2 a*2  U]] + ... + 2 h k a* b* 
U]2 / 
X y z U(eq) 
 9234 7650 87 49 
 8701 8013 864 49 
 10316 7303 766 49 
H(41) 6340 5026 976 29 
H(51) 4714 5616 2239 29 
 1543 5053 2097 33 
 1588 3897 2115 33 
 4072 4410 690 31 
 2098 4558 1 	920 31 
H(421) 7354 5007 2829 39 
H(431) 8599 3695 3409 52 
H(441) 9354 2305 2776 53 
H(451) 8976 2264 1548 52 
H(461) 7712 3575 960 41 
H(511) 2642 6303 1548 42 
 4484 6801 1419 42 
 3734 6049 850 42 
H(721) 1029 5557 3243 38 
H(731) 1789 5590 4443 47 
H(741) 4001 4595 4866 44 
H(751) 5378 3520 4095 39 
H(761) 4574 3453 2898 34 
H(821) 4706 2726 1659 35 
H(831) 4339 1068 1456 43 
H(841) 2248 530 652 50 
H(851) 553 1642 45 49 
H(861) 943 	1 3302 221 39 
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Figure 31: Crystal structure of thiobenzoate 256 
PART A Crystal data 
Empirical formula C25H27NO3S2 
Formula weight 453.62 
Wavelength 0.71073 A 
Temperature 150 (2) K 
Crystal system Orthorhombic 
Space group P 21 2121 
Unit cell dimensions A = 6.3431(2) A alpha = 90 deg. 
B = 15.4067(5) A beta = 90 deg. 
C = 28.3836(7) A gamma = 90 
deg. 
Volume 2285.19 (12) 
Number of reflections for cell 8956 (2.6 < 0 <23.4 deg) 
z 4 
Density (calculated) 1.318 Mg/m3  




PART B Data collection 
Crystal description colourless block 
Crystal size 0.40 x 0.40 x 0.25 mm 
Theta range for data collection 1.58 to 30.50 deg. 
Index ranges -8<h<=8, -21 <=k<=21, -30<=l<=33 
Reflections collected 66415 
Independent reflections 6883 [R(int) = 0.0565] 
Scan type Omega/phi scans 
Absorption correction Multiscans(Tmjti= 0.8429, Trnax 0.9400 
PART C Solution and refinement 
Solution Direct (SHELXS-97 (Sheldrick, 1990)) 
Refinement type Full-matrix least-squares on F2 
Program used for refinement CRYSTALS 
Hydrogen atom placement Geom. 
Hydrogen atom treatment Mixed 
Data 6883 
Parameters 289 
Goodness-of-fit on F2 1.031 
R 0.0419 
Rw 0.1029 
Absolute structure parameter 0.00(5) 
Final maximum delta/sigma 0.001 
Weighting scheme Sheidrick Weights 
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Table 20: Atomic coordinates (x 1O) and equivalent isotropic displacement 
parameters (A2 x 10) for 256 U(eq) is defined as one third of the trace of the 
orthogonalized UIj tensor 
x y z U(eq) 
 11362(3) 7787(1) 8582(1) 24(1) 
 13237(3) 7291(1) 8578(1) 25(1) 
C(21) 14195(3) 6877(1) 9102(1) 32(1) 
 14308(3) 7195(1) 8063(1) 29(1) 
 13602(4) 7574(1) 7561(1) 34(1) 
C(41) 14876(4) 7481(2) 7015(1) 46(1) 
 11750(3) 8045(1) 7578(1) 32(1) 
 10596(3) 8171(1) 8076(1) 27(1) 
C(61) 8636(3) 8731(1) 8024(1) 37(1) 
S(7) 10097(1) 7956(1) 9256(1) 26(1) 
0(71) 8167(2) 8410(1) 9155(1) 37(1) 
0(72) 10013(2) 7149(1) 9561(1) 32(1) 
N(8) 11595(3) 8595(1) 9624(1) 26(1) 
 12025(3) 9477(1) 9413(1) 26(1) 
C(91) 14295(3) 9563(1) 9206(1) 33(1) 
 11386(3) 10153(1) 9864(1) 25(1) 
 11398(3) 11065(1) 9619(1) 27(1) 
 13095(4) 11624(1) 9663(1) 35(1) 
 13050(4) 12443(1) 9408(1) 43(1) 
 11310(4) 12703(1) 9111(1) 45(1) 
 9604(4) 12155(2) 9064(1) 51(1) 
 9640(4) 11339(1) 9317(1) 39(1) 
S(11) 13082(1) 10012(1) 10489(1) 31(1) 
0(12) 9464(3) 10473(1) 10951(1) 45(1) 
 11215(3) 10191(1) 11043(1) 30(1) 
 11953(3) 9946(1) 11628(1) 32(1) 
 10585(4) 10090(1) 12079(1) 38(1) 
 11141(4) 9840(1) 12627(1) 43(1) 
 13056(4) 9440(2) 12725(1) 45(1) 
 14417(4) 9289(2) 12281(1) 43(1) 
1 13885(4) 9547(1) 11728(1) 38(1) 
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Table 21: Bond lengths (A)for 256 









































C(6)-C(1)-C(2) 120.82(16) C(9)-C(1 0)-S(1 1) 108.24(12) 
C(6)-C(1)-S(7) 121.62(14) C(102)-C(101)-C(106) 118.40(18) 
C(2)-C(1)-S(7) 117.46(13) C(102)-C(101)-C(10) 123.47(18) 
C(3)-C(2)-C(1) 118.22(17) C(106)-C(101)-C(10) 118.08(18) 
C(3)-C(2)-C(21) 117.52(17) C(1 01)-C(1 02)-C(1 03) 121.0(2) 
C(1)-C(2)-C(21) 124.24(17) C(104)-C(103)-C(102) 119.9(2) 
C(4)-C(3)-C(2) 122.09(19) C(1 03)-C(1 04)-C(1 05) 119.8(2) 
C(5)-C(4)-C(3) 118.20(18) C(1 04)-C(1 05)-C(1 06) 120.5(2) 
C(5)-C(4)-C(4 1) 121.71(19) C(101)-C(106)-C(105) 120.4(2) 
C(3)-C(4)-C(41) 120.1(2) C(12)-S(1 1)-C(1 0) 99.91(9) 
C(4)-C(5)-C(6) 123.09(18) 0(12)-C(12)-C(13) 122.63(18) 
C(5)-C(6)-C(1) 117.57(17) 0(12)-C(12)-S(1 1) 122.54(16) 
C(5)-C(6)-C(61) 116.44(17) C(13)-C(12)-S(1 1) 114.82(15) 
C(1)-C(6)-C(61) 125.98(18) C(14)-C(13)-C(12) 117.40(19) 
0(71)-S(7)-0(72) 118.32(9) C(1 8)-C(1 3)-C(1 2) 122.76(18) 
0(71)-S(7)-N(8) 106.99(9) C(13)-C(14)-C(1 5) 120.1(2) 
0(72)-S(7)-N(8) 106.53(8) C(16)-C(15)-C(14) 120.1(2) 
0(71)-S(7)-C(I) 108.09(9) C(1 7)-C(1 6)-C(1 5) 120.3(2) 
0(72)-S(7)-C(I) 109.30(8) C(1 6)-C(1 7)-C(1 8) 120.1(2) 
N(8)-S(7)-C(1) 107.08(9) C(1 3)-C(1 8)-C(1 7) 119.7(2) 
C(9)-N(8)-S(7) 119.62(13) C(14)-C(13)-C(12) 117.40(19) 
N(8)-C(9)-C(91) 111.18(16) C(18)-C(13)-C(12) 122.76(18) 
N(8)-C(9)-C(10) 110.34(14) C(13)-C(14)-C(15) 120.1(2) 
C(91)-C(9)-C(10) 114.07(16) C(16)-C(15)-C(14) 120.1(2) 
C(101)-C(10)-C(9) 111.48(14) C(17)-C(16)-C(15) 120.3(2) 
C(101)-C(10)-S(11) 114.21(13)  
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Symmetry transformations used to generate equivalent atoms 
U!! U22 U33 U23 U13 U12 
 26(1) 23(1) 22(1) 0(1) 0(1) -4(1) 
 29(1) 24(1) 23(1) -2(1) -3(1) -2(1) 
C(21) 35(1) 34(1) 27(1) 2(1) -2(1) 8(1) 
 33(1) 27(1) 27(1) -5(1) 1(1) 2(1) 
 47(1) 31(1) 23(1) -2(1) 1(1) -7(1) 
C(41) 59(2) 51(1) 28(1) -2(1) 6(1) 4(1) 
 40(1) 32(1) 23(1) 4(1) -6(1) -7(1) 
 27(1) 26(1) 28(1) 1(1) -5(1) -6(1) 
C(61) 34(1) 41(1) 36(1) 10(1) -9(1) 2(1) 
S(7) 25(1) 26(1) 27(1) 2(1) 3(1) -1(1) 
0(71) 25(1) 45(1) 42(1) 4(1) 4(1) 6(1) 
0(72) 38(1) 28(1) 31(1) 5(1) 7(1) -4(1) 
N(8) 33(1) 23(1) 23(1) 1(1) -2(1) 3(1) 
 32(1) 26(1) 20(1) 0(1) 0(1) 0(1) 
C(91) 35(1) 31(1) 32(1) -3(1) 9(1) 1(1) 
 26(1) 27(1) 23(1) -1(1) 1(1) 2(1) 
 35(1) 24(1) 22(1) -4(1) 3(1) 3(1) 
 42(1) 32(1) 32(1) -4(1) 1(1) -3(1) 
 60(2) 31(1) 38(1) -4(1) 12(1) -8(1) 
 67(2) 29(1) 40(1) 5(1) 15(1) 6(1) 
 56(2) 47(1) 49(1) 13(1) -2(1) 18(1) 
 37(1) 38(1) 41(1) 2(1) -2(1) 3(1) 
S(11) 32(1) 38(1) 23(1) 0(1) -1(1) 1(1) 
0(12) 52(1) 54(1) 31(1) 1(1) 3(1) 25(1) 
 42(1) 23(1) 26(1) -4(1) 4(1) 4(1) 
 46(1) 24(1) 25(1) -4(1) 1(1) 0(1) 
 54(1) 32(1) 28(1) -3(1) 3(1) 5(1) 
 63(2) 39(1) 25(1) -4(1) 6(1) -2(1) 
 67(2) 42(1) 25(1) 1(1) -9(1) -10(1) 
 47(1) 45(1) 37(1) 4(1) -10(1) 1(1) 
 42(1) 42(1) 28(1) -2(1) -2(1) 0(1) 
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Table 23: Anisotropic displacement parameters (A2 x 1O)for 256. The anisotropic 
displacement factor exponent takes the form: -2r2 [ h 2 a*2  U]] + ... + 2 h k a* b* 
U]2 1 
X y Z U(eq) 
H(21A) 15574 6631 9004 48 
H(21B) 13265 6414 9240 48 
H(21 C) 14368 7316 9402 48 
H(3) 15563 6859 8054 35 
H(41A) 14557 6922 6836 69 
H(41 B) 16383 7510 7106 69 
H(41 C) 14509 7953 6752 69 
H(5) 11242 8294 7233 38 
H(61A) 8472 8922 7627 55 
H(61B) 8774 9239 8274 55 
H(61C) 7398 8393 8139 55 
 12520(40) 8375(15) 9801(10) 38(7) 
 11096 9572 9073 31 
H(91A) 14556 9141 8901 49 
H(91B) 15260 9452 9525 49 
H(91C) 14527 10151 9059 49 
H(10) 9909 10020 9985 30 
 14311 11448 9870 43 
 14230 12820 9442 51 
 11276 13260 8937 54 
 8393 12336 8857 61 
 8453 10967 9283 47 
H(14) 9262 10361 12012 46 
H(15) 10204 9943 12937 51 
H(16) 13432 9268 13101 54 
H(17) 15726 9008 12350 52 
H(18) 14837 9450 11421 45 
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APPENDIX 4: CRYSTAL STRUCTURE DATA OF THIOPROPIONATE 239 
Figure 32: Crystal structure of thiopropionate 239 
PART A Crystal data 
Empirical formula C28H33NO3S2 
Formula weight 495.71 
Wavelength 0.71073 A 
Temperature 150 (2) K 
Crystal system Orthorhombic 
Space group P 21 21 21 
Unit cell dimensions A = 6.5383(2)  A alpha = 90 deg. 
B = 17.7883(5) A beta = 90 deg. 
C = 21.7315(5) A gamma = 90 deg. 
Volume 2527.49 A3  
Number of reflections for cell 5096 (2.0 < 0 <28.0 deg) 
z 4 
Density (calculated) 1.303 Mg/m3  
Absorption coefficient 0.241 mm 1  
F(000) 1056 
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PART B Data collection 
Crystal description colourless block 
Crystal size 0.46 x 0.25 x 0.15 mm 
Theta range for data collection 1.874 to 29.907 deg. 
Index ranges -8<=h<=7, -1 5<=k<24, 29<=l<=29 
Reflections collected 24671 
Independent reflections 6532 [R(int) = 0.032] 
Scan type Omega scans 
Absorption correction Semi-empirical from equivalents 
(Tm in 	0.75, Tmax0.96) 
PART C Solution and refinement 
Solution Direct (S1R92 (Altomare et al., 1994)) 
Refinement type Full-matrix least-squares on F2 
Program used for refinement CRYSTALS 
Hydrogen atom placement Geom. 
Hydrogen atom treatment Noref 
Data 6532 
Parameters 308 
Goodness-of-fit on F2 0.7824 
R 0.0431 
Rw 0.0979 
Absolute structure parameter -0.01(6) 
Final maximum delta/sigma 0.001 
Weighting scheme Sheldrick Weights 
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Table 24: Atomic coordinates (x 1O) and equivalent isotropic displacement 
parameters (A2 x 103   for 239. U(eq) is defined as one third of the trace of the 
orthogonalized Ui! tensor 
X  Z U(eg) 
S(1) 4134(1) -823(1) 4359(1) 24 
N(2) 5574(3) -106(1) 4170(1) 23 
C(3) 6164(3) -49(1) 3516(1) 23 
C(4) 4821(3) 495(1) 3138(1) 23 
C(5) 4787(3) 266(1) 2462(1) 24 
C(6) 3200(4) -185(1) 2262(1) 31 
C(7) 3108(4) -446(2) 1662(1) 40 
C(8) 4652(5) -255(2) 1254(1) 45 
C(9) 6243(5) 192(1) 1446(1) 41 
C(10) 6313(4) 456(1) 2046(1) 31 
S(11) 5607(1) 1473(1) 3245(1) 26 
C(12) 3213(4) 1937(1) 3139(1) 28 
C(13) 3381(4) 2783(1) 3205(1) 38 
C(14) 1800(5) 3209(2) 2836(1) 44 
0(15) 1632(3) 1609(1) 3036(1) 37 
C(16) 8447(4) 68(2) 3439(1) 40 
C(17) 6196(3) 431(1) 4638(1) 31 
C(18) 4565(3) 954(1) 4885(1) 25 
C(19) 4992(4) 1364(1) 5415(1) 34 
C(20) 3604(5) 1885(1) 5641(1) 40 
C(21) 1763(5) 1993(1) 5346(1) 39 
C(22) 1310(4) 1580(1) 4826(1) 33 
C(23) 2698(4) 1057(1) 4602(1) 28 
C(24) 5532(3) -1641(1) 4140(1) 22 
C(25) 7361(3) -1808(1) 4453(1) 24 
C(26) 8457(3) -2444(1) 4282(1) 27 
C(27) 7823(4) -2913(1) 3809(1) 29 
C(28) 5995(4) -2743(1) 3519(1) 28 
C(29) 4818(3) -2121(1) 3661(1) 26 
C(30) 2915(4) -2007(1) 3277(1) 34 
C(31) 9071(4) -3579(1) 3615(1) 38 
C(32) 8271(4) -1332(1) 4957(1) 30 
0(33) 3910(3) -792(1) 5011(1) 36 
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Table 25: Bond lengths (A)for 239 
Bond Length (A) Bond Length (A) 
S( 1 )-N(2) 1.6362(18) C(20)-C(2 1) 1.377(4) 
S(1)-C(24) 1.783(2) C(16)-H(163) 0.98 
S(1)-0(33) 1.4273(16) C(17)-C(18) 1.513(3) 
S(1)-0(34) 1.4338(16) C(17)-H(171) 0.99 
N(2)-C(3) 1.475(3) C(17)-H(172) 0.99 
N(2)-C(1 7) 1.456(3) C(1 8)-C(1 9) 1.390(3) 
C(3)-C(4) 1.545(3) C(18)-C(23) 1.380(3) 
C(3)-C(16) 1.516(3) C(1 9)-C(20) 1.388(4) 
C(3)-H(3) 1.000 C(20)-H(20) 0.95 
C(4)-C(5) 1.523(3) C(2 1 )-C(22) 1.380(4) 
C(4)-S(1 1) 1.828(2) C(21)-H(21) 0.95 
C(4)-H(4) 1.000 C(22)-C(23) 1.388(3) 
C(5)-C(6) 1.383(3) C(22)-H(22) 0.95 
C(5)-C( 10) 1.388(3) C(23)-H(23) 0.95 
C(6)-C(7) 1.385(3) C(24)-C(25) 1.408(3) 
C(6)-H(6) 0.95 C(24)-C(29) 1.425(3) 
C(7)-C(8) 1.386(4) C(25)-C(26) 1.390(3) 
C(7)-H(7) 0.95 C(25)-C(32) 1.507(3) 
C(8)-C(9) 1.374(4) C(26)-C(27) 1.386(3) 
C(8)-H(8) 0.95 C(26)-H(26) 0.95 
C(9)-C( 10) 1.387(3) C(27)-C(28) 1.385(3) 
C(9)-H(9) 0.95 C(27)-C(31) 1.501(3) 
C( 1 0)-H( 10) 0.95 C(28)-C(29) 1.383(3) 
S(1 1)-C(12) 1.784(2) C(28)-H(28) 0.95 
C(12)-C(13) 1.517(3) C(29)-C(30) 1.512(3) 
C(12)-0(15) 1.207(3) C(30)-H(301) 0.98 
C(13)-C(14) 1.512(4) C(30)-H(302) 0.98 
C(13)-H(13 1) 0.99 C(30)-H(303) 0.98 
C(13)-H(132) 0.99 C(3 I)-H(31 1) 0.98 
C(14)-H(141) 0.98 C(3 I)-H(312) 0.98 
C(14)-H(142) 0.98 C(3 I)-H(313) 0.98 
C(14)-H(143) 0.98 C(32)-H(32 1) 0.98 
C(1 6)-H(1 61) 0.98 C(32)-H(322) 0.98 
C(16)-H(162) 0.98 C(32)-H(323) 0.98 
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N(2)-S(1)-C(24) 105.91(9) C(10)-C(9)-H(9) 119.8 
N(2)-S(1 )-O(33) 106.21(10) C(5)-C(1 0)-C(9) 120.4(2) 
C(24)-S(1)-0(33) 110.36(10) C(5)-C(10)-H(10) 119.8 
N(2)-S(1)-0(34) 108.19(10) C(9)-C(10)-H(10) 119.8 
C(24)-S(1)-0(34) 107.56(10) C(4)-S(1 1)-C(12) 100.17(11) 
0(33)-S(1)-0(34) 117.97(10) S(1 1)-C(12)-0(15) 123.47(19) 
S(1)-N(2)-C(3) 116.46(14) C(13)-C(12)-0(15) 124.0(2) 
S(1)-N(2)-C(1 7) 119.80(14) C(12)-C(13)-C(14) 113.4(2) 
C(3)-N(2)-C(1 7) 123.74(18) C(12)-C( 13)-H(1 31) 108.5 
N(2)-C(3)-C(4) 114.01(17) C(14)-C(13)-H(13 1) 108.5 
N(2)-C(3)-C(16) 111.91(19) C(12)-C(13)-H(132) 108.5 
C(4)-C(3)-C(16) 114.48(18) C(14)-C(13)-H(132) 108.5 
N(2)-C(3)-H(3) 105.1 H(131)-C(13)-H(132) 109.5 
C(4)-C(3)-H(3) 105.1 C(13)-C(14)-H(141) 109.5 
C(1 6)-C(3)-H(3) 105.1 C(13)-C(14)-H(142) 109.5 
C(3)-C(4)-C(5) 110.68(17) H(141)-C(14)-H(142) 109.5 
C(3)-C(4)-S(1 1) 111.65(14) C(13)-C(14)-H(143) 109.5 
C(5)-C(4)-S(1 1) 112.41(14) H(141)-C(14)-H(143) 109.5 
C(3)-C(4)-H(4) 107.3 H(142)-C(14)-H(143) 109.5 
C(5)-C(4)-H(4) 107.3 C(3)-C(16)-H(161) 109.5 
S( 11 )-C(4)-H(4) 107.3 C(3)-C(1 6)-H( 162) 109.5 
C(4)-C(5)-C(6) 118.01(19) H(16 1)-C(16)-H(162) 109.5 
C(4)-C(5)-C( 10) 123.5(2) C(3)-C(16)-H(163) 109.5 
C(6)-C(5)-C(10) 118.4(2) H(161)-C(16)-H(163) 109.5 
C(5)-C(6)-C(7) 121.6(2) H(162)-C(16)-H(163) 109.5 
C(5)-C(6)-H(6) 119.2 N(2)-C(1 7)-C(1 8) 117.08(18) 
C(7)-C(6)-H(6) 119.2 N(2)-C(17)-H(171) 107.5 
C(6)-C(7)-C(8) 119.3(2) C(18)-C(17)-H(171) 107.5 
C(6)C(7)-H(7) 120.4 N(2)-C( 1 7)-H( 172) 107.5 
C(8)-C(7)-H(7) 120.4 C(18)-C(17)-H(172) 107.5 
C(7)-C(8)-C(9) 119.9(2) H(171)-C(17)-H(172) 109.5 
C(7)-C(8)-H(8) 120 C(17)-C(18)-C(19) 118.3(2) 
C(9)-C(8)-H(8) 120 C(1 7)-C(1 8)-C(23) 123.13(19) 
C(8)-C(9)-C( 10) 120.5(2) C(19)-C(18)-C(23) 118.5(2) 








C( 1 8)-C( I 9)-H( 19) 119.6 C(27)-C(28)-C(29) 123.6(2) 
C(20)-C(19)-H(19) 119.6 C(27)-C(28)-H(28) 118.2 
C( 1 9)-C(20)-C(2 1) 120.0(2) C(29)-C(28)-H(28) 118.2 
C(19)-C(20)-H(20) 120 C(24)-C(29)-C(28) 117.4(2) 
C(2 I)-C(20)-H(20) 120 C(24)-C(29)-C(30) 126.4(2) 
C(20)-C(21)-C(22) 119.7(2) C(28)-C(29)-C(30) 116.2(2) 
C(20)-C(2 I)-H(2 1) 120.2 C(29)-C(30)-H(301) 109.5 
C(22)-C(2 I)-H(2 1) 120.2 C(29)-C(30)-H(302) 109.5 
C(2 I)-C(22)-C(23) 120.2(2) H(301)-C(30)-H(302) 109.5 
C(21)-C(22)-H(22) 119.9 C(29)-C(30)-H(303) 109.5 
C(22)-C(23)C( 18) 120.7(2) H(301)-C(30)-H(303) 109.5 
C(22)-C(23)-H(23) 119.6 H(302)-C(30)-H(303) 109.5 
C(1 8)-C(23)-H(23) 119.6 C(27)C(3 I)-H(31 1) 109.5 
S(1)-C(24)-C(25) 118.61(16) C(27)-C(3 I)-H(312) 109.5 
S(1)-C(24)-C(29) 121.03(16) H(31 1)-C(3 I)-H(312) 109.5 
C(25)-C(24)-C(29) 120.36(19) C(27)-C(3 I)-H(313)  109.5 
C(24)-C(25)-C(26) 118.7(2) H(31 1)-C(3 I)-H(313)  109.5 
C(24)-C(25)-C(32) 124.6(2) H(312)-C(3 I)-H(313)  109.5 
C(26)-C(25)-C(32) 116.6(2) C(25)-C(32)-H(321) 109.5 
C(25)-C(26)-C(27) 122.3(2) C(25)-C(32)-H(322) 109.5 
C(25)-C(26)-H(26) 118.9 H(321)-C(32)-H(322) 109.5 
C(27)-C(26)-H(26) 118.9 C(25)-C(32)-H(323) 109.5 
C(26)-C(27)-C(28) 117.7(2) H(321)-C(32)-H(323) 109.5 
C(26)-C(27)-C(3 1) 121.4(2) H(322)-C(32)-H(323) 109.5 
C(28)-C(27)-C(3 1) 120.9(2)  
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Symmetry transformations used to generate equivalent atoms 
U!! U22 U33 U23 U13 U12 
S(1) 21(1) 24(1) 25(1) 2(1) 3(1) 2(1) 
N(2) 25(1) 22(1) 22(1) 0(1) 2(1) 0(1) 
 21(1) 24(1) 25(1) 3(1) 4(1) 5(1) 
 24(1) 19(1) 26(1) 2(1) 2(1) -1(1) 
 30(1) 17(1) 24(1) 3(1) -1(1) 4(1) 
 33(1) 28(1) 31(1) 1(1) 2(1) 0(1) 
 51(2) 31(1) 37(1) -7(1) -10(1) -4(1) 
 75(2) 34(1) 26(1) -5(1) 1(1) -1(2) 
 65(2) 27(1) 31(1) 2(1) 15(1) -3(1) 
 40(1) 23(1) 29(1) 2(1) 7(1) -4(1) 
S(11) 25(1) 22(1) 29(1) 0(1) -2(1) -1(1) 
 31(1) 29(1) 25(1) -1(1) 0(1) 7(1) 
 45(1) 25(1) 45(2) -5(1) 0(1) 5(1) 
 65(2) 30(1) 38(1) 1(1) 3(1) 14(1) 
0(15) 31(1) 31(1) 49(1) 4(1) -7(1) 2(1) 
 22(1) 53(2) 43(2) 17(1) 4(1) 10(1) 
 31(1) 32(1) 30(1) -3(1) -11(1) -1(1) 
 34(1) 19(1) 22(1) 0(1) 0(1) -2(1) 
 51(2) 26(1) 24(1) 1(1) -6(1) -7(1) 
 69(2) 27(1) 24(1) -4(1) 8(1) -7(1) 
 58(2) 24(1) 35(1) -1(1) 21(1) 0(1) 
 37(1) 25(1) 37(1) 3(1) 8(1) 4(1) 
 35(1) 24(1) 26(1) -4(1) 3(1) 0(1) 
 23(1) 22(1) 21(1) 3(1) 4(1) 0(1) 
 27(1) 25(1) 20(1) 3(1) 4(1) 1(1) 
 28(1) 30(1) 22(1) 3(1) -1(1) 4(1) 
 39(1) 24(1) 24(1) 4(1) 6(1) 3(1) 
 36(1) 26(1) 21(1) 1(1) 4(1) -2(1) 
 26(1) 29(1) 22(1) 4(1) 4(1) -7(1) 
 30(1) 36(1) 38(1) -1(1) -6(1) -4(1) 
 55(2) 29(1) 29(1) -2(1) -1(1) 14(1) 
 30(1) 33(1) 27(1) -2(1) -5(1) 6(1) 
0(33) 44(1) 34(1) 29(1) 5(1) 13(1) 9(1) 
0(34) 23(1) 35(1) 47(1) -1(1) -4(1) 2(1) 
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Table 27: Anisotropic displacement parameters (A2 x 1O) for 239. The anisotropic 
displacement factor exponent takes the form: -27r2 [ h 2 a*2  Ui] + ... + 2 h k a * b * 
U12] 
x  z U(eg) 
 5888 -558 3339 28 
 3390 449 3296 27 
H(6) 2147 -320 2543 37 
H(7) 1999 -752 1532 48 
H(8) 4610 -432 842 54 
H(9) 7302 321 1166 49 
H(10) 7412 769 2174 37 
 3210 2914 3645 46 
 4757 2940 3065 46 
 1988 3750 2898 66 
 427 3063 2972 66 
 1959 3089 2398 66 
 8778 103 3000 59 
 9184 -357 3621 59 
 8854 534 3646 59 
 6747 142 4991 37 
 7293 747 4460 37 
 6249 1285 5624 41 
 3925 2168 5998 48 
H(21) 810 2349 5500 47 
 43 1655 4620 40 
 2359 767 4249 34 
H(26) 9683 -2562 4496 32 
H(28) 5523 -3072 3205 33 
 2787 -2420 2981 52 
 1712 -1999 3546 52 
 3014 -1529 3055 52 
 8378 -3840 3276 56 
 9229 -3924 3963 56 
 10422 -3410 3477 56 
 9542 -1563 5103 45 
 7300 -1295 5299 45 
 8563 -828 4797 45 
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